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Scientific abstract 
 
Cancer is currently a leading cause of death in Australia, with recent data indicating a 
mortality rate of approximately 40,000 deaths per year. The projected cancer incidence in 
Australia for 2010 is almost 115,000 persons. Stereotactic radiotherapy is an increasingly 
common treatment modality for small lesions of the human body. 
 
However, the small radiation fields inherent to this method have characteristics which make 
their resulting dose distributions difficult to both measure and calculate. Any inaccuracy in 
dose prediction or delivery may have detrimental consequences for patients as a result of 
under-dosage of the tumour or over-irradiation of healthy tissues in the immediate periphery 
of a targeted lesion. Furthermore, despite the small fields involved, scattered and leaked 
radiation result in a radiation dose to the patient far from the primary field which, whilst 
generally much smaller than the dose received by the target, can nonetheless result in health 
complications as a consequence of the treatment. 
 
This thesis addresses the pressing need to characterise the fields used in stereotactic 
radiotherapy, to ensure accurate dose calculation and delivery, and thus the most positive 
outcome for patients. This refers to spectral, fluence and dosimetric properties in the primary 
beam and its immediate periphery (in-field), as well as in regions far from the primary field 
(out-of-field).  
 
To facilitate in-field characterisation, methodologies for three-dimensional dose verification 
using radiosensitive gel dosimeters have been developed and employed. A novel means of 
characterising the radiological properties of gel dosimeters via use of an energy-dependent 
effective atomic number is defined and used to establish the tissue-equivalence of dosimetric 
gels. Furthermore, high-resolution Monte Carlo radiation transport methods are employed to 
identify the optimum calibration method for absolute dosimetry. Gel dosimetry for 
verification of stereotactic radiotherapy treatment of intracranial lesions is demonstrated for a 
12-beam clinical treatment for a small meningioma in an anthropomorphic phantom, 
indicating good agreement with treatment planning predictions. In the context of stereotactic 
body radiotherapy, Monte Carlo methods are employed to investigate under-dosage to the 
periphery of lung tumours, providing a dataset for under-dosage estimation as a function of 
tumour size, location, beam energy and field size. Furthermore, for rigorous characterisation 
of stereotactic fields, a full Monte Carlo model of a linac-based stereotactic unit equipped 
with a mini-multileaf collimator as a tertiary collimation device was constructed. This 
  xix
dosimetrically matched model was used to generate spectral, fluence and dosimetric data for a 
systematic set of parameters and a number of trends are observed. The clinical consequences 
of spatial and field size dependent spectral variations are assessed in the context of ionisation 
chamber, radiographic film and thermoluminescent dosimetry. 
 
For investigation of the out-of-field dosimetric characteristics of stereotactic fields, two key 
studies were undertaken. The first was a systematic investigation of the variation of out-of-
field dose with a large set of parameters such as field size, depth in phantom, source-surface 
distance, collimator rotation, and so on. The second study was an investigation of out-of-field 
organ doses in an anthropomorphic phantom in the context of paediatric radiotherapy. 
Estimates for radiation-induced cancer based on typical treatments are provided. A number of 
straightforward methods for exploiting the spatial anisotropy of out-of-field dose are used to 
develop recommendations for risk minimisation. Appropriate choices for linac type, patient 
orientation and treatment type, for instance, may each reduce the out-of-field dose by at least 
half. 
 
While primarily concerned with stereotactic radiotherapy fields, the findings of this thesis are 
also applicable to other areas in radiotherapy where small fields and field segments are used. 
Intensity modulated radiotherapy is such an example. Most importantly, however, it is hoped 
that the outcomes of this thesis will help to make the treatment of patients more accurate and 
reproducible. By considering both theory and measurement, it is also hoped that building 
blocks for future work that further enhances treatment approaches have been created. 
 
 
 
  xx
 
 
 
 
 
 
 
 
 
 
EXECUTIVE SUMMARY 
 
 
 
 
  xxi
Executive summary † 
 
Cancer is one of the leading causes of deaths in Australia, with a mortality rate of 
approximately 40,000 deaths per year, contributing $3.8 billion AUD in direct health system 
costs. One advanced treatment modality for small tumours is stereotactic radiotherapy, which 
employs multiple beams of ionising radiation that spatially conform to a targeted lesion, using 
higher radiation doses in fewer fractions compared to other methods. This is increasingly 
popular because of patient convenience and an expectation of higher cure rates. 
 
This work investigates and characterises stereotactic radiotherapy fields with the objective of 
improved treatments and hence better patient outcomes. 
 
Calculation and measurement of in-field characteristics is complicated by issues such as 
electronic disequilibrium, spectral changes and detector volume averaging effects (when the 
detector is of comparable or larger size than the radiation field). In this work, 3D dosimetric 
methods based on radiosensitive gels are developed and implemented for dose measurement, 
and mathematical Monte Carlo radiation transport models are constructed and applied for 
accurate beam characterisation. 
 
Out-of-field doses (i.e. beyond the targeted region) are of interest for the potential health 
complications they may give rise to. Comparatively little attention is given to out-of-field 
doses from stereotactic fields, which this study investigates both systematically and in the 
context of paediatric radiotherapy, providing risk estimates for radiation-induced cancer. 
 
Key findings relate to the radiological properties and calibration of 3D gel dosimeters. Monte 
Carlo models reveal the spectral characteristics of stereotactic fields within and beyond the 
nominal treatment field, and these are investigated in terms of the effect on energy-dependent 
dosimeters. Investigations of out-of-field dose have revealed anisotropies in the radiation field 
far from the primary beam which may be exploited so as to minimise patient dose and 
corresponding risks. 
 
The present work has yielded 11 publications in international peer-reviewed journals, a 
further 3 publications currently under review or preparation, 19 conference papers and 7 
invited seminars.  
 
                                                 
†
 Intended for non-expert reader (<320 words). 
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Extremis malis, extrema remedia. 
Ίπποκράτης 
 
 
  2
 
CHAPTER 1 
Introduction 
 
 
CHAPTER ONE 1 
1.1 PROPOSITUM 3 
1.2 CONTEXT 3 
1.3 THE OBJECTIVE OF THIS THESIS 5 
1.4 THE SCOPE AND STRUCTURE OF THE PRESENT STUDY 7 
1.4.1 Radiotherapy with small fields 7 
1.4.2 Advanced dosimetric methods 10 
1.4.3 Theoretical dose calculation 10 
1.4.4 The in-field characterisation of stereotactic fields 11 
1.4.5 The out-of-field characterisation of stereotactic fields 12 
1.5 SCIENTIFIC PUBLICATIONS ARISING FROM THIS WORK 13 
1.5.1 Refereed publications 13 
1.5.2 Scientific papers submitted and in preparation 14 
1.5.3 Conference presentations 14 
1.5.4 Invited seminars 16 
  3
1.1 Propositum 
The aim of this thesis is to characterise the small radiation fields employed in stereotactic 
radiotherapy. This refers to spectral, fluence and dosimetric properties in the primary beam 
and its immediate periphery (in-field), as well as in regions far from the primary field (out-of-
field). Poor knowledge of in-field characteristics may lead to reduced treatment efficacy, 
whether by under-dosage of targeted tumours or over-irradiation of adjacent healthy tissues. 
Poor knowledge of out-of-field characteristics may result in adverse health consequences, 
such as radiation-induced carcinogenesis. Risk estimates of such negative outcomes are also 
provided in this work and, based on the investigations in this thesis, recommendations are 
made on improved means of dosimetry and treatment delivery.  
 
 
 
1.2 Context 
In the human body, cells grow and multiply in a regulated fashion to form tissues and organs 
which serve particular functions. Sometimes, however, abnormal behaviour is exhibited by 
cells that have incorporated a genetic mutation, whereby their normal inherent mechanism for 
cell population control fails, resulting in uncontrolled cellular proliferation. Such proliferation 
leads to formation of ‘tumours’ or ‘neoplasms’ – tissue masses that may be benign or 
malignant. The former case describes a growth that will not invade neighbouring tissues nor 
metastasise (spread to other parts of the body). Malignant forms are known as cancers – a 
name that encompasses a group of several hundred diseases, individually differentiated 
according to the type of cell and anatomic location from which it originated. 
  
Cancer is currently a leading cause of death in Australia, with recent data indicating a 
mortality rate of approximately 40,000 deaths per year. The projected cancer incidence in 
Australia for 2010 is almost 115,000 persons (AIHW 2008). Due mostly to premature death, 
cancer is the leading cause of the burden of disease and injury in Australia (19 % of the total 
loss of ‘healthy life’) (Begg et al. 2007). Furthermore, cancer contributes approximately $3.8 
billion (AUD) in direct health systems costs. 
 
There are a number of modalities for the treatment of cancer (and benign lesions), including 
radiation therapy (radiotherapy). The objective of radiotherapy is to deliver a lethal dose of 
radiation to a tumour, whilst minimising damage to surrounding healthy tissues. To facilitate 
this, it is necessary to spatially restrict the high dose to a volume of tissue that incorporates 
only the tumour, and a small margin to ensure elimination of microscopic tumour extensions 
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and account for any error in setup. Controlling tumours with use of ionising radiation is a 
probabilistic process, in as far as delivering a given dose to a given tumour results in a 
probability that all cancerous cells are killed. The greater the dose delivered, the lower the 
probability of cancer cell survival, but the greater the likelihood of complications to 
surrounding regions of healthy tissue.  
 
For the treatment of small lesions, stereotactic radiotherapy is often employed. It is 
appropriate to preface this discussion with a (lexical) definition of stereotactic radiotherapy, 
since it is not uncommon for the frequent and often unchecked usage of a term and 
unawareness of its etymology to result in obscuration of its meaning. In the field of medicine, 
the term stereotactic is synonymous with stereotaxic, which the Oxford English Dictionary 
defines as ‘involving or designed for the accurate three-dimensional positioning and 
movement of objects inside the brain’. A constituent of many scientific and technical terms, 
the prefix stereo- (or stere- before a noun) originates from the Greek στερεóς (stereos), 
meaning solid and three-dimensional. The other constituent root word, -taxis, would again 
suggest Greek origin: τάξις (taxis), meaning arrangement or order – a common suffix in 
biology when referring to the oriented movement of organisms in response to stimuli. The 
word tactic also holds this meaning, although there has been suggestion elsewhere (Sheehan 
and Pouratian 2009) that tactic in this context is the rarer definition borne of the Latin 
tangĕre, relating to touch. Radiotherapy is defined as ‘the treatment of disease (in particular 
cancer) by means of ionising radiation’. The English term is most likely based on the French 
radiothérapie, a combination of Latin (radius, in this case meaning a ray or beam) and Greek 
(θεραπία, therapia, meaning healing) terms. Historic definitions aside, a contemporary 
definition of stereotactic radiotherapy is presented here as ‘the use of beams of ionising 
radiation from multiple directions intersecting at a target (usually intracranial) spatially 
defined using a fixed three-dimensional coordinate system’ (Taylor et al. 2010b). Stereotactic 
radiosurgery may be defined similarly, with the difference that it implies a single fraction 
treatment. The term radio-surgery is something of a misnomer, since it is a non-invasive 
operation. 
 
Traditionally, stereotactic radiotherapy and radiosurgery have been applied to intracranial 
targets because of the obvious extension from invasive stereotactic procedures, the capacity to 
keep the head rigid and the relative homogeneity of the brain. Recently, targets at other 
anatomic locations have also been treated. 
 
Stereotactic radiotherapy is an increasingly common treatment modality for small lesions of 
the human body. Notably, it is a strongly patient-preference driven treatment method, with 
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many patients – when the option is made available – preferentially requesting stereotactic 
radiotherapy as an alternative to surgical procedures, the invasive nature of which is 
undesirable. However, the small radiation fields inherent to this method have characteristics 
which make their resulting dose distributions difficult to both measure and calculate. Any 
inaccuracy in dose prediction or delivery may have detrimental consequences for patients as a 
result of under-dosage of the tumour or over-irradiation of healthy tissues in the immediate 
periphery of a targeted lesion. Furthermore, despite the small fields involved, scattered and 
leaked radiation result in a radiation dose to the patient far from the primary field which, 
whilst generally much smaller than the dose received by the target, can nonetheless result in 
health complications as a consequence of the treatment. 
 
There is a pressing need to characterise the fields used in stereotactic radiotherapy, to ensure 
accurate dose calculation and delivery, and thus the most positive outcome for patients. The 
techniques and results discussed in this thesis are not restricted to stereotactic radiotherapy; 
small-field dosimetry is relevant to any number of new and emergent techniques, such as 
intensity-modulated radiotherapy, micro-beam radiotherapy, dose-painting and has extensions 
to proton/heavy-ion therapy. 
 
 
 
1.3 The objective of this thesis 
The objective of this thesis is to characterise the small fields used in stereotactic radiotherapy 
for the purpose of enabling accurate measurement and calculation of dose, both in-field and 
out-of-field. In-field characterisation refers to the determination of spectral and fluence 
information, and the dosimetric behaviour in the peripheral regions of the field. This is both 
important and complex for stereotactic fields, the small size of which means that penumbral 
regions occupy a significant portion of the field. In this work, promising methods of 
experimental dosimetry and dose calculation are implemented: gel dosimetry and Monte 
Carlo radiation transport methods. The studies described in this thesis not only involve 
application of these methods, but build on them fundamentally. In addition to the 
complexities of in-field doses are the issue of out-of-field doses – doses to distant critical 
structures of the patient that arise from scattered and leaked radiation. Epidemiological 
evidence shows that there is an increased relative risk of radiocarcinogenesis and other health 
complications that arises from exposure to relatively low radiation doses. These risks are 
particularly relevant for children and other patients with an otherwise long life expectancy. 
Such doses are not considered in the treatment optimisation process and limitations of 
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contemporary commercial planning systems do not allow accurate out-of-field dose 
calculation (nor are they designed for this). This restricts the detail of out-of-field dose 
available to clinicians. Studies presented in this thesis investigate out-of-field doses from 
linac-based stereotactic radiotherapy – which has received relatively little attention in 
published literature thus far – both in a systematic fashion (quantifying variation with 
treatment parameters) and in the context of paediatric radiotherapy. 
 
The present work attempts to address all of these issues, contextualising each discussion and 
study in thorough reviews of contemporary published literature.  
 
 
 
Figure 1.1 An overview of some of the complexities of stereotactic radiotherapy and the potential 
consequences that may arise as a result of them. 
 
 
STEREOTACTIC (BODY) RADIOTHERAPY 
Characteristics 
Small fields 
Heterogeneities 
Out-of-field dose 
Associated complexities Clinical consequences 
– CHARGED particle 
disequilibrium ∴ 
difficult dose calculation 
– DETECTOR volume 
averaging ∴ difficult 
dose measurement 
– SPECTRAL data less well 
known 
– Energy-dependent 
dosimeter response less 
well known. 
– CHARGED particle 
disequilibrium ∴ difficult 
dose calculation 
– INACCURATE output 
factors leads to 
erroneous monitor 
unit calculations 
– UNDER-DOSAGE of 
the tumour ∴ 
reduced treatment 
efficacy 
– OVER-DOSAGE of 
neighbouring tissue ∴ 
possible deterministic 
or stochastic health 
complications 
(including fatalities) 
– TYPICALLY ignored 
clinically 
– NOT incorporated into 
treatment planning ∴ hard 
to calculate clinically 
– CANCER induction 
and other health 
complications  
– PARTICULAR risk 
for paediatric 
patients 
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1.4 The scope and structure of the present study 
1.4.1 Radiotherapy with small fields 
This thesis encompasses the broad complexities of small-field radiotherapy, from pre-
treatment dose calculation, to dose delivery verification and risk assessment. Particular 
attention is given to in the potential detriment that may result from the irradiation of healthy 
tissues. The use of small fields is often considered to add a level of difficulty which, both 
anecdotal and published evidence suggests, renders clinicians less confident than when 
employing broader-beam treatments. An outline of the characteristics of stereotactic fields 
and their associated complexities is given in Figure 1.1. An overview of the content of the 
thesis is give in Figure 1.2 A concise introduction to these issues is given here, and more 
detail may be found in Chapter 2. 
 
The issue of charged particle equilibrium (CPE) is of great significance for the small fields 
employed in stereotactic radiotherapy. CPE describes the circumstance in which the energies, 
number and direction of charged particles are constant throughout the volume of interest 
(ICRU 1980). CPE is convenient because under such conditions the dose (a measurable 
quantity) is equivalent to kerma (a calculable quantity). For a 6 MV photon beam incident 
upon water, the range of resultant secondary electrons is approximately 16 mm, which is of 
the order of the lateral dimensions of a stereotactic field. For different spectra, the range may 
be much longer. As such, the nature of the resulting dose distribution is less readily calculated 
than a broad-beam dose distribution. This is especially the case for treatment planning 
systems, the dose algorithms of which frequently assume electronic equilibrium and hence 
may be of limited accuracy. This is further complicated if the targeted tumour is located in 
quite heterogeneous media, such as the lung or any other anatomy incorporating or juxtaposed 
with, for example, airways or bone. 
 
The measurement of small fields is made difficult by effects of detector volume averaging, 
which act to broaden measured penumbra. Clinically, this may lead to systematic exposure of 
larger volumes of healthy tissue in the vicinity of the targeted tumour and miscalculation of 
dose volume histograms, tumour control and normal tissue complication probabilities. Such 
issues are highlighted by a recently reported accident (KPSR 2010), in which it was found 
that 76 stereotactic patients received doses up to 50 % greater than the prescription, because 
the clinical physicist employed an unsuitable dosimeter to measure the small (< 11 mm) fields 
and hence miscalculated output factors. Errors in dose measurement and calculation can lead 
not only to over-dosage of healthy tissues, but also to tumour under-dosage. Unfortunately, 
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the latency and stochastic nature of the potentially dire outcomes means that errors are often 
not identified immediately. 
 
In addition to the aforementioned difficulties of small-field stereotactic radiotherapy and the 
associated – potentially hazardous – clinical consequences, there is the issue of out-of-field 
doses. In this thesis these are defined as doses to the patient at regions far from the primary 
field arising from leaked and scattered radiation. There is evidence that these low doses to 
untargeted structures have an associated probabilistic risk of inducing health complications 
such as secondary cancer. 
 
Background information regarding radiotherapy with small fields is presented in much greater 
detail in the following chapter (Chapter 2). The quantity ‘dose’ is defined and radiobiological 
processes and their importance are explained in the context of radiotherapy. Stereotactic 
radiotherapy is described in detail and a comprehensive literature review is provided which 
concentrates on post-irradiation toxicity so as to highlight the potential harm that may arise 
from poor prediction/delivery of dose. The complexities of small-field dosimetry from a 
calculation perspective are explained in terms of the routine assumption of electronic 
equilibrium, which breaks down for small fields. The difficulties of measurement of small-
fields are also introduced and addressed separately for different detector types. 
 
Chapter 2 provides background information regarding the physics of small radiotherapy fields 
and their clinical use. Clear from the discussion in Chapter 2 is the necessity for the 
characterisation of small fields, in order to improve the prediction and delivery of small-field 
dose distributions and thereby reduce the likelihood of potential detriment to the patient. This 
leads logically into the subsequent two chapters which deal with methods of dosimetry and 
dose calculation. 
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Figure 1.2 An overview of the content of the thesis. The study is focused on characterisation of 
stereotactic radiation fields both in and out of the primary field. A number of dose measurement and 
calculation methods are employed.  
 
 
 
 
 
KEY RESULTS 
 
Detailed knowledge of spectral and dosimetric characteristics of stereotactic radiation fields 
within the primary beam and the immediate periphery. 
 
Evaluation of intracranial and stereotactic body radiotherapy. 
 
Development of three-dimensional dosimetric methods. 
 
Correction factors for clinical estimation of lung tumour under-dosage. 
 
Detailed knowledge of doses far from the primary field and its systematic variation with 
treatment parameters. 
 
Clinical recommendations relating to treatment (particularly for paediatric patients) so as to 
minimise the risk of secondary cancer induction and other health complications. Paediatric Unit 
of Peter MacCallum Cancer Centre is planning changes to treatment protocols for paediatric 
patients based on recommendations presented. 
STEREOTACTIC RADIOTHERAPY 
In-field characterisation 
Dose calculation 
Out-of-field characterisation 
Dose measurement 
Monte Carlo Gel dosimetry 
Dose measurement 
Ionisation chamber TLD 
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1.4.2 Advanced dosimetric methods 
The measurement of small-fields is a notoriously tricky undertaking. There are a number of 
dosimeters available, each with its own limitations as applied to small-field dosimetry. In 
Chapter 3, an overview of contemporary dosimeters is given. Gel dosimeters show great 
promise, meeting many of the requirements of the ‘ideal’ dosimeter for small fields (in 
particular three-dimensionality); however, there are a number of practical difficulties 
encountered with gels. Accordingly, gel dosimeters are treated in relatively great detail. A 
comprehensive literature review is given, along with detail regarding radiochemical processes 
and readout mechanisms. Not widely used in a clinical context, the present work investigates 
some of the fundamental characteristics of gel dosimeters. 
 
The radiation interaction properties of gel dosimeters clearly differ from water and tissue 
because of the differences in their elemental composition. Many authors employ a single-
valued ‘effective atomic number’ in an attempt to characterise media and indicate the degree 
of such differences, however, this method is dated and of questionable usefulness. Novel 
results presented in Chapter 3 include a more comprehensive treatment of the effective atomic 
number concept. Presented in this chapter are calculations of energy-dependent effective 
atomic numbers of gel dosimeters, for total and partial interaction processes of photons and 
electrons, surpassing the limited and dubious single effective atomic number approximations 
typically employed. The water equivalence of gel dosimeters under calibration conditions was 
investigated using Monte Carlo radiation transport calculations. With the criterion of water 
equivalence, these studies identified the most appropriate combinations of gel type and 
published calibration methodology. 
 
 
1.4.3 Theoretical dose calculation 
The calculation of dose delivered to a patient is of critical importance to ensure the best 
possible treatment outcome. There are a range of mechanisms for the interaction of ionising 
radiation in materials, and a range of mathematical constructs to describe them – each of 
which has its own limitations and approximations.  
 
The algorithms employed by treatment planning systems typically sacrifice some level of 
accuracy during the treatment optimisation routine so as to generate efficient patient 
throughput. Chapter 4 introduces clinical dose calculation algorithms employed by 
commercial treatment planning systems, with a deliberate emphasis on the limitations of these 
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approaches. Considered to be the most accurate means of calculating dose and other relevant 
quantities, Monte Carlo radiation transport modelling is described in significant detail. The 
research projects included within this thesis primarily employ the Electron Gamma Shower 
transport code (Kawrakow 2000; Kawrakow and Rogers 2006), which is therefore discussed 
in greater detail. The process for commissioning a model of a linear accelerator is 
comprehensively described. Because each institution must commission their own model 
against measured data specific to their local machine, significant detail is given in Chapter 4 
discussing the methodology, justification of different approximations that may be employed, 
and so on. The methods described in this chapter are employed directly in studies presented in 
Chapters 5 and 6 on the characterisation of stereotactic fields. 
 
 
1.4.4 The in-field characterisation of stereotactic fields  
The limitations of various dosimeter types and commercial dose calculation algorithms 
combined with the small size of stereotactic radiotherapy fields makes the characterisation of 
small fields difficult. In particular, detector volume averaging effects and assumptions of 
electronic equilibrium limit confidence in the accuracy of dose measurement and calculation 
respectively. 
 
Chapter 5 describes in detail the use of Monte Carlo radiation transport calculations to 
investigate the characteristics of stereotactic fields from a linear accelerator. Spectral 
information is generally prohibitively difficult to measure in a clinical setting due to the high 
particle flux, so in this work spectral data is calculated using a dosimetrically-matched Monte 
Carlo model of a linac. To investigate the potential for gel dosimetry as a means of 
stereotactic field measurement, studies were carried out using polymer gels in an 
anthropomorphic head phantom exposed to clinical stereotactic radiotherapy treatments. The 
resulting dose distributions were read out with a laser optical computed tomography scanner 
and compared to film-stack measurements taken in the same head phantom, as well as the 
dose distribution calculated by the planning system. A study in the context of stereotactic 
body radiotherapy was also undertaken, investigating the extent of tumour under-dosage that 
may occur when small lung tumours are treated with stereotactic fields. Lung radiotherapy 
was chosen as a case study because of the strong recent interest in employing these 
techniques (Timmerman et al. 2009) and because the complexities of small-field dosimetry 
are compounded by the heterogeneity of tissues, which makes accurate dose calculation 
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difficult. The systematic set of results presented quantifies the extent of under-dosage to the 
tumour periphery. 
 
 
1.4.5 The out-of-field characterisation of stereotactic fields 
Despite the increasingly accurate means of dose delivery which conform the radiation beam 
to the geometry of the lesion, scattered and leaked radiation contribute a dose not just to the 
immediate periphery of the target, but to healthy tissues far from the primary field. There is 
epidemiological evidence to suggest that these doses, while low, nevertheless introduce an 
increased relative risk of radiation-induced carcinogenesis and other health problems such as 
cardiac or respiratory complications. 
 
Such doses are generally small compared to that received by the intended target, and so little 
consideration is typically given to these out-of-field doses when developing a treatment plan. 
While this thesis does not contest the notion that the curative benefits from radiotherapy 
treatments outweigh the potential risks resulting from out-of-field doses, the results presented 
nonetheless underscore the importance of maintaining an awareness of such doses. The 
increasing success of radiotherapy is resulting in longer patient lifetimes, and as such there is 
greater time in which (typically latent) radiation-induced cancers may become manifest. This 
is particularly the case for paediatric patients, who have a long expected lifetime and are 
relatively radiosensitive compared to adults. 
 
Chapter 6 provides a large review of the literature pertaining to the measurement and 
calculation of out-of-field doses. Significant detail is also provided in the description of 
radiocarcinogenesis and corresponding dose response behaviour. There is sometimes an 
impression amongst clinicians that the out-of-field doses from stereotactic fields (as opposed 
to larger fields) are likely to be small and hence less relevant. The novel studies undertaken in 
this work shine light on this misconception, and include a systematic study characterising the 
out-of-field doses from a linac-based stereotactic unit as well as a study of out-of-field doses 
from small fields as used in paediatric radiotherapy. 
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CHAPTER TWO 
 
It is necessary, with a view to the science we are investigating, that we first describe the 
questions which should first be discussed... For those who wish to get rid of perplexities it is 
first a good plan to go into them thoroughly… † 
 Άριστοτέλης (Aristotle) 
 
 
                                                 
†
 From Κεφάλαιον Β of Aristotle’s Τα Μετα Τα Φυσικά, translation due to H. Tredennick. This chapter deals with 
the complexities of stereotactic radiotherapy and poses the questions we wish to answer. 
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2.1 Overview 
This study relates to small-field stereotactic radiotherapy, with a particular interest in the 
potential detriment that may result from the irradiation of healthy tissues.  
 
When ionising radiation is incident upon human tissues, biological damage occurs as a result 
of a range of processes. In the case of radiotherapy, it is precisely the cell-killing function of 
ionising radiation that is the desired outcome. These processes are described in Section 2.2. 
When energy is deposited within human tissues, the tissue is said to have received a ‘dose’ of 
radiation. This concept and associated clinically-relevant conventions on dose specification 
are described in Section 2.3. Stereotactic radiotherapy is discussed in detail in Section 2.4, in 
the context of treatment of both intra- and extra-cranial lesions. The accurate delivery of 
small-fields for such treatments is inherently complex, because of issues such as charged 
particle equilibrium, which has a pronounced impact on small-field radiotherapy. As such, 
relevant background theory and a discussion of the difficulties of the measurement of small-
fields and their resulting dose distributions is presented in Section 2.5. 
 
This chapter provides background information regarding the physics of small radiotherapy 
fields and their clinical use, of relevance to the subsequent chapters. What is clear from the 
information presented in this chapter is a need for the characterisation of small fields, so as to 
improve their delivery and hence limit the potential detriment that may occur in the form of 
toxicity in the vicinity of the targeted region. One might ask: ‘what is meant by 
characterisation?’ There are gaps in scientific knowledge that are addressed by this study: 
– Knowledge of the spectral qualities of small fields, which receive decreased scatter from 
collimation devices and so on (compared to broad fields). 
– Knowledge of the penumbrae of small fields, which is typically difficult to determine 
because of detector limitations, and can have significant consequences in terms of patient 
outcome if inaccurate. 
– Methods of dose measurement that provide three-dimensional information without the 
limitations of other dosimeters, such as volume averaging etc. 
– Accurate means of dose calculation that remain robust even when using stereotactic fields 
of sizes approaching that of the secondary electron range in the (heterogeneous) media of 
interest. 
– Knowledge of out-of-field dose from small fields, which may lead to such long-term 
issues as radiocarcinogenesis. 
 
This chapter thus leads directly into the following two chapters, which are concerned with 
developing robust procedures for advanced media-matched three-dimensional dosimeters 
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(Chapter 3), and accurate dose calculation (Chapter 4). The issue of low-doses well beyond 
the targeted region (out-of-field doses) and the associated negative consequences shall be 
dealt with in detail in later chapters. 
 
 
2.2 The cell killing function of ionising radiation 
Photons interact with matter via a range of processes. At clinical (megavoltage) energies, the 
predominant mechanism of dose deposition in a biological medium is via interaction with 
electrons of high kinetic energy that have been liberated by initial photons from the linear 
accelerator (linac). It is these electrons that ultimately deliver a ‘dose’ to tissues. Various 
mathematical formulations exist that describe these processes. For simplicity, physicists often 
employ the Bethe-Bloch approximation that treats electron transport through media as a 
continuous, ‘slowing down’ process rather than the stochastic series of events that actually 
take place. This does not sufficiently describe the processes that eventually result in 
molecular modifications in the medium. Cell damage occurs as a result of discrete 
interactions whereby electrons lose their kinetic energy via ionisation events. There is 
scientific consensus that the cytotoxic effect of ionising radiation on cells results from 
damage to deoxyribonucleic acid (DNA) (Latarjet 1972; Hutterman et al. 1978; Teebor et al. 
1984; Errera 1985; Thacker 1986). Strands of DNA can be broken directly or indirectly, via 
interaction with free radicals. The term ‘direct action’ applies to ionisation that occurs within 
the DNA molecule. The fraction of cell-killing resulting from direct action is of the order of 
80 % for high linear energy transfer (LET) radiation, such as alpha particles or heavy ions 
(Roots et al. 1985). Indirect damage to DNA is caused by free radicals that are generated 
from the radiolysis of water – the predominant reaction in living systems for low LET 
radiation, such as x- or γ-rays. The processes of excitation and ionisation of water by radiation 
are described by the equations below (Alpen 1998): 
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Free radicals are a highly reactive chemical species. Although most free radicals formed in 
these reactions recombine to form oxygen and water in a time scale of ~ 10-5 seconds, some 
may interact with other chemical compounds and result in detrimental biological effects. Of 
the products of water radiolysis, the hydroxyl (OH*) radical (an oxidising species) is the most 
important radical in terms of damage to DNA (Cadet et al. 1999).  
 
Different tissues have differing sensitivities to ionising radiation. Over a century ago, 
Bergonié and Tribondeau studied the radiosensitivity of cells, concluding that (i) actively 
proliferating cells are the most radiosensitive, (ii) the degree of differentiation of cells is 
inversely related to their radiosensitivity and (iii) radiosensitivity of cells is proportional to 
the duration of mitotic activity they must undergo (Bergonie and Tribondeau 1906). 
Cancerous cells are thus relatively radiosensitive, compared to healthy tissues, which is 
ultimately what makes cancer amenable to treatment with radiotherapy. It is thus the objective 
of radiotherapy to destroy lesions with ionising radiation while sparing as much as possible 
the surrounding, healthy tissues. In other words, the aim is to deliver a lethal dose to the 
cancer whilst adjacent (healthy) tissues receive a sub-lethal dose. 
 
 
 
2.3 Dose 
2.3.1 A brief conceptual foundation of dose 
One may trace the origins of the concept of radiation dosimetry to the medical application of 
ionising radiation borne of the discovery of the x-ray (Röntgen 1895). Methods for prediction 
and reproduction of clinical observations are of clear necessity. The concept of ‘dose’, 
analogous to that in pharmacology, has been introduced into radiotherapy as the key quantity 
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relating to biological effects. However, ‘dose’ was initially not well defined and was 
historically thought to be akin to the energy of the incident radiation field. Christen referred to 
the dose as the energy absorbed by a unit volume (Christen 1914), and this is closer to the 
contemporary definition of absorbed dose. The key advancement was the recognition that the 
biological effect of radiation relates to the energy imparted to the tissue rather than that which 
is incident upon it. The energy imparted to the matter in a volume results from a number of 
discrete contributions from various processes occurring therein. For photon beams, with 
which this study is principally concerned, one must consider (i) attenuation of the photons via 
scattering / absorption processes, (ii) transfer of energy to charged particles, (iii) transport of 
and energy deposition by charged particles. When an x-ray interacts with matter via either the 
photoelectric, Compton or pair-production processes, charged particles are liberated and 
given momentum. These travel through the medium, undergoing a number of interactions 
until they deposit all their energy and stop. This collisional energy loss leads to the ionisation 
and excitation events that are ultimately responsible for biological damage. The ‘quantity of 
energy imparted by ionising radiation to matter in a volume of certain density’ is the 
fundamental quantity of radiation dosimetry, the determination of which logically requires 
that a volume and a time interval be specified. 
  
 
2.3.2 A brief mathematical description of dose 
A fundamental quantity in radiation dosimetry is the ‘energy imparted’, ε  (ICRU 1980). The 
energy imparted to matter in a given volume results from discrete contributions,δε , due to a 
number of radiation energy loss processes, i.e. 
 
∑=
i
iδεε . 2.1 
 
The expectation value for the energy imparted may be given by 
 
∑+−= QRR outinε , 2.2 
 
where R is the radiant energy (sum of kinetic or quantum energies of ionising particles), the 
subscripts in and out refer to radiant energy in and out of a volume of interest, and ∑Q  
corresponds to the release of rest-mass energy of nuclei (Krane 1988). 
 
The absorbed dose at a point within an infinitesimal volume, dv, of mass dm is thus given by: 
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dm
d
D
ε
= . 2.3 
 
In the context of radiotherapy, specifying the dose that a tumour should receive and reporting 
dose delivered is a fundamental necessity and is far from being a trivial activity. 
 
 
 
2.4 Stereotactic radiotherapy 
2.4.1 Overview 
Stereotactic radiotherapy is a means of delivering a highly localised dose to a small lesion. 
This method is frequently applied to intracranial lesions, and as such the following 
discussions primarily concern intracranial treatments. There are a number of methods for 
radiation delivery to intracranial lesions, including stereotactic radiotherapy (SRT), 
stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), intensity-modulated 
stereotactic radiosurgery and radiotherapy (IMSRS and IMSRT respectively), tomotherapy 
and a range of other approaches such as electron therapy, proton therapy, the use of internal 
alpha emitters and others. It is also not uncommon to implement multiple techniques, often as 
a concomitant boost.  
 
Stereotactic radiotherapy and radiosurgery are routinely employed for the treatment of 
intracranial lesions. Increasingly, extracranial tumours are being treated in a similar fashion.  
Figure 2. highlights this trend – with one paper relating to stereotactic radiotherapy published 
in the early sixties compared to over 1700 papers published in the last four years. In this 
section, the aim is to provide a broadly encompassing overview of the different aspects of 
stereotactic radiotherapy, with the objective of giving the reader an understanding of the 
complexities associated with the use of small fields in terms of dose measurement and 
calculation, as well as the clinical efficacy of stereotactic techniques. This includes a review 
of the clinical application of SRT, with a deliberate emphasis on the potential for detriment to 
the patient – so as to highlight the need for accurate radiation delivery and confident 
knowledge of the characteristics of the dose distributions resulting from such small fields. A 
notoriously difficult endeavour, the measurement of small-field dose distributions is also 
discussed. 
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A more detailed discussion of the efficacy of stereotactic radiotherapy and radiosurgery, 
highlighting the importance of accurate clinical dosimetry which is a focus of this thesis, may 
be found in a review paper by the candidate (Taylor et al. 2011d) 
 
 
 
Figure 2.1 An indication (based on a PubMed search of published literature) of the increasing 
implementation of both intra- and extra-cranial stereotactic radiotherapy. Note the logarithmic scale. 
 
 
 
 
2.4.2 Intracranial stereotactic radiotherapy (SRT) and radiosurgery (SRS): Efficacy and 
the potential for radiation-induced carcinoma and other complications 
The origins of stereotactic intracranial surgery may be traced back to work first presented at 
the 1906 meeting of the British Medical Association in Toronto. In 1908, after several years 
of use in studies of the structure and functions of the cerebellum in various animals, Horsley 
and Clarke published details of a stereotactic instrument that incorporated a frame attached to 
the skull and a three dimensional coordinate system that facilitated the precise application of 
an insulated needle for excitation or electrolysis (Horsley and Clarke 1908). Based on the 
same fundamental principles, stereotactic radiosurgery (SRS) is a single fraction radiotherapy 
modality for the treatment of intracranial lesions, employing stereotactic apparatus and 
multiple small beams delivered through non-coplanar isocentric arcs. The word 
‘radiosurgery’ is attributed to Leksell, a neurosurgeon (Leksell 1951). Initially, SRS was used 
primarily for treatment of arteriovenous malformations (AVM) (Steiner et al. 1992; 
Yamamoto et al. 1995) and other benign brain lesions (Flickinger et al. 1995). More recently, 
SRS has become increasingly applied for the treatment of malignant brain lesions, including 
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primary tumours and metastases. Stereotactic radiotherapy (SRT) refers to the same 
procedure as SRS, but involves multiple dose fractions. SRS and SRT rely on 3D localisation 
of the lesion, utilising immobilisation devices. The stereotactic apparatus is employed during 
imaging and treatment for target localisation and head immobilisation. This must be done 
with a high degree of accuracy, necessitating meticulous quality assurance (QA) processes. 
Conformity in dose is sought with use of collimated beams, optimised arc angles and multiple 
isocentres. Alternatively, it is possible to dynamically shape the field during rotation with use 
of mini- / micro- multileaf collimators.  
 
Stereotactic radiosurgery is typically delivered via either the Leksell Gamma-Knife system 
(LGK; Elekta), Cyber-Knife (Accuray) or with a conventional megavoltage (MV) linac. The 
former is a commercialised piece of equipment incorporating a modified 60Co unit with 201 
convergent beams directed through variable circular collimators (Leksell 1983). The Cyber-
Knife is a robotic mounted linac, similarly with circular collimators. SRS with a linac is 
sometimes referred to as ‘x-ray knife’ treatment. This involves the use of multiple non-
coplanar arcs of circularly or dynamically shaped fields that converge on the isocentre. A 
stereotactic frame is fixed to the patient’s head and locked onto the treatment couch. The 
target coordinates are matched to the machine isocentre with a high degree of precision. 
 
In summary, there are several key points that may be made regarding the efficacy of 
stereotactic approaches (Taylor et al. 2010b): 
– SRT results in comparable survival rates and better normal tissue sparing than 
conformal radiotherapy (Goyal et al. 2000; Le et al. 2003; Selek et al. 2004). 
– The use of linac-based stereotactic techniques (with a multileaf collimator) can be 
advantageous, in terms of dose homogeneity and normal tissue sparing (Shiu et al. 
1997; Tokuuye et al. 1998; Kulik et al. 2002; Combs et al. 2005; Aoki et al. 2006). 
– The addition of intensity modulation to stereotactic treatments results in improved 
dose conformality and improved organ-at-risk sparing (Carnidale et al. 1998; Bues et 
al. 1999; Pagnini et al. 1999; Benedict et al. 2001; Little et al. 2003). 
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The brain is known to exhibit sensitivity for acute and delayed radiation damage. Review of 
published clinical data reveals a number of key trends regarding complications following SRT 
and SRS (Taylor et al. 2010b): 
– There are a range of immediate SRT/SRS potential side-effects, affecting about one 
third of patients, though these are typically moderate and short term (Werner-Wasik 
et al. 1999).  
– Although accurate localisation reduces the likelihood, there is potential for severe late 
effects ranging from neurological impairment to death (Lee et al. 1988; Marks and 
Spencer 1991; Flickinger et al. 1995; Ianssen et al. 2004; Jensen et al. 2005; Korytko 
et al. 2006). 
– Little is known about long-term neuropsychological effects. Clinical findings show 
children exhibit cognitive decline subsequent to fractionated radiotherapy of brain 
tumours; data for adults is comparatively scarce, with preliminary finding suggesting 
some cognitive function, such as memory, may be particularly vulnerable (Roman 
and Sperduto 1995). 
– There is a risk of radiation-induced cancer (particularly meningiomas (Gomori and 
Shaked 1982)) resulting from intracranial treatments in general (Modan et al. 1974; 
Shore et al. 1976; Ron et al. 1988; Sadetzki et al. 2002); however, the likelihood of 
such tumours becoming manifest following stereotactic techniques is relatively low 
(Sheehan et al. 2006). 
– There are reported cases of radiation-induced tumours from stereotactic radiosurgery, 
the majority of which are glioblastomas (Brada et al. 1993; Yu et al. 2000; Kaido et 
al. 2001; Shamisa et al. 2001; McIver and Pollock 2004; Minniti et al. 2005). 
 
Stereotactic radiotherapy and radiosurgery may also be employed to extracranial regions. 
Generally referred to as stereotactic body radiotherapy, though the term extracranial 
stereotactic radiotherapy is often still applied, is discussed in the following section. 
 
 
 
2.4.3 Stereotactic body radiotherapy (SBRT) and the need for accurate dose delivery: 
The potential for radiation toxicity 
As mentioned earlier, stereotactic radiotherapy generally implies treatment of intracranial 
lesions. An obvious extension is to apply similar treatment techniques to small tumours at 
other anatomic locations; such treatments are often referred to as ‘extracranial stereotactic 
radiotherapy’ or ‘stereotactic body radiotherapy’ (SBRT). A review of the relevant scientific 
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literature indicates that extracranial treatments are of most interest in relation to the lung, liver 
and the spine.  
 
There are several key differences between conformal or intensity-modulated radiotherapy and 
SBRT. In the former case, doses of up to 3 Gy/fraction are typically given over 10-30 
fractions, whilst for SBRT up to 30 Gy/fraction may be given in just a few (< 5) fractions. 
Margins are also of the order of millimetres for SBRT, whereas IMRT margins are typically 
of the order of centimetres. It is important to note this latter point, since often treatment 
planning systems have a dose grid resolution of the same order of magnitude as the margins 
in the case of SBRT.  
 
One critical element of SBRT is the use of a suitable immobilisation methodology. The 
earlier forays into SBRT were facilitated by apparatus such as an extracranial stereotactic 
frame proposed by Hamilton et al for treatment of spinal lesions (Hamilton et al. 1995) and a 
body frame with vacuum bag implemented by Lax et al for treatment of lesions of the liver 
and lung (Lax et al. 1994). Ultimately, image-guidance may be considered the ideal approach, 
with applications in not only initial patient setup but also real-time monitoring of the target 
(or surrogate marker) during treatment. 
 
For lung treatments, a range of immobilisation and positioning devices have been employed: 
the Elekta Body Frame (Elekta Oncology, Stockholm) with accuracies ranging from 1.8 to 5 
mm (Wulf et al. 2000; Fukumoto et al. 2002; Nagata et al. 2002; Hof et al. 2003), the MI 
BodyFIX (Medical Intelligence, Schwabmuenchen) with accuracies ranging from 2.5 to 3 
mm (Fuss et al. 2004) and the Leibinger Body Frame (Leibinger, Freiburg) with accuracies of 
2 to 4.4 mm (Wulf et al. 2001). For liver treatments, the Elekta Body Frame has been used 
with an accuracy of ≤ 4.4 mm (Wulf et al. 2000), the MI BodyFIX has been employed with a 
reported accuracy of  ≤ 3.2 mm(Fuss et al. 2004) and the Leibinger Body Frame has been 
used for liver treatments with a reported accuracy of 1.8-4.4 mm (Herfath et al. 2001). 
Tokuuye et al found motion was significantly reduced just by making the patient lie ventrally 
on the couch and strapping the jaw and arms down (achieving an accuracy of approximately 5 
mm)(Tokuuye et al. 1997). For spinal treatments a range of approaches have been taken. 
These include use of the MI BodyFIX with approximately millimetre accuracy (Chang et al. 
2004), use of a body cast with ~3 mm accuracy (Lohr et al. 1999) and approaches using 
frameless real-time tracking of fiducial markers achieving accuracies of approximately 2 mm 
(Murphy 1997).  
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Stereotactic body radiotherapy is facilitated by such approaches to immobilisation, with 
further distinctions from other techniques in methods and importance of dose 
prescription/verification and hypofractionation. The ultimate objectives remain the same: the 
dose to the tumour volume must be maximised, whilst minimising doses to normal tissues; 
the following discussion concentrates on the clinically reported acute and delayed side-effects 
of SBRT.  
 
The reader is referred to the associated review paper by the candidate for a comprehensive 
discussion of the issues and efficacy of stereotactic body radiotherapy, focusing on the lung, 
liver, spine and pancreas (Taylor et al. 2010b). 
 
 
 
2.4.4 Concluding thoughts 
Stereotactic radio-therapy and –surgery for the treatment of tumours both intracranial and at 
other anatomical locations is widely employed because of the highly localised doses 
achievable. Furthermore, it is a highly patient-driven modality, because of its non-invasive 
nature. However, the approaches described invariably result in the irradiation of significant 
healthy tissue, despite the small fields involved. SRS (single fraction) and SRT (few 
fractions) are associated with high doses per fraction compared to other techniques and, as 
such, accurate localisation is critical. Consequences for irradiated tissue are more significant.  
 
There are many contributing factors that influence the extent of complications in a given 
treatment. The focus of the present work is that of small-field dosimetry, which – if inaccurate 
– can lead to complications for the patient. Quality assurance (QA) processes are routine in 
clinical radiotherapy departments and it would be unusual for a given QA to be performed 
incorrectly. Rather, the focus of the current paper is to address issues associated with the 
accuracy of current dose measurement and calculation methodologies as applied to 
stereotactic radiotherapy. Consider, for example, SBRT of the lung. There is a strong 
contemporary interest in motion compensation; patient fixation devices typically have 
accuracies of 2-5 mm. However, even if a tumour is guaranteed to be ‘stationary’ and modern 
treatment approaches facilitate precise delivery of planned doses – if the accuracy of the 
calculated dose is poor then this will have direct consequences for the patient. Doses to the 
periphery of lung tumours may be of the order of 10 % lower than at the centre, which is 
often not accurately predicted by treatment planning systems (Taylor et al. 2010a). It is worth 
bearing in mind that the use of multiple convergent fields is of course advantageous not only 
in the reduction of integral healthy tissue dose but also results in a reduction in peripheral 
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under-dosage. The study by Taylor et al (2010a) indicates that for circumstances where 
multiple beams or arcs are employed the aforementioned ~10 % under-dosage at the 
periphery of lung tumours drops to the order of 5 %. This is poorly predicted by conventional 
treatment planning algorithms such as pencil beam convolution, although better predicted by 
the analytical anisotropic algorithm (Haedinger et al. 2005). This was highlighted recently by 
Timmerman et al (2009), who reported on the Radiation Therapy Oncology Group 0236 
Phase II trial, whereby the prescribed 20 Gy per fraction dose (totalling 60 Gy) was found to 
be only 18 Gy per fraction (totalling 54 Gy) – an error that arose because of dose calculation 
inaccuracy. This highlights the necessity for accurate dose calculation. However, even if 
accurate dose calculation in treatment planning could be guaranteed, it is still nonetheless 
subject to the accuracy with which doses were measured during commissioning.  Dose 
calculation and dose measurement are of critical importance. 
 
This necessitates accurate knowledge of dosimetry – particularly of field edges and 
penumbra, which is difficult in the case of small fields, where the periphery occupies a large 
fraction of the field area. The complexities with dose prescription, measurement and 
calculation make understanding the dose characteristics of small fields a challenging task. 
These issues are discussed in the following sections. 
 
 
  
2.5 The difficulty of dose prescription 
One of the more complex issues in stereotactic radiotherapy is the choice of prescription point 
or volume. The system of prescribing and reporting described by the International 
Commission on Radiation Units and Measurements (ICRU) in their reports 52 and 60 is not 
commonly used for stereotactic procedures (ICRU 1993; ICRU 2000). While the concepts of 
clinical target volume (CTV), internal target volume (ITV) and planning target volume (PTV) 
are well accepted, the use of a reference point for reporting is rare. 
 
The reason for this is illustrated by Figure 2.2. If one prescribes to a location in the target 
such as the isocentre or the point of maximum dose, one would expect that no point in the 
target much less than the prescription dose; typically not more than 5 % less (ICRU 2000). In 
that case, the edge of the target would align with the 95 % isodose curve where the dose fall-
off is still relatively shallow. If one selects a lower isodose curve for prescription, the dose 
gradient is much sharper, leading to better conformality. The sacrifice in this case is reduced 
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target homogeneity – as the maximum dose will typically exceed the prescription dose by 
over 20 %. 
 
In different countries there is a different emphasis regarding the objective to be achieved 
when prescribing stereotactic radiotherapy (Hiraoka and Nagata 2004; Nagata et al. 2007; 
Timmerman et al. 2007b; Timmerman et al. 2007c; Fakiris et al. 2009; Nagata et al. 2009). In 
Japan, the emphasis is on dose homogeneity, in which case prescribing to an ICRU reference 
point is appropriate. In North America, the preferred approach is to prescribe to an isodose 
curve covering the target (or the large majority thereof). The latter method is also more 
common in intensity modulated radiotherapy (IMRT), whereby the inverse treatment 
planning process uses dose volume constraints that are more easily associated with 
prescription to isodose volumes. The Scandinavian approach in particular deliberately 
employs quite inhomogeneous dose distributions (Lax 1993; Baumann et al. 2006). 
 
Ultimately, it is quite difficult to compare the outcomes of clinical series that utilise the same 
nominal dose but employ different prescription systems. In practice, many approaches are 
possible, as illustrated in Figure 2.2. It is essential that reporting of dose delivered to targets 
in stereotactic procedures includes a clear description of the prescription rules. As many of 
the extracranial targets are also subject to motion, this must be taken into consideration when 
prescribing (ICRU 2000; Admiraal et al. 2008).  
 
 
 
Figure 2.2 A sketch of a tumour and isodose curves illustrating different concepts of dose prescription. 
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2.6 The complexities of small fields 
2.6.1 Overview 
Small, conformal fields are necessary for the treatment of small lesions. The three-
dimensional dose distributions delivered by techniques such as SRS, SRT and IMRT need to 
conform tightly to the planning target volume (PTV). This is particularly so in the case of 
SRS where the relatively high doses in a single fraction demand strict conformality. The 
historical limitations in the implementation of small fields may have included technical 
difficulties of small target localisation and the integration of diagnostic and therapeutic 
procedures, in addition to a lack of dosimetric data for small fields. Contemporary technology 
in the field of radiotherapy has overcome many of these technical limitations. However, 
despite being described as early as 1952 by Leksell, there is still concern regarding the use of 
small fields (generally below about 4 x 4 cm2) because of a lack of detailed knowledge about 
the characteristics of the radiation fields. To deliver small-field treatments with confidence, 
precise and accurate measurement of the dose profiles, percent depth-dose curves and output 
factors for small fields is necessary for input into the clinical planning software. There are 
difficulties associated with this as a result of ‘detector volume averaging’ – a smoothing of 
the penumbra resulting from the finite volume of the detector, and the lack of electronic 
equilibrium in small fields.  
 
 
2.6.2 Radiation equilibrium: A concise theoretical discussion 
2.6.2.1 Radiation equilibrium: An overview 
Calculation of absorbed dose is significantly simplified if a state of ‘radiation equilibrium’ 
exists in the region of interest. For a detailed discussion of the theory of radiation equilibrium, 
the interested reader is referred to Ch. IV of Attix (2004), Ch. II of Metcalfe et al (1997; 
2007) or Ch. I (Vol. I) of Kase et al (1987); though there are many other good references.  
 
Generally, authors define radiation equilibrium as the circumstance whereby the amount of 
radiant energy entering a certain volume is in balance with the amount leaving the volume. If 
the volume considered is infinitesimal, this may expressed mathematically via the divergence 
theorem† (for the net flux of content passing through a surface surrounding a region of space), 
i.e.  
 
0=Ψ∇ , 2.4 
 
                                                 
†
 This null case is in fact referred to as divergenceless.  
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where Ψ is the vectorial energy fluence This itself may be broken into components 
corresponding to charged (Ψc) and uncharged particles (Ψu), i.e. 
 
uc Ψ+Ψ=Ψ . 2.5 
 
In reality, the finite nature of media means that equilibrium conditions are rarely completely 
met; however, often for (one or more components of) a radiation field, a state of equilibrium 
may be met, albeit approximately, with a high degree of accuracy. In a finite homogeneous 
medium, equilibrium may exist at a given point for a particular radiation provided there is 
uniform production of such particles within all distances from the point up to the maximum 
range of the particles. An immediately apparent example would be a point within a large 
homogeneous volume consisting of a uniformly distributed radioactive source, where the 
distance from the point to the boundary of the volume is of a magnitude less than the range of 
the particles and their progeny. In the case of external photon beam radiotherapy, charged 
particle equilibrium may be approximately achieved (i.e. 0=Ψ∇ c ) at regions located beyond 
the maximum charged particle range within that medium. The International Commission of 
Radiation Units and Measurements (ICRU 1980) defines charged particle equilibrium as 
existing when “the energies, number and direction of the charged particles are constant 
throughout the volume of interest”.  
 
2.6.2.2 Full radiation equilibrium (RE) 
The absorbed dose may be defined as: 
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where the expectation value ε  is the mean of the energy imparted in an infinitesimal 
volume V, ρ is the mass density and ∑Q  corresponds to the release of rest-mass energy of 
nuclei (Krane 1988). In conditions of radiation equilibrium, this simplifies to: 
 






= ∑QdV
dD
ρ
1
. 2.7 
 
Under conditions of radiation equilibrium (RE), 0=− outin RR , thus:  
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and therefore: 
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where m is mass. What this means is that the absorbed dose is equal to the expectation value 
of the energy released by the radioactive sources (per unit mass), at a point in the medium 
where radiation equilibrium exists. 
 
 
2.6.2.3 Charged particle equilibrium (CPE) 
Where radiation equilibrium exists, so too, therefore, does ‘charged particle equilibrium’ 
(CPE), or simply ‘electronic equilibrium’ (sufficient for our purposes). Equivalently to 
radiation equilibrium, charged particle equilibrium exists for a volume if each charged 
particle of a certain type and energy exiting the volume is replaced by a particle of the same 
type and energy entering. Of particular interest is the case whereby finite homogeneous media 
are irradiated with uncharged ionising particles (such as photons from a medical linear 
accelerator). CPE is said to exist for the volume v provided the following general conditions 
on V are met (Burch 1955; Dutreix et al. 1965): 
 
- The media is homogeneous (in terms of atomic composition). 
- The media is homogeneous (in terms of mass density). 
- There exists a uniform field of (indirectly ionising) radiation, which is subject to 
negligible attenuation through the medium. 
- There are no net electric or magnetic fields that may perturb the path of charged 
particles. 
 
Although external radiation beams incident on a given body generally result in anisotropic 
radiation distributions, the anisotropy will be homogeneous throughout the volume V, and so 
CPE will be produced. The net ‘energy transferred’ in a given volume is the kinetic energy 
received by charged particles in V (not including kinetic energy transferred between charged 
particles), and may be written as: 
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( )rad
u
nonrad
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n
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where the subscript u refers to uncharged radiation, and the superscripts nonrad and rad refer 
to non-radiative and radiative losses respectively. With the condition that the volume v is 
sufficiently small to allow the escape of photons generated via radiative losses from charged 
particles, 
 
rad
u
nonrad
uoutuout
RRR += , 2.11 
 
and thus combining Equations 2.10 and 2.11 yields: 
 
n
trεε = , 2.12 
 
and therefore 
 
n
trdm
d
dm
d
εε = . 2.13 
 
Equation 2.13 is a key result, because the left hand side is the definition of absorbed dose, D 
(see Equation 2.9) and the right hand side is the definition of the ‘collision kerma’, Kc, i.e., 
 
c
CPE
KD = . 2.14 
 
This is an important relationship because it relates dose (a measurable quantity) to the 
collision kerma (a calculable quantity, proportional to the photon energy fluence). The 
parameters ntrε  and Kc do not incorporate radiative losses. If Bremsstrahlung is negligible, 
the absorbed dose is equal to the kerma, K, as shown in Roesch’s (1958) original work. 
 
Issues of CPE are of particular relevance where inhomogeneities exist. Consider two 
juxtaposed slabs of media identical in composition but differing significantly in density, 
irradiated with a photon beam. The range of secondary electrons in one medium will be 
significantly greater than that in the other. This means that in order to obtain CPE, a 
significantly larger volume (proportional to the density difference) of the low-density medium 
must be irradiated to generate an equivalent number of secondary electrons in a much smaller 
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volume of high-density medium. Since this is not always the case, there will be a discrepancy 
resulting in a difference in dose. This problem is evident in the well-known shape of a depth 
dose curve, which exhibits a ‘build-up’ region resulting from the air-water interface. The 
impact of the problem of heterogeneities as a compounding effect on the complexities of 
small fields will be discussed in greater detail in Chapter 5. 
 
 
2.6.2.4 Lateral disequilibrium 
Of particular relevance to small fields is lateral electronic equilibrium. Consider first a broad 
beam: lateral equilibrium exists along the central axis of the beam because electrons ejected 
out of the volume are replaced by a roughly equal number of electrons from neighbouring 
volumes. The edges of the fields do not receive these ‘replacement’ electrons from one side 
and as a result there is an electronic disequilibrium in these regions. Lateral disequilibrium is 
more significant for higher energy photons. The greater the energy of the incident beam, the 
greater the kinetic energy of laterally ejected electrons and hence the higher the number of 
electrons ranging outside the boundaries of the beam. Figure 2.3 illustrates the problem of 
lateral electronic disequilibrium. 
 
 
 
Figure 2.3 An illustration of lateral charged particle disequilibrium. The two inner regions irradiated 
by the photon beam exhibit charged particle equilibrium because secondary electrons leaving the 
regions are equally replaced. However, the outer regions are not in equilibrium, because there is a lack 
of replacement particles from adjacent regions. 
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As one may imagine, there is a significant problem relating to electronic disequilibrium as the 
lateral range of electrons extends beyond the radius of the field. As a result, small fields can 
be inherently difficult because, unlike broad beams, the doses within small fields are less well 
known. Furthermore, the density of the medium also influences the degree of disequilibrium. 
The range of electrons is inversely proportional to the density of the medium in which they 
travel, hence, for low density media, disequilibrium will exist even for relatively large field 
sizes. As a result, because of the densities and energies typical of radiotherapy, one must be 
cautious with fields smaller than about 4 x 4 cm2. 
 
The algorithms used to compute dose in contemporary radiotherapy treatment plans typically 
assume electronic equilibrium. This can result in the erroneous calculation of dose 
distributions, particularly in the vicinity of inhomogeneities and with small fields. This issue 
will be described in greater detail in Chapter 4 in the broad context of dose calculation. 
Treatment planning software requires measured depth-dose curves, profiles and so on, as 
input. The measurement of small fields for this purpose, and for the purpose of delivery 
verification, is inherently difficult. 
 
 
 
2.6.3 Measurement of small-field dose characteristics 
There are various challenges with the implementation of small fields for radiotherapy, with 
one significant issue being the measurement of small fields. To perform measurements of 
sufficient accuracy, the detector should be media-matched and not perturb the radiation field. 
A high degree of spatial resolution is required and, as such, a detector with a very small 
sensitive volume is required. The use of a detector of finite size leads to a detector volume 
averaging effect. In the case of very small fields, significant errors can occur if the size of the 
field approaches that of the active volume of the detector. A notable effect (which can occur 
for any field of sharp dose gradient) is broadening of the penumbrae of the dose profiles. The 
clinical consequence of this is increased field margins employed in treatments, and therefore 
systematic exposure of larger volumes of healthy tissue in the region of the targeted tumour. 
It also leads to miscalculation of dose volume histograms as well as tumour control and 
normal tissue complication probabilities. The measurement of small fields using conventional 
dosimeters and associated issues are discussed more comprehensively in the following 
chapter. 
 
The ideal dosimeter for stereotactic radiotherapy measurements would necessarily possess 
properties such that it would not be subject to volume averaging issues, as well as being 
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media-matched, so as not to perturb the radiation field. Consequently, gel dosimeters – which 
comprise both the detector and phantom material – are a very promising tool for investigation 
of small fields. In Chapter 3, methods for small-field dose measurement are discussed, with a 
focus on gel dosimetry because of its capacity for the accurate three-dimensional 
measurement of small fields.  
 
A further approach to the determination of small field dose characteristics is the use of Monte 
Carlo calculation. This explicitly models the transport of radiation, overcoming many of the 
limitations of contemporary treatment planning algorithms. There is a general scientific 
consensus that Monte Carlo dose calculation may be used as a standard by which to compare 
other calculation or measurement methods. Monte Carlo radiation transport is discussed in 
greater detail in Chapter 4.  
 
The in-field characteristics of stereotactic fields are investigated in depth in Chapter 5 , in the 
context of both intracranial and extracranial stereotactic radiotherapy, drawing on the 
methods for dose measurement and calculation described in Chapters 3 and 4  respectively. 
 
 
 
2.6.4 Issues beyond the primary field 
Despite the small field sizes involved, stereotactic radiotherapy nevertheless results in the 
delivery of radiation (and therefore dose) to regions outside of the primary field. Such doses 
are referred to as out-of-field or peripheral dose. The low-dose regimes involved require a 
different approach to dose measurement, with gel dosimeters not being suitable because of the 
high degree of sensitivity required. Doses to untargeted regions may have detrimental 
consequences for the patient, such as radiation-induced carcinogenesis. Such out-of-field 
doses are not specific to small field treatments, and hence a detailed discussion of out-of-field 
doses from stereotactic fields and the associated potential consequences for patients shall be 
left to Chapter 6. Anecdotal evidence from discussions with clinicians indicates a general 
feeling that the out-of-field doses from small-field treatments are likely to be so small that 
they can be safely ignored. This misconception is addressed later in this thesis. 
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2.7 Final comments 
There is the potential for both acute and long-term detriment in the immediate periphery of 
the targeted volume in stereotactic radiotherapy. The majority of secondary cancers form in 
the margins of the treatment volume. In the case of intracranial stereotactic radiotherapy, a 
significant number are also found in the lower-dose regions of the brain through which the 
beam passes. Conformality to the tumour volume and the dose characteristics of small fields 
are thus significant issues.  
 
Clinical dosimetry is thus critical for the efficacious delivery of intra- and extra-cranial SRT 
and SRS. There is, however, a greater uncertainty associated with clinical dosimetry for small 
fields relevant to stereotactic techniques (Alfonso et al. 2008). 
 
This is because there is a high level of complexity in the measurement and calculation of 
these fields. In the present study, three-dimensional gel dosimetry and Monte Carlo dose 
calculation (discussed in Chapters 3 and 4) are employed to overcome some such limitations 
and hence quantify these dose characteristics.  
 
 
  
  
 
 
 
 
 
 
 
CHAPTER THREE 
 
Water is the principle material of the world. † 
Θαλής ο Μιλήσιος (Thales of Miletus) 
 
 
                                                 
†
 Not a direct quote of Thales’, but a paraphrasing of an interpretation by Aristotle in his µετα τα φυσικά 
(Metaphysics). The first natural philosopher – and by extension the first physicist – Thales of Miletus, held that all 
things were ultimately composed of water (what he called the archê, or ‘cause’). An interesting scientific 
hypothesis, but somewhat inaccurate – at least radiologically – hence the desideratum of a media-matched 
dosimeter, as discussed in this chapter. 
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CHAPTER 3 
Advanced dosimetric methods 
 
Theoretical investigation of media-
matched, three-dimensional dosimeters 
for in-field measurement of 
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 3.1 Overview of chapter 
The objective of this chapter is to demonstrate the suitability of three-dimensional dosimetry 
– in particular dosimetric gels – for the characterisation of stereotactic radiotherapy fields. 
Specifically, investigations in this chapter are undertaken from a theoretical perspective and 
pertain mostly to the fundamental radiological characteristics of the dosimeters. 
 
In the present study, a number of dosimeters have been employed, including ionisation 
chambers, radiation sensitive films and thermoluminescent dosimeters. These tools are widely 
used in both experimental and clinical contexts, and a comprehensive discussion of their 
efficacy and accuracy is not the objective of this work. However, to evaluate the dose 
distributions delivered to an anthropomorphic head phantom in three dimensions, dosimetric 
gels have been employed. Gel dosimeters are more novel and far less widely implemented in 
a clinical context. As a result, an investigation of several aspects of gel dosimetry was 
conducted to support its use in this study. 
 
In this chapter, an overview of the various available methods of dose measurement has been 
provided, and gel dosimetry is discussed in comparatively greater detail. A discussion of the 
relevant radiochemical processes, accuracy and use of gels in radiotherapy is provided based 
on a review of scientific literature. 
 
To develop the usability of gels, innovative results are presented in this chapter relating 
predominantly to the water equivalence of gel dosimeters. Energy-dependent effective atomic 
numbers of gel dosimeters have been calculated here for the first time, for total and partial 
interaction processes of photons and electrons, surpassing the limited single effective atomic 
number approximations typically employed. From these works two key outcomes may be 
noted: the first being that gel dosimeters match water (radiologically) well over a broad 
energy range and, secondly, that the routinely employed method for single-valued 
parameterisation of effective atomic number is flawed. A study of the water equivalence of 
gel dosimeters under calibration conditions (where surrounding materials may affect the dose 
absorbed) has also been undertaken using Monte Carlo calculation. There has previously been 
no publication of a standard protocol for gel calibration. The novel works described in this 
thesis identify (from a range of published approaches) the optimum calibration methods in 
terms of minimisation of systematic error due to deviation from water equivalence. 
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3.2 The difficulty of measuring small-field dosimetric characteristics 
using conventional dosimeters 
3.2.1 Overview 
Contemporary treatment techniques allow for accurate, highly conformed dose distributions, 
and so any uncertainty in the delivery process may result in under / over dosage. For this 
reason, verification of dose delivery is of great importance. The principal aim of this study is 
to quantify the dose delivered to both the tumour volume and untargeted structures, which 
necessitates a discussion of the dosimetry methods available. Calorimeters and chemical 
dosimeters provide absolute dose information, but no spatial information. There are a range of 
zero- and one-dimensional dosimeters that provide accurate dose data at a single spatial 
location, and radiation-sensitive films that provide two-dimensional dose information. These 
have been well studied and are typically considered to be reliable measurement tools. 
However, the advent of techniques for delivery of very complex dose distributions means that 
the ideal dosimeter would provide three-dimensional dose information. Gel dosimeters satisfy 
this criterion; however, they are not widely implemented clinically and are the subject of 
much research. An overview of various dose measurement modalities is provided heretofore 
and, being the most promising dosimeter, gels are discussed separately and more rigorously in 
the subsequent section of this chapter. 
 
 
3.2.2 The difficulty of small-field measurement: Volume averaging 
Stereotactic radiosurgery of small tumours was proposed almost sixty years ago (Leksell 
1951), but difficulties with the implementation of small fields for radiotherapy still remain, 
with one significant issue being the measurement of small fields. To perform measurements 
of sufficient accuracy, the detector should be media-matched and not perturb the radiation 
field. A high degree of spatial resolution is required and, as such, a detector with a very small 
sensitive volume is required. 
 
The use of a detector of finite size leads to a detector volume averaging effect. In the case of 
very small fields, significant errors can occur if the size of the field approaches that of the 
active volume of the detector. A notable effect (which can occur for any field of sharp dose 
gradient) is broadening of the penumbrae of the dose profiles. The clinical consequence of 
this is systematic exposure of larger volumes of healthy tissue in the region of the targeted 
tumour. It also leads to miscalculation of dose volume histograms (DVH) as well as tumour 
control and normal tissue complication probabilities (TCP and NTCP respectively).  
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3.2.3 Available dosimeters and their potential limitations 
3.2.3.1 Ionisation chambers 
Ionisation chambers are the standard radiation dosimeter in a clinical medical physics 
department. Absolute dosimetry with ionisation chambers for small photon fields is often 
limited by the lack of electronic equilibrium in the radiation field and the size of the chamber 
cavity volume (Sibata et al. 1991; Heydarian et al. 1996). It is important that the chamber 
cross-section be smaller than the homogeneous dose regions in which it is placed (Bjarngard 
et al. 1990; Boyer 2001); chamber positioning should be known to better than 1 mm (Low et 
al. 1998b). The finite size of an ionisation chamber introduces a volume averaging effect 
which can lead to overestimation of penumbra (Rice et al. 1987; Westermark et al. 2000). 
Micro-ionisation chambers have been developed to help overcome the volume limitation. A 
study of a micro-chamber, Farmer chamber and waterproof scanning chamber showed that 
the larger the chamber, the greater the under-response at the field’s centre for small fields 
(Low et al. 2003). Calibration involves the use of broad beams, which means that this 
dosimetric data may not be directly applicable in the case of small fields. Stopping power 
ratios facilitate conversion of dose in the chamber cavity to dose in surrounding water. The 
depth dependence of water / air stopping power ratios has been studied via Monte Carlo 
simulation showing that, for a 6 MV photon spectrum, discrepancies of around 1 % may exist 
between broad and narrow fields (Andreo and Brahme 1986; Heydarian et al. 1996; 
Verhaegen et al. 1998), with greater disparity for higher energies (Sanchez-Doblado et al. 
2003). A study of a new parallel-plate micro-chamber showed that the dosimeter was under-
responsive for small fields, as verified by comparison with Monte Carlo (Francescon et al. 
1998). Martens et al showed that the PinPoint type ionisation chamber over-responds to low 
energy Compton scattered photons and is limited to fields greater than 2 cm (Martens et al. 
2000). Water-proof sleeves for ionisation chambers can result in discrepancies of up to 0.8 % 
depending on the material and beam energy (Ross and Shortt 1992). All these works 
ultimately indicate that the applicability of ionisation chambers to small field measurements 
may be limited and a combination of measurement modalities may be appropriate. 
 
 
3.2.3.2 Semiconductor dosimeters 
The use of smaller detectors may introduce other problems. For instance, semiconductor 
dosimeters such as silicon diodes and metal oxide semiconductors – field effect transistors 
(MOSFET) may be used for small field dosimetry. These have the significant advantage of 
small size and real-time readout. However, diode detectors are not without limitations. These 
include temperature dependence (Grusell and Rikner 1986) and dose rate dependence 
(Wilkins et al. 1997), between which there also exists a correlation (VanDam et al. 1990; 
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Heukelom et al. 1991). There is also a directional dependence that arises from the junction 
geometry (Bjork et al. 2000; Higgins et al. 2003). There is typically an over-response to low 
energy components of the spectrum; diodes have been shown to overestimate output factors 
by up to 7 % because of low-energy photons (Westermark et al. 2000). For this reason, 
backscatter filters are sometimes used (Grusell and Rikner 1986). Correction factors are often 
needed for the field size, focus to surface distance and phantom thickness (Heukelom et al. 
1991). MOSFET dosimetry is achieved via assessment of the radiation damage to the device; 
the consequence of this is a radiation sensitivity that changes over time and finite life. In 
general, the characteristics of diodes must be checked, as they differ even for the same type of 
diode produced by the same manufacturer (Leunens et al. 1990; Li et al. 1995; Alecu et al. 
1999). 
 
 
3.2.3.3 Thermoluminescent detectors 
Kron gives a detailed overview of the application of thermoluminescent detectors (TLD) in 
dosimetry (Kron 1994; Metcalfe et al. 1997). TLD have the advantage of small size and are 
routinely used in clinical environments (Horowitz 1984; Kron 1994). The most common 
material used to construct TLD is lithium fluoride doped with magnesium and titanium 
(LiF:Mg,Ti), or, more recently with magnesium, copper and phosphorous – resulting in 
greater sensitivity (Horowitz 1993a; Delgado et al. 1995). Sensitivity depends on composition 
and thermal history, and may vary between and even within batches. Sensitivity has been 
shown to decrease at a rate of about 1.5 % per 10 Gy of absorbed dose (Horowitz 1993a). 
Supralinearity is also an issue and must be corrected for. TLD do not appear to exhibit 
significant dose-rate dependence up to 108 Gy/s (Tochilin and Goldstein 1966). The TL signal 
does, however, vary with the radiation quality in a manner that is most significant for low 
energy photons (Metcalfe et al. 1997). The use of high Z-number dopants may lead to over-
response because of the greater interaction probability of low-energy photons. Above 1 Gy, 
the energy response changes according to the energy spectrum of photons and is not readily 
corrected for, potentially resulting in a loss of precision for high doses. Radiation attenuation 
within the TL material may also have an effect, as does the readout process and thermal 
history. Ultimately, the factors relating dose to light emission are many and complex, which 
means that TLD are often restricted to relative dosimetry. TLD precision down to ± 0.2 % is 
possible (Martenssen 1969), but typically a reproducibility of ± 2 % for a single rod is 
achievable with effort (Metcalfe et al. 1997). 
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3.2.3.4 Diamond detectors 
Being very small and suited to use in regions of high dose gradient, diamond detectors have 
been of recent interest in dosimetry. Simply, these consist of a diamond housed in a small 
cylinder with a bias applied via two gold contacts - the resistance being inversely proportional 
to the dose rate of the incident radiation. Theoretical aspects have been studied by Hoban et al 
(1994). A good overview of the advantages of diamond detectors is provided by Laub et al 
(1999). They exhibit resistance to radiation damage of 0.05 % kGy-1 (Planskoy 1980), a 
sensitivity of approximately 0.05 µC Gy-1 (Vatnitsky and Jarvinen 1993) and a stability of 
0.67 % SD (over 13 weeks) (Hoban et al. 1994). It has been shown that to obtain sufficient 
response stability, pre-irradiation of several Gy is required if the detector has not been used 
for more than one hour. An extra dose is required if the bias was left on while irradiation was 
interrupted – even for a few minutes. The most apparent problem is dose rate dependence, 
necessitating the use of correction factors (Laub et al. 1999). 
 
 
3.2.3.5 Radiosensitive film 
Films are one of the earliest applied methods of detecting x-rays and their use in a clinical 
environment is standard practice. One problem with film is the over-response to low-energy 
photons resulting from the high atomic number of the active material. There are further 
processes that may result in darkening of the film during processing that mean film is not 
readily usable for absolute dosimetry. Underexposure may occur when measuring low-energy 
photons (Muench et al. 1991; Kron et al. 1998) with radiochromic films. Broadly, 
disadvantages include energy dependence, orientation of radiochromic films, processing 
conditions, film density variation and inhomogeneities due to air pockets inside the film 
jacket (Cheng and Das 1996). The obvious limitation of film is the inability for in vivo 
measurement and the restriction of two dimensional planar dosimetry. Attempts to obtain 3D 
detail by stacking radiographic films within a phantom (Robar and Clark 2000) are simple 
methods to obtain 3D dose information, but are limited by the geometry of the positioning 
structure and the loss of tissue-equivalence.  
 
 
3.2.4 Published works dealing with the measurement of small fields using various 
dosimeters 
There are a number of published studies describing the measurement of small fields with 
various dosimeters. Garcia-Vicente et al (2005) investigated the detector size effect in 
conformal radiotherapy (CRT) and found that organs at risk (OAR) received higher doses 
when a 5.5 mm detector was used to measure profiles as compared to when a 2 mm detector 
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was used. The NTCP of the brain stem in hypophysis chordoma treatments was doubled when 
the larger detector was used. Laub and Wong (2003) investigated the effect of detector size on 
the dosimetry of small fields and steep dose gradients in the context of intensity modulated 
radiotherapy (IMRT). They found discrepancies of 10 % when comparing measurements 
taken with film to calculated profiles based on ionisation chamber measurements used in 
commissioning the IMRT tool. Discrepancies of around 6 % were found (at isocentre) when 
using a 0.6 cm3 Farmer chamber. In the same experimental arrangement, differences of about 
2 % were found when using a 0.015 cm3 pinpoint ion chamber. 
 
Dawson et al (1984) studied the penumbra of 60Co, 6 MV and 31 MV x-rays using three 
commercially available detectors (a silicon diode and two ionisation chambers) and a series of 
in-house ionisation chambers of internal diameters between 0.3 and 1.4 cm. They 
demonstrated that the width of the penumbrae increase linearly with the internal diameter of 
the ionisation chamber. True penumbrae were determined via extrapolation. Metcalfe et al 
(1993) took a similar approach, extrapolating back from measurements taken with multiple 
detectors of different sensitive volumes. They measured the penumbral width at Dmax with a 
diode, film and TLD. The sensitive widths of these measurement systems were 2.5, 2.0 and 
1.0 mm respectively and the 80-20 % penumbra was measured to be 3.6, 3.6 and 3.4 mm 
respectively. Westermark et al (2000) undertook measurements using a diamond detector, 
liquid ionisation chamber, plastic scintillator and two Si diodes. One of the diodes was a 
double-diode using two parallel opposed active volumes with compensating interface 
perturbations. The volumes of the scintillator and ionisation chamber result in a broadened 
penumbra. Deviations in output factors varied up to around 10 % amongst the detector types. 
The diamond detector matched the ionisation chamber within 1 % for field sizes ranging from 
3 x 3 cm2 to 15 x 15 cm2. 
 
Sibata et al (1991) corrected for the ionisation chamber detector size effect in beam profile 
measurements by extrapolation to zero detector size and a simple convolution method. 
Higgins et al (1995) also implemented an analytical deconvolution algorithm (similar to those 
used in radiology applications) to correct for the influence of the finite detector volume on the 
measured dose. Chang et al (1996) undertook a computational convolution approach to 
investigate the detector averaging effect. This was found to match penumbrae widths using 
the backwards extrapolation approach described earlier. Garcia-Vicente et al (1998) 
determined the spatial convolution kernel for several detectors experimentally, and later used 
an analytical solution of the integral equation for a general profile fitting function using 
Gaussian convolution kernels (Garcia-Vicente et al. 2000). Van’t Veld et al (2001) used the 
latter model and measured data to determine the detector line spread functions of an 
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ionisation chamber exposed to various energy sources. They found that, following correction, 
larger volume detectors (such as the IC15, Wellhöfer) can then be used for high resolution 
relative dosimetry. More recently, Sahoo et al (2008) employed two semi-empirical methods 
to determine true profiles by elimination of the detector volume averaging effect. The first 
method shifts the profile based on published deconvolution methods, while the second shifts 
the measured profile according to the value of an analytical function related to the second 
derivative of the real profile at a given point. 
 
Figure 3. shows a comparison of different detector types as applied to small-field 
measurements. The main figure shows the relative central axis dose factors for stereotactic 
fields as a function of field diameter (or diameter of equivalent area) for a 2mm plane-parallel 
ionisation chamber (McNiven et al. 2006), silicon electron diode (Scanditronix, Wellhofer 
Germany), Kodak EDR2 radiographic film (Kodak Inc., Rochester, NY), micro-MOSFET 
(Wollongong, Australia), Type 31006 PTW PinPoint cylindrical ionisation chamber (PTW-
Freiburg, Germany) and GafChromic Type HS Radiochromic film (ISP Corp.,Wayne, NJ). 
Measurements are in each case normalised to the standard 10 x 10 cm2 reference field. 
Beneath the main figure is a plot of the same data presented relative to the 2 mm plane-
parallel ionisation chamber. Note that for 0.5 cm fields discrepancies vary from a factor of 1.1 
up to 1.7, and with increasing field size the disparity between the different measurement 
techniques decreases. This highlights the complexity of small-field measurement. 
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Figure 3.1 The main figure shows a comparison of different detector types as applied to small field 
measurement, based on data from McNiven et al (2006). Shown are the relative central axis dose 
factors for stereotactic fields as a function of field diameter (or diameter of equivalent circle) for a 
2mm plane-parallel ionisation chamber, silicon electron diode, Kodak EDR2 radiographic film, micro-
MOSFET, Type 31006 PTW PinPoint cylindrical ionisation chamber and GafChromic Type HS 
Radiochromic film. Measurements are in each case normalised to the standard 10 x 10 cm2 reference 
field. Beneath the main figure is a sub-plot of the same data presented relative to the 2 mm plane-
parallel ionisation chamber. 
 
 
 
 
3.2.5 Concluding thoughts 
An overview has been given of a broad range of dosimeters, each suited to different 
applications, each typically yielding zero or two dimensional spatial information (zero-
dimensional dosimeters can often be scanned for one-dimensional information). The ideal 
dosimeter for small-field dosimetry would be a media-matched (discussed in the following 
section), dose-integrating device that provides three dimensional information about the spatial 
distribution of dose. Gel dosimeters exhibit many of the desirable qualities that approach 
these criteria. There are, however, various issues associated with gel dosimetry that have thus 
far limited their clinical implementation. Of these, issues of composition and tissue 
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equivalence, as well as systematic errors in calibration have been chosen as a particular focus 
in this work. The following sections of this chapter are devoted to novel investigations 
concerned with the latter topics. 
  
 
 
3.3 The importance of ‘media matching’ in dosimetry 
There is a significant amount of theory devoted to the interpretation of dosimeter readings. 
The reason for this is simple: the dose to a dosimeter is never the ultimately desired quantity – 
rather, it is the dose to the region occupied by the dosimeter in whatever medium the 
dosimeter is placed. Unfortunately, dosimeters typically do not exhibit the exact same 
radiological properties as the medium of interest. This is because their composition generally 
differs from that of the medium. As a result, whilst dosimeters function to measure dose, their 
presence may also perturb it. 
 
Following the nomenclature of Attix (2004), if the wall (w) and the sensitive volume (g) of 
the detector match (in terms of composition and mass density), then the doses delivered to 
each are such that: 
 
An improvement upon the latter case would be if the wall and sensitive volume were 
identical, and then matched to the medium of interest (x). If such matching could be 
performed perfectly, then 
 
Cavity theory (Bragg 1912; Gray 1936) allows w and g to differ, which potentially provides 
the flexibility of needing only to match w and x. Matching the sensitive volume to the 
medium of interest is typically complicated by further dosimetric requirements on g.  
 
Deviation from these ideal circumstances necessitates corrective steps in terms of the 
geometric design of the dosimeter or calculations based on knowledge of the spectrum and 
stopping power ratios in the applied context.  
 
gw DD = .  
gwx DDD == .  
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Ultimately, the ideal dosimeter would possess radiological properties identical to that of the 
medium of interest, would not perturb the radiation field, and would have the capacity to 
yield multidimensional dosimetric information. The most promising dosimeter that closely 
meets these criteria is radiosensitive gel. Composed mostly of water (the dose to which is 
considered to be well known), gel dosimeters show great potential, acting as both the 
phantom and dosimeter material. However, their clinical implementation has been limited so 
far. In this work, the radiological properties of gel and, in particular, their water or tissue 
equivalence as assessed by the ‘effective atomic number’ concept are a focus of study. Gel 
calibration methods are also considered, as not only the gel but also the containment vessels 
influence the conditions of media-matching and non-perturbation. These issues are 
investigated thoroughly in the following sections. 
 
 
 
3.4 Three dimensional dosimetry: Radiosensitive gels 
3.4.1 An overview 
Gel dosimetry dates back to the 1950s, when radiation doses were investigated with use of 
radiation sensitive dyes infused in gel matrices (Day and Stein 1950). In early studies, the 
radiation-induced changes were studied via spectrophotometry (Andrews et al. 1957), but 
contemporary gel dosimetry typically employs magnetic resonance imaging. Gels possess 
certain advantages over other more ‘standard’ dosimeters, such as ionisation chambers, 
radiosensitive films and thermoluminescent dosimeters. To obtain fully three-dimensional 
dose information with the latter detectors is not feasible. This is because only a limited 
number of one-dimensional points or two-dimensional planes may be measured at one time, 
and the simultaneous use of multiple detectors or stacking of film can be detrimental by 
reducing the effective water equivalence and influencing the dose distribution. Gel 
dosimeters, on the other hand, possess radiological properties similar to that of water and 
integrate dose regardless of direction of incidence, yielding dose information over a three-
dimensional volume. There are two categories of gel dosimeter: ferrous-sulphate doped 
(Fricke) gels and polymer type gels. 
 
 
3.4.2 Ferrous-sulphate doped (Fricke) gel dosimeters: An overview 
In 1927 Fricke and Morse published a paper describing the use of dilute ferrosulphate 
solutions as a means of dose measurement (Fricke and Morse 1927). A key advancement 
since Fricke’s work was the proposal by Gore (1984) to employ magnetic resonance imaging 
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to facilitate three-dimensional radiation dosimetry, where the aqueous Fricke solution is 
integrated into a gel matrix. 
 
Fricke gels are prepared in air, and are typically composed of deionised water, ferrous 
ammonium sulphate (the source of ferrous ions), sulphuric acid and gelatin or agarose. More 
recently, Chu et al (2000) described Fricke solution and xylenol orange integrated into a 
polyvinyl alcohol (PVA) cyrogel / hydrogel. The proposed advantage of this method is 
reduced post-irradiation ion diffusion, however, in-house studies have shown that diffusion is 
still a limiting factor. 
 
Schreiner (2004) has summarised some of the radiochemical processes relevant to Fricke 
dosimetry. The physical principle which enables the dosimetric use of Fricke gels is the dose 
dependant transformation of the ferrous Fe2+ ions into ferric Fe3+ ions. Irradiation initiates 
water decomposition and the hydroperoxy radical is produced: 
 
∗∗ →+ 22 HOOH  
 
The reactions oxidising ferrous ions to ferric ions (Fricke and Hart 1966) are given below: 
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The change in concentration of ferric ions is proportionate to the energy absorbed per unit 
mass, as described by the following equation: 
 
[ ] ( )
eN
FeGDFe
A ⋅
⋅⋅
=∆
+
+ ρ1033
, 
 
wherein D is the dose, G(Fe3+) is the chemical yield of Fe3+ is ions per heV, ρ is the density in 
kg.litre-1, NA is Avogadro’s number and e is the number of Joules per eV. The gel 
macromolecules provide additional pathways for ion conversion, and as such there is a greater 
yield of ferrous ions than for the aqueous Fricke solution. 
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The relaxivity of Fe3+ ions can be probed via nuclear magnetic resonance (NMR), and is 
linear with dose within the range of doses relevant to radiotherapy. Fricke gels also exhibit 
dose-dependent changes in optical density. Podgorsak and Schreiner (1992) showed that the 
Fricke solution requires tens of Gy to exhibit measurable radiation-induced changes. Fricke 
gels, however, are significantly more sensitive than in solution (Schulz et al. 1990; Hazle et 
al. 1991), but are less sensitive than polymer-type gel dosimeters. This generally does not 
present a significant problem unless working in very low dose / dose-rate regimes.  
 
Contemporary dose delivery often involves fields of very high dose gradients. The major 
limitation of Fricke gel dosimetry is diffusion of ferrous and ferric ions within the gel. This 
imposes a time constraint, restricting the available time between irradiation and imaging. A 
number of authors have reported on this problem; see for instance (Olsson et al. 1992; 
Balcolm et al. 1995; Harris et al. 1996; Pederson et al. 1997; Baldock et al. 2001; Chu and 
Wang 2001). This limitation was the primary impetus for the development of polymer-based 
gel dosimeters. 
 
 
3.4.3 Polymer gel dosimeters: An overview 
The diffusion of ferrous and ferric ions in Fricke gels presents time constraints for post-
irradiation imaging – a problem that has led to the increased development and implementation 
of polymer gel dosimeters. These consist of monomers dissolved in a hydrogel, which 
undergo dose-dependent polymerisation. 
 
Polymer gels are predominantly water (around nine tenths), with a gelling agent (gelatine or 
agarose) and a monomer (an organic hydrocarbon). When irradiated, radiolysis of water 
occurs, generating (highly reactive) radicals from the dissociation of H2O molecules which 
can then react with the monomers. The binding of a radical to an electron of the double bond 
of a monomer initiates polymerisation. These polymers can have reactive double bonds which 
also react with the radicals. Propagation occurs, whereby the loose ends of polymer chains 
continue to react with monomers, forming progressively larger macromolecules. 
 
Peroxide radicals are generated if there is oxygen within the gel. These react quickly with 
other radicals, inhibiting the polymerisation process. As such, polymer gels are generally 
prepared in an inert gas atmosphere to avoid oxygen. Recently, normoxic polymer gel 
dosimeters have been introduced that employ antioxidants, allowing gel preparation in the 
presence of oxygen (Fong et al. 2001). Polymerisation can also be terminated by the reaction 
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of two polymer radicals with each other. The rate of polymerisation has been shown to 
decrease with increasing gelatine concentration (Lepage et al. 2001a). 
 
Early polymer gels were made with acrylamide and N-N’-methylenbisacrylamide (Bis) 
(Maryanski et al. 1993) as monomers (note that Bis also acts as a cross-linker). This is 
illustrated in Figure 3.2. Other monomers have been employed by other researchers and these 
have their own characteristics; some of these are illustrated in Figure 3.3. 
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Figure 3.2 The molecular structure of (a) acrylamide, (b) N-N’-methylenbisacrylamide (Bis) and (c) 
polyacrylamide. Note in (c) that acrylamide molecules have linked together to form a long polymer 
chain (circled in red, large-dash), and the Bis molecules facilitate cross-linking between polymer 
chains (circled in blue, short-dash). This figure has been adapted from Gustavsson (2004). 
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Figure 3.3 The molecular structure of several monomers used in different polymer gel dosimeter 
formulations: (a) methacrylic acid, (b) 2-hydroxyethyl acrylate, (c) acrylic acid and (d) 2-hydroxyethyl 
methacrylate. Adapted from (Lepage et al. 2001a). 
 
 
The formation of polymers results in an optical change within the gel (increased opacity) that 
allow optical evaluation of the gels. The polymers in the gel also influence the mobility of 
H2O molecules and therefore affect the nuclear magnetic resonance (NMR) spin-spin 
relaxation rate, facilitating evaluation via magnetic resonance imaging (MRI). 
 
 
 
3.5 Evaluation of gel dosimeters 
3.5.1 Magnetic resonance imaging (MRI) 
3.5.1.1 Fricke gel dosimeters 
Irradiation of a Fricke dosimeter results in the oxidation of ferrous Fe2+ ions to ferric Fe3+ 
ions. Fe2+ and Fe3+ ions possess different magnetic moments. Gore (1984) proposed that this 
feature could be exploited to facilitate the evaluation of radiation induced changes in a Fricke 
dosimeter via nuclear magnetic resonance (NMR) relaxation measurements. The spin-spin 
and spin-lattice relaxation times (T2 and T1 respectively) of the hydrogen nuclei in the gel are 
affected by the concentration of the different ions, which means that the NMR relaxation is 
dose-dependent. It is common to determine the spin-spin and spin-lattice relaxation rates (R2 
= T2-1 and R1 = T1-1 respectively) and relate this back to the dose absorbed. 
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Audet and Schreiner (1996) presented a model for R1 dose response: 
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wherein D is the dose, G(Fe3+) is the chemical yield of Fe3+ is ions per heV, ρ is the density in 
kg.litre-1, NA is Avogadro’s number, e is the number of Joules per Ev, R0 is the relaxation rate 
of the unirradiated dosimeter and is a constant for a given gel concentration. The quantities 
r
3+
 and r2+ are the ‘relaxivities’ of the two ions† (these are known quantities). For a given 
formulation, one can therefore simplify this equation to: 
 
01 RdDR += , 
 
where d, the coefficient of the dose, is called the ‘dose sensitivity’ of the dosimeter. This is 
experimentally evaluated by determining the gradient of a plot of R1 as a function of the dose, 
D. 
 
 
3.5.1.2 Polymer gel dosimeters 
Polymerisation of gel dosimeters is dose-dependent and, as such, evaluation of the extent of 
polymerisation is indicative of the dose received. Because of the different relaxation 
behaviour of the protons in different chemical arrangements within the gel, such evaluation 
may be performed using MRI. 
 
Lepage et al (2001b) suggested the idea of considering protons within various ‘pools’. There 
are protons associated with free water and monomer molecules, protons associated with the 
polymeric chains and protons bound to the gel matrix. The mobility of the protons within 
these pools differs and so does that rate of thermal motion of the molecules containing them. 
This influences the spin-spin interaction and therefore the different proton pools will have 
different relaxation rates, facilitating quantitative study. 
 
                                                 
†
 Nota bene the relaxivity of the ferric ion, r3+, is actually an effective relaxivity that must be 
determined for the gel system, because the ferric ion hydration is affected by the gelling agent. 
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The total relaxation rate is the weighted average of the spin-spin relaxation rates of the 
different proton pools in the whole sample, and therefore will change with the amount of 
monomer converted to polymer (DeDeene 2004): 
 
gelgelpolymerpolymerfreefree RfRfRfR 2222 ++= . 
 
The protons in the gel pool are assumed to be unaffected by dose (i.e. remain unchanged in 
the irradiated and unirradiated sample). The ‘free’ protons from the water and monomer pool 
are transferred to the polymer pool. This results in an overall reduction in the relaxation time 
of the system. 
 
 
3.5.1.3 Practical issues with MRI of gel dosimeters and the problem of MRI accessibility for 
gel dosimetry in Australia 
In normal clinical MRI for diagnostic purposes, uncertainties in T2 of up to around 10 % are 
generally considered acceptable. In gel dosimetry, many of the problems associated with 
clinical MRI (such as patient movement – both internal and external) are non-issues, thus 
allowing a much improved level of uncertainty to be achieved. An MRI pulse sequence is 
developed or carefully selected for a particular gel formulation, scanning time and image 
resolution such that imaging artefacts and stochastic noise are minimised. Field 
inhomogeneities, non-linearities in the gradient and eddy currents may result in geometrical 
distortions of the obtained images. Ultimately, MRI is not a quantitative tool. 
 
One significant limitation on the use of MRI for gel dosimetry in Australia is simply 
accessibility – something which may come as a surprise to scientists in other countries. 
Patient diagnostics generally take precedence over research. As such, research time generally 
must be paid for, access if often ad hoc, or research must be undertaken out of hours, which 
may in cases be prohibited by the administering department. 
 
The attractiveness of a low-cost, easy-access alternative has driven a strong interest in 
alternative imaging methods for gel dosimeters (which is not restricted to Australia), such as 
x-ray computed tomography or optical tomography methods. 
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3.5.2 X-ray computed tomography (CT) imaging 
As an alternative to MRI, Hilts et al (2000) raised the possibility of employing x-ray 
computed tomography (CT) for read-out of polymer gel dosimeters. This is facilitated by the 
density change that occurs in polymer gel dosimetry, which results in different photon 
attenuation (Trapp et al. 2002) and hence gels exhibit a dose-dependent change in Hounsfield 
number, albeit with a very low sensitivity. Adding antioxidants (for normoxic gel 
formulations) has been shown to reduce the dose sensitivity even further, compared to the 
hypoxic formulations (Jirasek et al. 2006). However, there may be flexibility to design gel 
dosimeters specifically intended for read-out via CT. For instance, adding a co-solvent has 
recently been shown to increase x-ray CT sensitivity (Koeva et al. 2009). 
 
In addition to the limitation of low sensitivity, the other obvious problem with x-ray CT read-
out of gel dosimeters is that additional dose is delivered to the dosimeter. This generates 
further polymerisation of the gel, which restricts the use of many image averages per slice as 
a means of resolution improvement. Baxter et al (2007) investigated the CT dose and 
corresponding change in Hounsfield number for a range of imaging protocols for 
polyacrylamide gel. For volumetric imaging, the CT dose was of the order of several cGy and 
the change in CT number was 0.1 to 0.15. For single slice, the dose ranged from 0.7 up to 2.1 
cGy, and the CT number change ranged from 0.04 to 0.13. 
 
Another imaging modality that may overcome some of the limitations of x-ray CT is optical 
computed tomography (OCT). 
 
 
3.5.3 Optical imaging 
As a relatively inexpensive alternative to MRI, Gore et al (1996) suggested the use of optical 
computed tomography (OCT) as a read-out method for polymer gels. There are two main 
types of OCT: a laser-scanning type and a broad-beam type. Both reconstruct a large number 
of projections through the sample to obtain a three-dimensional dose distribution, relying on 
dose-dependent changes in light transmission properties of the irradiated gel. The laser type 
OCT scanners are typically much slower than the broad-beam scanners. The downside of the 
latter scanners, however, is that they can exhibit greater scattering artefacts. 
 
The high diffusion rates of Fricke type gels make polymer gels an attractive alternative – 
particularly for normoxic type gels which are relatively simple to manufacture – but OCT of 
polymer gels is more problematic. Unlike xylenol-orange Fricke gels, which tend to attenuate 
light through absorptive processes, polymer gels remove light from the beam path through 
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scattering processes. This can give rise to imaging artefacts. To illustrate this, an example 
was performed in-house (see Figure 3.4): a MAGIC normoxic polymer gel was 
manufactured and irradiated using a Varian 600C with a 5 x 5 cm2 field. When read out with a 
Modus Medical ‘Vista’ Optical CT Scanner, a ‘cupping’ artefact was observed that results 
from scatter at the periphery of the irradiated region in the polymer gel. 
 
 
Figure 3.4 An example of the ‘cupping’ artefact that occurs when polymer gels are scanned with a 
broad-beam optical CT scanner. The example shown in this figure was performed in-house using a 
Modus Medical ‘Vista’ Optical CT Scanner. (a) Shows a surface reconstruction of a MAGIC-type 
polymer gel (in a cylindrical container) irradiated with a 6 MV, 5 x 5 cm2 field. (b) Indicates a line 
profile taken across a slice in the middle of the gel. The two spikes towards the edges of the line profile 
correspond to the interface with the container (reflecting the poor refractive index matching between 
the container of gel and the liquid bath in which it was placed). Rather than a relatively flat profile in 
the high dose region, we see a ‘cupping’ effect which arises because of the scatter effects. Before 
dosimetric information may be derived from such data, scatter corrections must be applied – something 
which has been achieved with only limited success in published literature. 
 
 
Oldham et al (Oldham et al. 2003; Oldham and Kim 2004) have described in detail the 
artefacts that may be encountered in OCT of polymer gels, and the interested reader is 
referred to their work and the references therein. Rather than focus on dealing with the 
potential complications of gel read-out, the work described in this chapter deals with other 
aspects of gel dosimetry. Namely, the radiological properties of gel dosimeters and the 
accuracy of gel calibration. The strong interest in gel dosimetry for small-field applications is 
evidenced by a number of recent publications. 
 
 
 
(a) (b) 
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3.6 Gel dosimetry for small-field measurement: A summary of published 
works and comparison with alternative dosimeters 
The ideal dosimeter for stereotactic radiotherapy measurements would necessarily possess 
properties such that it would not be subject to volume averaging issues, as well as being 
media-matched, so as not to perturb the radiation field. Consequently, gel dosimeters – which 
comprise both the detector and phantom material – are a very promising tool for investigation 
of small fields. Read-out of the gels may be performed using magnetic resonance imaging 
(MRI), optical computed tomography (OCT) or x-ray computed tomography (CT). There 
have been a number of publications detailing the application of gel dosimetry to the small 
fields involved in stereotactic radiotherapy.  
 
The majority of works describing gel dosimeters for stereotactic field characterisation are 
applied to Gamma-Knife, and most of these involve MRI readout (Coffey et al. 1993; Guo et 
al. 1996; Cosgrove et al. 2000; Ertl et al. 2000; Watanabe et al. 2002; Isbakan et al. 2005; 
Papagiannis et al. 2005; Sandilos et al. 2006; Isbakan et al. 2007; Pourfallah et al. 2009). 
Most studies compared gel measurements for field sizes of the order of millimetres to TPS 
and other dosimeters, often observing discrepancies. Watanabe et al (2005) used BANG-type 
gel dosimeters to calculate the tumour control probability (TCP) and the normal tissue 
complication probability (NTCP) for Gamma-Knife treatments. TCP values based on 
measured data were up to 7 % smaller than those based on calculated data, while NTCP 
values were 7-24 % higher (for two-thirds of treatments). 
 
Linac-based stereotactic fields with conical collimators have also been investigated. For 
instance, Pappas et al (2001) used VIPAR-type gel dosimeters (read out with MRI), 
radiographic film and a PinPoint ionisation chamber to investigate 5 and 10 mm stereotactic 
fields. A spatial resolution of 0.13 mm was achieved with the gel, and a significant difference 
was found between penumbral measurements. The penumbrae from 5 and 10 mm collimators 
were 1.34 and 1.70 as measured with gel, 2.23 and 2.45 mm as measured with film and 2.25 
and 2.52 mm as measured with the PinPoint chamber.  
 
Linac-based stereotactic radiotherapy with fields shaped using multileaf collimators have also 
been studied (Grebe et al. 2001; Pappas et al. 2001; Audet et al. 2002). Wong et al (2007) 
used PAG-type gel dosimeters to study 6 x 6 mm2 and 18 x 18 mm2 fields. The penumbral 
dose was shown to drop off more rapidly with the gel measured data compared to data 
obtained using radiochromic film and diode measurements. Gels have also been used to verify 
doses in unusual contexts, particularly where conventional treatment planning systems may 
  62
be inaccurate. For instance,  Geso et al (2008) used PAG-type gel dosimeters and Gafchromic 
film to measure the dose enhancement in the vicinity of an aneurism clip – as relevant to 
intracranial stereotactic radiotherapy. Dose increases of the order of 20 % were observed 
close to the clip surface. Results were verified using Monte Carlo dose calculations. 
 
Gels have even found use in dosimetry of very small stereotactic fields applied to rat brains 
(Novotny et al. 2002a; Novotny et al. 2002b; Charest et al. 2009) and in the characterisation 
of synchrotron fields (Boudou et al. 2004; Boudou et al. 2007).  
 
It is common for gels to be employed in the assessment of stereotactic treatments, typically 
comparing measurements to other dosimeters (Bjoreland et al. 2008; Babic et al. 2009), and 
one makes the observation that – for small stereotactic fields – there is often significant 
variation in measured characteristics between detector types. Pappas et al (2008) undertook 
measurement of small fields with a pinpoint ion chamber, a diamond detector and a silicon 
diode array, using measurements taken with a polymer gel dosimeter as the reference data. 
Profiles were obtained for 7.5, 15 and 30 mm small fields that were delivered with a 
BrainLAB conical collimation device mounted on a Varian 600C Clinac. Measurements of 
the full-width half-maximum (FWHM) obtained using gel were shown to match the nominal 
fields well, compared to other dosimeters; see Figure 3.5.  
 
 
 
Figure 3.5 (a) The agreement between nominal beam diameters and those measured (FWHM) with 
VPL radiosensitive gel. The y = x line indicates perfect agreement. (b) A comparison of beam 
diameters as measured with various dosimeters, expressed as a ratio with the measured data plotted in 
(a). The PinPoint detector suggests larger penumbra, while the diamond and silicon diode (DOSI) 
detectors give lower estimates of the penumbra. Based on data from Pappas et al (2008). 
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The large number of studies employing gel dosimetry clearly reflect the recognition of their 
potential for three-dimensional small-field dosimetry. However – as evidenced by the 
aforementioned papers – despite being used widely for such applications since the mid-
nineties, gel dosimetry is rarely used as part of routine clinical practice. There are a number of 
limitations associated with gel dosimetry that must be overcome for this to be achieved. For 
instance, it is often not practical to have a laboratory space within a clinical physics 
department that facilitates chemical handling and the manufacture of gel dosimeters. The 
reproducibility of gel dosimeters is also an issue, requiring additional volumes of gel to be 
made within the same batch for the purposes of calibration. Read-out of gel dosimeters using 
MRI requires not only development of an associated protocol, but MRI time and access are 
often difficult or expensive to obtain. The advent of optical computed tomography for gel 
readout may help solve the latter problem. However, broad-beam optical scanners are 
generally designed for light-absorbing gels such as XO Fricke gels, which suffer from rapid 
ion diffusion, and the use of polymeric gel dosimeters is not straightforward, since these are 
light-scatterers and hence generate artefacts that hide the true dose information. 
 
 
 
Figure 3.6 This shows the measured output factors for 5 mm, 7.5 mm and 10 mm beams from a 
CyberKnife unit. The majority of dosimeters underestimate the output factors, relative to measurements 
made with gel (VIPAR). For the Gafchromic film (Wilcox and Daskalov 2007; Pantelis et al. 2008), 
diode (Yu et al. 2004; Francescon et al. 2005; Wilcox and Daskalov 2007; Francescon et al. 2008) and 
PinPoint chamber (Francescon et al. 2005; Francescon et al. 2008; Pantelis et al. 2008) measurements 
the error bars represent the standard deviation in different published values while the error bars for the 
gel (Pantelis et al. 2008) and TLD measurements (Yu et al. 2004) correspond to the uncertainty of the 
published measurements. 
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Figure 3.6 compares output factors corresponding to 5 mm, 7.5 mm and 10 mm beams from a 
CyberKnife unit for different detector types. In the case of the 5 mm field, there is good 
agreement (within uncertainty) between the gel, Gafchromic film and diode. In the case of the 
diode, there appears to be (statistically insignificant) overestimation of the output factor; this 
is most likely a consequence of the reduced water equivalence of the Silicon detector, which 
has been shown to result in such overestimation (Araki 2006). The PinPoint detector tends to 
underestimate the output factors, which is a consequence mostly of volume averaging effects.  
 
There are a number of dosimeters available for measurement of small field characteristics, 
and although the discussion of dosimeters has been relative to gels, this does not imply that 
gels are a ‘gold standard’. Each dosimeter possesses its own attractive properties and 
limitations. Table 3.1 gives a qualitative overview of the advantages and disadvantages of 
various detector types for the measurement of small-field dose distributions. Ultimately, gel 
dosimeters are in principle highly suited to the measurement of small fields. One significant 
strength is the level of media-matching; however, this has not been rigorously established 
(particularly with regard to effective atomic numbers). A further issue noted is that of 
calibration – there is no standardised accepted methodology. These issues are investigated in 
depth in this chapter. 
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Table 3.1 A qualitative overview of the advantages and disadvantages of the different dosimeters as 
applied to small field dosimetry. 
 
Dosimeter Advantages Disadvantages General comments 
Ionisation chamber High precision; wide 
variety of chambers 
available; real time 
measurement; no dose 
rate dependence; 
standard dosimeter that 
is well documented and 
investigated. 
One-dimensional (1D); 
geometry restricts 
applications; typically 
inappropriate for 
stereotactic fields 
because of volume 
averaging effects.  
Standard clinical tool 
for calibration; 
acquisition of data for 
planning, QA. 
Radiosensitive film Two-dimensional (2D) 
dose information; 
integrative; good spatial 
resolution  
Single-use; energy and 
(to a lesser extent) dose 
dependence; geometry 
may restrict 
applications. 
Standard clinical tool 
for measurements in 
solid phantoms, 
qualitative dosimetry, 
QA.  
Semi-conductor Small size; real-time 
measurement; arrays for 
2D information 
Degradation (finite life 
and changing radiation 
sensitivity); energy, 
temperature, dose rate 
and directional 
dependence; requires 
recalibration.  
Diodes increasingly 
common (MOSFET less 
so); can be used for 
water tank 
measurements and in 
vivo. 
TLD Small size; various 
materials and forms 
available; large number 
can be used; small size 
and lack of cables etc 
allows greater flexibility 
in measurement 
geometry; standard LiF 
good for stereotactic 
spectral qualities. 
Precision typically 
lower than ionisation 
chambers; read-out is 
delayed and relationship 
between dose and light 
emission is very 
complex; sensitivity 
may change with history  
Measurements in 
phantom (slab or 
anthropomorphic) and 
in vivo; personal 
dosimetry; may be used 
for inter-clinic 
comparisons.  
Diamond detector Small size; real time 
measurement; no 
directional dependence. 
Dose-rate dependence; 
requires pre-irradiation 
for stability (if not used 
for > 1 hr); directional 
dependence. 
Have been used for 
measurement of 
penumbra and 
stereotactic fields; have 
been used as TLDs. 
Radiosensitive gel Water equivalent; 
simultaneously acts as 
phantom and dosimeter; 
three-dimensional dose 
information; high 
spatial resolution; large 
number of types 
available; integrative; 
multiple readout 
methods; high 
flexibility in geometry. 
Requires lab for 
manufacture or as-
needed purchase from 
commercial vendors; 
each batch requires 
calibration; single-use; 
MRI readout may not be 
feasible at some clinics; 
optical readout of 
polymer-type gels 
nontrivial. 
Limited clinical 
application; have been 
used for stereotactic 
fields; commercially 
available; published 
‘recipes’ allow in-house 
manufacture. 
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3.7 The radiological properties of gel dosimeters and ‘water equivalence’ 
As discussed earlier, media-matching of dosimeters is advantageous. Gel dosimeters are 
unique in that they function as both the dosimeter and phantom material. Water or tissue 
equivalence is a typical requirement of phantom materials. This implies that the radiological 
properties of the phantom material match those of water sufficiently within the desired regime 
of applicability. The term ‘tissue equivalence’ is widely used, and perhaps misused, in the 
field of radiation dosimetry. For two different materials to scatter and absorb photons and 
electrons in the same way, five quantities must be the same: (i) mass attenuation coefficients 
(µ/ρ), (ii) mass energy absorption coefficients (µen/ρ), (iii) electron mass stopping powers 
(s/ρ), (iv) electron mass angular scattering powers (θ2/ρl) and (v) mass density (ρ). To be 
more precise, their partial, as opposed to total, coefficients and powers must be identical.  
 
The formulation of materials which are tissue equivalent is traditionally approached in one of 
two ways. The first is in terms of elemental equivalence. Mixtures of water, urea, glycerol 
and so forth are produced so as to try and mimic the formula for soft tissue; see for instance 
(Rossi and Failla 1956). This method is not widely employed and there is comparatively little 
relevant literature. The second method, however, is frequently adopted. The ‘effective atomic 
number’ approach involves calculation of, usually, a single value which is taken to 
characterise photon interactions in the medium. 
 
Since the original work of Moseley (1913), the atomic number, Z, has been identified as 
being fundamentally connected with various properties of the elements. Of particular interest 
is the dependence of photon interactions on the atomic number of a material, as shown in 
early photon absorption studies (Bragg and Peirce 1914; Owen 1919; Richtmyer and 
Warburton 1923). The latter authors have shown that the interaction cross section per atom is 
proportional to the atomic number raised to some power, i.e.  
 
where m is a constant that varies depending on (amongst other things)  the interaction process. 
This Z-dependency gives rise to the notion of an ‘effective atomic number’, Zeff, of mixtures 
and compounds that have composite elemental composition. 
 
For historical reasons, only the effective atomic number for photoelectric processes is 
considered; for a long period only low energy x-rays were produced in medical applications. 
This practice demands revision for at least two reasons. Contemporary applications involve 
mZ∝σ   
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MeV particles and ‘tissue equivalence’ must thus be considered over a broader range of 
energies (and ergo a greater number of interaction processes). Furthermore, the strong Z-
dependence of the photoelectric effect means that small errors in the effective atomic number 
generate significant errors in the ultimate quantity of interest, and so the accuracy and 
appropriateness of the values used must be well investigated. 
 
It is commonplace in the field of gel dosimetry to support statements of tissue equivalence by 
calculation of a single effective atomic number using a simplistic, energy-independent power-
based formula. In the subsequent section of this chapter it is shown that there is significant 
variability of the effective atomic number over the range of energies relevant to radiotherapy. 
 
 
 
3.8 The effective atomic number of dosimetric gels 
3.8.1 Background 
There are a range of gel dosimeters in contemporary usage and the selection of a gel 
formulation involves many considerations, one of which is the degree to which the 
radiological properties of the gel match those of water. In this regard, it is common to 
compare parameters such as density, mass attenuation, stopping powers, scattering powers 
and ‘effective atomic number’. In a number of papers, a single Zeff is calculated to support 
water equivalence of gels used in radiotherapy dosimetry (e.g. (Farajollaha et al. 1999; 
Pantelis et al. 2004; Venning et al. 2005a; DeDeene et al. 2006; Jirasek et al. 2006; Luci et 
al. 2007)). The commonly used Zeff calculation of Mayneord (1937) was originally developed 
based on low energy attenuation measurements, though it is frequently quoted in MeV gel 
dosimetry publications. Extrapolation to the high energy regime requires consideration of 
energy dependence. 
 
In this thesis, a novel approach is employed for the calculation of Zeff of gel dosimeters that 
accounts for energy-dependence, allows use of a spectrally-weighted mean for applications 
requiring single-valued Zeff and demonstrates the questionable usefulness of routine methods. 
 
A frequently employed method for determination of atomic number is that used by Mayneord 
in a discussion of the Röntgen (see Equation 3.) (Mayneord 1937), used in the context of gel 
dosimetry since the work of Kron et al (1993). The relative electron fraction of the ith element 
Zi is given by fi, such that ∑ =1if . Mayneord used a value of 2.94 for the exponent m, and 
this method may be found in contemporary radiotherapy textbooks (Kahn 2003). 
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A further frequently referenced paper is Spiers’ (1946) work on the absorption of energy in 
tissues wherein the mass absorption coefficient of a compound is derived. To do so, Spiers 
uses Walter’s (1929) expression for the photoelectric absorption coefficient, and employs the 
same expression for effective atomic number as Mayneord. The absorption of x- and γ-rays is 
a combination of multiple processes. Other authors have attempted to describe heterogeneous 
media in terms of a single effective atomic number using a single exponent, for example 
Murty (1965), however the differing dependency of the exponent m and hence Zeff on the 
interaction process and material composition means that this cannot be done without 
compromising accuracy. 
 
The influence of different interaction processes on the total photon interaction cross section in 
a given material varies with energy. Hine (1952) highlights that there should be a different 
effective atomic number for each of the chief interaction processes. With reference to 
Equation 3., Hine uses values for m of 3.1 and unity for photoelectric and pair production 
respectively. Weber and van den Berge (1969) suggest the use of two effective atomic 
numbers – one associated with the photoelectric effect and another with coherent scattering, 
using values for m of 3.4 and 1.7 respectively. White’s (1977) results involve multiple 
energy-dependent values of m that reflect earlier comments by McCullough (1975). 
Henriksen and Baarli constructed a simple argument against the use of an equation of the 
form of Equation 3., suggesting a different power relationship, but this suffers from the same 
limitations (1957). In later work, White (1978a) employed the relatively complex ‘extended Ỹ 
method’ and tabulated a number of Zeff values that vary with the photon energy and the 
interaction process. Ultimately, a number of studies have involved the use of multiple 
exponents to estimate the effective atomic number, but none are suitable over a large energy 
range (Jackson and Hawkes 1981). This suggests that comparisons of radiological properties 
should be made over a range of energies with consideration of all interaction processes. 
 
A qualitative comparison of radiological properties should include consideration of Zeff (or 
equivalently interaction cross sections) over a relevant energy range. Energy dependent data 
has been presented elsewhere for biological and other materials of relevance to dosimetry 
(Kumar and Reddy 1997; Prasad et al. 1997) (n.b. older studies employ outdated cross section 
data (Jayachandran 1971; Rao et al. 1985; Parthasaradhi et al. 1989)). In this study, we 
present the effective atomic number for fifteen types of ferrous-sulphate and polymer gel 
m m
iieff ZfZ ∑=  3.1 
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dosimeters as a function of energy between 10 keV and 10 MeV. For comparative purposes, 
the effective atomic number for water, soft tissue, muscle and bone are also evaluated. Data is 
presented relative to water so as to allow direct comparison over relevant energy or 
interaction regimes. The significant variability of these curves over the keV-MeV energy 
range (see Figure 3.7) should persuade the reader that the use of a single Zeff value is likely to 
be problematic if this energy dependence is not considered. For those applications benefiting 
from the simplification a single value allows, we recommend the use of an appropriately 
chosen value or weighted mean based on the source spectrum in question. 
 
A more detailed discussion of the evaluation of effective atomic numbers of gel dosimeters 
that establish radiological properties as being suitable for application in characterisation of 
stereotactic fields may be found in two key papers by the candidate (Taylor et al. 2008; 
Taylor et al. 2009b). 
 
 
3.8.2 Gel dosimeters investigated 
Data is presented for a Fricke gel dosimeter (Keall and Baldock 1999) and the hypoxic 
polymer gel dosimeters PAG (polyacrylamide gelatine) (Maryanski et al. 1993), BANG-1 
(Maryanski et al. 1994) and BANG-2 (Maryanski et al. 1996; Farajollaha et al. 1999) (bis-
acrylamide nitrogen gelatine), PABIG (polyethylene glycol diacrylate bis gelatine) (Sandilos 
et al. 2004) and VIPAR (N-vinyl pyrolidone argon gel) (Pappas et al. 1999; Kipouros et al. 
2001; Pappas et al. 2003). Also studied are the normoxic polymer gel dosimeters MAGIC 
(methacrylic acid, ascorbic acid in gelatine initiated by copper) (Fong et al. 2001), HEAG 
(hydroxy-ethyl-acrylate gel) (Gustafsson et al. 1994), MAGAS (methacrylic acid, gelatine gel 
with ascorbic acid), MAGAT (methacrylic acid, gelatine gel and tetrakis hydroxyl methyl 
phosphonium chloride) (DeDeene et al. 2002a; Hurley et al. 2005; Venning et al. 2005b), 
PAGAT (polyacrylamide, gelatin and tetrakis hydroxyl methyl phosphonium chloride) 
(Venning et al. 2005a), nPAG (normoxic polyacrylamide gel), nMAG (normoxic methacrylic 
gel) (DeDeene et al. 2006), ABAGIC (ascorbic acid, bis-acrylamide, in gelatine initiated by 
copper) (DeDeene et al. 2002b) and NIPAM (N-isopropylacrylamide) (Senden et al. 2006b). 
Water and various human tissues (ICRU 1989) are also presented for comparison. 
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3.8.3 Effective atomic numbers of gel dosimeters for photon interactions 
The transport of photons through matter is related to energy and atomic number (Barkla and 
Sadler 1907; Barkla and Sadler 1909) with use of the mass attenuation coefficient. In the 
present work, energy dependent Zeff values are calculated from the mass attenuation data 
compiled by Hubbell et al (1995). For the composite materials studied here, the total mass 
attenuation coefficients are determined additively considering their fractional weightings. The 
total cross section is simply derived (see for example, Hubbell (1999)) from the mass 
attenuation coefficients. The present work draws on the x-ray mass attenuation data (Hubbell 
1982) without the renormalisation proposed by Scofield (1973), as it has been shown that 
agreement with experiment is improved without renormalisation (Saloman et al. 1988). 
 
Zeff may be determined via exploitation of the smooth correlation between atomic cross 
section and atomic number (Parthasaradhi 1968). The tabulated mass attenuation coefficient 
data was obtained for the first thirty elements and the corresponding cross section values were 
calculated. A matrix of cross sections was constructed spanning atomic numbers Z = 1 to 30 
for photon energies ranging between 10 keV and 10 MeV. The cross sections for the gel 
dosimeters studied were calculated via linear additivity. These gel cross section values were 
then contrasted with the cross section matrix as a function of Z, and an effective Z number for 
each energy was obtained by interpolation of Z values between the adjacent cross section 
data. Care must be taken at low photon energies in the region of the K-absorption edge where 
discrete jumps in Zeff may be apparent that correspond to photoelectric absorption at K-shell 
binding energies. For compounds of higher atomic number there exist relatively pronounced 
discontinuities in Zeff and, for this reason, Zeff must be applied cautiously with high Z 
elements (Z > 50). All materials studied here have Z ≤ 30 and in this regard are not 
problematic. 
 
The effective atomic number as a function of photon energy (from 10 keV to 10 MeV)  has 
been calculated for nine normoxic and five hypoxic polymer gel dosimeters, a Fricke gel 
dosimeter and three biological materials. Figure 3.7 shows the effective atomic number of 
water as it varies with energy. To evaluate the degree of water equivalence, we have taken the 
ratio of the Zeff values of the various materials with the Zeff values of water over the full 
energy range. This ratio, Zeff,R, is plotted in Figure 3.8 and Figure 3.9. 
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Figure 3.7 The effective atomic number (Zeff) of water as a function of energy between 10 keV and 10 
MeV. 
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Figure 3.8 Zeff,R: The ratio of Zeff values of various materials with those of water as a function of 
energy, shown for (i) Fricke and the normoxic dosimeters (ii) MAGAT, MAGIC and NIPAM, (iii) 
nMAG, nPAG and ABAGIC and (iv) MAGAS, PAGAT and HEAG. 
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Figure 3.9 Zeff,R: The ratio of Zeff values of various materials with those of water as a function of 
energy, shown for the hypoxic dosimeters (i) BANG-1, BANG-2, PABIG, (ii) PAG and VIPAR as 
well as the biological materials (iii) tissue (soft), muscle (striated) and (iv) bone (cortical). 
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The effective atomic numbers are presented here over a broad energy range to facilitate 
detailed comparison. Single values may nonetheless be convenient and, depending on the 
application and extent of approximation allowable, one may consider specific values or 
average within certain energy bands etc. Provided the spectral content of the photon source is 
known, one may generate a single effective atomic number by appropriate weighting. As an 
example, performing such weighting yields a Zeff value for MAGIC of 3.41 for the 6 MeV 
photon spectrum defined by Mohan et al (1985). As one would expect, this coincides with the 
effective atomic number at an energy of around 2 MeV, which is approximately the mean 
energy of the spectrum from a 6 MV medical linear accelerator. This compares to a value of 
Zeff = 7.37 calculated elsewhere (Sellakumar et al. 2007) using Equation 3. where the authors 
chose a value of m = 3.5. The latter power originates from the dependence of the photoelectric 
effect, which varies with the photon wavelength to the power of approximately three and four 
at low and high energies respectively. For this example, the power method underestimates the 
percentage discrepancy between Zeff of water and that of MAGIC (1.5 % for the weighting 
method and 0.7 % for the latter method). The effective atomic numbers of gel dosimeters 
calculated using the Mayneord method are invariably higher than those calculated using the 
more robust method presented here, even within the intended regime of applicability (where 
discrepancies are typically at least 20 %). 
 
By consideration of the mean disparity, the effective atomic number of BANG-1 is most 
similar to water, as shown in Figure 3(i). HEAG and VIPAR, shown in Figure 3.8 (iv) and 
Figure 3.9 (ii) respectively, also match that of water closely, both having no constituents of Z 
> 8. Of the polymer gels, MAGAT is the least similar in Zeff to water, as shown in Figure 3.8 
(ii). Observation of Figure 3.8 (i) shows that Fricke, the gel matching water least well, has Zeff 
values systematically greater than that of water over the full energy range studied. 
 
 
 
3.8.4 Effective atomic numbers of gel dosimeters for electron interactions 
A comprehensive study of the effective atomic numbers of gel dosimeters corresponding to 
electron interactions has thus far not been published. As discussed in the previous section, for 
photon interactions, it is common to derive the effective atomic number of a compound by 
summation of the constituent elemental atomic numbers raised to the power m (where m is a 
constant) and weighted according to their fractional electron content. It should be noted, 
however, that this simple, single Z-exponent method is typically not appropriate over 
extended energy ranges (White 1978a; Jackson and Hawkes 1981). The availability of such 
exponent data is comparatively limited for electron interactions, and the importance of H, C, 
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N and O (the primary constituents of gel dosimeters) is often ignored in their derivation 
(White 1977). 
 
The interaction of electrons is of key importance whether as primary or secondary particles. 
The various current and future applications of gel dosimetry necessitate consideration of 
radiological properties in different energy regimes. In this study, effective atomic numbers are 
determined for a range of gel dosimeters, as well as for water and several biological materials 
for comparative purposes, for electron energies between 10 keV and 100 MeV. Effective 
atomic numbers are calculated for total and partial interaction processes using ICRU stopping 
powers (ICRU 1984b). The mass stopping power of the composite material is then 
determined via linear additivity of stopping powers of the constituent elements, taking into 
consideration their fractional weighting. This is then contrasted with a matrix of stopping 
powers that spans the elements Z = 1 to 30 for energies between 10 keV and 100 MeV. The 
effective atomic number at a given energy may then be obtained by interpolation of Z values 
between adjacent stopping power data. The uncertainty due to such interpolation is < 0.2 %. 
The uncertainties in the collisional stopping powers employed are 2 % to 3 % below 100 keV 
and 1 % to 2 % above. The uncertainties in the radiative stopping powers are 5 % below 2 
MeV, 2 % to 5 % between 2 MeV and 50 MeV and 2 % above 50 MeV; the relative 
contribution of the radiative process is negligible at lower energies where the uncertainties are 
higher. Effective atomic numbers are calculated in this way for collisional, radiative and total 
electron interaction processes. 
 
Table 3.2 gives the effective atomic numbers for five hypoxic and nine normoxic polymer gel 
dosimeters, a Fricke gel dosimeter, water and soft tissue. The effective atomic number varies 
by approximately 30 % over the energy range studied (10 keV ≤ E ≤ 100 MeV). This is also 
evident from Figure 3.10 which shows the variation of Zeff with energy for each interaction 
process for a representative gel (PAG), plotted alongside the percentage discrepancy between 
Zeff of PAG and Zeff of water. Table 3.3 shows the mean, minimum and maximum values of 
Zeff for the partial and total interaction processes over the considered energy range. 
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Figure 3.10 For a representative gel (PAG): (a) the variation of effective atomic number with energy 
for collisional, radiative and total electron interaction processes; (b) the percentage difference between 
Zeff of PAG and Zeff of water, ∆Zeff. 
 
 
It is common practice to use Zeff as one of the parameters (generally in conjunction with other 
parameters; see for instance (Constantinou 1978; White 1978b)) to indicate water/tissue 
equivalence. Zeff values for water are typically lower than those for the gels (up to 
approximately 2 %), with the discrepancy decreasing as energy increases (see Figure 3.10 (b) 
for an example). As one would expect, this discrepancy, ∆Zeff, is greater between the Zeff 
values of gels and tissue than gels and water. For the radiative interaction process the 
difference is fairly constant, Zeff for gels are approximately 3 % higher than for tissue, 
decreasing gradually with increasing energy. The discrepancy for the collisional process 
increases with energy; ∆Zeff is over 1 % from 10 keV to 100 keV, 2 % at 1 MeV, 3.5 – 4 % at 
10 MeV and 4.5 – 5 % at 100 MeV. Because of the dominant influence of the collisional 
process, this also reflects the discrepancy in the total interaction process, until approximately 
10 MeV at which point the influence of the radiative process results in a reduction of the 
discrepancy between Zeff for gels and tissue between 10 MeV and 100 MeV (such that ∆Zeff 
remains between 3 and 4 %). Ultimately, the discrepancy between Zeff for tissue and for gels 
is of the same magnitude as the difference between tissue and water. 
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Table 3.2 The total effective atomic numbers of gel dosimeters, water and biological materials at a selection of energies between 10 keV and 100 MeV calculated from total 
stopping power data. 
 
  Energy (MeV)                       
Zeff 0.01 0.1 0.2 0.6 1 4 6 8 10 20 30 40 50 100 
                              
ABAGIC 3.10 3.22 3.25 3.32 3.37 3.47 3.61 3.72 3.81 3.88 4.10 4.20 4.27 4.37 
BANG-1 3.07 3.19 3.22 3.30 3.35 3.45 3.60 3.71 3.80 3.87 4.09 4.20 4.26 4.37 
BANG-2 3.10 3.22 3.25 3.32 3.38 3.48 3.62 3.73 3.82 3.90 4.11 4.22 4.29 4.39 
Fricke 3.10 3.22 3.25 3.33 3.39 3.49 3.64 3.76 3.85 3.92 4.14 4.26 4.32 4.43 
HEAG 3.07 3.19 3.22 3.30 3.35 3.45 3.60 3.71 3.80 3.87 4.09 4.20 4.26 4.37 
MAGAS 3.11 3.22 3.25 3.32 3.38 3.47 3.62 3.73 3.81 3.88 4.10 4.21 4.27 4.38 
MAGAT 3.11 3.22 3.25 3.33 3.38 3.48 3.62 3.73 3.81 3.88 4.10 4.21 4.27 4.39 
MAGIC 3.10 3.22 3.25 3.32 3.37 3.47 3.61 3.72 3.81 3.88 4.09 4.20 4.26 4.37 
NIPAM 3.06 3.18 3.21 3.29 3.34 3.44 3.59 3.70 3.78 3.86 4.08 4.19 4.25 4.37 
nMAG 3.08 3.20 3.23 3.30 3.36 3.46 3.60 3.71 3.80 3.87 4.09 4.20 4.26 4.37 
nPAG 3.09 3.21 3.24 3.31 3.37 3.47 3.61 3.72 3.81 3.88 4.10 4.21 4.28 4.39 
PABIG 3.09 3.21 3.24 3.31 3.37 3.47 3.61 3.72 3.81 3.88 4.10 4.21 4.27 4.38 
PAG 3.09 3.21 3.24 3.31 3.37 3.47 3.62 3.73 3.82 3.89 4.11 4.22 4.28 4.39 
PAGAT 3.08 3.20 3.23 3.30 3.36 3.46 3.60 3.71 3.80 3.88 4.10 4.21 4.27 4.38 
VIPAR 3.07 3.19 3.22 3.29 3.35 3.45 3.59 3.70 3.79 3.86 4.08 4.19 4.25 4.36 
Water 3.04 3.16 3.19 3.27 3.33 3.43 3.58 3.70 3.79 3.86 4.09 4.20 4.27 4.37 
Tissue 3.06 3.17 3.20 3.26 3.31 3.39 3.51 3.61 3.69 3.75 3.96 4.07 4.13 4.25 
Muscle 3.01 3.13 3.16 3.23 3.28 3.37 3.50 3.61 3.69 3.76 3.98 4.09 4.16 4.19 
Brain 3.05 3.17 3.20 3.27 3.31 3.40 3.54 3.64 3.73 3.80 4.02 4.12 4.19 4.23 
Lung 3.14 3.26 3.29 3.36 3.41 3.51 3.65 3.76 3.85 3.92 4.13 4.24 4.30 4.34 
Breast 2.99 3.10 3.12 3.18 3.22 3.28 3.39 3.48 3.55 3.61 3.81 3.92 3.99 4.03 
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Table 3.3 The mean, minimum and maximum effective atomic numbers (with standard deviation) for gels, water and biological materials, calculated for collisional, radiative 
and total electron interaction processes between 10 keV and 100 MeV. 
 
  COLLISIONAL     RADIATIVE       TOTAL     
Zeff Mean 
Std. 
Dev. Min. Max.   Mean 
Std. 
Dev. Min. Max.   Mean 
Std. 
Dev. Min. Max. 
                              
ABAGIC 3.38 0.40 4.21 2.85   4.62 0.11 4.75 4.37   3.41 0.45 4.37 2.85 
BANG-1 3.36 0.41 4.21 2.83   4.62 0.11 4.76 4.36   3.39 0.46 4.37 2.83 
BANG-2 3.38 0.41 4.23 2.85   4.65 0.11 4.79 4.39   3.42 0.47 4.39 2.85 
Fricke 3.39 0.42 4.27 2.84   4.69 0.11 4.83 4.41   3.43 0.48 4.43 2.84 
HEAG 3.36 0.41 4.21 2.83   4.62 0.11 4.76 4.36   3.39 0.46 4.37 2.83 
MAGAS 3.38 0.40 4.21 2.85   4.63 0.11 4.76 4.37   3.42 0.45 4.38 2.85 
MAGAT 3.38 0.40 4.21 2.85   4.65 0.11 4.79 4.38   3.42 0.46 4.39 2.85 
MAGIC 3.38 0.40 4.21 2.85   4.62 0.11 4.76 4.37   3.41 0.46 4.37 2.85 
NIPAM 3.35 0.41 4.19 2.83   4.63 0.11 4.77 4.36   3.38 0.46 4.37 2.83 
nMAG 3.36 0.41 4.20 2.84   4.62 0.11 4.76 4.37   3.40 0.46 4.37 2.84 
nPAG 3.37 0.41 4.22 2.84   4.65 0.11 4.79 4.38   3.41 0.46 4.39 2.84 
PABIG 3.37 0.41 4.22 2.84   4.63 0.11 4.77 4.37   3.41 0.46 4.38 2.84 
PAG 3.38 0.42 4.24 2.84   4.64 0.11 4.78 4.38   3.41 0.47 4.39 2.84 
PAGAT 3.36 0.41 4.21 2.84   4.64 0.11 4.78 4.38   3.40 0.47 4.38 2.84 
VIPAR 3.35 0.41 4.19 2.83   4.61 0.11 4.75 4.36   3.39 0.46 4.36 2.83 
Water 3.34 0.43 4.22 2.81   4.63 0.11 4.77 4.36   3.37 0.48 4.37 2.81 
Tissue 3.30 0.35 4.04 2.83   4.52 0.10 4.65 4.29   3.34 0.42 4.25 2.83 
Muscle 3.28 0.38 4.08 2.80   4.54 0.10 4.67 4.29   3.32 0.44 4.27 2.80 
Brain 3.32 0.38 4.11 2.82   4.58 0.11 4.72 4.32   3.36 0.44 4.31 2.82 
Lung 3.42 0.40 4.24 2.87   4.68 0.11 4.81 4.41   3.45 0.46 4.41 2.87 
Breast 3.21 0.31 3.87 2.79   4.39 0.09 4.51 4.18   3.26 0.39 4.11 2.79 
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3.9 Systematic variations in polyacrylamide gel calibration due to 
container influence and deviations from water equivalence 
3.9.1 Overview 
As a water-equivalent three-dimensional integrating dosimeter, gels would appear, in 
principle, to be the ideal dosimeter. In the previous sections the radiological properties of gel 
dosimeters have been examined, with a specific emphasis on the effective atomic number, 
since this is not dealt with sufficiently well in published scientific literature. Another practical 
issue to be considered if the use of gel dosimeters is desired is that of gel calibration. 
Inspection of the literature highlights that there are a wide number of methods employed, and 
the absence of a standard methodology. 
 
The work presented in this section of the chapter is a detailed Monte Carlo investigation into 
the accuracy of published calibration techniques. A concise overview of the key findings of 
this work is presented here, and the interested reader is referred to a much more 
comprehensive discussion of the investigated methods and results that may be found in two 
publications by the candidate (Taylor et al. 2007; Taylor et al. 2009a): 
 
 
3.9.2 Introduction 
Gel dosimeters are often used for relative dosimetry; however for quantitative information it 
is necessary to calibrate each batch of gel individually. In principle, this is undertaken by 
irradiating gel with varying doses, with the assumption that the doses received are equivalent 
to that in water under the same conditions. A dose calibration curve is then constructed by 
association of the presumed dose at such points with the corresponding relaxation rate values 
obtained via MRI, or with Hounsfield units from x-ray computed tomography, attenuation 
coefficients from optical computed tomography, or similar. The importance of calibration is 
self evident and, in the case of gel dosimeters, uncertainty in calibration has been the subject 
of various studies (Baldock 1999, Trapp 2004a).  
 
Of particular note is the fact that there has been little consideration of the effect of backscatter 
from containers on the absorbed dose in gel dosimeters. Michael et al (2000) concluded that 
the presence of glass containers and Nitrogen pockets therein had no significant effect on the 
total absorbed dose within a vial of gel. However, alternative calibration techniques and the 
local effects of containment vessels coupled with the compounded effects of juxtaposition of 
multiple containers have not been previously investigated in detail. 
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Numerous practical techniques for gel calibration exist, described in detail by Taylor et al 
(2007; 2009a); in summary: 
- Multiple small vials in a water phantom that are given different doses (Maryanski et 
al. 1994; Baldock et al. 1998; Baldock et al. 1999) 
- A large volume flask of gel placed in air, into which numerous small fields of varying 
doses are directed (Maryanski et al. 1994; Maryanski et al. 1996; Oldham et al. 
1998a). 
- A long gel-filled test tubes placed within a water phantom and irradiated through the 
bases so that a depth-dose distribution exists along the length of the tube (allowing 
multiple calibration points to be obtained from a single test tube) (Oldham et al. 
1998b). 
- Gel-filled test tubes placed 5 cm deep in a water phantom with their axes 
perpendicular to the irradiation field (McJury et al. 1999; DeDeene et al. 2001; 
Vergote et al. 2004). 
 
 
3.9.3 Summary of method 
Accurate measurement of effects such as backscatter and cross-talk is not feasible and, as 
such, the investigation is highly amenable to Monte Carlo dose calculation. The water 
equivalence of five gels in five different calibration arrangements is modeled here using the 
Electron Gamma Shower (EGSnrc) code V4-2-2-5 (EGSnrc 2006). It is well accepted that 
Monte Carlo generates accurate dose calculations, even in zones of electronic disequilibrium, 
such as interfaces between materials of high and low density. In this work, several of the 
aforementioned gel calibration arrangements are modelled to determine the extent to which 
containment vessels affect the absorbed dose in gel dosimeters. This allows an informed 
choice between the common dose calibration methods to minimise the systematic errors 
introduced by calibration. The radiotherapy beam modeled is a 6 MeV endpoint 
bremsstrahlung spectrum (Mohan et al. 1985). Refer to Taylor et al for a detailed description 
of the simulation geometries (2007; 2009a). Briefly, the different methods incorporate small 
vials, test tubes and a large flask. The small vials are 55 mm long, have a 25 mm internal 
diameter and are made with 1 mm thick borosilicate glass with a polyethylene cap. The test 
tube is similar, though 200 mm long. The large flask is modeled as a Perspex tub of inner 
diameter 130 mm and height 45 mm with a wall thickness of 6 mm. A 6 MV beam is used in 
all cases. A schematic of the modeled geometry is provided in Figure 3.11. 
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Gel in 1mm thick Pyrex container 
Polyethylene lid 
Water 
Gel in 6mm thick acrylic container 
(a) Method A: Small vial (b) Method B: Large Flask 
(c) Method C: Perpendicular test tube (d) Method D: Perpendicular test tube 
(e) Method E: Long coaxial test tube KEY 
Ø 100 mm Ø 40 mm 
Ø 300 mm Ø 200 mm 
Ø 100 mm 
25 mm 
25 mm 
200 mm 100 mm 
10 mm 
55 mm 
45 mm 
200 mm 
25 mm 
Photon beam 
Figure 3.11 Overview of modelled geometries; a key is also provided. (a) Method A: a small Pyrex 
vial at 50 mm depth in water. (b) Method B: a large acrylic container filled with gel, irradiated with a 
small field. (c) Method C: a perpendicularly-oriented Pyrex test tube at 50 mm depth in water. (d)
Method D: a similar orientation, with a smaller test tube. (e) Method E: A large test tube, coaxial with 
the beam, positioned at the surface of a water phantom. ` 
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3.9.4 Results 
For each method of calibration modeled, difference plots are provided that show the ratio of 
the dose in gel to the dose in water; this highlights the differences that are the subject of the 
present study (see Figure 3.12 to Figure 3.16). The plots given are depth dose curves and 
radial plots that show the range of influence of inhomogeneities. In each case Fricke is used 
as the representative gel. For comparison to other gel formulations, Table 3.4 and Table 3.5 
quantify the difference between calculated dose to water and dose to gel (Dgel – Dwater)/Dwater 
for clinically appropriate volumes. The data presented in Table 3.4 and Table 3.5 are dose 
values averaged over a small volume (~80 mm3), so as to reflect clinical practice, where 
relaxation rates from MRI or attenuation coefficients from optical computed tomography etc. 
are volume-averaged at certain locations. These voxel values are then associated with the 
known values of dose to water such that a calibration curve can be constructed. The results 
we present here highlight the differences between dose to water and dose to gel which thus 
indicates any systematic uncertainty introduced by this practice. The low dose ratios observed 
at locations corresponding to the containers are due to the higher density of the container 
materials. 
 
 
3.9.4.1 Method A: Small vial 
Figure 3.12 (a) shows the ratio of a depth dose curve in Fricke gel to a depth dose curve in 
water (the field size is 100 mm). Figure 3.12 (b) shows the ratio of the radial dose 
distributions of gel and water at a depth corresponding to the mid-point of the vial. The abrupt 
drop at a depth of 5 cm corresponds to the glass base of the vial (which faces the oncoming 
beam). Taking an area of about 80 mm2 around the centre of the vial at its mid-point and 
averaging the voxel values would yield a value lower than the dose to water by 0.4 (± 0.2) % 
for Fricke, the same for PAG, 0.7 (± 0.2) % for MAGIC, 0.3 (± 0.2) % for BANG-1 and 0.8 
(± 0.2) % for BANG-2. 
 
 
3.9.4.2 Method B: Large flask 
Based on the calibration technique outlined by Oldham et al (Oldham et al. 1998a), we have 
modeled a large flask with and without a nitrogen gap. For greater generality, the results 
shown in Figure 3.13 correspond to the model with no nitrogen gap (thus filled entirely with 
gel), however other simulations indicate its effect (particularly at the point of maximum dose, 
Dmax) is negligible, as shown in Figure 3.14. Figure 3.13 (a) shows the ratio of depth dose 
curves in Fricke and in water, corresponding to a 2 cm diameter circular field incident on the 
centre of the flask. Figure 3.13 (b) shows the ratio of the radial distributions in Fricke and 
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water at a depth corresponding to Dmax (the field size is 40 mm). The equivalent information 
is shown for a large flask of gel with a nitrogen gap in Figure 3.14 (a) and (b). The dose in the 
build up region is several percent higher in the gel than the water, matching to within 1 % 
between depths of 1 and 2 cm. Between 2 cm and 5 cm the calculated dose in gel matches 
water within about 2 %. Taking an area of 80 mm2 at Dmax, with a voxel thickness of 2 mm, 
shows the mean dose to Fricke is the same as that to water, within an uncertainty of about 0.3 
%. For PAG this difference is 0.2 (± 0.1) %, for MAGIC it is 0.5 (± 0.2) %, for BANG-1 it is 
0.1 (± 0.2) % and for BANG-2 there is zero difference with an uncertainty of about 0.2 %. 
 
 
3.9.4.3 Method C: Large perpendicular test tube 
Figure 3.15 (a) shows the ratio of the central axis dose profile in Fricke gel and in water alone 
for a 20 cm long test tube oriented perpendicular to the beam with its centre at a depth of 5 
cm within a water phantom (the field size is 300 mm across). In this case a radial dose profile 
would not yield useful information. The objective of this method is to obtain a large number 
of points (over the length of the tube) so as to average the voxel values and reduce uncertainty 
in the corresponding dose value. Taking an area of 13 mm2 and averaging the values in this 
way (taking care to avoid the ends of the tube) indicates that the dose to Fricke is 0.4 (± 0.1) 
% lower than the dose to water. Similarly, the difference for PAG is 0.7 (± 0.1) %, for 
MAGIC it is 0.9 (± 0.1) %, for BANG-1 it is 0.6 (± 0.1) % and for BANG-2 the difference is 
0.7 (± 0.1) %. 
 
 
3.9.4.4 Method D: Small perpendicular test tube 
Figure 3.15 (b) shows the ratio of the central axis dose profile in Fricke gel and in water alone 
for a 10 cm long test tube with a diameter of 10 mm, oriented perpendicular to the beam with 
its centre at a depth of 5 cm within a water phantom (200 mm field size). There is significant 
statistical noise because of the smaller voxel sizes (~0.016 cm3) used to define the geometry. 
Averaging over a lateral area of 13 mm2 over the length of the tube, the difference between 
dose to Fricke and dose to water is 0.2 (± 0.2) %. For PAG this difference is 0.4 (± 0.3) %, for 
MAGIC it is 0.3 (± 0.2) %, for BANG-1 it is 0.0 (± 0.2) % and for BANG-2 the difference is 
0.1 (± 0.2) %. 
 
 
3.9.4.5 Method E: Long coaxial test tube 
Figure 3.16 (a) shows the ratio of a depth dose curve in Fricke gel to a depth dose curve in 
water alone for a 20 cm long test tube the base of which is at the surface of a water phantom, 
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oriented parallel to the beam. The radial dose distribution varies with depth and the ratio of 
the radial dose for Fricke and water is thus presented at depths of 5, 10 and 15 cm. These are 
shown in Figure 3.16 (b), (c) and (d) respectively. Choosing an area of 80 mm2 around the 
centre of the test tube at each of these depths and average the dose values yields multiple 
calibration points, but ones typically increase in disparity with the dose to water, as indicated 
in Table 3.5. 
 
 
 
 
Figure 3.12 Ratio of calculated dose to Fricke gel compared to dose in water for Method A: a small 
vial at a depth of 5 cm. (a) shows the ratio of depth dose curves and (b) shows the ratio of radial dose. 
Gel-filled regions are shaded for clarity. 
 
 
 
 
 
 
Figure 3.13 Ratio of calculated dose to Fricke gel compared to dose in water for Method B: a large 
flask in air. (a) shows the ratio of depth dose curves and (b) shows the ratio of radial dose. The notable 
peak occurs as a result of the increased secondary electron fluence immediately beyond the (relatively 
high density) container wall. 
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Figure 3.14 Ratio of calculated dose to Fricke gel compared to dose in water for Method B: a large 
flask in air with a Nitrogen gap (evident at 4.5 cm depth). (a) shows the ratio of depth dose curves and 
(b) shows the ratio of radial dose. 
 
 
 
 
 
Figure 3.15 (a) corresponds to Method C, showing the ratio of dose to gel and dose to water along the 
central axis of a large (200 mm long, 20 mm diameter) test tube. (b) corresponds to Method D, 
showing the ratio of dose to gel and dose to water along the axis of a small (100 mm long, 10 mm 
diameter) test tube. Gel-filled regions are shaded for clarity. 
 
 
 
Table 3.4 Percentage difference between calculated dose to gel and dose to water. 
 
  Method A     Method B     Method C     Method D   
  
Diff. (%) σ   Diff. (%) σ   Diff. (%) σ   Diff. (%) σ 
  
                      
  
                      
PAG 0.4 0.2   0.2 0.1   0.7 0.1   0.4 0.3 
Fricke 0.4 0.2   0.0 0.3   0.4 0.1   0.2 0.2 
MAGIC 0.7 0.2   0.5 0.2   0.9 0.1   0.3 0.2 
BANG 1 0.3 0.2   0.1 0.2   0.6 0.1   0.0 0.2 
BANG 2 0.8 0.2   0.0 0.2   0.7 0.1   0.1 0.2 
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Figure 3.16 (a – d) all correspond to Method E, a long test tube coaxial with the beam. The ratio of 
depth dose curves is shown in (a), and the ratio of radial dose distributions are shown in (b), (c) and (d) 
corresponding to depths of 5, 10 and 15 cm respectively. 
  
 
 
Table 3.5 Differences between calculated dose to gel and dose to water for a  long test tube coaxial 
with the beam (Method E).  
 
Depth in test tube 5 cm     10 cm     15 cm   
Gel Diff. (%) σ   Diff. (%) σ   Diff. (%) σ 
                  
PAG 0.7 0.2   1.1 0.3   2.0 0.3 
Fricke 0.4 0.2   0.6 0.3   0.8 0.3 
MAGIC 0.4 0.2   1.6 0.3   2.2 0.3 
BANG 1 0.5 0.3   1.1 0.3   1.0 0.3 
BANG 2 0.5 0.2   1.1 0.3   1.0 0.3 
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Table 3.6 Statistical data for each calibration method, analysed by gel type. 
  
Calibration method Diff (%) St. Dev. 95 % CI 
        
Method A (small vial) 0.5 0.2 0.2, 0.8 
Method B (large flask) 0.2 0.2 -0.1, 0.4 
Method C (large perpendicular test tube) 0.7 0.2 0.4, 0.9 
Method D (thin test tube) 0.2 0.2 0.0, 0.4 
 
 
 
Table 3.7 Statistical data for each calibration method, analysed by calibration type. 
 
Gel dosimeter  Diff (%) St. Dev. 95 % CI 
        
PAG 0.4 0.2 0.1, 0.8 
Fricke 0.3 0.2 -0.1, 0.6 
MAGIC 0.6 0.3 0.2, 1.0 
BANG-1 0.3 0.3 -0.2, 0.7 
BANG-2 0.4 0.4 -0.3, 1.0 
 
 
 
 
3.9.5 Discussion 
It is clear that the majority of calibration methods evaluated in the present study, provided 
they are performed in a precise manner, accurately reflect the dose given to water within the 1 
% uncertainty limit typically specified in the context of radiotherapy. For all methods 
excepting the long coaxial test tube, the 95 % confidence interval for the percentage 
difference between the calculated dose to gel and the dose to water is contained in the interval 
[-1.0 %, 1.0 %]. 
 
While results for different methods and different materials are not necessarily from consistent 
distributions, it is useful to impose some statistical analysis of the data. Nine analyses were 
undertaken as shown in Table 3.6 and Table 3.7 considering each calibration method and gel 
material individually. Note that although the data are only reported to one significant figure, 
confidence intervals were calculated exactly prior to rounding. In all cases the distribution 
was consistent with a normal distribution. 
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For the calibration methods, the mean is significantly different to zero at the 95 % confidence 
level for 3 methods, but the 95 % confidence interval spans zero for the large flask method. 
For the different gel materials, the PAG and MAGIC gels gave results significantly different 
to zero at the 95% confidence level, while the other 3 did not. In all 5 cases the confidence 
interval was [-1.0 %, 1.0 %]. 
 
For all the combinations of gel type and calibration geometry, the various differences lie a 
large number of standard deviations from -1 %, and the probability that a difference will 
occur beyond this is negligible (i.e. the differences are close to zero – far from -1 % even if 
you consider the tail end of σ). Applying a normal distribution, the probability that a random 
occurrence of the difference lies beyond 1 % is less than 1 % for the vast majority of the 
arrangements. The exceptions are MAGIC and BANG-2 in Method A, MAGIC in Method C 
and PAG in Method D, for which the probability of the difference exceeding 1 % is 7 %, 16 
%, 16 % and 2 % respectively. 
 
Users of those combinations of gel and geometry yielding the possibility of >1 % dose 
differences should consider incorporating these differences into calibration correction factors. 
Method E (a long test tube coaxial with the beam) exhibits results quite different to the other 
techniques. As shown in Table 3.5, differences between dose to gel and dose to water begin 
within 1 % at one sigma at a depth of 5 cm, and increase with depth to up to 2.2 % at 15 cm. 
This is due to the cumulative effect of the different attenuating properties over the relatively 
long path length in gel. Readers may employ the data presented here to help influence their 
choice of calibration technique, by preferentially considering those which exhibit the least 
difference to water. 
 
As shown in Table 3.4 and Table 3.5, broadly, the Fricke formulation exhibits the least 
difference with water. For most of the calibration methods studied, the influence of the 
container on the dose to gel is small, so long as measurements are taken at specific points. 
The radial dose plots indicate that the dose varies laterally. The magnitude of the disparity is 
influenced by the volume over which the dose is averaged. 
 
Knowledge of the radial distributions as presented in this work makes it possible to minimize 
the error introduced. The volume may be chosen such that build-up effects and the low dose 
regions caused by attenuation may compensate for one another. The small vial technique is 
sometimes performed so that multiple vials are irradiated simultaneously in an array, so as to 
reduce total beam time. The radial plots indicate the closest proximity a neighboring vial may 
be placed such that the cross-talk is minimized. 
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There are observable trends associated with the different methods. Ranking the methods in 
terms of increasing disparity, it is clear that Method B using a large flask is the optimal 
technique. In terms of set-up, this method is also likely to be more straightforward than the 
other techniques. The presence of a small nitrogen pocket has a negligible effect on the 
measurement at Dmax. It is the least difficult to position for both irradiation and subsequent 
measurement. All other techniques shown here involve vessels of gel submerged in a water 
phantom, which likely involve more complex positioning structures and so forth given the 
necessity for accurate localization. The next best method is the small test tube placed 
perpendicular to the beam at a depth of 5 cm within a water phantom (Method D). After this, 
a small vial, coaxial with the beam, placed 5 cm deep within a water phantom where the dose 
gradient is relatively linear (Method A). Exhibiting a slightly greater difference is the method 
involving a large test tube perpendicular to the beam at a depth of 5 cm (Method C). The 
technique resulting in doses to gel least close to that of water is the method whereby a long 
test tube is placed at the surface of a water phantom coaxial with the beam, such that a dose 
distribution is achieved along its length (Method E). 
 
We have employed Monte Carlo radiation transport modeling to evaluate the water 
equivalence of five different gel formulations under varying conditions corresponding to five 
different methods of calibration. From this we can identify that BANG-1 and Fricke are the 
most water equivalent gel formulations and the ‘large flask’ and ‘small vial’ methods exhibit 
the smallest differences. 
 
 
 
3.10 Summary 
There are many types of dosimeter that may be employed for the measurement of dose in the 
context of radiation therapy. The three most commonly employed dosimeters in a typical 
clinic are ionisation chambers, radiosensitive films and thermoluminescent dosimeters. All 
dosimeters have various advantages and disadvantages. For stereotactic fields, a review of the 
literature has shown that typically a number of dosimeters are employed to characterise small 
fields – and often there are significant discrepancies between dosimeters when measuring the 
same field. 
 
Here, gel dosimeters – which act as both dosimeter and phantom material – have been 
identified as showing great promise for the measurement of three-dimensional dose 
distributions in stereotactic radiotherapy. 
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In this chapter, an overview of aspects of gel dosimetry has been given, including their 
manufacture, mechanisms for radiation response and read-out. However, clinical 
implementation of gel dosimeters has been very limited by comparison to other methods. 
There are a number of reasons for this, which include very practical issues such as a lack of 
chemical handling and preparation facilities in clinical physics departments. 
 
In the present work, the focus has been on investigation of the composition and radiological 
interaction properties of the various gel dosimeters available – in particular their effective 
atomic number. In this thesis, effective atomic numbers have been calculated in a novel 
fashion for gel dosimeters, indicating energy dependence and the very limited regime of 
applicability of the power-law method that is typically employed in published literature. One 
important finding is that the subtle differences in effective atomic number between water and 
gels may be considered negligible for most radiotherapy applications. 
 
Furthermore, no standard protocol for gel calibration has been published. As such, the second 
half of this chapter has focused on assessing, via Monte Carlo methods, systematic variations 
in gel dosimeter calibration due to container influence and deviation from water equivalence 
for a range of gels and calibration methodologies. From this, optimum methods have been 
identified that minimise systematic error. 
 
Gel dosimetry has been identified as being highly suited to the characterisation of stereotactic 
radiotherapy fields, and its use is demonstrated for verification of clinical treatments as 
described in Chapter 5. 
 
At the cutting edge of dose calculation – rather than measurement – of stereotactic fields is 
Monte Carlo radiation transport, which is discussed in significant detail in the following 
chapter. 
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CHAPTER FOUR 
 
The apparition of these faces in the crowd; 
Petals on a wet, black bough. † 
Ezra Pound 
 
 
                                                 
†
 Perhaps this concise poem written in haiku style about the underground Parisian metro seems chosen randomly, 
but the elegant simplicity of imagist poetry – of which Pound is my most admired proponent – seems appropriate 
for a chapter devoted, essentially, to mathematical calculation. Indeed Pound himself was quoted as saying with 
reference to this poem that the faces of those in the metro were best put into a poem not with a description, but 
with an equation. 
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CHAPTER 4 
Theoretical dose calculation 
 
Radiation transport modelling for the 
investigation of small-field beam 
characteristics 
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4.1 Overview 
There are a wide range of mathematical descriptions of the different interactions of ionising 
radiation in materials, each with different limitations and approximations. The calculation of 
dose deposited by radiation as a result of such interactions in the context of radiotherapy is of 
critical importance. Treatment planning systems (TPS) employ algorithms to calculate doses 
in patients as part of the treatment optimisation process, sacrificing some level of accuracy in 
order to achieve rapid calculation times and hence ensure efficient patient throughput in a 
clinical context. There are a range of potential issues: 
– Approximations in TPS algorithms often result in insufficiently accurate treatment of 
charged particle equilibrium. 
– This has consequences for small fields (in particular where the size of the field 
approaches the range of secondary electrons) and for heterogeneities. 
– Calculation of small fields with TPS is still reliant upon broad-beam measured data 
for input, and is thus limited by the accuracy of the dosimeter employed and 
suitability of extrapolation to small fields. 
 
Ideally, for the characterisation of stereotactic fields, it is necessary to have an accurate means 
of calculating dose distributions (and, if possible, other quantities such as fluence, spectra, 
etc). Monte Carlo radiation transport methods are widely accepted as the most accurate means 
of calculating dose and other relevant quantities. 
 
This chapter essentially describes the development of a capability for accurate 
characterisation of stereotactic fields – spectral and dosimetric: 
– Dose calculation algorithms implemented in commercial treatment planning systems 
are described, with an emphasis on noting their limitations. 
– The Monte Carlo method of simulating radiation transport is described in more detail, 
being considered the most accurate approach for dose calculation. 
– The Electron Gamma Shower (EGSnrc) code is employed for many applications in 
this study, and consequently is described thoroughly. 
– The key result of this chapter is the development and commissioning of a Monte 
Carlo model of a Varian 600C medical linear accelerator with mounted BrainLAB™ 
mini-multileaf collimator. 
 
The methods developed in this chapter are employed for numerous investigations 
characterising stereotactic fields, described in later chapters. 
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4.2 Dose calculation in clinical treatment planning systems and the 
limitations thereof 
4.2.1 Calculation of dose 
As has been discussed, the absorbed dose is the relevant parameter for planning and reporting 
a radiotherapy treatment. Contemporary radiotherapy treatment planning systems (TPS) 
provide the capacity to computationally determine the dose delivered to a patient, superseding 
the relatively laborious and limited hand-planning techniques. Because three-dimensional 
measurement of dose within a patient is not feasible, in a clinical setting there is no choice but 
to model in some way the dose given in a treatment plan. Recent developments in imaging 
modalities have improved the capacity for target delineation. With this come attempts to 
improve delivery precision; contemporary methods such as IMRT select treatment 
arrangements via an optimisation method within the range of available degrees of freedom in 
delivery. Initially, treatment planning involved the use of empirical techniques, which clearly 
limits the treatment geometries that can be employed confidently. Despite knowledge of 
transport equations, analytical dose algorithms sometimes lack the generality required for use 
in many treatment geometries. Monte Carlo methods represent the gold standard in dose 
calculation, modelling the interactions of all primary radiations and those generated from 
subsequent cascades. This, however, is not widely adopted in a clinical context because of the 
high demand on the central processing unit (CPU) time. Hence, the option most frequently 
employed is to adopt semi-analytical algorithms. Invariably, these incorporate approximations 
and hence are limited in their accuracy. The AAPM / ASTRO working group categorises dose 
computation algorithms as correction-based broad-beam algorithms, correction-based pencil 
beam algorithms, superposition or convolution kernel-based algorithms and Monte Carlo 
algorithms (IMRT-CWG 2001). 
 
 
4.2.2 Density scaling and approaches to heterogeneities 
The dose information used in treatment planning is predominantly derived from dose to water 
data. Dose in other media and the presence of inhomogeneities is often treated using ‘density 
scaling’. Dating back to 1954, one theory suggests that when a medium of constant elemental 
composition but varying density is subjected to a constant photon fluence, the fluence of 
secondary particles is also constant (Fano 1954). The primary assumptions here are that the 
cross sections per unit mass are independent of the density of the medium, and that the 
primary photon attenuation, density effect and the generation of secondary photons are 
negligible processes. O’Conner presented a theory suggesting that the ratio of fluences of 
secondary to primary radiations is constant in two media of different density but same atomic 
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composition, provided that relevant geometrical distances (such as field sizes) are scaled 
inversely to the density (O'Conner 1957). Though widely implemented, analysis of the 
accuracy of the density scaling method in its treatment of inhomogeneities by comparison 
with Monte Carlo has shown that discrepancies ranging up to 50 % may exist (Woo and 
Cunningham 1990). 
 
There are a range of approaches to heterogeneity corrections, a comprehensive review of 
which may be found in Ahnesjo and Aspradakis (1999). Many approaches consider densities 
only along the path of the primary photon, approximating the medium as a series of slabs that 
are laterally infinite. Applicable for water-like media only, the ‘effective path length’ method 
involves scaling the broad beam dose distribution according to the factor that the primary 
fluence at the point of calculation has changed by, as compared with the homogeneous case. 
Sontag and Cunningham showed that this method is not accurate for highly heterogeneous 
media, nor for interfacial regions (Sontag and Cunningham 1977). The ‘power-law method’ 
was first suggested by Batho and then generalised by Sontag and Cunningham, using 
correction factors based on build-up depth shifted tissue-maximum-ratios (Batho 1964; 
Sontag and Cunningham 1977). However, this method has been shown to be of limited 
applicability, being inaccurate for large inhomogeneities (Wong and Henkelman 1982) and 
for small fields (Thomas 1991). The equivalent tissue-air-ratio method (Sontag and 
Cunningham 1978) drew on computed tomography (CT) data, employing the density scaling 
theorem and thus being subject to the associated limitations thereof. 
 
 
4.2.3 Modelling scattered radiation  
Calculation of the scatter dose is of understandable importance. Less computationally 
demanding than full Monte Carlo modelling, ‘implicit modelling’ of scattered particles may 
be performed. The most widely implemented approach to this is the ‘kernel’ method. This 
functions on the principle of superimposed, weighted responses to point irradiations – 
‘kernels’. Each individual kernel represents the dose deposition due to secondary radiations 
resulting from a point irradiation, typically calculated via Monte Carlo. This can be done for a 
range of monoenergetic primary photons and the results stored in a database; superposition of 
these for a beam of known spectrum can then yield kernels. A variation of the point kernel 
method is the pencil-beam method, a correction-based algorithm, which represents the dose 
deposition in a semi-infinite medium from a point monodirectional beam (Mohan et al. 1986; 
Mohan and Chui 1987; Ahnesjo et al. 1992). These are calculated via Monte Carlo either 
directly or by superposition of point kernels. The point kernel and pencil-beam methods are 
illustrated in Figure 4.. 
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Figure 4.1 Illustration of (a) a point dose kernel and (b) a pencil-beam dose kernel. 
 
 
The pencil-beam method is the most frequently employed, however, the method is not 
without limitations, relying on broad beam scaling corrections for heterogeneities. The 
primary problem is the lack of lateral electron transport (Nilsson and Knoos 1992); 
superposition accounts for the range of electrons ejected by primary photon interactions, 
however, linear electron paths are assumed and are scaled by the density only, ignoring lateral 
deflection due to scattering (Hoban et al. 1990). In regions of insufficient charged particle 
equilibrium, there are discrepancies in the calculated dose that increase significantly with 
energy (Knoos et al. 1995). On the low energy scale, overestimations of dose exist that are 
attributed to the approximation for the integration volume for scatter calculations (Hurkmans 
et al. 1995).  
 
The kernel superposition approach is relatively time efficient compared to full Monte Carlo 
modelling, however, reasonable throughput in clinical practice requires that the calculations 
be as fast as possible. As a result, numerous algorithms exist that attempt to speed up the 
process. Of particular note is the ‘collapsed cone convolution’ of point kernels method 
(Ahnesjo 1989), which has been shown to improve the match with measured and Monte Carlo 
dose distributions, as compared with the standard pencil-beam method (Partridge et al. 2006). 
A range of commercially available IMRT treatment planning systems and their associated 
dose calculations algorithms are given in Table 4., and their clinical performance has been 
compared by Fogliata et al (2007).  
 
 
 
 
 
(a) (b) 
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Table 4.1 A range of commercial treatment planning systems (TPS) and their calculation algorithms. 
References: a (Nizin et al. 2001), b (Chui et al. 1994), c (Spirou and Chui 1998), d (Ulmer and Harder 
1995), e (Ulmer and Harder 1996), f (Alber and Nusslin 1999), g (Alber and Nusslin 2001), h (Bortfeld 
et al. 1993), i (Gustafsson et al. 1994), j (Gustafsson et al. 1995), k (McNutt 2002), l (Wu et al. 2003), m 
(McNutt 2002), n (Hardemark et al. 2004) and o (Xiao et al. 2000). 
 
TPS Calculation algorithm 
  
Corvus (5.0) Pencil beam a 
Eclipse (7.5 14.3) Anisotropic analytical algorithm b,c,d,e 
Hyperion (2.1.4) Monte Carlo f,g 
KonRad (2.2 18) Pencil neam h 
Oncentra Master Plan (1.5) Pencil beam i,j 
Pinnacle 3 EUD (7.4f) Collapsed cone k,l 
Pinnacle 3 Phys (7.4f) Collapsed cone m,n 
PrecisePLAN (2.03) Pencil beam o 
CMS Xio Collapsed cone 
Radionics X-Knife Pencil beam 
iPlan Pencil beam 
  
 
 
 
4.2.4 The iPlan™ Dose calculation algorithm 
At the William Buckland Radiotherapy Centre (The Alfred Hospital, Melbourne), small fields 
are delivered by a Varian 600C Clinac with mounted BrainLAB m3 mini-multileaf collimator 
(MMLC). Plans are generated with iPlan (BrianLAB, Feldkirchen) dose calculation software. 
The iPlan software employs a pencil beam dose calculation algorithm. Pencil beams have 
been discussed briefly in the previous section, with an emphasis on their limitations. The 
iPlan algorithm is discussed more specifically in this section, as it is the planned doses that 
will be compared to that measured experimentally and calculated via Monte Carlo methods. 
 
The iPlan pencil beam algorithm uses photon beam data calculated by Mohan et al (1985; 
1986; 1987). In this method, the incident beams are subdivided into small ‘beamlets’. For 
each beamlet, a radiological path length correction is applied to correct for density 
inhomogeneity. A fast Fourier transform (FFT) is applied for the beam kernel convolution 
with the fluency distribution of the beam. 
 
The convolution between pencil beam kernels and photon fluence assumes that pencil beam 
kernels are translation invariant in x and y directions (a homogeneous medium is assumed). 
For doses near inhomogeneities this assumption can fail. Further approximations are 
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incorporated into the equation for the tissue maximum ratio (TMR). The TMR characterises 
the dose as a function of depth, similarly to the common percentage depth dose (PDD), with 
the main difference being (effectively) independence of SSD. However, the corresponding 
equation incorporates assumptions that introduce an error, the size of which increases for 
increasing depth and decreasing field size. 
 
Ultimately, a range of dose calculation algorithms exist, each of which is subject to various 
approximations and limitations. Of particular note is the broad assumption of electronic 
equilibrium, which reduces the accuracy of the dose calculations for small fields and for 
regions in the vicinity of high-low density interfaces. For this reason, it may be necessary to 
verify the accuracy of such calculated dose distributions, whether experimentally or via 
Monte Carlo modelling. 
 
 
4.2.5 A comment on limitations in the context of out-of-field dose calculation  
Treatment planning systems (TPS) are normally commissioned using measured data that 
extend only a few centimetres beyond the field edge, with penumbra defined as 80 % to 20 % 
of the maximum dose for the field. Dose extending outside the field is not intended to be used 
for the overall calculation of the dose distribution or contribute to the inverse optimisation 
procedure. Therefore, one would expect the dose distributions predicted by the iPlan TPS to 
be inaccurate in regions far from the primary field. Even low-dose regions in close proximity 
to the main treatment field have been shown to be calculated inaccurately by treatment 
planning systems. Jang et al (2008) showed this recently for intensity-modulated radiotherapy 
by comparison to Monte Carlo dose calculation. 
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4.3 The principles of Monte Carlo radiation transport 
Analytical (i.e. non-numerical) calculation of the integro-differential equations that describe 
the development of electromagnetic showers in matter is prohibitively difficult without 
significant approximations. Briefly referred to in the previous section, Monte Carlo radiation 
transport is the only broadly applicable solution. Monte Carlo simulation is widely accepted 
as the best means of dose calculation because it explicitly models many of the interaction 
processes ignored or simplified by treatment planning software algorithms.  
 
In a general sense, when the Monte Carlo technique is employed for the purpose of studying 
physical phenomena, as opposed to purely mathematical applications, it can be best described 
as a numerical solution to a (macroscopic) problem that models the (microscopic) interaction 
of objects with other objects or environments via simple object-object or object-environment 
relationships. A solution is determined via random sampling of the microscopic interactions 
until a convergent result is obtained (Bielajew 2001). The generation of random numbers for 
this purpose is thus the key element of a Monte Carlo simulation. True random number 
generation is in practice not implemented because of its inherent complexity and the difficulty 
of interfacing it with the Monte Carlo code. As such, it is ‘pseudo’ random numbers which 
are generated – something which in itself constitutes a field of mathematical study. The 
pseudo-random quality of Monte Carlo simulations emulates the true stochastic nature of 
radiation interactions. A sampling method (devoted to which there is again much theory) is 
then implemented to select and reject generated values according to defined probability 
distributions. Uncertainty estimation in Monte Carlo simulation is crucial. The stochastic 
nature of the process means that calculated values are subject to statistical variance.  
 
 
 
4.4 Monte Carlo calculation of small-field dose characteristics 
4.4.1 Dose calculation for treatment planning 
Monte Carlo radiation transport methods represent the best means of dose calculation, 
however, are not widely adopted in a clinical context because of the high demand on the 
central processing unit time. Semi-analytical algorithms are more common in clinical 
treatment planning systems. While of acceptable accuracy for many applications, the use of 
TPS-calculated dose distributions for very small fields is sometimes dubious. This is 
compounded in the vicinity of inhomogeneities. Monte Carlo methods provide the potential 
for more accurate calculation of stereotactic field quanta. 
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4.4.2 General purpose Monte Carlo radiation transport codes 
Monte Carlo radiation transport simulation explicitly models the interaction of individual 
particles. There is a general scientific consensus that Monte Carlo dose calculation may be 
used as a standard by which to compare other calculation or measurement methods. There are 
numerous available Monte Carlo radiation transport codes that may be employed for the 
investigation of stereotactic fields. These include the Electron Gamma Shower (EGS) codes  
and in particular the BEAMnrc (Rogers et al. 1995) extension of EGSnrc (Kawrakow and 
Rogers 2006), the Monte Carlo N-Particle (MCNP) code (Team 2003), and GEANT4 
(Agostinelli et al. 2003). The latter two codes were originally developed for high-energy 
applications. As indicated in Figure 4.2, in the context of stereotactic radiotherapy the EGS 
codes are most frequently employed. Aside from confidence in the accuracy of the transport 
algorithms, the reason for the widespread use of this code in particular is likely to be due to 
the easy implementation of the BEAMnrc package, which makes component-by-component 
modelling of a linear accelerator readily achievable.  
 
 
Figure 4.2 A breakdown of thirty-seven relevant scientific papers (employing general Monte Carlo 
codes) indicates that the Electron Gamma Shower codes are the primary codes employed in the study 
of stereotactic fields, with EGS4 being employed most frequently in the early 2000s and EGSnrc being 
employed in the late 2000s. 
 
 
 
4.4.3 Studies employing EGSnrc and EGS4 for small-field dose calculation  
The majority of papers dealing with Monte Carlo calculations in the context of stereotactic 
radiotherapy from the late 1990s to early 2000s employed EGS4. It has been common for 
EGS4 to be used to verify small field measurements undertaken with various detectors 
(Heydarian et al. 1996; Westermark et al. 2000; Haryanto et al. 2002; Tsougos et al. 2004), 
often identifying quite significant discrepancies (tens of percent) compared to routinely-
employed dosimeters such as ionisation chambers and film (De Vlamynck et al. 1999; 
EGS4
36%
MCNPX
3%
PENELOPE
11%
EGSnrc
50%
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Cheung et al. 2000) (Deng et al. 2003; Paskalev et al. 2003). Poor calculation by treatment 
planning systems has been demonstrated (Scielzo et al. 1998) and the spectral characteristics 
of stereotactic fields have also been evaluated (Verhaegen et al. 1998) – a key aspect of 
stereotactic radiotherapy field characterisation, and one which is discussed at length in 
Chapter 5.  
 
Readers are referred to the relevant review paper by the candidate for greater detail (Taylor et 
al. 2011d), but in general one may make several key observations: 
– EGS was the Monte Carlo code of choice for stereotactic radiotherapy applications in 
the 1990s. 
– Comparisons of EGS to treatment planning calculations revealed discrepancies of up 
to 5 % and 20 % for PTVs in homogeneous and heterogeneous regions respectively. 
– Dosimeter measurements have been compared to EGS for field sizes of the order of 
millimetres, with the Monte Carlo code used to identify issues of detector volume 
averaging. 
 
EGSnrc is the most widely used full Monte Carlo code for contemporary studies in 
stereotactic radiotherapy. Numerous authors have investigated small fields via Monte Carlo 
methods, comparing findings to experimental measurements for linac-based stereotactic fields 
(Sanchez-Doblado et al. 2007; Ding et al. 2008; Heydarian et al. 2008; Zhao et al. 2008) and 
Cyber-Knife fields (Araki 2006; Francescon et al. 2008). In many cases, dosimeters are 
shown to measure small-field characteristics very poorly, with discrepancies in the order of 
tens of percent for fields in the mm – cm range (Capote et al. 2004; Ding et al. 2006; Scott et 
al. 2008). Extrapolation to ‘zero’ field size has been demonstrated via Monte Carlo methods 
(Cheng et al. 2007). Evidence for the characteristics of small fields being highly sensitive to 
the electron beam incident on the bremsstrahlung target has been established (Scott et al. 
2009) (Sanchez-Doblado et al. 2007) – a concept which shall be discussed in greater detail 
when describing the model constructed in the present study. EGSnrc has also been used to 
highlight the limitations of treatment planning systems, which may exhibit inaccuracies of the 
order of tens of percent compared to Monte Carlo, particularly in the vicinity of 
heterogeneities (Jones et al. 2003; Jones and Das 2005; Lydon 2005; Ding et al. 2007; Sterpin 
et al. 2007; Moiseenko et al. 2010). 
 
The interested reader is referred to the review paper by the candidate for more detail (Taylor 
et al. 2011d), but in summary one may note several key findings: 
– EGSnrc is currently the most frequently employed full Monte Carlo code for 
stereotactic radiotherapy applications. 
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– EGSnrc has highlighted poor treatment planning system dose calculations, 
particularly in the vicinity of heterogeneities. 
– EGSnrc has been used to verify detector measurements of stereotactic fields, and has 
informed the correction of output factors for small field sizes. 
 
 
 
4.4.5 Studies employing other available codes for small-field dose calculation  
Other codes have also been employed for the study of stereotactic fields, albeit with less 
frequency than the EGS-based transport codes. Boudou et al (2005) used MCNPX to 
investigate the potential for synchrotron-based SRT (with beam energies of 50-85 keV). 
Moskvin et al (2002) verified PENELOPE for Monte Carlo calculation of Gamma-Knife SRS 
fields against measured data and calculations by other authors (using EGS4). Two years later, 
Moskvin et al (2004) investigated the effects of inhomogeneities using PENELOPE and a 
heterogeneous phantom (again, for their Gamma-Knife unit), and found that the TPS 
underestimated dose by up to 7 %. Lax et al (2006) compared pencil beam and cone-
convolution algorithms to PENELOPE calculations (for a Varian 2300CD), finding that the 
pencil beam in particular significantly overestimated dose. Panettieri et al (2007) compared 
three TPS algorithms to PENELOPE Monte Carlo calculations for a Varian 2100CD. The 
TPS was found to overestimate dose by up to 10 % in the periphery of the gross-target 
volume. 
 
 
4.4.6 Monte Carlo codes optimised for radiotherapy applications 
The complexity of non-equilibrium dosimetry means that Monte Carlo calculated small-field 
dose distributions would be the clinical ideal; however, prohibitively long computation times 
restrict routine clinical use. The discussion thus far has deliberately focused on general 
purpose Monte Carlo codes which are capable of modelling a large number of particle types 
and interaction modes over a very broad energy range. The advent of simplified Monte Carlo 
TPS algorithms that employ some simplifications and approximations are likely to be an 
improvement over other contemporary TPS algorithms. These include hybrid approaches in 
treatment planning systems whereby some component of the calculation is undertaken with 
Monte Carlo whilst others are undertaken using more computationally efficient algorithms 
(Freud et al. 2007; Freud et al. 2008). Another strategy is to employ a Monte Carlo code 
which has been entirely optimised for radiotherapy applications. See the TG105 report for 
greater detail on the clinical implementation of Monte Carlo (Chetty et al. 2007). Table 4.2 
summarises available Monte Carlo codes optimised for radiotherapy. Ultimately, it is 
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probable that a high-efficiency full Monte Carlo model that explicitly simulates all aspects of 
radiation transport will remain the ultimate desideratum. Such a code, if one could be made to 
run within a clinically-acceptable timeframe, would be attractive because of its flexibility, in 
the sense that functionality beyond the most common treatment conditions would be 
available. 
 
Rogers and Mohan (2000) suggest comparisons in terms of geometry (both homo- and hetero-
generous), uncertainties and issues of approximations in the underlying physics. Figure 4.3 
shows a comparison of simulation times for various full Monte Carlo and treatment planning 
optimised Monte Carlo codes, relative to EGS4, achieved when using a simple standard 
geometry specified by Rogers and Mohan. This indicates the speed that may be achieved with 
the TPS Monte Carlo implementations. 
 
 
 
Figure 4.3 A comparison of the simulation times of various treatment planning optimised and full 
Monte Carlo radiation transport codes. The data is based on that compiled by Chetty et al (2007). The 
times presented are relative to EGS4 (which were performed using the PRESTA algorithm and in a 
Cartesian geometry, DOSXYZ). The simulations were undertaken for the simple geometry specified by 
Rogers and Mohan (2000), under which conditions the codes generally agreed within 1 %. Note the 
logarithmic scale. 
 
 
 
VMC++
XVMC
MCDOSE
MCV
EGS4 PEREGRINE
MCNPX
GEANT4
0.01
0.1
1
10
Monte Carlo code
Si
m
u
la
tio
n
 ti
m
es
 
(re
la
tiv
e 
to
 E
G
S4
)
  105
 
Table 4.2 A summary of different Monte Carlo codes optimised for radiotherapy applications. 
 
Code Ref. Description 
MMC (Neuenschwander 
and Born 1992; 
Neuenschwander 
et al. 1995) 
Macro Monte Carlo (MMC) implemented in commercial 
TPS (‘eMC’, Varian) for electron beams. Data pre-calculated 
with EGSnrc for electrons in small spherical voxels. 
Transport through CT phantom based on latter.  
PEREGRINE (Cox et al. 1997) Simulates radiation through collimators using pre-calculated 
source input. Source obtained using BEAM modelling of 
linac head. Transport through beam shapers involves several 
approximations (Schach von Wittenau et al. 2000). 
MCDOSE (Li et al. 2000; 
Ma et al. 2002) 
Based on EGS4. Modifications (for efficiency) are mostly to 
electron transport algorithms. Uses source model for 
accelerator head; input into patient-specific beam modifiers 
(tongue-and-groove effect in mini-multileaf collimators 
ignored). Shown to match EGS4 well in various geometries 
(Li et al. 2000). 
VMC, XMVC, 
VMC++ 
(Kawrakow et al. 
1996; Fippel 
1999; 2000) 
Voxel Monte Carlo (VMC) originally intended for electron 
beams; photons incorporated later (XVMC). Kawrakow and 
Fippel later developed VMC++, with modifications such as 
relativistic spin and ‘exact’ multiple scattering (Kawrakow 
and Bielajew 1998). VMC-based codes being incorporated 
into commercial TPS packages by several vendors, including 
Elekta, BrainLAB, Nucletron and Varian. 
MCV (Siebers et al. 
2000) 
Monte Carlo Vista (MCV) implemented as part of 
commercial TPS (Pinnacle, Philips Radiation Oncology 
Systems). Accelerator head modelled with BEAM, stored 
and used as input for patient-specific geometries. Patient-
specific calculations may be performed using DOSXYZnrc 
(an EGSnrc usercode), VMC++ or MCVRTP – a code 
developed by Philips (based on EGS4). 
RTMCNP (DeMarco et al. 
1997) 
Radiotherapy-oriented MC code, functions as a pre-processor 
for MCNP4. Only implemented for research applications so 
far. Source library is used, and RTMCNP converts patient 
CT into lattice geometry with set number of defined media. 
Patch used to modify standard transport algorithms. 
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Ultimately, while such codes will likely be a significant improvement over traditional TPS 
algorithms, one must be cautious not to make the inference that Monte Carlo dose calculation 
in a treatment planning system necessarily refers to explicit modelling of all particles and 
their progeny.  
 
The reason for the strong interest in Monte Carlo methods as applied to stereotactic 
radiotherapy is the increased confidence it gives in the accuracy of calculated dose 
distribution, which can be very complex for small fields. Acceptable for some applications, 
there does exist published Monte Carlo data regarding beams of radiation from medical 
linacs. 
 
 
 
4.5 Linac beam data in the public domain: The Mohan spectra 
4.5.1 Overview 
Imperative to the characterisation of a treatment beam is knowledge of the spectral qualities. 
Such data can be employed to determine subsequent dose distributions in the medium of 
interest. Unfortunately, direct experimental measurement of beam spectra is prohibitively 
difficult (namely due to the high particle fluxes involved). However, the energy spectra may 
be determined readily via Monte Carlo radiation transport modelling of a linac. The seminal 
work in this area was presented by Mohan et al (1985) a quarter of a century ago, and the data 
therein is still frequently used and referred to today. As such, where generality and 
reproducibility are deemed to be of high importance in the original works detailed in this 
thesis, the ‘Mohan spectra’ have often been employed.  When this is not the case, an in-house, 
dosimetrically-matched Monte Carlo model has been employed, and this is discussed in latter 
sections. 
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4.5.2 The Mohan spectra 
Mohan et al used Electron Gamma Shower (EGS) Version 3 to model Varian Clinac-4, -6, -
18, -20 and -2500 linear accelerators. They employed energy cut-offs of 0.01 MeV for 
photons and 1 MeV for electrons. Energy spectra were scored in a plane perpendicular to the 
central axis at a specified distance from the target. Annular bins of various sizes were used to 
score the data. Figure 4.4 shows the energy spectra for 4, 6, 10 and 24 MV linacs. The mean 
energies are given in Table 4.3.  
 
While the Mohan spectra are useful in some contexts because of their wide availability and 
the generality and reproducibility that facilitates, thorough characterisation of the beams 
(which is the objective of this study) necessitates construction of a fully-detailed 
dosimetrically-matched linac model. This endeavour, undertaken using the Electron Gamma 
Shower Monte Carlo code, is discussed in detail in the following sections. 
 
 
Table 4.3 The mean energies (in MeV) of various nominal-energy linacs as calculated by Mohan et al 
(1985), for various radial bins (away from the central axis). The standard deviation in each is < 5 %. 
 
 Nominal (MV) 
Radial bin (cm) 4 6 10 15 24 
0-2 1.51 1.92 2.97 4.11 6.30 
2-3 1.41 1.91 2.88 3.94 5.97 
3-5 1.38 1.88 2.80 3.88 5.81 
5-10 1.34 1.81 2.52 3.58 5.33 
10-15 1.27 1.69 2.23 3.28 4.68 
15-20 1.17 1.51 1.92 3.03 3.95 
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Figure 4.4 The energy spectra calculated by Mohan et al (1985) for (a) 4 MV, (b) 6 MV, (c) 10 MV 
and (d) 24 MV beams. In each case, the spectrum is taken for a radial bin of 0-3 cm about the central 
axis for a 10 x 10 cm2 field, with the exception of the 24 MV beam which has a radial bin of 0-2 cm. 
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4.6 The Electron Gamma Shower code 
4.6.1 Overview  
The Electron Gamma Shower (EGS) code is a general purpose package for the Monte Carlo 
simulation of coupled electron-photon transport in arbitrary, user-defined geometries for 
energies ranging from a few keV up to hundreds of GeV. In this study, EGSnrc has been 
employed. EGSnrc is an enhancement of EGS4 (Nelson et al. 1985), and a detailed description 
of the code may be found in the EGSnrc manual (Kawrakow and Rogers 2006). The transport 
of photons, electrons and positrons may be simulated in any element, compound and mixture, 
with particle steps that are random in length rather than discrete. This section of the chapter 
gives an overview of various aspects of the code, including its validation and suitability for 
the applications described in this work. 
 
 
4.6.2 Pseudo-random number generation in EGSnrc 
Being the fundamental element of a Monte Carlo code in general, it is first worth mentioning 
the random number generator. The default random number generator in EGSnrc is RANLUX 
(James 1994; Luscher 1994), and has a period of over 10165. The random number generator is 
portable, and as such results are machine-independent. Multiple levels of ‘luxury’ are 
available (between 0 and 4). A luxury level of 0 may exhibit some errors; however, for luxury 
levels above 0 no problems have been reported. With luxury levels of 1 and 4, RANLUX uses 
around 20 % or 60 % of the total CPU calculation time respectively. A luxury level of 4 
requires roughly double the CPU calculation time than for a luxury level of 1 (Kawrakow and 
Rogers 2006).  
 
 
4.6.3 Radiation interactions 
EGSnrc models a range of photon interaction processes, which are summarised in Table 4.4. 
The simulation of electron and positron transport is more complicated than for photons. As it 
slows down through matter, a fast electron (and all the secondary particles created by it) 
undergoes scores of interactions within its medium. Modelling electron transport with an 
interaction-by-interaction approach is thus inordinately computationally demanding. 
However, in the majority of cases, a single collisional event with an atom results in only small 
changes to the particle’s energy and direction. This thus allows the ‘condensed history’ 
approach for charged particle simulation, which involves condensing large numbers of 
transport and collisional processes into a single ‘step’ (Berger 1963). This simplification is 
ultimately what facilitates the Monte Carlo simulation of charged particles in a reasonable 
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time frame, but it gives rise to the concept of a ‘step-size’, which can influence the result 
obtained and thereby introduce artefacts. The cumulative effect of collisions during a given 
step is taken into account by sampling energy and directional changes from multiple 
scattering distributions at the end of the step. In EGSnrc, an energy threshold (defined 
according to the context and desired accuracy) separates these statistically grouped 
interactions and what are known as ‘catastrophic’ interactions. Bremsstrahlung processes that 
generate photons above a certain threshold energy kc, and inelastic collisions that generate 
atomic electrons with kinetic energies above Tc, are simulated explicitly and secondaries 
transported. Sub-threshold events are subject to grouping, and the associated electron 
transport equations employ what is known as the ‘continuous slowing down approximation’ 
(CSDA). The electron interactions modelled by EGSnrc are summarised in Table 4.5. 
 
 
 
4.6.5 Accuracy of the code 
Monte Carlo radiation transport is widely accepted as an accurate means of modeling dose 
distributions, particularly in regions of electronic disequilibrium such as interfaces of high 
and low density media. In the field of radiotherapy, EGSnrc is extensively used for Monte 
Carlo calculations, and has found to be accurate at the sub-percent level in the context of 
external beam radiotherapy (Chibani and Li 2002; Doucet et al. 2003). Validation of the code 
is not the purpose of this study, however, there are a number of works that have been carried 
out which investigate the accuracy of the physics in EGSnrc. In the first instance, the reader is 
pointed to a list of approximately three hundred papers detailing validation of different 
aspects of the Electron Gamma Shower code (Kawrakow 2005). In the Monte Carlo 
investigations carried out here, a step size of 0.25 (maximum fractional energy loss, ESTEPE) 
was employed. EGSnrc has been shown to produce step-size independent results at a sub 0.1 
% level even at interfaces of high Z media in fine geometries (Kawrakow 2000; Verhaegen 
2002). The work undertaken in this study employs the PRESTA-II electron-step algorithm with 
the EXACT boundary crossing algorithm such that the electron transport will go into single-
scattering mode within three elastic mean free paths of the boundary, giving the necessary 
accuracy at peak efficiency. 
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Table 4.4 A summary of the photon interactions handled by EGSnrc. 
 
Interaction Description 
  
Pair production – Pair production in the field of the nucleus (photon materialises into an 
electron-positron pair, facilitated by a third body, a nucleus, required for 
conservation of energy and momentum). Threshold 2mec2. 
– Triplet production in the field of atomic electrons; EGSnrc does not explicitly 
model triplet production, but rather uses the total pair-triplet cross section to 
sample distances to subsequent pair production collisions. Threshold at 
4mec2. 
– Reader is referred to reviews on the pair production interaction process for 
detailed descriptions (Davies et al. 1954; Motz et al. 1969) and a simplistic 
discussion is presented by Raymond (1972). 
Incoherent 
scattering 
– A.k.a. Compton scattering (Compton and Allison 1935). 
– Ejection of atomic electron by incident photon; the wavelength of the 
recoiling photon is altered by an amount dependent upon how much energy 
is given to the electron. 
– EGSnrc incorporates binding effects (an advancement on EGS4) and Doppler 
broadening according to the impulse approximation (Ribberfors 1975). 
Photoelectric – Dominant interaction at low energies.  
– Incident photon absorbed by an atom and an electron is ejected with energy 
equal to that of the photon minus the binding energy of the electron. Atom is 
left with a vacancy in the ionised shell, and relaxes through fluorescence and 
emission of Auger and Coster-Kronig electrons.  
Coherent 
scattering 
– Otherwise known as Rayleigh scattering. 
– Elastic scatter of photons from atoms. 
– Coherent scattering in EGSnrc uses total coherent scattering cross sections 
from Storm and Israel (1970) and the atomic form factor from Hubbel and 
Øverbø (1979). 
– For molecules, the independent atom approximation is implemented in 
EGSnrc, although it should be noted that there is some evidence for 
sensitivity to molecular structure (Johns and Yaffe 1983). 
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Table 4.5 A summary of the electron interactions handled by EGSnrc. 
 
Interaction Description 
  
Bremsstrahlung – Modelled in EGSnrc with the NIST bremsstrahlung cross section database 
(Seltzer and Berger 1985; Seltzer and Berger 1986), 
– Employs Coulomb-corrected extreme relativistic cross sections above 50 
MeV (Koch and Motz 1959), partial wave analysis calculations below 2 
MeV (Pratt et al. 1977) and spline interpolation for the range of energies 
between 2 and 50 MeV. 
Møller & 
Bhabha 
scattering 
– Møller (1932) cross section describes electron-electron scattering and the 
Bhabha (1935) cross section describes positron-electron scattering. 
– In EGSnrc, binding effects are ignored in the treatment of electron and 
positron inelastic scattering with atomic electrons. 
Positron 
annihilation 
– As positron energy tends to zero, cross section for annihilation tends to 
infinity (positrons always annihilate at rest if they have not already). 
– Higher order processes (in nuclear field) are less likely than the one-body 
process, thus EGSnrc restricted to modelling two-photon annihilation. 
Bethe-Bloch 
continuous 
energy loss 
– Assumption: energy is lost continuously along particle path according to the 
Bethe-Bloch theory (Bethe 1930; Bethe 1932; Bloch 1933). 
– EGSnrc employs the formulae recommended by Berger and Seltzer (1964) 
and the International Commission on Radiological Units (ICRU 1984b).  
– Restricted stopping power approach employs a mean ionisation energy and 
EGSnrc employs a density effect correction Sternheimer and Peierls’ (1971). 
Scattering – EGSnrc models electron and positron elastic scattering with the option for 
inclusion of spin effects or elastic scattering based on the screened 
Rutherford cross section. 
– For multiple elastic scattering, EGS4 implements Moliere’s (1948) theory, 
but EGSnrc employs an exact formulation for multiple scattering dependent 
upon the underlying elastic scattering cross sections. 
– EGSnrc also incorporates spin effects in its treatment of multiple scattering. 
Electron steps 
and boundary 
crossings 
– Between catastrophic events, charged particles are transported in short 
straight-line paths along which energy is lost continuously via collisional 
interactions and bremsstrahlung (Kawrakow 2000). 
– At the end of each path-length, the multiple scattering angle is determined 
according to a theoretical distribution.  
– In heterogeneous media, EGSnrc employs an exact boundary crossing 
algorithm, whereby simulation uses single elastic scattering whenever an 
electron comes closer to a boundary than some defined distance.  
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4.6.6 Modelling of linear accelerators using EGSnrc: The BEAMnrc code 
BEAMnrc is a Monte Carlo simulation system (Rogers et al. 1995) for modelling radiotherapy 
sources which was developed as part of the OMEGA project to develop 3-D treatment 
planning for radiotherapy (with the University of Wisconsin). BEAMnrc is built on the EGSnrc 
Code System. The code is designed to deal with a range of geometric structures with different 
symmetries and so on, as suited to the different components of a linear accelerator. It also has 
the capacity to track each particle’s history and allows the total dose to be separated out into 
components corresponding to different sources of scattered radiation.  
 
 
 
4.7 Modelling the Varian 600C medical linear accelerator with mounted 
mini-multileaf collimator 
4.7.1 Overview 
Monte Carlo simulation of radiation transport has been employed in a medical context for a 
number of decades. Although the complexity of the simulated sources and geometries has 
historically been limited by computational power, nowadays simulation of the transport of 
radiation through a medical linear accelerator (linac) is readily achievable. Using Monte 
Carlo methods to simulate radiation transport through a linac treatment head is an accurate 
method for the calculation of complex dose distributions, fluences, energy spectra and so on, 
with the capacity to identify different scattering components. The advent of advanced 
treatment delivery techniques and the limitations of the dose calculation algorithms in 
contemporary treatment planning systems mean that the capacity to accurately calculate 
delivered doses is a useful further clinical verification tool. 
 
A wide variety of Monte Carlo radiation transport codes are now available. One such code, 
EGSnrc (Kawrakow 2000), is interfaced with BEAMnrc (Rogers et al. 2007), allowing 
straightforward modelling of, in particular, radiotherapy linear accelerators. Although there is 
strong interest in Monte Carlo modelling of linear accelerators, the clinical implementation of 
Monte Carlo methods is not widespread in Australia at present. 
 
 If the calculated dose distributions are to be considered to accurately represent those 
delivered, the simulated beam must be validated against an appropriate set of measured data. 
This section of the chapter describes the commissioning of a BEAMnrc model of the Varian 
600C with mounted BrainLAB MMLC. The geometry of the model is based primarily on 
specifications provided by Varian. Many parameters are selected via a process of optimising 
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the match between simulated and measured dose distributions. Justification of the use of 
certain parameters or simplifications is based on data already in the public domain, and as 
such a comprehensive literature review is presented in this section.  
 
 
4.7.2 Key components of the linear accelerator model and simulation parameters 
4.7.2.1 Machine specifications 
The Varian 600C is a standing gantry accelerator with a maximum field size of 40 x 40 cm2. 
It has a standing-wave guide accelerator structure with a 2.5 MW magnetron and diode type 
gun. The geometry and material specifications were obtained from Varian under a non-
disclosure agreement (NDA), and as such the details provided in this section are limited. 
Figure 4.5 is an illustration of the basic components of the accelerator that are replicated in 
the model. An electron beam is made incident upon the upper surface of a target. The 
(primarily bremsstrahlung) photons produced are first collimated by the primary collimator. 
Inset into the primary collimator is a flattening filter, which has a complex contour, and 
functions to flatten the fluence profile of the resulting radiation field. The beam then passes 
through an ionisation chamber, which is composed of a complex number of layers of plastic, 
metallic casing and electrodes for charge collection. This is simplified in the model. The 
mirror is also explicitly modelled, though its influence is likely to be negligible. The Y-jaws 
sit above the X-jaws, and serve to shape the beam. Below this is a light field reticule. 
Mounted at a distance of 49.2 cm from the source is the BrainLAB mini-multileaf collimator 
(MMLC). BEAMnrc facilitates ‘tagging’ components of the model with LATCH bits. This 
allows the total dose to be separated out into components based on where the contributing 
particles have interacted, for instance one may select to only evaluate dose resulting from jaw 
scatter, et cetera.  
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Figure 4.5 Simplified 2D illustration of the basic components of the linear accelerator. The waveguide 
etc is not explicitly modelled. Instead, an electron beam (with user-specified characteristics) is made 
directly incident upon the top of the target. The LATCH numbers for each component are also shown in 
this figure. This figure is intended to illustrate the concept of treating accelerator components 
individually, and is not to scale. 
 
 
 
4.7.2.2 The primary electron beam 
The spot size and energy of the primary electron beam incident on the target is a critical 
parameter that influences dose and fluence distributions. BEAMnrc allows for multiple source 
types, the most appropriate of which in this context is a parallel circular beam of electrons 
with a Gaussian radial distribution, with the option for either a monoenergetic or spectral 
source. 
 
The assumption of monodirectionality is justifiable because the angular divergence from 
central axis is typically between 1 and 5 milliradians (Karzmark et al. 1993), the cosine of 
which is effectively unity. 
 
Target (LATCH = 1) 
Primary collimator (LATCH = 2) 
Flattening filter (LATCH = 3) 
Ionisation chamber (LATCH = 4) 
Mirror (LATCH = 5) 
Y-jaws (LATCH = 6) 
X-jaws (LATCH = 7) 
Mini-multileaf collimator (MMLC) 
(LATCH = 9) 
Light field reticule (LATCH = 8) 
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The beam energy spread is typically restricted to ± 10 % about its central value (Karzmark et 
al. 1993), and is much smaller in modern linacs with a bending magnet. For a Varian 1800 
dual photon linac, the full-width half-maximum of the Gaussian distributed energy spectrum 
for both 6 MeV and 18 MeV has been shown to be 3 % (Tanabe and Hamm 1985). Where 
spectral information of the electron source is unavailable, a monoenergetic beam yields 
acceptable results. The simplest way to determine the energy of the initial electron spot is via 
an iterative modelling approach that circumvents direct measurement. As a first step, one may 
estimate the initial energy of the electron beam, which is most likely slightly lower than the 
nominal energy (6 MeV) in the case of the Varian 600C (Hinson et al. 2008). By simulating a 
10 x 10 cm2 field incident upon a voxelated water phantom, depth dose curves may be 
compared to the equivalent data from water tank measurements. At Dmax and beyond, local 
dose discrepancies should be within 1 to 2 %, and the initial energy should be iteratively 
adjusted until this condition is met. There is some evidence that smaller field sizes may 
exhibit greater sensitivity to variations in the primary electron energy, thus allowing more 
precise refinement (for instance, Siantar et al (2001) suggest 2 x 2 cm2).  
 
Measurement of the spot size and shape is a difficult undertaking. Lutz et al used a slit 
camera constructed from tightly packed thin strips of lead and cardboard with radiographic 
film placed beneath the device, though found quantitative measurements of small spot sizes to 
be difficult, making use of the camera more appropriate for the measurement of relative 
changes over time (Lutz et al. 1988). Shortly after Lutz et al, Munro and Rawlinson (1988) 
used large lead collimators, a diode detector and tomographic reconstruction to determine the 
source size in a range of linacs. They found that the sources (excluding 60Co) were elliptical 
with various eccentricities, and had spot sizes between 0.7 and 3.3 mm full-width half-
maximum (FWHM). Jaffray et al (1993) employed a similar method, finding spots sizes 
between 0.5 and 3.4 mm at FWHM . Loewenthal et al (1992) used two Cu-W alloy blocks to 
create a long slit and obtained a series of images by translating the slit horizontally. The 
images were then examined with a microdensitometer. Using an analytical model they found 
the spot size to be 1.5 ± 0.1 mm for both 8 and 18 MV. Von Wittenau et al (2002) used a 
tungsten rollbar technique to characterise the source spot edge function, and thus size and 
shape, of a megavoltage linac. Treuer et al (2003) used a micro multileaf collimator and grid 
field dose measurements using film dosimetry to determine the spatial intensity distribution of 
the photon source of an Elekta SL25.  
 
Determination of a spot size for use in the BEAMnrc model does not necessarily involve direct 
measurement. Some of the literature described earlier indicates that the shape of the spot may 
be elliptical; however, in practice a circular beam spot is sufficient to generate the 
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experimentally observed photon dose distributions. Depending on the type of beam transport 
system, the shape of the ellipse may change from being tilted one way, to circular, to being 
tilted another way, but presuming there are no nonlinear forces its area will not change. It is 
evident from consideration of the beam optics that the absence of a bending magnet in the 
Varian 600C reduces the potential for energy spread, radial displacement and radial 
divergence that may otherwise occur (though the energy slit and doubly-achromatic bending 
magnets employed by Varian for horizontal waveguide linacs do generate electrons beams 
well focused spatially/energetically). Once there is an optimal match between measured and 
simulated depth dose curves from variation of the primary electron energy, the FWHM of the 
Gaussian beam fluence profile may be determined. Again, this does not necessarily require 
direct measurement, but may be evaluated by an iterative method of varying the radius of the 
spot within the simulation so as to best match output with measured results. The results of the 
aforementioned spot size measurements indicate that 1.5 or 2 mm is an appropriate initial 
estimate of the FWHM. Dose profiles for large fields from water tank measurements may 
then be compared to the simulation results, and the FWHM can be varied until profiles match. 
Depth dose curves should still match, and if this is not the case the energy and FWHM must 
be adjusted again until this is achieved. A recent study by Sham et al (2008) showed that for 
very small diameter beams relevant to radiosurgery, the modelled dose distributions critically 
depend on the diameter of the circular focal spot used in the simulation. 
 
Applying this methodology, the electron beam of the Varian 600C model was chosen to have 
an energy of 5.65 MeV, with a Gaussian radial distribution of FWHM 2.2 mm. This energy is 
close to the experimentally reported value (Hinson et al. 2008) of maximum photon energy 
for a 600C, 5.7 MeV. The FWHM of the spatial distribution is within the expected range 
based on the aforementioned studies. 
 
 
4.7.2.3 Target 
To produce a beam of photons, the electron beam is made incident upon a target at the top of 
the linac head. The target design is of key importance and is discussed in detail here. The 
spectrum of photons generated by MeV electrons incident on the target is complex, being 
composed of a discrete spectrum of positron annihilation photons and characteristic x-rays 
superimposed on a continuous bremsstrahlung spectrum. Collisional interaction in the target 
predominantly results in heat generation, with a small fraction resulting in fluorescence. L-
shell binding energies are small and of little interest compared to K-shell fluorescence. An 
electron (or photon) of kinetic energy greater than 69.5 keV can eject a Tungsten (for 
example) K-shell electron via collision. Transitions to the K-shell result in the emission of 
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characteristic x-rays. Fluorescence emission is a secondary transition process following a 
primary event. As a result, there is no angular correlation with the incident particle and as 
such fluorescence emission is isotropic in energy and intensity. Bremsstrahlung, however, is 
highly anisotropic, with the photons emitted in a direction strongly correlated with that of the 
incident electron. In a linac, bremsstrahlung is the more relevant process. The energy of the 
incident electrons is reduced rapidly by Coulombic interaction with the force fields of atomic 
nuclei, which results in the emission of bremsstrahlung radiation as the electron decelerates. 
From Figure 4.6 it can be seen that for electron interaction in Tungsten, for instance, the 
fractional component of the total stopping power corresponding to radiative energy loss is 
about 36 % for 6 MeV electrons.  
 
 
Figure 4.6 The relative (%) contributions of radiative and collisional interactions on the total stopping 
power of electrons in Tungsten.  
 
 
 
The design of the target has a pronounced effect on the photon beam and thus dose 
distribution, as highlighted by an early paper by Rawlinson and Johns (1973). They found that 
the 25 MeV Varian Clinac-35 produced a beam of photons noticeably softer to those 
produced by the 25 MeV Allis Chalmers Betatron. The depth dose curve produced by the 
former was in fact more similar to the betatron operated at 16 MeV. The significant 
discrepancy between the two was attributed to the different designs of the target and 
flattening filter. 
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Determining angular and spectral information about the bremsstrahlung radiation from targets 
has been the subject of much research. Approaches to this include experimental measurement, 
analytical and Monte Carlo calculation. A brief overview of some studies is given heretofore, 
though it is difficult to separate them by the methodology employed because, as one would 
expect, most involve cross-comparison between the aforementioned techniques. 
 
Analytical attempts at determination of the spectral and angular bremsstrahlung distributions 
from electrons incident on targets may be found as early as the 1930s. Sommerfeld (1939) 
integrated the Bethe-Heitler formula over the angular coordinates of fast electrons exiting a 
thin target in order to find an approximate solution for the bremsstrahlung produced. This is 
not appropriate for thick targets where multiple scattering occurs. Schiff (1946) showed that 
applying Williams’ (1940) theory for the angular distribution of electrons per unit solid angle 
with Sommerfeld’s (1939) gives an approximation for the energy-angle distribution of the 
resultant photons, provided that straggling is not significant. Agreement with experiment was 
shown for high energy electrons (> 20 MeV) incident on tungsten of thicknesses less than 
about half a millimetre. In a later body of work restricted to thin targets, Schiff (1951) 
incorporated screening effects. Studies of Schiff’s method for small angles (Sirlin 1957) and 
multiple scattering (Hisdal 1957) have also been undertaken. Koch and Motz (1959) provide a 
detailed review of analytical bremsstrahlung calculations up to 1959. Several decades later 
Desobry and Boyer (1991) presented an overview of Schiff’s method and a comparison with 
Monte Carlo calculations undertaken with EGS4 (1985). Levy et al (1974) used the method of 
Hansen and Fultz (1960) to calculate the thick-target spectrum, employing an approximation 
for bremsstrahlung radiated when an electron is stopped in a thick target. This was compared 
with measurements taken using an NaI(Tl) spectrometer with pin-hole collimation of the 
photons from a 25 MeV accelerator (Tungsten target) and 19 MeV betatron (Platinum target). 
The same methodology was applied later to an 8 MeV linear accelerator (Levy et al. 1976). 
 
Other researchers have also employed experimental methods to try and evaluate photon 
fluence information from targets. The yield of photons in the forward direction at the central 
axis has been shown to be independent of the Z number of the target (Podgorsak et al. 1974), 
but the total yield of electrons does increase with Z, in agreement with theoretical predictions 
(Koch and Motz 1959). While the photon fluences for high- and low-Z targets are similar in 
the forward direction, for high-Z targets there is comparatively greater fluence at large angles 
(Podgorsak et al. 1974; Faddegon et al. 1991). This is because the impingent electrons 
undergo greater deviations than in a low-Z material, which correspondingly produce x-rays at 
greater angles. The electrons undergo fewer collisions after being scattered at a large angle, 
relative to that in a low-Z target, producing more energetic x-rays at these angles. This means 
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that, where a low-Z target is employed, it is likely to be more difficult to flatten the beam for 
an extended field without compromising useful output. 
 
The significant approximations employed in analytical evaluation, and the complexity of 
experimental measurement of the bremsstrahlung fluence from linac targets means that Monte 
Carlo radiation transport is a highly suitable alternative. Patau et al seem (1978) to be the first 
to simulate components of a medical linac (CGR-MeV Neptune) to determine the photon 
fluence emanating from a target / flattening filter combination. Details of their simulation 
technique may be found in earlier work (Patau 1971), the most notable improvement upon 
which was implementation of Koch and Motz (1959) cross sections. Their model consisted of 
a 5.7 MeV beam of electrons incident on a bilayer target composed of 1 mm thick tungsten 
brazed onto 2 mm of Copper, downstream of which was a lead flattening filter followed by a 
collimator. McCall et al (1978) employed the EGS3 code to calculate bremsstrahlung spectra, 
examining a range of materials for target and flattening filter combinations. EGS4 used 
bremsstrahlung angular sampling from the Koch and Motz (1959) distribution, superseding a 
less accurate method in an earlier iteration of EGS4 that generated photons at a fixed angle 
dependent upon the incident electron direction. EGS4 was employed by Faddegon et al in 
addition to their experimental measurements mentioned earlier (1991). DeMarco et al (1995) 
also compared Monte Carlo calculations to the experimental results of Faddegon et al, using 
the MCNP4A transport code. 
 
The photon target in the Varian 600C is composed of a metal bilayer. There is a block of 
high-Z material upstream (in which most of the primary electrons are absorbed), brazed onto 
a relatively thicker block of medium-Z material. The exact dimensions and composition of the 
target employed in the model are those specified in schematics provided by Varian under a 
confidentiality agreement, and may not be disclosed here. 
 
To investigate the effect on the photon fluence of using a metal bilayer as opposed to a single-
Z material, fluence calculations have been performed using the Monte Carlo code FLURZnrc, 
which is part of the EGSnrc (2006) distribution. The simulation geometry is illustrated in 
Figure 4.7 (a). A 6 MeV pencil beam (radius 1.3 mm) of electrons is incident upon the high-Z 
layer and the fluence is measured in a plane immediately below the medium-Z layer. Two 
other simulations were performed with same the geometry as the true target: one simulation 
was performed with the high-Z material only and another with the medium-Z material only. 
Figure 4.7 (b) shows the fluence (per incident electron fluence) distribution radially outward 
from the central axis for each of the three target designs. Figure 4.7 (c) shows the fluence 
resulting from the high-Z target and medium-Z target relative to the fluence from the true 
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target, expressed as a percentage. For a target composed entirely of the medium-Z material, 
the photon fluence after the target is much more forward directed. On axis the fluence is 
roughly equal to that of the bilayer design, but at 1 cm away from the central axis the photon 
fluence it is about 50 % less. For a target composed entirely of the high-Z material, from a 
point on axis to a point about 5 cm off axis the fluence drops from being 20 % less than the 
bilayer design to about 50 % less. The ratio of the total mass radiative stopping power to mass 
collision stopping power is proportional to TZ (where T is the kinetic energy of the electron). 
As such, high-Z targets convert a larger proportion of the electron’s energy into 
bremsstrahlung compared with lower-Z targets. These findings agree with the experimental 
results discussed earlier. The bilayer design results in a photon fluence that is higher than both 
of the single-Z targets simulated here and is less forward directed, distributing the fluence 
more broadly. This is useful because ultimately a flat fluence profile is desired. 
 
The flattening filter, the next component in the linac beneath the target, functions to achieve a 
flat profile by preferentially attenuating photons on the central axis where the fluence is 
higher. Clearly a flattening filter could be designed to accomplish this regardless of the target 
design, however, if the photon fluence from the target is too forward directed then greater 
attenuation will be required and ultimately will result in an efficiency loss. 
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Figure 4.7 (a) Diagram illustrating the geometry of the target and electron source as modelled using 
FLURZnrc. The simulation assumes radial symmetry. (b) shows the photon fluence at the exit of the 
target. Three simulations have been performed using FLURZnrc. The first models the target with 
dimensions and composition as specified by Varian; the corresponding curve is the solid line labelled 
as “High-Z brazed on medium-Z target”. Two other targets were modelled, both using the same 
dimensions as the true target, but being composed fully of the high-Z material in one case and the 
medium-Z material in the other. (c) shows the fluence at the exit of the two latter target designs, 
relative to the fluence from the true bilayer target (expressed as a percentage). 
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4.7.2.4 Primary collimator and flattening filter 
The primary collimator is a diverging conical structure made of a high-Z material with a 
small opening at the top, above which is the target. The primary collimator is designed to 
allow only forward scattered photons to escape the linac. The large opening at the bottom of 
the cone is typically of dimensions such that a circular beam of approximately 50 cm would 
be incident at 100 cm source-surface distance (SSD) in the absence of secondary collimators 
(Metcalfe et al. 1997). The primary collimator also helps prevent head leakage. The influence 
of the primary collimator on the absorbed dose beneath the linac is relatively small. An early 
study by Nilsson and Brahme (1981) found that for a 6 MV beam, 1.5 % of the integral dose 
was due to collimator scattered photons. Faddegon et al (1999) found that scatter from the 
primary collimator contributes about 3 % of the dose at Dmax on the central axis. Similarly, 
Mohan et al (1985) found that 2.8 % of the photons reaching a point at 100 cm SSD had been 
scattered from the primary collimator. 
 
In the Varian 600C, the flattening filter sits within the primary collimator. The former is also 
composed of a high-Z material, though different to that of the collimator. As has been 
discussed in the previous section, the design of the flattening filter has a pronounced effect on 
the photon fluence. 
 
Levy et al (1974) measured the bremsstrahlung spectra from a 25 MeV linac and a 19 MeV 
betatron, both of which have lead flattening filters, and compared the results to analytical 
calculations. They felt that the use of low-Z materials for flattening filters was preferential. 
Podgoršak et al (1974) had earlier performed a comparison of Al and Pb flattening filters, and 
found that a photon beam may be flattened as readily with an Aluminium target/flattening 
filter combination as with a Lead target/flattening filter combination. However, it is Monte 
Carlo simulations that have really provided the insights into the influence of flattening filter 
design on the photon fluence. 
 
McCall et al (1978) investigated a range of flattening filter materials with the Monte Carlo 
technique, and found that while low-Z flattening filters are able to produce a flat field, there 
are practical difficulties with their implementation because of their relatively large size and 
they exhibit a significant energy spread in large fields. They felt that a medium-Z material 
was far more preferable. Mohan et al (1985) investigated a range of Varian linear accelerators 
with EGS3 (Clinac-4, Clinac-6, Clinac-18 and Clinac-2500) and modelled the flattening filters 
therein with greater accuracy than had been previously performed. The cross sectional 
variation of the flattening filter thickness results in spectral variation arising from selective 
hardening of the beam. The average energy of the beam is typically lower for peripheral 
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regions (Kahn 2003). This softening is observed in the results of Mohan et al (1985), and in 
the results of Lovelock et al (1995), who found that at a distance of 20 cm away from the 
central axis, the beam was about 25 % softer with the flattening filter in place, and only 10 % 
softer without it. Lee (1997) employed EGS4 to investigate the effects of the flattening filter 
on the properties of the photon beam from a Varian 2100C operated at 6 MV, and similarly 
showed that beam hardening decreases with off-axis distance (softening by about 27% at 20 
cm). Faddegon et al found that at the central axis, scatter from the flattener contributes about 
4 % of the dose.  This agrees with the study by Mohan et al, wherein 3.5 % of photons 
reaching a point at 100 cm SSD had undergone scattering interactions in the flattening filter. 
They also found that they could reproduce the flatness of a field from a steel flattening filter 
with one made from brass (which was chosen because of the relative ease of machining) to 
within 2 %, however the useful output was reduced by over 20 % (Faddegon et al. 1999). 
 
The flattening filter in the Varian 600C has a complex shape, and the corresponding 
component module in the BEAMnrc model of the linac is the most detailed of all the modules 
(excluding the mini-multileaf collimator). The dimensions and composition of the primary 
collimator and flattening filter in the model are based on the specifications provided by 
Varian under a confidentiality agreement. The next component downstream from the 
flattening filter is the monitor chamber. 
 
 
4.7.2.5 Monitor chamber 
After the flattening filter, the beam passes through twin parallel plate multichannel ionisation 
chambers. These consist of layers of typically either mica or kapton with gold plated 
electrodes. The function of the ionisation chamber is to integrate charge and thereby monitor 
the dose output in real-time during delivery, and may also be used to monitor beam flatness 
and symmetry (by being divided in half and mounted such that one chamber plate is rotated at 
90° to the other). 
 
One key issue with monitor chambers is the potential for backscatter from downstream 
collimation devices to influence the signal. Clearly, for small fields, this effect will be more 
pronounced because of the increased backscatter. If this occurs, the ultimate effective output 
of the linac will be lower than the desired number of monitor units. This effect is dealt with 
automatically in measured output factors in a clinical context, or minimised by improved 
design of monitor chambers (with use of a backscatter plate). In Monte Carlo simulations of 
dynamic delivery, the situation may be more complex because the number of particle histories 
to be simulated may need to decrease with increasing backscatter (i.e. decreasing field size). 
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This is only relevant for absolute dosimetry and explicit modelling of charge in monitor 
chamber. 
 
This problem has been investigated experimentally in a number of studies. These include 
photoactivation of a foil placed downstream from the target (Patterson and Shragge 1981), 
beam current measurements from the target (Huang et al. 1987) and water tank measurements 
with an ionisation chamber with and without a sheet of Lucite downstream of the monitor 
chamber (Luxton and Astrahan 1988). Pulse counting (Sharpe et al. 1995; Yu et al. 1996) and 
charge integration (Lam et al. 1998) from the target have also been applied. Monte Carlo 
simulations have also been performed to investigate backscatter to monitor chambers. Liu et 
al (1997a) compared Monte Carlo calculations (Liu et al. 1997b) to a pulse counting method 
(Sharpe et al. 1995) for a Varian 2100C, and later investigated backscatter more explicitly via 
Monte Carlo (BEAM) (Liu et al. 2000). A Monte Carlo model of a Siemens unit found that 
backscatter to the monitor chamber was < 1 % for all jaw positions (Verhaegen and Das 
1999). A study by Verhaegen et al (2000) of the Varian 2100C showed that a correction of 2-
3 % was required for small fields when Monte Carlo is used to determine output factors or 
model dynamic fields. 
 
The monitor chamber in the Varian 600C is composed of numerous layers of different 
materials. Some simplification has been employed in implementation of the model used in the 
present study. Ionisation chambers are typically filled with gas (nitrogen in the case of mica 
chambers and oxygen-enriched air in the case of kapton) and then sealed to avoid the 
complications of gas density correction et cetera (Metcalfe et al. 1997). In this model, it is 
assumed that the influence of the gas composition is negligible, and normal air has been used 
with the definition provided by the ICRU (1989) (C, O, N and Ar with a density of 1.2048 
mg/cm3). Furthermore, the many layers in the monitor chamber have been simplified in the 
model into a more simplistic set of a total of fourteen layers of material. The total thickness of 
each of the materials traversed by the beam is still the same (i.e. several thin layers of each 
material are simplified into single thick layers of equivalent thickness for geometric 
simplicity). Ultimately, the influence of the monitor chamber on the photon fluence is not 
significant.  
 
 
4.7.2.6 Jaws 
Downstream from the monitor chamber is a mirror that reflects the field light, the latter thus 
kept out of the primary beam. The field light mirror is a very thin non-retracting polyester 
sheet, the influence of which on the beam is not significant, but is nonetheless incorporated in 
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the model. Further downstream is a secondary collimation system consisting of two pairs of 
high-Z metal blocks called jaws. In the Varian 600C, these function to produce field sizes 
between 0 x 0 cm2 and 40 x 40 cm2 (at the patient plane). The jaws are thick and, as a result, 
one pair is mounted above the other, which does not seem to influence dose profiles. The 
upper (Y) jaws are mounted such that they travel in an arc-like motion about a point of 
rotation defined by the source. This design means that the angle closely matches the angle of 
beam divergence at different field sizes. Unlike the upper jaws, the lower (X) jaws tilt to 
match this angle and slide back and forth in a plane perpendicular to the beam axis. 
 
Some approximation has been employed in the jaw design in the model. The arc motion of 
the Y-jaws is not explicitly modelled, nor is the tilting of the X-jaws, but the faces of the jaws 
are altered to reflect angular changes at different field sizes. The jaws are modelled with a 
trapezoidal shape whose face angle is chosen to match the divergent beam. This has a 
minimal effect on the resulting dose distributions. The discrepancy between the thicknesses of 
material traversed by the beam through the real and modelled jaws can be estimated from 
geometrical considerations. The jaws in the model will present a greater thickness to an 
incoming ray compared to the true jaws, increasing with the angle (i.e. field size) up to a 
maximum possible discrepancy of approximately 10 mm thickness at the far edge defined by 
the angle of the primary collimator. An estimate of the discrepancy in fluence is obtained by 
modelling a 6 MeV photon spectrum (defined by Mohan et al (1985)) with FLURZnrc through 
slabs of the high-Z material corresponding to the two thicknesses. In a region immediately 
below the jaws, the fluence from transmitted photons is about 0.25 % of the unshielded 
fluence. The maximum discrepancy possible will occur for a point about 10 cm beyond the 
edge of a 40 x 40 cm2 field and corresponds to approximately 0.13 % of the unshielded 
fluence. For smaller field sizes this discrepancy will be significantly less; a maximum of < 3 
mm along the line defining a point 50 cm off-axis, for instance, for the 9.8 x 9.8 cm2 jaw field 
typically implemented when the mini-multileaf collimator is employed. 
 
 
4.7.2.7 The BrainLAB m3 MMLC 
At the William Buckland Radiotherapy Centre, a BrainLAB m3™ mini-multleaf collimator 
(MMLC) is mounted on the Varian 600C as a tertiary collimation device. The maximum 
effective field size is 9.8 x 9.8 cm2 at isocentre, shaped by 26 leaf pairs: 14 of width 3 mm, 
six of width 4.5 mm and an outer set of six with 5.5 mm width (nominal widths are at 
isocentre). The leaves move orthogonally to the beam axis, and have a complex tongue and 
groove cross-section. This cross section is also shaped to match the beam divergence across 
the field. The leaf edges are not curved, but rather have three angled straight edges. Cosgrove 
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et al (1999) reported that each section corresponds to one third of the total length of the leave 
edge (totalling 6 cm), but this was contradicted by Belec et al (2005)† who stated the upper, 
middle and lower sections were 2.3, 1.4 and 2.3 cm respectively. The middle section is milled 
parallel to the beam axis to match the (non-) divergence of the beam when centred. The upper 
section is at an angle corresponding to the beam divergence when the leaf is fully extended (5 
cm beyond the centre), and the angle of the lower section corresponds to full retraction (5 cm 
back from the centre). The true geometry of the BrainLAB m3 was obtained from BrainLAB 
directly under a non-disclosure agreement. For that reason, the level of detail that may be 
revealed within this work is restricted. The end of the leaf is illustrated in Figure 4.8, the leaf 
side is shown in Figure 4.9, a three-dimensional representation is provided in Figure 4.10 and 
Figure 4.11 illustrates the complexities of the leaf bank as a whole. 
 
 
 
Figure 4.8 A sketch showing an example of the end shape of one of the 26 leaves in the BrainLAB m3. 
There are 30 nodes defining each side of the contour of the leaf end. The circle corresponds to the 
screw. 
 
 
 
Figure 4.9 A sketch showing example of the side shape of one of the 26 leaves in the BrainLAB m3.  
 
                                                 
†
 Nota bene there is a small error in Figure 2 (c) of Belec et al (2005): the lower section of the leaf is erroneously 
shown to be 1.3 cm thick. This error did not feature in their code. 
64 mm 
42 mm 64 mm 22 mm 
112 mm 
θ = 2.862° 
  128
 
 
Figure 4.10 A three-dimensional rendering of a single leaf of the BrainLAB MMLC. 
 
 
 
 
Figure 4.11 A schematic of the leaf bank indicating dimensions and the complexity and divergence of 
the leaves. A 0.1 mm leaf-gap is assumed. 
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Xia et al (1999) provide an early evaluation of the BrainLAB MMLC attached to a Varian 
2100C operated at 4 MV. They found that, particularly for large circular fields, MMLC step 
artefacts are clearly evident for the 80 % isodose curve, but are less pronounced for the 20 % 
isodose curves. The penumbrae of the circular fields were comparable to square fields, but 
somewhat broader than the standard conical collimators employed in stereotactic 
radiosurgery. The penumbrae were sufficiently narrow (1.8 – 2.6 mm) to facilitate collimation 
for small target volumes with varying field shapes. The interleaf leakage was shown to be 
about 2 %, while intraleaf leakage was 1.3 % (based on film measurements). The leaf position 
precision was found to be sub-millimetre. In the same year, Cosgrove et al (1999) published 
commissioning information for the BrainLAB MMLC, mounted to a Varian 2100C operated 
at 6 MV. The beam penumbrae were found to be invariant with increasing square field sizes 
and asymmetric fields, and varied non-linearly with diagonal straight edges. They found the 
average intraleaf transmission to be 1.9 % and interleaf leakage to be 2.8 %. The average 
transmission through abutted leaves positioned at 4.5 cm off-axis (it is standard practice to 
close leaves off-axis) was found to be 4.5 %. With the leaves closed centrally, this increased 
to 15 %. Cheung et al investigated the potential for multileaf collimators (MLC) to replace 
beam blocks in the treatment of nasopharyngeal carcinoma, comparing the BrainLAB MMLC 
to a Varian MLC with 40 leaves of 1 cm projected width at isocenter. To this end, they found 
both were acceptable alternatives to blocks. They found that the MMLC, with its smaller 
effective penumbra, was more appropriate for the treatment of tumours close to critical 
structures, being limited only by its maximum field size (Cheung et al. 1999). Monk et al 
(2003) compared the BrainLAB m3 to the 120 leaf multileaf collimator of the Varian 2100EX 
for stereotactic conformal radiotherapy fields, the latter possessing 5 mm leaves. Results 
showed that the MMLC provided improved planning target volume (PTV) conformity and 
normal tissue sparing than the MLC, however, the improvements were small. Chern et al 
(2006) performed a similar study, comparing a BrainLAB MMLC to the Varian Millennium 
MLC. Again, the MMLC consistently provided better target conformity and normal tissue 
sparing than the MLC for stereotactic radiosurgery, using dynamic conformal arcs. Jin et al 
(2005) studied the BrainLAB MMLC for dynamic conformal arcs and intensity-modulated 
radiosurgery, comparing it to 5 mm and 10 mm MLCs. They found significant dosimetric 
differences between the conformity indices and target coverage of the three MLCs, increasing 
with field size, for dynamic conformal arcs. For intensity modulated radio- surgery/therapy, 
the difference was less significant between the 3 mm and 5 mm MLCs, but more significant 
between the 3 mm and 10 mm MLCs. 
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A number of BEAMnrc component modules have been made available for modelling multi-
leaf collimators (Rogers et al. 2007), including VARMLC, MLCP, MLCQ, MLCE and 
DYNVMLC. Belec et al (2005) developed a component module based on VARMLC that is 
suitable for modelling the BrainLAB m3. For a comprehensive description, the reader is asked 
to refer to Belec et al (2005). The leaf shape was simplified from the true leaf shape. The 
interleaf air gap was chosen to be 0.14 mm. The angle of the top and bottom edges of the leaf 
end was 1.8º. The m3 is modelled by Belec et al (2005) as three component modules on top of 
each other, corresponding to the upper, central and lower sections of the leaves. The true 
leaves have three tongues and three grooves on each side of the leaf. In the model, there are 
one tongue and four grooves on the left side, and four tongues and one groove on the right 
side, with a combined thickness equal to the true leaf so as to result in the same beam 
attenuation. The MMLC leaves were modelled as a tungsten alloy, W:Ni:Fe (95:3.4:1.6), with 
a density of 18 gcm-3 (Boyer et al. 2001).  
 
Implementation of Belec’s code in this work would have necessitated re-writing the model. 
Referring back to the earlier description of the true geometry of the MMLC, one must note 
that the Belec model corresponds only to the model of m3 that is fitted to linacs that already 
have an in-built MLC. The linac used in this work does not have an MLC, and consequently 
the geometry of the m3 used here differs slightly from that modelled by Belec et al (2005). 
This aside, unfortunately, the portability of the Belec et al (2005) code is evidently limited 
and, after several months of attempts, there was ultimately no success in running the code 
error-free. Numerous FORTRAN compilers were tested, and much of the code was re-written 
to remove the numerous tests for equality – which are prone to errors resulting from limited 
numerical precision – and replace them with more robust tests.  
 
As a corollary of the present work, an in-house model of the BrainLAB m3 is currently being 
developed, which models the MMLC in full geometric detail. The code elegantly breaks the 
structure up into trapezoidal ingots, allowing the MMLC to be simulated in full detail with 
fewer numbers of regions than the (relatively simplistic) model of Belec et al (2005). This 
results in greater computational efficiency. Furthermore, the trapezoidal regions allow for 
more elegant spatial orientation checking algorithms, with a factor of four fewer 
computations per region than the Belec model, again increasing the computational efficiency. 
This model is still a work in progress. As such, the present approach is to employ the standard 
VARMLC code and vary the geometrical definition to best match the BrainLAB m3. This has 
been shown by collaborators at the Queensland University of Technology to produce dose 
distributions that match measured doses to a high degree of accuracy (Kairn et al. 2010b). 
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The geometric parameters of the MMLC model chosen to best match experimentally 
measured data are listed in Table 4.6. An indication of the modelled leaf shape is given in 
Figure 4.12. Different options and simplifications concerning the transport physics are 
facilitated by BEAMnrc, and these are discussed in the following section. 
 
 
Table 4.6 Description of variables and their attributed values as used in the VARMLC model of the 
BrainLAB MMLC. All units are in millimetres. 
 
Variable Value 
  
Leaf thickness 64  
Radius of leaf end 427.3  
Screw width / height 0  
Height of tongue & groove 2.2  
Width of tongue & groove 0.003 
5.5 mm leaf (x6) width 2.828  
4.5 mm leaf (x6) width 2.313 
3.0 mm leaf (x14) width 1.538 
  
 
 
 
 
Figure 4.12 An illustration of the geometry of VARMLC leaf ends, as employed in the present model 
of the BrainLAB MMLC.  
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4.7.3 Radiation transport simulation parameters 
EGSnrc and BEAMnrc allow for various radiation transport options. The key simulation 
parameters broadly implemented in this study are summarised here:  
- The (global) maximum fractional energy loss per particle step is 25 %. 
- The maximum first elastic scattering moment per step is 0.5 
- The ‘EXACT’ boundary crossing algorithm (BCA) has been implemented. This 
means that the algorithm will enter into single-scattering mode at a distance from a 
boundary determined by the ‘skin depth’ for BCA. 
- The aforementioned skin depth for BCA is set to three elastic mean free paths from 
the boundary (this yields peak efficiency without compromising accuracy). 
- The electron step algorithm (used to account for lateral and longitudinal 
correlations in a condensed history step) is PRESTA-II.  
- Spin effects for elastic electron scattering are implemented. 
- Electron impact ionisation is not implemented. 
- ‘Simple’ bremsstrahlung angular sampling is used – i.e. only the leading term of the 
Koch-Motz distribution is used to determine the emission angle of bremsstrahlung 
photons. 
- Bethe-Heitler bremsstrahlung cross sections are used with Coulomb correction 
above 50 MeV.  
- The differential cross sections for Compton scattering are generally determined 
according to the Klein-Nishina formula. 
- ‘Simple’ pair angular sampling is implemented to determine the positron / electron 
emission angles (relative to the incident photon) – i.e. only the leading term of the 
angular distribution is employed. 
- Photoelectron angular sampling is not employed, and as such photoelectrons are 
given the direction of the incident photon from which they were generated. 
- Coherent Rayleigh scattering is generally not employed to avoid increasing 
computation time, since coherent scattering is less relevant outside very low energy 
applications. 
- Atomic relaxation (after Compton or photoelectric events) is not implemented.  
- Storm-Israel photon cross sections are used. 
 
Various methods are available for the reduction of statistical uncertainty, and these are 
discussed in the following section. 
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4.7.4 Variance reduction 
An overview of variance reduction methods employed for in-field dose calculations is given 
here. The need for variance reduction arises because of the nature of Monte Carlo dose 
computation – i.e. a numerical approach is taken to determine a convergent result, which 
therefore has associated with it some level of statistical noise. Variance reduction techniques 
function to reduce the statistical uncertainty without compromising the accuracy of the result. 
One means of reducing this statistical uncertainty would be to model a greater number of 
particle histories. The key benefit of more elegant variance reduction methods is that the 
uncertainty may be reduced without increasing the simulation time to the extent that would be 
required to achieve the same uncertainty via the aforementioned approach. 
 
One broadly implemented variance reduction method is range rejection. This involves the 
termination of a charged particle history if its residual range is such that it cannot escape the 
current region. A subroutine in the transport code computes tables of residual ranges to a 
(user-specified) threshold energy for each medium as a function of electron energy. These 
residual ranges are the pathlengths travelled by electrons slowing to the cut-off energy if they 
do not undergo any discrete interactions. Bremsstrahlung photons that would have been 
generated by the electrons as they slow down are assumed not to escape from the region in 
which the electron is terminated. The impact of this approximation can be minimised by 
specifying a maximum energy for which a particle history can be terminated. This increases 
the potential for bremsstrahlung to escape from the region in which the particle which gave 
rise to it is unable to escape from.  
 
The statistics of bremsstrahlung photons borne of electron interactions can be improved via a 
variance reduction technique called bremsstrahlung splitting. In this study, directional 
bremsstrahlung splitting (DBS) is employed. The broad principle is that bremsstrahlung 
photons aimed towards a field of interest (enveloping the treatment field) are split at the point 
of creation, and those beyond the field are not. DBS uses a combination of interaction 
splitting for bremsstrahlung, annihilation, Compton scattering, pair production and photo-
absorption and Russian Roulette to achieve improved simulation efficiency. For a detailed 
description of the DBS algorithm, readers are referred to Kawrakow et al (2004). For each 
event, DBS splits the photons a user-specified number of times (NBRSPL). The resulting 
photons each have their weighting multiplied by NBRSPL-1. The optimum splitting number is 
approximately 1000. The field of interest is defined by the treatment field size and source-
surface distance (SSD). For a 10 x 10 cm2 field at 100 cm SSD, a splitting field radius of 10 
cm is sufficient (Kawrakow et al. 2004). Clearly, DBS was not implemented where the out-
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of-field doses were of key interest, in which case its implementation would have had a 
detrimental influence. 
 
 
4.7.5 Comparison of simulation results with measured data: Varian 600C 
4.7.5.1 Overview 
To ensure that the model is trustworthy in its prediction of complex dose distributions, the 
model must be commissioned against measured data. This is done by comparison to measured 
dose profiles and depth dose curves where the doses are relatively ‘well known’. Depth dose 
curves and dose profiles for modelled data have been compared to water tank measurements 
(0.13 cm3 ionisation chamber, Wellhöfer, USA) for a number of arrangements. 
 
To illustrate the accuracy of the model, a standard 10 x 10 cm2 field is shown; also shown is a 
30 x 30 cm2 field so as to demonstrate good agreement at larger field sizes. Large field sizes 
are, however, less important to this study, since we are dealing with stereotactic fields which 
when using the BrainLAB MMLC are restricted to a maximum field size of 9.8 x 9.8 cm2. 
The agreement of smaller fields is shown in the subsequent section dealing with the accuracy 
of the MMLC model. Also shown here is a half-blocked (i.e. off-axis) 20 x 20 cm2 field and a 
40 x 40 cm2 field (with dose profiles measured diagonally across the field) which function to 
demonstrate the limitations of the model. 
 
During commissioning of the model, parameters within the model are iteratively adjusted to 
optimise the match between simulation and measurement. One key parameter is the geometry 
and energy of the electron beam incident on the target. 
 
 
4.7.5.2 Summary of electron beam parameters 
Once the geometry of the linac has been accurately represented in the model, the key 
simulation parameters that must be adjusted to obtain the best match between experiment and 
the model relate mostly to the electron beam which is incident upon the target. The best 
match for the linear accelerator at the William Buckland Radiotherapy Centre has been 
achieved with the following electron beam parameters: 
- A monoenergetic electron beam of energy 5.65 MeV, 
- Incident perpendicular to the target surface, such that (u,v,w) = (0,0,1), 
- A circular beamspot and 
- A Gaussian beam profile with a full-width half-maximum of 220 µm. 
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These parameters have been determined based on matching of depth-dose curves and dose 
profiles for a number of different fields. Typically, 5.1 × 109 histories were modelled on 10 
processors (AMD Barcelona 2.3 GHz quad core) requiring a total of approx. 45 hours. This is 
sufficient to achieve statistical uncertainties in (subsequently scored) doses of a fraction of a 
percent in 2 mm voxels. 
 
 
4.7.5.3 Comparison of measured and modelled fields 
When commissioning a commercial treatment planning system, it is necessary to input 
measured dose profile data. Similarly, refining of parameters in the Monte Carlo model is 
necessarily based upon measured profiles. The standard reference field is 10 x 10 cm2. Figure 
4.13 shows a depth dose curve in water for a 10 x 10 cm2 field at 100 cm source-surface 
distance (SSD) and dose profiles at depths of 1.5, 5 and 10 cm. The simulated depth dose 
curves at profiles at multiple depths all match experimental data very closely. Large field 
sizes are particularly sensitive to the shape of the electron beam incident on the target. Figure 
4.14 shows a depth dose curve in water for a 30 x 30 cm2 field at 100 cm source-surface 
distance (SSD) and dose profiles at depths of 1.5, 5 and 10 cm. Figure 4.15 corresponds to a 
40 x 40 cm2 field at 95 cm SSD, where the dose profiles have been taken diagonally across 
the field at depths of 1.5, 5 and 10 cm. This reflects the increased influence of the primary 
collimator. There is a noticeable discrepancy between the modelled and measured data mostly 
related to a pronounced asymmetry in the experimental data. The inherent symmetry of the 
modelled geometry makes this effect prohibitively difficult to match. While not ideal, this is 
not a critical issue because the present study is concerned with small field sizes, which exhibit 
very good agreement. Figure 4.16 shows crossplane profiles at depths of 1.5, 5 and 10 cm for 
a half-blocked 20 x 20 cm2 field at 95 cm SSD; i.e. with y-jaw positions of -10 cm and +10 
cm and x-jaw positions of -20 cm and 0 cm from the central axis, the latter having coordinates 
of (0,0). The modelled field is slightly flatter than the measured field, being noticeably 
different towards x = -20 cm, where the calculated dose has a smaller penumbral ‘horn’.  
 
For the reference (10 x 10 cm2) case, using a cubic spline interpolation on the measured data 
and no convolution for finite detector size, comparison with the calculated data reveals an 
average agreement within 0.3 % over the full range, with discrepancies of up to ~3 to 4 % in 
the penumbral region. Considering not only statistical uncertainties in the model but also 
variation that occurs between experimental measurement, compounded with issues relating to 
the sensitive detector volume and spatial location, this may be considered an acceptable level 
of agreement. 
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The modelled depth dose curve has a finer resolution (1 mm) in the region of maximum dose 
(Dmax). The conformality of the modelled depth dose curve to the measured curve reflects the 
accuracy of the electron beam energy. In the build-up region of the depth dose curve there is a 
small discrepancy. This observation is not specific to the work described here, but is a widely 
reported phenomenon. BEAM simulation of a Varian 21EX 18 MV beam with a 40 x 40 cm2 
field predicted doses lower than that measured by more than 10 % at 1 mm depth and 5 % at 1 
cm depth in water (Ding 2002). In a study using the radiation transport code PEREGRINE, 
Hartmann-Siantar et al (2001) took the somewhat dubious step of increasing the number of 
electrons incident on the surface by 50 % so as to achieve a better match with experiment, 
without actually postulating the source of the additional electrons. Ding (2002) investigated 
the influence of a 2 mm Pb foil on contaminant electrons and reached the conclusion that such 
a source of additional contaminant electrons could not explain the dose discrepancy. A further 
study by Ding et al (2002) found that photoneutron dose did not explain the discrepancy in 
the build-up region. A study by Abdel-Rahman et al (2005) concluded that inaccurate 
modelling of triplet production was also not the source of the discrepancy in surface dose. 
 
Ultimately, the broad consensus is that the discrepancy is not a modelling artefact, but is due 
rather to the limitations on measurement accuracy in the build-up region, and is typically 
explained by the steep dose gradient and the uncertainty in the position of the ionisation 
chamber. Studies by Kawrakow (2006) and McEwen et al (2008) have shown that the 
standard shift for cylindrical ionisation chambers (-0.6r, where r is the internal cavity radius) 
recommended in dosimetry protocols is incorrect, which can result in errors of around 0.5 mm 
and up to 1.4 mm depending on chamber design. These studies have shown that, once the 
accelerator geometry and electron beam parameters have been accurately modelled, use of the 
correct effective point of measurement results in a match with experimental data of 0.2 mm or 
better. Parallel-plate ionisation chambers, rather than cylindrical chambers, are recommended 
for measurement in the build-up region. 
 
The high level of agreement between modelled and measured data indicates that the geometry 
and electron beam parameters have been simulated correctly, and that subsequent simulations 
are likely to truthfully predict what would be observed experimentally. 
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Figure 4.13 A comparison of doses measured at the William Buckland Radiotherapy Centre (WBRC, 
solid line) and doses calculated via BEAMnrc (dashed line) for a Varian 600C (6 MV) with a 10 x 10 
cm2 field, at 100 cm SSD. A cubic spline was employed to fit data. Mean agreement is sub-percent. (a) 
Depth dose curve in water, (b) dose profile at 1.5 cm depth, (c) dose profile at 5 cm depth, and  (d) 
dose profile at 10 cm depth. The 10 x 10 cm2 field is the ‘standard’ field in radiotherapy, being used as 
a reference cases in multiple contexts; it is thus important that the model reproduces this field 
accurately. The 10 x 10 cm2 is the maximum field size of interest in this study.  
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Figure 4.14 A comparison of doses measured at the William Buckland Radiotherapy Centre (WBRC, 
solid line) and doses calculated via BEAMnrc (dashed line) for a Varian 600C (6 MV) with a 30 x 30 
cm2 field at 100 cm SSD. A cubic spline was employed to fit data. Mean agreement is within ~2 %.  (a) 
Depth dose curve in water, (b) dose profile at 1.5 cm depth, (c) dose profile at 5 cm depth, and (d) dose 
profile at 10 cm depth. Although not strictly relevant to this study, it is nonetheless reassuring that the 
model is able to accurately reproduce experimentally measured dose distributions with such a broad 
field size. 
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Figure 4.15 A comparison of doses measured at the William Buckland Radiotherapy Centre (WBRC, 
solid line) and doses calculated via BEAMnrc (dashed line) for a Varian 600C (6 MV) with a 40 x 40 
cm2 field at 95 cm SSD: (a) Depth dose curve in water, (b) diagonal dose profile at 1.5 cm depth, (c) 
diagonal dose profile at 5 cm depth, and (d) diagonal dose profile at 10 cm depth. This figure 
demonstrates the limited accuracy of the model for very large field sizes, particularly where the 
primary collimator begins to significantly influence the final treatment field. Although such large fields 
are irrelevant for the purposes of this study, it is nonetheless of interest to illustrate the extent to which 
the model is able to accurately predict doses. 
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Figure 4.16 A comparison of doses measured at the William Buckland Radiotherapy Centre (WBRC, 
solid line) and doses calculated via BEAMnrc (dashed line) for a Varian 600C (6 MV) with a half-
blocked 20 x 20 cm2 field at 95 cm SSD: (a) A scatterplot showing the spatial location of 10,000 
particles scored at an SSD of 95 cm, (b) dose profile at 1.5 cm depth, (c) dose profile at 5 cm depth, 
and (d) dose profile at 10 cm depth. This figure also illustrates the limitations of the model at very large 
field sizes, which while not of interest in this study (which deals with stereotactic fields < 10 x 10 cm2 
that are predicted very accurately by the model) are nonetheless interesting. 
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4.7.6 Comparison of calculations with measured data: Varian 600C with MMLC 
4.7.6.1 Overview 
As stated earlier, since the geometrically-accurate high-efficiency model of the BrainLAB 
MMLC being developed in-house is not yet commissioned, a different approach using the 
‘VARMLC’ component module available with the standard BEAMnrc package was tailored to 
suit the mini-multileaf collimator. Despite the more ‘generic’ geometry, this has been shown 
to reproduce experimental dose distributions to a high degree of accuracy in the case of the 
BrainLAB MMLC (Kairn et al. 2010a; Kairn et al. 2010b). In this section of the chapter, an 
accurate match between measured and modelled dose distributions is demonstrated. This 
chapter deals with development and commissioning of the model, whilst the subsequent 
chapter involves application of the model for characterisation of the stereotactic fields in 
terms of spectral qualities, scatter and so forth. 
 
 
4.7.6.2 Comparison of measured and modelled MMLC-defined fields 
Figure 4.17 through to Figure 4.22 show dose profiles in the inplane and crossplane directions 
at 5 cm depth in water at 95 cm source-surface distance (SSD), obtained using a Scanditronix 
IC6 (0.06 cm3) ionisation chamber. Modelled and measured dose distributions are compared 
for: 
– 6 x 6 mm2, 
– 24 x 24 mm2, 
– 42 x 42 mm2, 
– 60 x 60 mm2, 
– 80 x 80 mm2 and 
– 98 x 98 mm2 fields. 
 
Figure 4.23 shows percentage depth dose (PDD) curves at 95 cm SSD. Modelled and 
measured dose distributions are compared for: 
– 6 x 6 mm2, 
– 18 x 18 mm2, 
– 24 x 24 mm2, 
– 30 x 30 mm2, 
– 42 x 42 mm2, 
– 60 x 60 mm2 and 
– 80 x 80 mm2. 
 
The agreement is very good, with only small discrepancies far from the primary field.
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Figure 4.17 Measured (diode) and Monte Carlo modelled profiles for a 6 x 6 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
 
 
 
 
Figure 4.18 Measured (diode) and Monte Carlo modelled profiles for a 24 x 24 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
 
 
 
 
Figure 4.19 Measured (diode) and Monte Carlo modelled profiles for a 42 x 42 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
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Figure 4.20 Measured (diode) and Monte Carlo modelled profiles for a 60 x 60 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
 
 
 
 
Figure 4.21 Measured (diode) and Monte Carlo modelled profiles for a 80 x 80 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
 
 
 
 
Figure 4.22 Measured (diode) and Monte Carlo modelled profiles for a 98 x 98 mm2 field at 95 cm 
source-surface distance and 5 cm depth: (a) cross-plane and (b) in-plane. 
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Figure 4.23 Percentage depth dose curves obtained via measurement (95 cm SSD with a diode) in a 
water phantom, compared to those obtained using the Monte Carlo model, shown for various field 
sizes: (a) 6 x 6 mm2, (b) 12 x 12 mm2, (c) 18 x 18 mm2, (d) 24 x 24 mm2, (e) 30 x 30 mm2, (f) 42 x 42 
mm
2
, (g) 60 x 60 mm2 and (h) 80 x 80 mm2. 
 
 
 
(a) 6 x 6 mm2 
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 
(no
rm
al
ise
d)
Measured
Monte Carlo
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 50 100 150 200 250 300
Depth (mm)
D
o
se
 (n
o
rm
al
ise
d)
Measured
Monte Carlo
(c) 18 x18 mm2 
(b) 12 x 12 mm2 
(d) 24 x 24 mm2 
(e) 30 x 30 mm2 (f) 42 x 42 mm2 
(g) 60 x 60 mm2 (h) 80 x 80 mm2 
  145
4.7.7 Conclusions 
A Monte Carlo model of a Varian 600C with mounted BrainLAB mini-multileaf collimator 
has been constructed and commissioned against measured data. An acceptable level of 
agreement has been achieved, particularly for small fields which are the focus of the present 
body of work. The geometry was based on specifications provided by Varian and BrainLAB 
under confidentiality agreements. Model parameters were iteratively adjusted to optimise the 
match with experimental data. Confidence in the accuracy of the model allows calculations of 
fluence and spectral data to be undertaken – something which is prohibitively difficult to 
measure experimentally – so as to fully characterise the stereotactic fields. Furthermore, the 
commissioned model facilitates calculation of dose distributions in complex geometries 
where the standard treatment planning system may be of limited accuracy. It is also possible 
to interrogate contributions to the primary dose field resulting from scatter and other 
influences. Such investigations are described in Chapter 5. 
 
 
 
4.8 Chapter summary 
Accurate calculation of the dose distributions delivered in stereotactic radiotherapy is of 
critical importance, for the confident delivery and assessment of clinical treatments. The dose 
calculation algorithms employed by treatment planning systems often incorporate 
approximations that potentially reduce the accuracy of calculated doses in the context of 
stereotactic radiotherapy, which involves small fields and (in the context of stereotactic body 
radiotherapy) may be in close proximity to interfaces of high- and low-density media. Not 
only is calculation of such dose distributions difficult, but measurement of small fields is 
notoriously complicated. Furthermore, key beam characteristics such as fluence and spectral 
data are often not possible to determine via measurement in a clinical context. To overcome 
many of these issues, this chapter has described the development of a Monte Carlo model of a 
linac-based stereotactic unit. This model has been commissioned against measured data, and – 
in the following chapter – will be used to determine the aforementioned critical properties of 
stereotactic fields. 
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CHAPTER FIVE 
 
Aut quid non miraculo est, cum primum in notitiam venit? Quam multa fieri non posse prius 
quam sunt facta iudicantur? † 
Gaius Plinius Secundus, Naturalis Historia 
 
 
                                                 
†
 “Rather, what exists that does not seem wondrous when it first comes to our notice? How many things are judged 
to be impossible, until their occurrence?” A familiar observation by Pliny the Elder (Book VII of the Naturalis 
Historia), who of course wrote extensively on the topic of science and medicine. My own translation. 
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CHAPTER 5 
Characterisation of 
stereotactic fields: 
In-field 
 
Spectral qualities, dose evaluation for 
intracranial treatments and the influence 
of heterogeneities in extracranial 
treatments 
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5.1 Chapter overview 
In this chapter, a dosimetrically-matched Monte Carlo model of a linac equipped with a mini-
multileaf collimator (the development of which is discussed in Chapter 4) is used to calculate 
a systematic dataset of stereotactic field characteristics.  
 
Stereotactic fields were characterised in air, both in and beyond the primary field. The data 
presented include photon spectra, contaminant electron spectra, the spatial variation of mean 
photon energy, the spatial variation of mean electron energy and the angular distribution of 
photons. Spectral data in water is also of significant importance, thus photon energy fluences, 
electron energy fluences and mean energy distributions were all scored at depths of 5, 10 and 
15 cm in water. 
 
In this chapter, observations are made about the significant differences in spectra in- and out-
of-field, for both photons and contaminant electrons. There are strong trends with spatial 
location and field size. Notable differences are also exhibited in terms of mean energy and 
‘structure’ in fluence outside the primary field when comparing fields that have a static 98 x 
98 mm2 jaw opening to those fields that are backed-up completely by the jaws. 
 
There are a number of observations to be made about spectra in water. For instance, photon 
spectra harden with depth, and the mean energy of the primary photon beam decreases 
significantly with increasing field size. Out-of-field mean photon energies decrease with 
increasing field size. The fraction of total photons in the low-energy regime is much higher 
for larger fields (for example, the 98 x 98 mm2 field has ~1000 % more photons of energy < 
250 keV than the 6 x 6 mm2 field). 
 
The relevance of varying spectra is illustrated using three examples. Firstly, the typical 
assumption of unchanging secondary electron spectra when calibrating an ionisation chamber 
with a broad-beam reference field was investigated. The results in this chapter demonstrate 
both field-size and depth dependence of mean restricted stopping power ratios; the 
discrepancy when compared to the reference field increases with decreasing field size and 
increasing depth. Although there is a difference, within the primary field the systematic error 
introduced is less than 1 % and may be safely ignored. However, outside the primary field the 
error is larger (> 1 %) and increases with increasing field size. This is a direct result of the 
spatially-varying spectra as shown in this chapter, and would be impossible to determine 
experimentally. The second example presented in this chapter is an investigation of the over-
response of radiographic film. The film was modelled at a depth of 5 cm in water and was 
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irradiated with an 18 x 18 mm2 field. A further simulation was undertaken, scoring dose to 
water at an equivalent location. The radiographic film is shown to exhibit an over-response to 
the incident field (> 1 %), which varies spatially. This is a result of the spatial variation in the 
spectrum, and has consequences for the experimental characterisation of dosimetric properties 
in and slightly beyond the penumbral region when measuring with film. The third study 
undertaken was an investigation of the radiological properties of LiF TLD-100 
thermoluminescent dosimeters relative to water and tissue. Specifically, the difference 
between TLD-100 and water are highlighted using the energy-dependent effective atomic 
number (Zeff, see Chapter 3). Of particular note is the fact that the peak photon fluence 
coincides with the maximum discrepancy in Zeff.  
 
The suitability of gel dosimeters for the measurement of small stereotactic dose distributions 
is demonstrated in a novel study presented in this chapter. The potential for stereotactic 
treatment validation using normoxic polymer gel dosimetry (with optical-CT readout) in an 
anthropomorphic head phantom was assessed. A 12-field stereotactic treatment plan for 
meningioma was recalculated onto a computed tomography scan of the head phantom with 
gel insert and was delivered using a Varian 2100 linear accelerator with mounted BrainLAB 
m3 mini-multileaf collimator.  
 
An additional study was undertaken in the context of stereotactic body radiotherapy. Lung 
tumours present challenges in terms of treatment planning dose calculations, because of the 
juxtaposition of high and low density media. This may affect the minimum dose received by 
lesions and is particularly important when prescribing dose to covering isodoses. The study 
presented in this chapter quantifies under-dosage in key regions around a hypothetical target 
using Monte Carlo dose calculation methods. A systematic set of calculations are undertaken 
using two Monte Carlo radiation transport codes (EGSnrc and GEANT4). A factor for clinical 
estimation of such under-dosage is also presented; this allows informed interpretation of 
patient treatment plans and retrospective analysis of clinical trial data. 
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5.2 Spectral qualities of stereotactic fields 
Critical to the thorough characterisation of small fields is the investigation of spectral 
properties. In fact, Attix (2004) states that “specification of a spectrum is still the most 
rigorous means of beam characterisation”. Direct measurement of MeV linac spectra is often 
prohibitively difficult because of the high beam flux. It is possible to employ techniques such 
as the use of scattering foils with a detector at an angle to the central axis, in order to derive 
some spectral information based on knowledge of Compton scattering under that particular 
arrangement etc. However, such approaches are very difficult, especially for small fields, and 
do not readily yield information on spatial variation of spectral qualities. Ultimately, the most 
effective means of doing this is to employ a dosimetrically-matched Monte Carlo model. This 
is the approach undertaken in the present work. A model of the BrainLAB m3 mini-multileaf 
collimator (MMLC) has been commissioned, as described in Chapter 4. In this section, the 
Monte Carlo model is used to assess the fluence and spectral characteristics of a range of 
small fields. Also of particular interest is the spectrum within and just beyond the penumbra 
of small fields, which is likely to be different to the primary beam, raising questions of dose 
response in detectors that exhibit energy dependence. 
 
 
5.2.1 Background 
For improved accuracy of dose calculation models and measurements with energy-dependent 
detectors, it is valuable to have knowledge of the fluence distributions and energy spectra 
from medical linear accelerators (linacs). For stereotactic radiosurgery and stereotactic 
radiotherapy, the necessity for accurate dose delivery is self-evident, given the potential for 
detriment if the target is under-dosed or if adjacent critical structures are subjected to 
excessive dose. The general complexities of dose calculation and measurement are 
compounded with the use of small fields because of issues of lateral electronic equilibrium. 
Clinical treatment planning systems have been shown to significantly miscalculate dose for 
small fields (Lydon 2005), particularly outside the primary field (Taylor et al. 2010c). 
Experimentally, ionisation chambers are often not appropriate for use with stereotactic fields 
because of their (relatively large) magnitude, and many of the alternative dosimeters (such as 
film, diodes and thermoluminescent dosimeters) are known to exhibit energy-dependence. For 
dosimeters that are not entirely media-matched (i.e. ‘tissue equivalent’), any change in the 
photon (or electron) spectrum causes a change in response relative to a tissue equivalent 
detector. 
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The importance of spectral characterisation is evidenced by the high number of citations (366 
as of July 2010, according to ISI Web of Knowledge) of the work of Mohan et al (1985). This 
work also highlights the usefulness of Monte Carlo radiation transport methods in the 
determination of such spectra. In this way, the difficulties of direct spectral measurement 
(such as high beam flux) are circumvented. For small fields (such as those employed in 
stereotactic radiosurgery/radiotherapy) there have been explicit investigations of spectral 
qualities, because beam collimation affects the energy of the primary beam.  
 
One of the earliest studies employing Monte Carlo calculations to determine the spectral 
changes due to collimation was that of Amols et al (1984), who modelled monoenergetic 
photon beams incident on a lead collimator. They found that for a 10 MeV beam the average 
energy transmitted through a 1 cm aperture was 9.7 ± 0.3 MeV compared to 7.0 ± 0.8 MeV 
for a 0.1 cm aperture. A further interesting finding was that a significant increase in 
collimator thickness results in far less degradation of the transmitted photon beam energy. 
One would expect that such energy reduction will result in secondary electrons of reduced 
range and consequently a shallower depth of maximum dose (dmax), and indeed this has been 
demonstrated. Serago et al (1992) showed this result for field diameters ranging from 10 to 40 
mm and energies from 4 to 24 MV (Clinac 6/100). Sixel and Podgorsak (1993) also 
demonstrated this for apertures ranging from 10 to 30 mm and energies from 6 to 18 MV 
(Clinac 18 and Clinac 2100C). Verhaegen et al (1998) also noted the shallower dmax and 
lower energies with decreasing field size, for field diameters of 0.5 to 5.0 cm for a 6 MV 
beam (Clinac-600SR). These energies were observed at the collimator exit, and it is worth 
noting spectral trends in water. Beam hardening with depth is typically observed, and with 
larger fields there is often a decrease in beam energy resulting from the increased number of 
low energy photons arising from phantom scatter (Cunningham et al. 1986). This has been 
investigated in the context of radiographic film response, with different reports on the 
magnitude of the response variation (Sykes et al. 1999; Danciu et al. 2001; Chetty and 
Charland 2002; Palm et al. 2004). 
 
There have been numerous studies concerned with the commissioning and implementation of 
stereotactic radiosurgery beams with micro-multileaf collimators; for instance (Cosgrove et 
al. 1999; Benedict et al. 2001; Deng et al. 2004). Belec et al (2005) and Ding et al (2006) 
have investigated the characteristics of stereotactic fields shaped with the BrainLAB 
(Feldkirchen) m3 mini-multileaf collimator (MMLC), however, a comprehensive 
investigation of spectral properties with varying field sizes has not been undertaken. In this 
thesis, Monte Carlo methods are employed to undertake systematic characterisation of the 
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spectra of small stereotactic fields shaped by a dosimetrically-matched model of the 
BrainLAB MMLC.  
 
 
5.2.2 Using a dosimetrically-matched Monte Carlo model to determine beam spectra 
A wide variety of Monte Carlo radiation transport codes are now available. One such code, 
EGSnrc (Kawrakow 2000), is interfaced with BEAMnrc (Rogers et al. 2007), allowing 
straightforward modelling of, in particular, radiotherapy linear accelerators. In this work we 
have constructed a model of the Varian 600C Clinac with a mounted BrainLAB mini-
multileaf collimator using BEAMnrc. The detail of this is presented in Chapter 4, and the key 
transport parameters are summarised here for completeness. The model was constructed 
based on schematics provided by Varian Medical Systems under a non-disclosure agreement 
and on direct measurements of the MMLC. In this work a simplified model of the m3 is 
employed, dosimetrically-matched to measured data using percent depth-dose curves, profiles 
and scatter factors (see Chapter 4 for this detail). A step size of 0.25 (maximum fractional 
energy loss, ESTEPE) was employed. EGSnrc has been shown to produce step-size independent 
results at a sub 0.1 % level even at interfaces of high Z media in fine geometries (Kawrakow 
2000; Verhaegen 2002). Here we have employed the PRESTA-ii electron-step algorithm with 
the exact boundary crossing algorithm such that the electron transport will go into single-
scattering mode within three elastic mean free paths of the boundary, giving the necessary 
accuracy at peak efficiency. Calculations were performed on the VPAC Tango AMD Opteron 
system, which consists of 95 nodes, each with two AMD Barcelona 2.3 GHz quad core 
processors (totalling 760 cores). Typically, fifteen processors were employed per simulation, 
each simulation thus requiring approximately 24 hours for 1010 incident particle histories. In-
field, uncertainties are negligible; out-of-field, uncertainties in photon fluences in air are of 
the order of 0.1 % and for spectra uncertainties range up to (in the worst case) the order of 
several percent.  
 
In this work, the energy spectrum is characterised as it varies with field sizes for fields 
including: 6 x 6 mm2, 12 x 12 mm2, 18 x 18 mm2, 24 x 24 mm2, 30 x 30 mm2, 42 x 42 mm2, 
60 x 60 mm2, 80 x 80 mm2 and 98 x 98 mm2. Characteristics are investigated within and just 
beyond the primary field. Far from the nominal field where leakage begins to dominate over 
scatter, it is likely that the Monte Carlo model would be limited in accuracy (since linac 
shielding was not incorporated). However, for the intermediate fields explored here, the 
model is expected to accurately represent the true beam. 
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5.2.3 Results and discussion 
5.2.3.1 Spectral data in air 
Spectral information has been scored in air at a source-surface distance (SSD) of 100 cm. 
Figure 5. to Figure 5.9 show spectral information for a range of field sizes between 6 x 6 mm2 
and 98 x 98 mm2. Each figure illustrates: 
– The contaminant electron fluence (scored both in a region equivalent to twice the 
nominal field size and in a plane extending out to 15 cm off-axis distance). 
– The photon fluence (scored both in a region equivalent to twice the nominal field size 
and in a plane extending out to 15 cm off-axis distance). 
– The mean photon energy (scored both in a region equivalent to twice the nominal 
field size and in a plane extending out to 15 cm off-axis distance). 
 
Figure 5.10 summarises some of the notable trends that may be observed as a function of field 
size, within the primary beam, beyond the penumbra and far from the primary field. 
 
Figure 5.11 demonstrates the variation of spectral distributions with field size, relative to the 
(maximum) field size of 98 x 98 mm2. 
 
Figure 5.12 to Figure 5.14 show the angular distribution of photons at 100 cm SSD for 
various field sizes, scored both in a region equivalent to the nominal field size and a large 
scoring plane of 30 x 30 cm2 centred at the central axis. 
 
Where normalised data is presented, the normalisation is with respect to the maximum (not 
the central-axis value), unless otherwise stated. 
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Figure 5.1 Spectral characteristics of a 0.6 x 0.6 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.2 Spectral characteristics of a 1.2 x 1.2 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.3 Spectral characteristics of a 1.8 x 1.8 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.4 Spectral characteristics of a 2.4 x 2.4 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.5 Spectral characteristics of a 3.0 x 3.0 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.6 Spectral characteristics of a 4.2 x 4.2 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.7 Spectral characteristics of a 60 x 60 cm2 field. The information of interest is scored in air at 
a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.8 Spectral characteristics of a 8.0 x 8.0 cm2 field. The information of interest is scored in air 
at a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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Figure 5.9 Spectral characteristics of a 98 x 98 cm2 field. The information of interest is scored in air at 
a distance of 100 cm from the target. (a) Electron fluence distribution from central axis (CAX) out to 
double the primary field width. (b) Electron fluence distribution from central axis (CAX) out to a 
distance of 15 cm. (c) Photon fluence distribution from central axis (CAX) out to double the primary 
field width. (d) Photon fluence distribution from central axis (CAX) out to a distance of 15 cm. (e) 
Mean photon energy distribution from central axis (CAX) out to double the primary field width. (f) 
Mean photon energy distribution from central axis (CAX) out to a distance of 15 cm. 
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There are a number of observations that may be made about the fluence and spectral qualities 
of the stereotactic fields modelled; these are demonstrated by Figure 5.10 shows the mean 
energy in the primary beam, 2 cm beyond the field edge and at an out-of-field point (12 cm 
off-axis) for a range of field sizes. Percentage differences in mean energy are also given 
relative to the 9.8 x 9.8 cm2 case. The percentage differences are defined as: 
 
( )
8.98.9
8.98.9100(%)
×
×−
=
E
EEE FSdiff ,  
 
where the subscript FS refers to field size (variable) and 9.8x9.8 corresponds to the 9.8 x 9.8 
cm2 field. 
 
Notably, the out-of-field photon fluence is approximately 1 % of the primary beam fluence, 
whilst the fluence of contaminant electrons is approximately 30 % of the fluence within the 
primary beam. What is also demonstrated, is that the photon fluence has a sharp gradient at 
the field edge, whereas the fluence of contaminant electrons does not exhibit a sharp gradient. 
It is also clear from Figure 5. to Figure 5.9 that there is a non-uniform fluence profile just 
beyond the primary beam for field sizes < 9.8 x 9.8 cm2 because of the interleaf leakage 
through the mini-multileaf collimator. Beam hardening by the collimation device is evidenced 
by the fact that the mean energy of the primary beam is lower than that of the beam periphery. 
This pronounced for small fields, but less noticeable for larger fields that are better shielded 
by the jaws. In all cases, the mean energy drops again in out-of-field regions – to 
approximately 80 % of the primary beam energy (up to 15 cm off-axis distance). As shown 
by Figure 5.11, the photon energy fluence varies with field size. The variation is most 
pronounced at low energies (below approximately 1 MeV), where small fields are shown to 
have much lower fluences – the difference decreasing with increasing energy. The difference 
also decreases with increasing field size, as one would expect. 
 
Figure 5.12, Figure 5.13 and Figure 5.14 show the angular distribution of photons at a source-
surface distance (SSD) of 100 cm in air. These figures show that the photon beam is far more 
forward-directed for small fields. For instance, the distribution peaks at 0 º for a 6 x 6 mm2 
field but for a 98 x 98 mm2 field the peak is at 4 º. What is also evident, is the fact that beyond 
the primary field the photons are much less forward-direction, which is to be expected since 
these (bremsstrahlung photons borne of the target) are mostly scattered in the linac head. 
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Figure 5.10 Variation of mean energy with field size. (a) The mean energy in the centre of the primary 
beam, at 12 cm off-axis-distance (‘out-of-field’) and at a point 2 cm beyond the field edge in each case. 
(b) Ratio of the mean energy in each case to the 9.8 x 9.8 cm2 field. (c) Percentage difference in mean 
energies in the primary beam, relative to the 9.8 x 9.8 cm2 field. (d) Percentage difference in mean 
energies at a point 12 cm from the central axis, relative to the 9.8 x 9.8 cm2 field. 
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Figure 5.11 The variation of spectral distribution with field size. The information of interest is scored 
in air at a distance of 100 cm from the target. (a) The spectral distribution for a 9.8 x 9.8 cm2 field. (b) 
An indication of the relationship between the spectral distribution and field size, illustrated by 
presentation of the ratio of difference field spectra to the 9.8 x 9.8 cm2 field spectrum. The most 
pronounced variation is in the low energy regime (below approximately 1 MeV), where small fields 
exhibit significantly lower fluence. The discrepancy above 1 MeV decreases with increasing field size 
(from 20-30 % lower for a 0.6 x 0.6 cm2 field to < 10 % for the large field sizes. 
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Figure 5.12 Angular distribution of particles (100 cm from the target) scored in nominal field sizes and 
in a large (30 x 30 cm2) scoring plane for the following field sizes: (a),(b) 0.6 x 0.6 mm2 (c),(d) 1.2 x 
1.2 mm2 (e),(f) 1.8 x 1.8 mm2. 
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Figure 5.13 Angular distribution of particles (100 cm from the target) scored in nominal field sizes and 
in a large (30 x 30 cm2) scoring plane for the following field sizes: (a),(b) 2.4 x 2.4 mm2 (c),(d) 3.0 x 
3.0 mm2 (e),(f) 4.2 x 4.2 mm2. 
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Figure 5.14 Angular distribution of particles (100 cm from the target) scored in nominal field sizes and 
in a large (30 x 30 cm2) scoring plane for the following field sizes: (a),(b) 6.0 x 6.0 mm2 (c),(d) 8.0 x 
8.0 mm2 (e),(f) 9.8 x 9.8 mm2. 
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There are a number of observations one may make from the data presented. These are 
summarised here in point form: 
– Out-of-field photon fluence ~1 % of primary beam fluence. 
– Out-of-field electron fluence ~30 % of primary beam fluence. 
– Photon fluence has sharp gradient at field edge. 
– Electron (contaminant) fluence does not have a sharp gradient at field edge. 
– ‘Structure’ evident in fluence profiles just beyond the primary beam (due to interleaf 
leakage through collimator). 
– Mean energy of primary photon field lower than surrounding peripheral regions (due 
to beam hardening by collimators) for small fields; mean energy drops again in far 
out-of-field regions. 
– Photon energy fluence varies with field size, most notably at low energies (below ~1 
MeV). 
– The photon beam is more forward directed for smaller fields, as evidenced by the 
primary field angular photon distributions (in fact, for the 9.8 x 9.8 cm2 field the 
distribution peaks at approx. 3º rather than 0 º). 
– The photons outside the primary field are much less forward-directed. 
 
 
5.2.3.2 Spectral data in water 
Radiation spectra change significantly within water and, as such, spectral data has also been 
presented for various depths in water for various field sizes. Figure 5.15 to Figure 5.23 
present this information for field sizes varying from 0.6 x 0.6 cm2 to 9.8 x 9.8 cm2. Each 
figure contains: 
– The mean photon energy spatial distribution as a function of distance from the central 
axis (CAX). In each case spectral data is plotted from the central axis to a distance 
twice that of the nominal field size, and also out to a distance of 15 cm (so that out-
of-field spectral qualities may be observed. 
– The spectral distribution (fluence as a function of energy) for both electrons and 
photons. 
– In each case, data for depths in water of 5, 10 and 15 cm is given. 
 
Several trends may be observed. Figure 5.24 shows the difference in mean energy for 
different field sizes, for both the primary field (i.e. at the central axis) and at a distance of 12 
cm off-axis (so as to illustrate mean energy trends out-of-field) at a depth of 5 cm in water 
with an SSD of 95 cm.  
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Percentage differences are also given relative to the 9.8 x 9.8 cm2 case. The percentage 
differences are defined as: 
 
( )
8.98.9
8.98.9100(%)
×
×−
=
E
EEE FSdiff ,  
 
where the subscript FS refers to field size (variable) and 9.8x9.8 corresponds to the 9.8 x 9.8 
cm2 field. 
 
One notable feature of the spectral distributions is that there are greater low-energy photons 
contributing to the primary field with larger field sizes. Figure 5.25 illustrates this trend 
(varying with field size), indicating the percentage fraction (of the total) of photons with less 
than 250 keV and less than 500 keV. The percentage difference between the different field 
sizes and the 0.6 x 0.6 cm2 case are also given, defined similarly to the mean energy 
difference, where Ψ is the fluence: 
 
( )
6.06.0
6.06.0100(%)
×
×
Ψ
Ψ−Ψ
=Ψ FSdiff .  
 
Make special note that this difference is relative to the 0.6 x 0.6 cm2 case, unlike the 
difference in mean energy is given relative to the 9.8 x 9.8 cm2 field. This is so that the 
difference remains a positive number. 
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Figure 5.15 Spectral characteristics of a 0.6 x 0.6 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.16 Spectral characteristics of a 1.2 x 1.2 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.17 Spectral characteristics of a 1.8 x 1.8 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.18 Spectral characteristics of a 2.4 x 2.4 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.19 Spectral characteristics of a 3.0 x 3.0 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.20 Spectral characteristics of a 4.2 x 4.2 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.21 Spectral characteristics of a 6.0 x 6.0 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.22 Spectral characteristics of a 8.0 x 8.0 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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Figure 5.23 Spectral characteristics of a 9.8 x 9.8 cm2 field. Each parameter of interest is scored at 
multiple depths (5, 10 and 15 cm) within a water phantom. (a) Mean energy distribution from central 
axis (CAX) out to double the primary field width. (b) Mean energy distribution from central axis 
(CAX) out to a distance of 15 cm. (c) Energy fluence of electrons in a scoring plane equal to the 
nominal field size. (d) Energy fluence of photons in a scoring plane equal to the nominal field size. 
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The systematic set of in-water spectral data clearly reveals a number of trends. The photon 
and electron spectra harden with depth in water. As Figure 5.24 shows, the mean energy of 
the primary photon beam decreases with increasing field size. The largest (9.8 x 9.8 cm2) field 
is approximately 30 % softer than the 0.6 x 0.6 cm2 field, as made evident in Figure 5.24(b). 
Out-of-field characteristics are illustrated at a distance of 12 cm off-axis. The mean photon 
energies decrease with increasing field size as shown in Figure 5.24(c), where the 0.6 x 0.6 
cm2 field is approximately 250 % harder than the 9.8 x 9.8 cm2 field. 
 
The lower mean energy of the larger beams is expected (since opened collimators present 
more surface area to the beam and concomitantly more scatter) and may be indicated by the 
relative fraction of low-energy photons in the primary beam spectra. This is highlighted 
clearly by Figure 5.25. The fraction (of the total) of photons with energies of < 250 keV and < 
500 keV is shown for various field sizes. There is strong field size dependence. For instance, 
the 9.8 x 9.8 cm2 field has approximately 1000 % more photons of energies < 250 keV than 
the 0.6 x 0.6 cm2 beam. 
 
The electron spectrum also changes with field size, most evidently in the sub-MeV regime. 
The larger fields have a larger fraction of low-energy electrons, decreasing with decreasing 
field size. This is illustrated in Figure 5.26. 
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Figure 5.24 This figure indicates the difference in mean energy for different field sizes, shown for both 
the primary field (at the central axis) and at a distance of 12 cm off-axis (to illustrate the mean energy 
trend out-of-field) at a depth of 5 cm in water (95 cm source-surface distance). (a) The mean energy of 
the primary field and at a point 12 cm off-axis as a function of field size. (b) The percentage difference 
between the mean primary beam energy for various field sizes relative to the 98 x 98 mm2 field. (c) The 
percentage difference between the mean out-of-field (12 cm off-axis) beam energy for various field 
sizes relative to the 98 x 98 mm2 field. 
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Figure 5.25 (a) The fraction of photons (as a percentage of the total from 0 – 6 MeV) with energies 
less than 250 keV or 500 keV, for various field sizes between 0.6 x 0.6 cm2 and 9.8 x 9.8 cm2. Scored 
at 5 cm depth in a water phantom at 95 cm source-surface distance. (b) A comparison of the low-
energy photon fraction for the different field sizes, presented as the percentage difference relative to the 
0.6 x 0.6 cm2 case (this is so that the percentage differences remain positive; see main body text for 
explanation). 
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Figure 5.26 (a) Spectral distribution of electrons for a 9.8 x 9.8 cm2 at 5 cm depth in water. (b) 
Spectral distribution of electrons for various field sizes, presented as a ratio to the distribution for a 9.8 
x 9.8 cm2. The ratio is only shown to 4.5 MeV because of the high uncertainty associated with the 
(negligible) fluence at high energies. 
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There are a number of observations that may be made based on the data presented pertaining 
to spectral qualities in water, which are summarised in point form here: 
– Photon spectra harden with depth in water. 
– Electron spectra harden with depth in water. 
– Mean energy of primary photon beam decreases with increasing field size (6 x 6 mm2 
beam is 30 % harder than 98 x 98 mm2 beam). 
– Out-of-field mean photon energies (at 12 cm off-axis distance) decrease with 
increasing field size (6 x 6 mm2 beam is 250 % harder than 98 x 98 mm2 beam). 
– The fraction of total photons in the low energy regime increases with field size (98 x 
98 mm2 beam has ~1000 % more photons with energies < 250 keV than 6 x 6 mm2 
beam). 
– Electron spectrum varies with field size, most notably in the low-energy regime (< 1 
MeV), such that larger fields have a larger fluence of low-energy electrons. 
 
 
5.2.3.3 Comparison with ‘backed-up’ fields 
Thus far the focus has been on fields shaped entirely with the mini-multileaf collimator. The 
reason for this is twofold: firstly, in clinical practice, the ‘back-up’ jaw sizes are determined 
by the maximum MMLC field sizes only and remain static and, secondly, for the sake of 
brevity – it is not feasible to include all possible combinations of MMLC and jaw sizes. 
Nevertheless, it is of interest to compare the spectral and fluence characteristics of purely 
MMLC shaped field with those shaped by both the jaws and MMLC. As such, several field 
sizes have been chosen for comparison. 
 
Scored in air at 100 cm source-surface distance, mean photon energy distributions, photon 
and electron spectral distributions and photon angular distributions are shown in Figure 5.27 
to Figure 5.29. The spectral distributions of photons and electron in-field show great 
similarity, and are clearly not greatly affected by the presence of back-up jaws. For the 
smaller fields in particular, the mean energy distributions beyond the primary field differ 
noticeably. The mean energies typically increase closer to the field edge than the non backed-
up case, are relatively low in the shadow of the MMLC, then remain higher far from the 
primary field (most likely because of the finite lateral width of the jaws). There is also a 
noticeable difference in the angular distribution of photons at the patient plane, being more 
forward-directed for smaller fields but less so for larger fields (relative to the non backed-up 
case). 
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Figure 5.27 Comparison of MMLC-shaped fields, with and without back-up jaws with the same field 
opening of 24 x 24 mm2. (a) The photon mean energy distribution shown from the central axis to a 
distance twice that of the nominal field size. (b) The photon mean energy distribution, shown out to 15 
cm from the central axis. (c) The spectral distribution for photons in the primary field. (d) The spectral 
distribution for (contaminant) electrons in the primary field. (e) Angular distributions of photons within 
the primary beam. (f) Angular distribution of photons in a large (30 x 30 cm2) scoring plane. 
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Figure 5.28 Comparison of MMLC-shaped fields, with and without back-up jaws with the same field 
opening of 30 x 30 mm2. (a) The photon mean energy distribution shown from the central axis to a 
distance twice that of the nominal field size. (b) The photon mean energy distribution, shown out to 15 
cm from the central axis. (c) The spectral distribution for photons in the primary field. (d) The spectral 
distribution for (contaminant) electrons in the primary field. (e) Angular distributions of photons within 
the primary beam. (f) Angular distribution of photons in a large (30 x 30 cm2) scoring plane. 
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Figure 5.29 Comparison of MMLC-shaped fields, with and without back-up jaws with the same field 
opening of 60 x 60 mm2. (a) The photon mean energy distribution shown from the central axis to a 
distance twice that of the nominal field size. (b) The photon mean energy distribution, shown out to 15 
cm from the central axis. (c) The spectral distribution for photons in the primary field. (d) The spectral 
distribution for (contaminant) electrons in the primary field. (e) Angular distributions of photons within 
the primary beam. (f) Angular distribution of photons in a large (30 x 30 cm2) scoring plane. 
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5.2.4 Clinical relevance 
The results presented in this work clearly indicate that photon and electron (contaminant and 
secondary) spectra vary spatially, for different field sizes, different media and different depths 
in water phantoms. While identifying associated trends is interesting from a purely academic 
perspective, there are also clinical consequences. Primarily, these are concerned with dose 
measurement with dosimeters that exhibit energy dependence. Considering dose-effect 
curves, a 5 % shift in dose may result in a 10 or 20 % shift about a tumour control probability 
(TCP) of 50 %. Complication rates in normal tissues may be affected by 20 or 30 % with the 
same 5 % shift in dose. A patient’s response to a 7 % difference in dose may be clinically 
detectable by an oncologist (Papanikolaou et al. 2004). Accurate dosimetry is of critical 
importance. 
 
As discussed in earlier chapters, media-matching of dosimeters is of significant importance. 
Where the radiological properties of the dosimeter deviate from those of the medium (such as 
water), then corresponding energy dependence may generate inaccurate measurements when 
the spectra of the radiation fields change. 
 
To illustrate this point, several clinically-relevant cases are presented here. Firstly, the 
acceptability of the use of a standard 10 x 10 cm2 reference field for ionisation chamber 
calibration with the assumption that secondary electron spectra are field-size and depth 
independent is investigated in the context of stereotactic radiotherapy. Secondly, the response 
of radiographic film for small-field measurement is investigated. Thirdly, the response of 
thermoluminescent dosimeters (in- and out-of-field) for stereotactic radiotherapy dosimetry is 
studied. The latter two approaches have both involved explicit Monte Carlo dose calculation. 
 
Much of the work presented in this section has been submitted for publication (Taylor et al. 
2011a). 
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5.2.4.1 Measurement of absorbed dose with an ionisation chamber 
It is possible to relate the dose to the gas in an ionisation chamber to that in the medium of 
interest occupied by the dosimeter (Attix 2004), such that the dose in the medium is given by: 
 
wallreplion
med
gas
gasmed PPP
LMND 





=
ρ
, 5.1 
 
where M is the electrometer reading, Ngas is the gas cavity calibration factor, ( )medgasL ρ/ is the 
ratio of the mean restricted stopping power of the medium (phantom material) to that of the 
chamber gas (air). Pion is a factor that accounts for ionisation recombination losses (the 
inverse of the ionisation collection efficiency). Prepl is a replacement correction depending on 
the type and energy of radiation, the gradient of the depth dose curve where the measurement 
is made and the radius of the chamber cavity. Pwall is unity when the chamber wall and 
medium are of the same composition, and otherwise is a stopping power based correction 
which may be found elsewhere (Schulz 1983; Attix 2004). These various factors account for 
the fact that the ionisation chamber perturbs the dose field.  
 
The ratio of the mean restricted stopping powers, ( )medgasL ρ/ , may be given by: 
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where, in this case, we will assume the medium (med) refers to water and the gas is air, 
( )dEEd /)(Φ  is the energy spectrum of electrons and ∆ is the cut-off energy. This stopping 
power ratio is often assumed to be constant, since the variation in the energy spectrum in the 
case of broad-beam photon irradiation is typically slight (for instance, calibration is 
performed with a 10 x 10 cm2 field). However, as has been established in this study, there are 
changes to the spectrum in the case of small fields (as relevant to stereotactic radiotherapy). 
As such, it is of interest to try and quantify any dependence of field size and phantom depth 
on the stopping power ratio.  Monte Carlo methods are employed to explicitly investigate the 
extent of the influence of changing spectra on the absorbed dose as measured using an 
ionisation chamber, and thus to identify any corresponding systematic errors that may be 
introduced. 
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The spectral distributions of electrons in the primary field calculated via Monte Carlo 
methods were multiplied by collisional stopping powers (ICRU 1984b) at the same electron 
energies (each matrix having >400 data points) and integrated between ∆ = 10 keV and the 
maximum kinetic energy 6 MeV. This was done for both water and air and the ratio 
calculated for field sizes between 0.6 x 0.6 cm2 and 9.8 x 9.8 cm2 at depths in water of 5, 10 
and 15 cm. The calculated values of ( )medgasL ρ/  are given in Table 5.1. 
 
The ratios for the various cases were compared against the calibration reference condition of a 
9.8 x 9.8 cm2 field – the largest possible and closest to 10 x 10 cm2 as recommended by 
various protocols (Schulz 1983; Almond et al. 1999; IAEA 2000) at a depth (d) of 5 cm. This 
is represented by ( )RL ρ/ in Equation 5.3 below. 
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This is given in Table 5.2 for the various field sizes (FS). To illustrate the extent of the 
discrepancy for different field sizes and depths, the percentage difference is plotted in Figure 
5.30, where the difference (for various field sizes, FS, and depths, d) is defined as: 
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The results clearly show that although there is a spectral change, it is not significant enough 
to generate discrepancies greater than half a percent relative to the reference condition (for the 
range of field sizes and depths studied here). It should be noted that these results correspond 
only to the primary field, and differences may be more pronounced for out-of-field 
measurements. This point is highlighted by Figure 5.31. 
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Table 5.1 The mean collisional stopping power ratio (where the medium med is water and the gas is 
air) for various field sizes at various depths (5, 10 and 15 cm). 
 
Field size 
cmdepth
med
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L
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

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
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ρ  
cmdepth
med
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L
10=
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
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cmdepth
med
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L
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











ρ  
0.6 x 0.6 cm2 1.1158 1.1153 1.1141 
1.2 x 1.2 cm2 1.1167 1.1160 1.1152 
1.8 x 1.8 cm2 1.1170 1.1163  1.1156 
2.4 x 2.4 cm2 1.1173 1.1167  1.1160 
3.0 x 3.0 cm2 1.1175 1.1169  1.1161 
4.2 x 4.2 cm2 1.1177 1.1172 1.1166 
6.0 x 6.0 cm2 1.1180 1.1176  1.1171 
8.0 x 8.0 cm2  1.1183 1.1180  1.1176 
9.8 x 9.8 cm2 1.1185 1.1185 1.1185 
 
 
 
Table 5.2 The ratio of mean collisional stopping power ratios (where the medium med is water and the 
gas is air) for various field sizes at various depths (5, 10 and 15 cm), relative to the reference case of 
field size 9.8 x 9.8 cm2 and depth 5 cm. 
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0.6 x 0.6 cm2 0.9976 0.9971 0.9961 
1.2 x 1.2 cm2 0.9984 0.9977 0.9970 
1.8 x 1.8 cm2 0.9986 0.9981 0.9974 
2.4 x 2.4 cm2 0.9990 0.9984 0.9978 
3.0 x 3.0 cm2 0.9991 0.9985 0.9979 
4.2 x 4.2 cm2 0.9993 0.9988 0.9983 
6.0 x 6.0 cm2 0.9996 0.9992 0.9988 
8.0 x 8.0 cm2  0.9998 0.9995 0.9991 
9.8 x 9.8 cm2 1.0000 1.0000 1.0000 
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Figure 5.30 The difference in mean stopping power ratios, ( )[ ]
diff
med
gasL ρ/  (defined in Equation 5.4), 
between various field sizes and the reference case (9.8 x 9.8 cm2 at 5 cm depth). The discrepancy is 
clearly larger for smaller field sizes and greater depths, but is nonetheless less than 1 %. 
 
 
 
 
 
Figure 5.31 The objective of this figure is to demonstrate that although the mean energy of the 
secondary electron spectrum within the primary field is similar for (significantly) different field sizes, 
beyond the primary beam discrepancies of almost a factor of two may exist. (a) The mean energy as a 
function of distance from the central axis (CAX) for a 6 x 6 mm2 field (solid line) and a 98 x 98 mm2 
field (broken line). (b) The ratio of the mean energy of the small field to the large field as a function of 
distance from the central axis. 
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In the case of out-of-field doses, an example is demonstrated for the 6 x 6 mm2 field. The 
difference in electron spectra in- and out-of-field is illustrated by Figure 5.31, which shows 
the mean energy as a function of distance from the central axis, as well as the ratio of mean 
energy for the 6 x 6 mm2 relative to the 98 x 98 mm2 field. The discrepancy in mean energy is 
clearly larger in the region approximately 6 to 11 cm off-axis. Calculations of ( )medgasL ρ/  
corresponding to the out-of-field spectrum for the 6 x 6 mm2 and 60 x 60 mm2 fields were 
undertaken. Comparing these to ( )medgasL ρ/  for the 98 x 98 mm2 primary field, the percentage 
differences, ( )[ ]
diff
med
gasL ρ/ , were determined. These are summarised in Table 5.3.  
 
Although the difference between the two is opposite (i.e. negative) to the primary field 
comparison observed earlier, the difference is still nonetheless < 1 % for the case of small 
fields. However, this is the case purely because the small-field out-of-field electron spectrum 
– while differing from the primary beam spectrum – happens to be close to that of the large-
field primary beam spectrum. 
 
Referring to Figure 5.31(a), it is clear that the mean out-of-field energy for the small-field 
case is comparable to the mean energy of the primary beam of the 98 x 98 mm2 field. Unlike 
the previous cases, where small fields have exhibited the largest discrepancy, Figure 5.31(a) 
indicates that for out-of-field measurements, large fields might be more problematic (the 
mean out-of-field energy for the large field is approximately half that of the primary field). As 
such, the stopping power ratios have also been calculated for the out-of-field electron spectra 
for the 60 x 60 mm2 and 98 x 98 mm2 beam. This is also summarised in Table 5.3; the 
discrepancy is much more pronounced for out-of-field spectra for larger fields – ranging up to 
approximately 1.2 %. 
 
As such, for the vast majority of applications, it may be stated that the approximation of a 
constant stopping power ratio obtained with use of a broad beam (typically 10 x 10 cm2) is 
acceptable, since the associated error is small (< 1%). 
 
However, for out-of-field measurements that, in particular, employ larger field sizes, there 
may be a systematic error > 1 % attributable to the assumption of unchanging electron spectra 
for different field sizes and spatial locations within the phantom. 
 
 
 
  195
 
Table 5.3 The mean collisional stopping power ratios (med refers to water and gas is air) for the out-of-
field spectra (6 – 12 cm off-axis) for a 6 x 6 mm2, 60 x 60 mm2 and 98 x 98 mm2 field. Also shown is 
the percentage difference compared to the reference 98 x 98 mm2 field. These are shown for depths of 
5, 10 and 15 cm in water. Note in particular that the percentage differences are in this case negative, 
unlike the difference for a primary field comparison. Please see the main body text for definition of the 
parameters in this table. 
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  196
5.2.4.2 Dose measurement with radiographic film 
Radiographic film is used for radiation dosimetry with advantages in spatial resolution, 
reading permanence, commercial availability, geometry (for field-mapping), linearity with 
dose and dose-rate independence (Attix 2004). However, radiographic film is known to 
exhibit energy dependence, with an over-response (factor of 10-50) to photons less than 100 
keV in particular. See, for instance, early work such as that of Herz (1969) and more recent 
publications such as Task Group 69 on radiographic film (Pai et al. 2007). Yeo (Yeo et al. 
2004) showed EDR2 overestimates by ~9% in clinically-relevant conditions. Radiographic 
film consists of an emulsion of microscopic grains of silver bromide (AgBr) dispersed in a 
gelatine layer on both sides of a supporting film base. Incident charged particles generate ion 
pairs in/near the grains, converting Ag+ ions to Ag atoms. Chemical processing removes the 
bromine and leaves behind an (opaque) microscopic grain of silver, the presence of which 
may be detected optically and related quantitatively to the dose absorbed. 
 
Palm et al (2004) investigated the response of Kodak XV radiographic film. They assumed a 
uniform mix of AgBr with cellulose nitrate, describing the film as having a fractional 
elemental composition by weight given by H:0.023948, C:0.222374, N:0.099407, 
O:0.473944, Br:0.076736 and Ag:0.103592. The density is 1.731 gcm-3 and the total 
thickness is 7.8 µm (3.9 µm either side of a polyethylene terephthalate substrate). In this 
study, an in silico investigation of the response of radiographic film (compared to water) is 
undertaken using EGSnrc. The composition given by Palm et al is used to define a 187.8 µm 
thick radiographic film in a water phantom. For computational efficiency, a cylindrically-
symmetric geometry was defined. This is illustrated in Figure 5.32. 
 
 
Figure 5.32 A representation of the modelled geometry. Monte Carlo radiation transport calculations 
were undertaken on a cylindrically-symmetric geometry incorporating a 3.9:180:3.9 µm emulsion-
substrate-emulsion film at a depth of 5 cm in water. Equivalent simulations were undertaken with water 
in place of film, so as to determine the relative response of the film. A 18 x 18 mm2 6 MV beam 
(generated with the commissioned model of the Varian 600C with mounted MMLC) was made incident 
upon the cylindrical phantom. Dose was scored in radial bins of 2.5 mm width. 
 
Beam (18 x 18 mm2) 
150 mm 
100 mm 
50 mm 
H2O 
Film 
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Figure 5.33 (a) The dose profile across the film and water at an equivalent location, at 5 cm depth in 
water for a 18 x 18 mm2 field. (b) A close-up of the two dose profiles, indicating the over-response of 
radiographic film. The response of the film is up to approximately 1.2 % higher than that to water. (c) 
In this case, the dose to film corresponds only to the 3.9 µm emulsion layer on top of the polyethylene 
terephthalate substrate (similarly dose to water is scored in a 3.9 µm layer). (d) A close-up of the two 
dose profiles, indicating the over-response of radiographic film. The response of the film is ~ 2 % 
higher than that to water. 
 
 
The film was modelled at a depth of 5 cm in water and irradiated with an 18 x 18 mm2 field. 
The radiographic film is shown to exhibit an over-response to the incident field (Figure 5.33). 
The dose to the film is approximately 1.2 % higher than that to water at an equivalent spatial 
location irradiated with the same field. Considering only the 3.9 µm emulsion layer, the 
discrepancy between film and water is higher – approximately 2 %. Note also that the 
discrepancy varies spatially. One might hypothesise a greater concern may be the difference 
in spectrum between small fields and the larger reference field used for calibration. 
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5.2.4.3 Dose measurement with thermoluminescent dosimeters 
Thermoluminescent dosimeters (TLD) are widely employed in a clinical context because of 
their applicability to small field measurement, in vivo dosimetry and out-of-field dose 
measurement. In clinical dosimetry, Lithium Fluoride is the most commonly employed 
thermoluminescent material, and for a comprehensive review the interested reader is referred 
to the manuscript by Kron (1994). Lithium Fluoride doped with Magnesium and Titanium 
(LiF:Mg,Ti), known as TLD-100, is the most widely implemented. For applications requiring 
greater sensitivity, LiF doped with Magnesium, Copper and Phosphorous (LiF:Mg,Cu,P) 
TLDs, known as TLD-100H, are often employed. This includes such applications as 
measurement of out-of-field organ doses in radiotherapy (Taylor et al. 2011c), where 
scattered and leaked radiation dominates and the radiation spectrum differs notably from the 
primary field. McKeever et al (1995) and the references therein provide a good overview of 
the characteristics of TLD-100 and TLD-100H dosimeters, the radiological properties of 
which are of significant interest (Horowitz 1993b; Mobit et al. 1998; Horowitz 1999; Saez-
Vergara et al. 1999; Schoner et al. 1999; Bilski 2002; Horowitz and Olko 2004). 
 
The dose information ultimately yielded by TLDs after exposure to ionising radiation is not 
straightforward, with many contributing factors. One parameter of interest is the effective 
atomic number, Zeff – often used as a means of characterising the radiological properties of 
dosimeters. This is because, as McKeever et al (1995) state, it is ‘the critical material 
parameter’, the value of which determines which interaction processes dominate.  
 
There is a notable difference between the effective atomic number of thermoluminescent 
dosimeters compared to water and soft tissue. This is illustrated by Figure 5.34 and Figure 
5.35. The maximum discrepancy between Zeff of TLD and of water coincides with the 
maximum photons fluence. See Taylor (2011) for a more comprehensive discussion of the 
effective atomic numbers of TLD-100 and TLD-100H and the influence of dopants and 
impurities. 
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Figure 5.34 (a) The effective atomic numbers (Zeff) for total photon interaction processes calculated 
using the method of Taylor (2011), for water, soft tissue (ICRU 1989), TLD-100H and the PAGAT 
polymer gel dosimeter (Venning et al. 2005a). (b) The same Zeff data for the various media is presented 
as a ratio to that of water. The gel matches water very closely, more so in fact than soft tissue. The 
effective atomic number of the TLD is consistently higher than water, especially (and perhaps 
surprisingly) in the Compton regime. 
 
 
 
 
Figure 5.35 Effective atomic numbers (Zeff) for total photon interaction processes calculated using the 
method of Taylor (2011), for water, soft tissue (ICRU 1989), TLD-100H and the PAGAT polymer gel 
dosimeter (Venning et al. 2005a). Overlayed is the photon spectrum at 5 cm depth in water for a 18 x 
18 mm2 field. The photon fluence is greatest at energies where the discrepancy between Zeff of water, 
tissue and gel are similar, but the difference between water and TLD-100H is high. 
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5.2.5 Conclusions 
A systematic study of stereotactic beam characteristics has been undertaken, calculated with a 
dosimetrically-matched Monte Carlo model of a Varian 600C with mounted BrainLAB 
MMLC. A large dataset has been obtained to facilitate thorough characterisation, including: 
– Photon spectra, 
– Contaminant electron spectra, 
– Spatial variation of mean photon energy, 
– Spatial variation of mean electron energy, and 
– Angular distribution of photons. 
 
Spectral data in water at several depths (5, 10 and 15 cm) has also been calculated, including: 
– Photon energy fluences, 
– Electron energy fluences, and 
– Mean energy distributions. 
 
Further data has been compiled for comparison using ‘backed-up’ field, i.e. jaws set at the 
same field opening as the MMLC. Mean energy, spectral and angular distributions were 
calculated for several representative cases. 
 
Furthermore, three examples have been given to illustrate the effect of energy dependent 
dosimeters. In the first case, it is shown that the routine calibration of ionisation chambers 
performed with a reference (10 x 10 cm2) field and the assumption of unchanging secondary 
electron spectra does result in a systematic error that increases for decreasing field size. 
However, this error is less than 1 % within the primary field and may be considered 
negligible. Conversely, measurements taken beyond the primary field are subject to greater 
errors that increase with field size. The latter phenomenon is a direct result of the different 
spectra in- and out-of the primary field. The second example demonstrated is the over-
response of radiographic film. Film is shown to over-respond by up approx. 1.2 % compared 
to water alone. This over-response varies in degree spatially, being high in the primary field, 
then low in the immediate periphery, then rising again slightly in the out-of-field region. The 
third example involves TLD-100 LiF thermoluminescent dosimeters. Studying the energy 
dependence of the effective atomic number of the TLD shows the maximum discrepancy 
between Zeff of the TLD and of water coincides with the peak of the photon spectrum.  
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5.3 Dosimetric characteristics of small stereotactic fields 
The dosimetric characteristics of small fields as used in stereotactic radiotherapy are difficult 
to measure in comparison to broad-beam fields. This issue has been discussed in greater detail 
in previous chapters. Issues of charged particle equilibrium raise questions about the accuracy 
of dose calculation using conventional treatment planning systems. Even newer, more 
rigorous dose calculation algorithms are nonetheless reliant upon measured dose profiles for 
input, and are thus still subject to the limitations of the experimentally measured doses. These 
limitations include effects such as detector volume averaging, which complicates the accurate 
measurement of penumbra and limits the field size measurable. It is common clinical practice 
to employ multiple dosimeter types for the measurement of small fields, and then average the 
measured results. 
 
The first half of this chapter has involved thorough characterisation of spectral qualities of 
stereotactic fields. The subsequent half of the chapter investigates dosimetric aspects of 
stereotactic radiotherapy. Specifically, this is undertaken for two ‘case studies’ – one 
intracranial and one extracranial. 
 
In previous chapters, the potential for three-dimensional gel dosimetry for the measurement 
of small-field characteristics has been described. In this chapter, polymer gel dosimetry is 
employed to investigate the dose distribution in an anthropomorphic phantom to demonstrate 
the feasibility of gel dosimetry stereotactic plan verification.  
 
Also presented in this chapter is an investigation of lung tumour under-dosage; this study is 
an example where Monte Carlo calculations show great promise in complementing or even 
replacing measurements. As stated, electronic disequilibrium may complicate the calculation 
of absorbed dose at interfaces of dissimilar media. One such example is that of a lung tumour 
(which has a density close to that of soft tissue or water) within lung tissue (which has a 
density approximately one third that of soft tissue). In such a case, treatment planning system 
algorithms such as pencil beam convolution are expected not to accurately predict the dose to 
peripheral regions. Even calculation via more advanced algorithms is often limited by the 
dose grid size. Furthermore, clinical trials often employ algorithms such as the pencil beam. 
As such, it is useful to be able to estimate the extent of peripheral under-dosage in order to 
determine (whether prospectively or retrospectively) the dose to a lung tumour. This chapter 
provides a systematic investigation of lung tumour under-dosage. 
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Both of the following sections of this chapter constitute self-contained papers prepared for 
submission to scientific journals. As such, there is a separate introduction to highlight the 
clinical relevance and case specific conclusions. However, both sections serve to explore the 
complexity of the three-dimensional dose distributions encountered in small-field dosimetry. 
They were chosen to highlight the role of experimental and theoretical methods for this 
purpose. Some of the introductory material has been covered earlier in greater detail and the 
reader may elect to pass over some of the prefatory sections. 
 
 
 
5.4 Validation of stereotactic treatments for small intracranial tumours 
via normoxic polymer gel dosimetry (PAGAT) with optical CT readout† 
Stereotactic radiotherapy and radiosurgery often employ small photon fields in the treatment 
of intracranial targets. Complexities associated with small fields, such as an absence of 
charged particle equilibrium, make measurement of such fields inherently difficult and 
impose a level of uncertainty on the treatment. A particular focus of this thesis is the 
applicability of three-dimensional (3D) gel dosimetry as a potential solution to many of the 
problems associated with small-field dosimetry. This has been discussed in detail in Chapter 
3. 
 
Here, the potential for stereotactic treatment validation using normoxic polymer gel dosimetry 
(with optical-CT readout) in an anthropomorphic head phantom is assessed. A 12-field 
stereotactic treatment plan for meningioma was recalculated onto a computed tomography 
scan of the head phantom with gel insert and was delivered using a Varian 2100 linear 
accelerator with mounted BrainLAB m3 mini-multileaf collimator. Via quantitative 
comparison using indices such as percentage pixel agreement and gamma analysis, it is 
demonstrated that 3D gel dosimetry may be readily employed for assessment of PTV 
coverage. Gamma analysis showed that above the 80 % isodose line, ~90 % of the gamma 
values were less than unity (for criteria of 2%/2mm). Poorer agreement was observed at low 
isodoses, most likely because in these regions: (i) the gel receives only low doses and may 
exhibit nonlinearity, (ii) the effects of slight misregistration of the plan and gel dose 
distributions may be more pronounced, (iii) optical scatter and (iv) the treatment planning 
system may not accurately calculate dose adjacent to the container wall. 
 
                                                 
†
 Note for the sake of scientific integrity, this section of the chapter repeats the associated publication 
verbatim; ML Taylor et al, Three-dimensional dose verification for clinical treatments of small 
intracranial tumours, Medical Physics, in prep 
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5.4.1 Introduction 
Cancers of the brain and central nervous system account for 1.6 % of new cancers and 1.8 % 
of cancer deaths globally. The highest rates of all developed nations are observed in Australia 
and New Zealand (Parkin et al. 1999). Despite being less common than some other cancers of 
the human body, a relatively large variety of benign and malignant brain tumours exist. These 
are often treated by means of intracranial radiotherapy, as are vascular disorders such as 
arteriovenous malformations (AVM).  
 
The brain exhibits a high degree of sensitivity for radiation damage, both acute and delayed. 
Immediate side effects occur in one third of patients (N = 78) treated with SRS and SRT, but 
are usually moderate (Werner-Wasik et al. 1999). The typical acute effect of high radiation 
doses to the brain is an increased intracranial pressure, arising from brain oedema (an 
abnormal build-up of serous fluid between tissue cells). Contemporary radiotherapy methods 
of dose delivery and fractionation effectively eliminate the potential for acute radiation 
damage, however, there can be a delayed reaction to brain irradiation that is likely to result 
from transient interruption of myelin (which acts as an insulator between nerve fibres) 
synthesis by oligodendrocytes (Rider 1963). This manifests itself in forms of neurological 
deterioration. This is generally nonfatal and the aforementioned effects are often temporary, 
however, severe late radiation damage is typically permanent and can result in effects ranging 
from mild neurological impairment to death. Such radiation necrosis is the gravest potential 
consequence of therapeutic brain irradiation. This can occur with relatively high probability 
when treatment plans exceed 40 Gy in 20 fractions, or 60 Gy in 30 fractions in five weeks, or 
when fractions exceed 3 Gy (Lee et al. 1988; Marks and Spencer 1991). Adverse radiation 
reactions have been reported in applications of radiosurgery, despite the small treatment 
volumes involved (Flickinger et al. 1995; Ianssen et al. 2004; Jensen et al. 2005). High dose 
focal and whole brain irradiation are often performed for intracranial lesions, though little is 
known about long-term neuropsychological effects. Clinical findings show children exhibit 
cognitive decline subsequent to radiotherapy of brain tumours; data for adults is 
comparatively scarce, with preliminary finding suggesting some cognitive function, such as 
memory, may be particularly vulnerable (Roman and Sperduto 1995). 
 
The potential for such detriment necessitates a high degree of conformality in the delivered 
dose, particularly in the case of SRS which employs high-dose single-fraction treatments. In 
vivo measurement of dose is not feasible. The treatment planning system employs a dose 
computation algorithm (pencil beam) that is limited in its treatment of electronic disequilibria, 
such as those which occur in the vicinity of interfaces and with small fields. In this study, the 
efficacy of gel dosimetry for dosimetric verification of stereotactic fields is investigated using 
a radiosensitive polymer gel in an anthropomorphic head phantom. 
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5.4.2 Experimental method 
5.4.2.1 Clinically-relevant stereotactic treatment delivered to phantom 
A 12-field stereotactic treatment plan for a patient with meningioma was recalculated on a 
computed tomography (CT) scan of an anthropomorphic head phantom with an intracranial 
cavity (CIRS, Virginia). The cubic (63.5mm3) cavity contains a block with a gel container – a 
cylindrical vessel (with a very slight divergence) 43 mm in diameter (at base) by 63 mm in 
length. Figure 5.36 shows a three-dimensional (3D) render and two-dimensional (2D) slice 
generated from the CT scan, as well as a photo of the head phantom. The treatment plan was 
calculated using the pencil beam algorithm in iPlan RT Dose (BrainLAB, Feldkirchen). The 
phantom was scanned and treated with a thermo-transformable fixation mask for 
reproducibility (this is also evident in the 3D render in Figure 5.36). A total dose of 5.19 Gy 
was delivered to the PTV in a single fraction with 12 conformal fields (see Table 5.4 for more 
detail). The planned dose distribution was exported with 0.5 mm resolution and analysed 
using Matlab (MathWorks Inc., Massachusetts). 
 
 
 
 
Table 5.4 The beam arrangement for the clinical treatment plan. Field weights, doses to isocentre 
(Disoc), gantry, couch and collimator angles are all shown. 
 
Conformal field Weight (%) Disoc (Gy) Gantry (°) Couch (°) Collimator (°) 
1 9.8  0.37 25 0 135 
2 5.7 0.29 300 0 90 
3 9.8 0.39 10 0 0 
4 9.8 0.36 350 0 90 
5 9.8 0.49 225 0 5 
6 4.6 0.26 231 336 0 
7 7.4 0.43 268 338 90 
8 6.2 0.34 294 338 90 
9 10.0 0.58 285 300 60 
10 6.9 0.42 320 300 90 
11 9.8 0.56 330 270 90 
12 9.9 0.37 20 270 90 
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5.4.2.2 Gel dosimeter 
In this work we employed a normoxic polyacrylamide gel (PAG) dosimeter containing 
tetrakis (hydroxymethyl phosphonium chloride (THP) as an anti-oxidant, known as PAGAT 
(polyacrylamide, gel and THP). This gel dosimeter contains (in order of concentration) pure 
water, gelatine, bis, acrylamide, hydroquinone and THPC. Readers are referred to the original 
work by Venning et al (2005a) for details of the gel manufacturing process. The gel exhibits 
good water/tissue equivalency as evidenced by Table 5.5, which shows the mean effective 
atomic numbers for photon and electron interactions, weighted a 6 MV photon spectrum 
using a method described elsewhere (Taylor et al. 2008; Taylor et al. 2009b). ‘Large 
tub’(Taylor et al. 2007; Taylor et al. 2009a) calibration is the most appropriate approach . 
 
 
5.4.2.4 Optical readout of the gel dosimeter 
The gel was read out using an Octopus-IQ laser optical computed tomography (CT) scanner 
(MGS Research Inc., Madison USA). Although the scan speed is slower than cone-beam 
optical CT scanners, the advantage of the laser scanner is significantly reduced scatter 
artefacts when reading out polymer gels as compared with broad beam techniques. The scan 
employed a slice thickness of 0.5 mm and 720 angular projections for 0.5 mm pixels. The 
refractive index matching fluid was approximately 70 % water to 30 % glycerol, with food 
dye and trace amounts of sulphuric acid and sodium benzoate (< 0.1 %) to prevent algae 
growth. 
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Figure 5.36 A (a) render and (b) midsagittal slice generated from a CT scan of the anthropomorphic 
head phantom. The fixation mask is readily noticeable in the render. In the sagittal slice one can clearly 
see the large intracranial cavity, filled with two solid spacers on the left and the gel container on the 
right. (c) A photo of the head phantom (MGS Research Inc., Madison USA), in this case with a film 
stack in the intracranial cavity rather than the gel insert. 
 
 
 
Table 5.5 Data indicating the water / tissue equivalence of PAGAT gel. Compositional details of soft 
tissue sourced from ICRU data. The mass densities of PAGAT, water and soft tissue are given. The 
effective atomic number of a material varies significantly with the energy of the incident radiation. 
Calculated here are mean effective atomic numbers corresponding to the total interaction cross section 
for photons and electrons, weighted by a 6 MV photon spectrum (Mohan et al. 1985), as described 
elsewhere (Taylor et al. 2008; Taylor et al. 2009b). 
 
Material ρ, kg.m-3 effZ  (Photons) effZ  (Electrons) 
PAGAT 1026 3.40 3.37 
Water 1000 3.36 3.40 
Soft tissue 1060 3.36 3.35 
 
(a) 3D render (b) 2D slice  
(c) Photo  
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5.4.3 Results and discussion 
Figure 5.37 illustrates the 3D dose distribution as measured with the gel dosimeter. A number 
of methods have been employed to compare the measured dose distribution with that 
calculated by the treatment planning software. The treatment was delivered such that the 
isocentre was located at the centre of the gel container, so as to maximize the distance from 
interfaces. Figure 5.38 shows 2D dose maps and profiles to illustrate the agreement between 
the gel measurements and treatment planning predictions. The good agreement in high-dose 
regions is also reflected in Figure 5.40, which graphically indicates the level of agreement via 
histograms of pixel agreement. The high dose regions clearly match well, indicating good 
agreement in the PTV dose and its immediate periphery. Poorer agreement exists at lower 
isodoses. This is also made clear from Table 5.6 which quantifies the percentage of pixels that 
match within 2 %. The dose to the PTV matches well, with >96 % of pixels matching better 
than 2 % above the 90 % isodose curve. Figure 5.39 shows line profiles illustrating the level 
of agreement between the measured and calculated doses. 
 
 
 
 
Figure 5.37 Illustration of the 3D dose distribution measured with the gel dosimeter (dark = 90 % 
isodose, medium = 80 % isodose and light = 75 % isodose). The scale is in pixel numbers (where the 
pixel size is 0.5 mm). 
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Figure 5.38 Surface plots corresponding to 2D slices through the isocentre for the (a) gel and (b) iPlan 
dose distributions. The most pronounced difference is the scatter artefacts caused by the gel container. 
The colour-bar and vertical axis correspond to relative dose, ranging from 0 to 100 %. The x- and y-
axes correspond to distance, with 10 mm increments. 
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Figure 5.39 (a) Horizontal and (b) vertical line profiles through 2D planes in the gel and iPlan dose 
distributions. There are notable scatter artefacts corresponding to the container walls.  
 
 
 
One may observe that in Figure 5.39 there is a notable discrepancy between measured and 
predicted (treatment planning system) doses. There are likely to be a range of reasons for such 
differences, but it is important to note that more recent work involving replication of this 
experiment using Monte Carlo methods indicates much better agreement with the gel dose 
than the treatment planning system (Kairn et al. 2011). Not only other there many physics 
approximations in the pencil beam algorithm employed, but the commissioning data is limited 
for such small fields (uncertainties in scatter factors may range beyond 10 %) and the 
cumulative effect for such a complex treatment as this one may be significant. Indeed, this 
may be seen as an important result, highlighting again the complexities of small fields which 
are the focus of this thesis. 
 
Gamma (γ) analysis was also undertaken to quantify the level of agreement. The γ evaluation 
method involves the combination of a dose-difference criterion and a distance-to-agreement 
(DTA) criterion to assess the discrepancies between two dose distributions (Low et al. 
1998a). In brief, the measured dose distribution, ( )gelgel rD , is compared to the calculated dose 
distribution, ( )calccalc rD , at points gelr  and calcr such that the dose difference may be specified 
as: 
 
( ) ( ) ( )calccalcgelgelcalcgel rDrDrr −=,δ , 5.5 
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and the spatial difference may then be given by: 
 
( ) ( ) ( )calcgelcalcgel rrrrr −=, . 5.6 
 
Specifying acceptance criteria for dose and distance-to-agreement of ∆D and ∆d respectively, 
one may then define the γ-function as: 
 
( ) ( ) ( )2222 ,,, d rrrD rrrr calcgelcalcgelcalcgel ∆+∆= δγ . 5.7 
 
A γ value less than unity is considered as accepted. One must be careful in the interpretation 
of the γ evaluation; for instance, for criteria of ∆D = 3 % and ∆d = 3 mm, a dose difference of 
2.9 % and distance disagreement of 2.9 mm would result in γ > 1 and fail the γ test. 
 
The results of the γ analysis (with criteria of ∆D = 2 % and ∆d = 2 mm, and ∆D = 5 % and ∆d 
= 5 mm) are given in Table 5.7. For the PTV, above the 90 % isodose, γ agreement of 86 % 
was exhibited for 2%/2mm criteria. Above the 60 % isodose γ agreement is ~80 %, dropping 
to 20 % at the 20 % isodose for the same criteria.  
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Figure 5.40 A set of relative-frequency histograms (normalised to unity) illustrating the level of 
agreement between doses measured in the radiosensitive gel and those predicted with iPlan, 
highlighting the good PTV coverage (as evidenced by (b), which shows good agreement above the 90 
% isodose) and the difficulties in obtaining accurate measured data in the low-dose regions in close 
proximity to the walls of the gel container, such as in (e) and (f). Subfigures (a) through (f) show the 
percentage differences between the measured and planned dose distributions (from the maximum dose 
out to the isodoses indicated in each case). 
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Table 5.6 An indication of the agreement between the planned and measured dose distributions. Here, 
‘Agreement’ refers to the number of pixels values that agree within 2 %. The mean difference and 
standard deviation are also given. There is clearly poorer agreement at lower isodoses. 
 
Isodose (%) Agreement (%) Mean difference (%) σ (%) 
90 96.2 -0.844 10.2 
80 89.2 -0.37 11.1 
70 87.8 -0.396 8.85 
60 83.7 0.006 10.5 
50 77.0 -1.50 11.2 
40 74.4 -1.22 8.42 
30 63.4 3.74 8.49 
20 35.6 -0.238 8.75 
10 29.5 5.86 10.5 
Mean 70.7 0.56 9.78 
 
 
 
Table 5.7 This table indicates the agreement between the planned and measured dose distributions via 
2D gamma map analysis (through the isocentre). Gamma criteria of 2%/2mm and 5%/5mm are shown. 
 
Isodose (%) γ (2% / 2mm) γ (5% / 5mm) 
90 86.3 94.4 
80 84.6 94.2 
70 81.5 92.7 
60 79.8 88.4 
50 74.6 81.7 
40 66.4 78.5 
30 56.7 64.8 
20 19.7 38.6 
10 17.9 27.0 
Mean 63.1 73.2 
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There are a range of issues that may potentially influence the agreement between the plan and 
the measured dose: 
 
(i) Registration accuracy. The CT (and therefore the dose distribution calculated by 
the treatment planning system) was not aligned with the Cartesian axes, which, 
combined with the limited resolution of the plan, made alignment of the 
measured and calculated dose distributions difficult. The registration was 
optimized, but is unlikely to be ideal. 
(ii) Dose response. The maximum dose delivered to the gel was 5.19 Gy. Although 
the dose response of PAGAT when readout optically (or with MRI) is fairly 
linear out to about 10 or 15 Gy, at low doses (particularly <1 Gy) the response of 
PAGAT is poorly known (Senden et al. 2006a; Bosi et al. 2007). 
(iii) Optical scatter. Despite subtraction of a ‘background’ matrix (an optical scan of a 
gel in the same arrangement with zero dose), there were issues of optical scatter 
around the interface of the container and gel; this is indicated in Figure 5.41. 
Stray light due to scattering from the dose distribution itself is also expected, 
since the polymer gel scatters (rather than absorbs) light. 
(iv) Normalisation/calibration. The TPS-calculated and gel doses are compared by 
normalising to maximum dose. If the gel exhibits a non-linear dose response at 
higher doses then the agreement at low doses will be poorer. Furthermore, optical 
scatter is greater at higher doses, which again will affect the agreement (the total 
signal is a combination of light transmitted through the gel and scatter; thus, for 
high dose regions there is low transmittance and a greater fraction of scattered 
light). 
(v) Accuracy of pencil beam at interfaces. The poor match of experimental data and 
that calculated using the iPlan pencil beam algorithm occurs within the vicinity of 
the interface with the container. One would not expect the error in dose 
prediction to be significant in this region since the radiological properties of the 
two juxtaposed media are not dissimilar; however, the influence of a possible 
miscalculation in this region may not be discounted. Also relevant is the accuracy 
of the commissioning of small-field data. Scatter factors for very small fields 
exhibit relatively high uncertainty; the integral dose result for this 12 beam case 
may also result in significant discrepancies. This notion is supported by high 
agreement between Monte Carlo and the gel results presented here (Kairn et al. 
2011). 
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Figure 5.41 A two-dimensional slice through the dose distribution as measured in gel and scanned 
using the optical CT scanner; the scale shows percentage isodoses. This figure illustrates the 
interference of the container walls, despite subtracting a background matrix of a container of 
unirradiated gel. The distance scales on the axes are arbitrary. The colour scale indicates isodoses (%). 
 
 
 
5.4.4 Conclusions 
There is a demonstrated requirement for accurate dosimetry of stereotactic fields, such as the 
12-field treatment for a small meningioma as investigated here. Gel dosimetry is not subject 
to limitations such as volume averaging, yielding a fully three-dimensional dose distribution 
for verification of a planned clinical treatment. Agreement close to the PTV is generally 
good; above the 90 % isodose, γ evaluation indicated 86 % agreement for criteria of 2%/2mm 
Limitations in low-dose regions may be attributable to nonlinearity of dose response when 
read out optically, optical scatter at interfaces, poor registration and potentially the limited 
accuracy of the pencil beam algorithm for dose calculation (the container is 63 mm in 
diameter and the electron range is ~16 mm).. Though it is tempting to attribute discrepancies 
to the limitations of gel dosimetry, it is important to remember that the accuracy of the dose 
calculation (to which the gel measurements are compared) is questionable. This is due not 
only to the inherent limitations of the pencil beam algorithm, but the scatter factors for such 
small fields are not well known. Spatially, the PTV occupies a region only 10-17 mm across. 
Clinically, scatter factors are typically known down to about 1 x 1 cm2 or 2 x 2 cm2, and 
interpolation to smaller field sizes may be dubious (particularly since measured output factors 
employed clinically typically exhibit standard deviations up to the order of 15 % at 99% CI). 
Evidence for the clinical feasibility of gels for plan verification has been provided, making 
special note of the fact that agreement is much stronger between gel and Monte Carlo than gel 
and TPS (Kairn et al. 2011).  
63 mm 
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5.5 Small-field radiotherapy of lung tumours: A systematic investigation 
of under-dosage due to electronic disequilibrium 
Prediction of dose distributions in close proximity to interfaces is difficult. In the context of 
radiotherapy of lung tumours, this may affect the minimum dose received by lesions and is 
particularly important when prescribing dose to covering isodoses. The objective of this work 
is to quantify under-dosage in key regions around a hypothetical target using Monte Carlo 
dose calculation methods, and to develop a factor for clinical estimation of such under-
dosage. A systematic set of calculations are undertaken using two Monte Carlo radiation 
transport codes (EGSnrc and GEANT4). Discrepancies in dose are determined for a number of 
parameters, including beam energy, tumour size, field size and distance from chest wall. 
Calculations were performed for 1 mm3 regions at proximal, distal and lateral aspects of a 
spherical tumour, determined for a 6 MV and a 15 MV photon beam. The simulations 
indicate regions of tumour under-dose at the tumour-lung interface. Results are presented as 
ratios of the dose at key peripheral regions to the dose at the centre of the tumour, a point at 
which the TPS predicts the dose more reliably. Comparison with TPS data (pencil beam 
convolution) indicates such under-dosage would not have been predicted accurately in the 
clinic. We define a Dose Reduction Factor (DRF) as the average of the dose in the periphery 
in the six cardinal directions divided by the central dose in the target, the mean of which is 
0.97 and 0.95 for a 6 MV and 15 MV beam respectively. The DRF can assist clinicians in the 
estimation of the magnitude of potential discrepancies between prescribed and delivered dose 
distributions as a function of tumour size and location. Calculation for a systematic set of 
‘generic’ tumours allows application to many classes of patient case, and is particularly useful 
for interpreting clinical trial data. 
 
For the sake of scientific integrity, this section of the chapter repeats the associated 
publication verbatim (Taylor et al. 2011b). 
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5.5.1 Introduction 
It is known that the periphery of lung tumours is under-dosed in radiotherapy due to 
electronic disequilibrium at the interfaces of tumour and lung tissue (Metcalfe et al. 2007). 
Knowledge or estimation of the degree of dose inhomogeneity is required so as to interpret 
outcomes from clinical trials or for the design of new treatment protocols. While the best of 
contemporary treatment planning systems may be able to calculate these effects adequately, 
those clinics using more simplistic algorithms (such as pencil beam convolution) and clinical 
trial data from treatments planned using earlier algorithms require further information for 
accurate assessment (Timmerman et al. 2006). The aim of this work was to develop a 
generalised method with a simple geometry involving several variables to allow a straight 
forward estimation of the magnitude of peripheral under-dosage. This is facilitated by 
tabulation of minimum doses at key points and the introduction of a ‘dose reduction factor’ – 
a mean value representing the under-dosage to the peripheral ‘shell’ of a lung tumour relevant 
for multiple-field or arc therapy. Assessment of incorrect dose prediction in the periphery of 
the tumour would be particularly important if the prescription is based on a covering isodose. 
A generic model can be used to inform protocols and used to interpret clinical data 
retrospectively. It can also be useful when evaluating new plans if accurate dose calculation 
on a millimetre scale are not available. 
 
The extent of under-dosage was evaluated using Monte Carlo radiation transport methods. 
Monte Carlo simulation is accepted as an accurate means of modelling dose distributions, 
particularly in regions of electronic disequilibrium such as interfaces of high and low density 
media. In the field of radiotherapy, EGSnrc is extensively used for Monte Carlo calculations, 
and has found to be accurate at the sub-percent level in the context of external beam 
radiotherapy (Chibani and Li 2002; Doucet et al. 2003). Moreover, a literature survey of 
papers involving Monte Carlo methods in the context of stereotactic (body) radiotherapy 
indicates EGSnrc is employed with far greater frequency than other Monte Carlo transport 
codes. For this reason, the results shown in this work were derived using EGSnrc. 
Nevertheless, to strengthen the results, agreement with an alternative transport code (GEANT4) 
was assessed. GEANT4 (GEometry ANd Tracking) is a detector simulation toolkit for the 
simulation of the passage of particles through matter using Monte Carlo methods and an 
Object Oriented (C++) basis. GEANT4 simulations have been compared with established and 
authoritative reference data taken from open and recognised databases (NIST, ICRU, etc.). 
Poon and Verhaegen (2005) validated the photon and electron transport of the GEANT4 toolkit 
by examining cross sections and sampling algorithms, and showed an agreement with EGSnrc 
to within 2% except in the buildup region for depth-dose distributions in water. Perturbation 
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effects near high-Z and low-Z interfaces can be overcome by careful selection of physics 
processes and transport parameters. In particular, use of step-size restrictions can yield 
accurate results at interfacial regions (Poon et al. 2005). The use of two transport codes based 
on different physical models improves the confidence in results presented in this study. 
 
 
 
5.5.2 Method 
In this study, Monte Carlo methods are employed to develop a systematic set of data that may 
be used by clinicians to estimate the magnitude of dose prediction error that may occur as a 
result of the complex nature of the treatment and limitations of clinical planning tools. The 
accurate modelling of radiation interactions, particularly in the vicinity of heterogeneities, by 
Monte Carlo techniques facilitates assessment of tumour under-dosage. The modelled 
geometry is shown in  
Figure 5.42. The EGSnrc model used rectilinear 1 mm3 voxels, while the geant4 model 
employed spherical 1 mm3 voxels at the dose calculation points. A virtual tumour within lung 
tissue that lies beyond a soft tissue layer (such as the chest wall) was irradiated with an 
external photon beam. Several factors were varied to determine influences on dose 
distributions. These parameters include beam energy, field size, tumour size and distance of 
the tumour from the internal chest wall, as summarised in Table 5.8. A parallel beam of flat 
profile was chosen to remove inverse-square law contributions and relate to an isocentric 
arrangement, with field sizes chosen to extend 10 mm beyond the tumour boundary. For 
reproducibility the photon spectra employed are those given by Mohan et al (1985). Photon 
beams of 6 and 15 MV were chosen because 6 MV is commonly employed clinically and 15 
MV is at the high end of the possible treatment energy choices, and serves to illustrate the 
energy dependence of the results. Thus, readers may be able to estimate intermediate values 
relevant to their own clinic. The tissue compositions, outlined in Table 5.9, are those defined 
by the International Commission on Radiological Units (ICRU 1989) except for that of the 
lung tumour, which was determined by Maughan et al (1997) using combustion analysis of 
excised squamous cell lung carcinoma.  
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Figure 5.42 Schematic of simulated geometry. A photon beam (the energy spectrum, E, and field size, 
FS, of which are varied) is made incident upon a voxelated phantom consisting of a wall of soft tissue 
followed by lung tissue, in which exists a spherical tumour. The thickness of soft tissue is set to 20 mm. 
The distance, d, from the soft-lung tissue interface to the tumour is varied. The diameter of the tumour, 
Øt, is also varied, and determines the field size. The uniform voxel size is 1 mm3. 
 
 
 
 
 
 
Table 5.8 Systematic set of simulation parameters varied to indicate the influence on dose. Multiple 
photon spectra were modelled using the well known definitions provided by Mohan et al (1985). 
 
Varied parameters  
Photon beam spectrum, E (MV) 6 and 15 
Tumour diameter, Øt (mm) 10, 16, 20, 30 and 50 
Field size, FS (mm2) 30 x 30, 35 x 35, 40 x 40, 50 x 50 and 70 x 70 
Distance from chest wall, d (mm) 5, 10, 20 and 40 
 
 
Lung tissue Normal (soft) tissue Tumour 
d Øt 
Polyenergetic photon 
beam, E, defined by 
Mohan et al (1985). 
Varying field size, FS. 
20 mm 110 mm 
80 mm 
80 mm 
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Physics processes in EGSnrc include: bremsstrahlung production, positron annihilation (in 
flight and at rest), multiple scattering by coulomb scattering from nuclei, Møller scattering, 
Bhabha scattering, continuous energy loss between discrete events, pair/triplet production, 
Compton scattering, Rayleigh scattering, the photoelectric effect, atomic relaxation and 
electron impact ionisation. The work undertaken with EGSnrc employs the PRESTA-II electron-
step algorithm with the EXACT boundary crossing algorithm such that the electron transport 
will go into single-scattering mode within three elastic mean free paths of the boundary, giving 
the necessary accuracy at peak efficiency. In the Monte Carlo investigations carried out here, a 
step size of 0.25 (maximum fractional energy loss, ESTEPE) was employed. EGSnrc has been 
shown to produce step-size independent results at a sub 0.1 % level even at interfaces of high 
Z media in fine geometries (Kawrakow 2000; Verhaegen 2002).  Calculations were performed 
on the VPAC Tango AMD Opteron system. Typically, four processors (AMD Barcelona 2.3 
GHz quad core) were employed per simulation, each simulation thus requiring approximately 
9 hours for 1010 initial particle histories. 
 
The GEANT4 package allows construction of complex scoring and transport geometries of any 
element, mixture, or compound, as well as transportation and tracking of a variety of particles 
which fall under the classes leptons, mesons, baryons, bosons, short-lived particles and ions. 
For the purposes of this study however, only photons, electrons and positrons are considered. 
Physics processes include those listed for EGSnrc above as well as photonuclear interactions 
and high-energy processes. GEANT 4.9.4 beta was used in this study and is currently the latest 
release. For the GEANT4 simulations, energy cut-offs for photons were set to 990 eV and 
electron energy cut-offs to 40 keV. These energies correspond to range cut-offs of 0.1 mm. 
Processing time is on the order of ten to twenty times that of EGSnrc for the same number of 
histories. Hence, in most cases, a factor of 10 fewer particle histories were simulated with 
GEANT4, the output of which thus exhibits correspondingly higher statistical uncertainties.  
 
For comparison, dose calculations were also performed for the same geometry using a 
commercial treatment planning system for radiotherapy dose calculations (Eclipse 8.2, Varian 
Medical Systems) with the pencil beam convolution (PBC) algorithm. The phantom was 
defined in the system with the same densities as employed in the Monte Carlo calculations. A 
6 MV divergent photon beam corresponding to a Varian 21 IX linear accelerator was used 
with the centre of the lesion at the isocentre. The maximum spatial resolution was used (i.e. a 
grid size of 1.25 mm; note this corresponds to a voxel size approximately twice that of the 
Monte Carlo model). 
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Table 5.9 The density and elemental composition (percentage by weight) of the various tissues 
modelled in this study. The lung carcinoma data was determined by combustion analysis of excised 
squamous cell lung carcinoma (Maughan et al. 1997) and other data is from the International 
Commission on Radiological Units (ICRU 1989). †The density of lung carcinoma is taken to be that of 
water (1 g.cm-3). 
 
 Soft tissue Lung tissue Lung carcinoma 
ρ (g.cm-3) 1.06 0.26 1.00 † 
H 10.2 10.3 9.9 
C 14.3 10.5 19 
N 3.4 3.1 4.5 
O 70.8 74.9 65.45 
Na 0.2 0.2 0.1265 
P 0.3 0.2 0.253 
S 0.3 0.3 0.322 
Cl 0.2 0.3 0.1955 
K 0.3 0.2 0.253 
 
 
 
 
5.5.3 Result 
5.5.3.1 EGSnrc determination of under-dosage 
Results are given as the ratio of doses at the boundaries of tumours (region facing beam, 
region where beam exits tumour and the four lateral sides of the tumour intersected by 
Cartesian axes) and a reference point, chosen to be the centre of the tumour, i.e. 
 
ref
boundary
t D
D
EFSdR =),Ø,,( , 
 
where R is the ratio of dose at the given boundary (Dboundary) to the (reference) dose at the 
centre of the tumour (Dref). R is effectively a function of the beam energy, E, the distance of 
tumour from chest wall, d, and field size, FS, the latter being dependent on the tumour 
diameter, Øt. The tabulated results are those calculated with egsnrc. Table 5.10 and Table 
5.11 present the dose ratios for 6 and 15 MV photon beams respectively. Each table is divided 
into three sections, corresponding to the ratios of the dose at the entrance, exit and lateral 
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points of the tumour to the reference (central) point of the tumour. ‘Entrance’ and ‘exit’ refer 
to the closest and furthest points on the tumour with respect to the source of the beam. The 
statistical uncertainty (1σ in each ratio is given in parentheses. The calculation points are 1 
cubic millimetre in volume and their locations are illustrated in Figure 5.43. 
 
 
 
  
Figure 5.43 Diagram indicating the points of the tumour at which dose ratios are calculated (marked 
with a black x); illustrated through central cross-sections of the tumour volume. ‘Prox’ refers to the 
proximal (beam entrance) point, ‘Dist’ to distal (exit), ‘Ref’ to reference and ‘Lat’ to lateral points. The 
incident photon beam is indicated by the shaded area (a square field, directed along the z-axis). The x-y 
and x-z planes are shown, the latter also being equivalent to the y-z plane.   
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5.5.3.2 The ‘dose reduction factor’ (DRF) 
 
Table 5.12 presents the estimated dose reduction factor (DRF) which is effectively the ratio of 
the mean of the total surface dose to that at the central point for a given arrangement. 
Calculations show that considering the dose to the total outer ‘shell’ of the tumour is 
equivalent (i.e. exhibits a statistically insignificant difference) to using weighted mean doses 
at the proximal, distal and four equispaced lateral points, such that: 
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This is relevant for clinical contexts such as arcs or multiple-field therapy where the beam is 
incident upon the tumour from numerous directions.  
 
 
 
  
 
Figure 5.44 (a) The dose reduction factor (DRF) for a 20 mm diameter tumour at various distances. 
Plotted alongside is equivalent calculated data within a homogeneous phantom composed entirely of 
soft tissue. This highlights the discrepancy between doses to the peripheral ‘shell’ and the centre of a 
tumour that arise purely from attenuative effects (the DRF for the homogeneous case remains within ~1 
% of unity, which is indicative mostly of the curvature of a depth dose curve tail in soft tissue). (b) The 
ratio of dose to the centre of the tumour, to an equivalent point in a homogeneous (soft tissue) phantom. 
Expectedly, the points at further distances rise above unity due to the greater attenuation in the 
homogeneous case compared to that in lung tissue in the tumour model. The points at closer distances, 
roughly < 20 mm from the chest wall, are below unity, indicating the under-dosage due to effects of 
disequilibrium. 
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Table 5.10 The dose ratios, R (d, FS, Øt, E), for a 6 MV photon spectrum. The ratios are presented for 
various tumour diameters (Øt), field sizes (FS) and distances from the chest wall to the tumour (d). The 
table is divided into three sections, corresponding to ratios of entrance-to-central dose, exit-to-central 
dose and lateral-to-central dose. The standard deviation, σ, is given in parentheses. 
 
Entrance dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 1.0016 (± 0.01) 1.0405 (± 0.01) 1.0154 (± 0.01) 1.0571 (± 0.02) 1.0664 (± 0.02) 
10 0.9835 (± 0.01) 1.0056 (± 0.01) 1.0315 (± 0.01) 1.0447 (± 0.02) 1.0768 (± 0.02) 
20 0.9748 (± 0.01) 0.9667 (± 0.01) 1.0169 (± 0.01) 1.0321 (± 0.02) 1.0732 (± 0.02) 
40 0.9628 (± 0.01) 0.9571 (± 0.01) 0.9739 (± 0.01) 0.9834 (± 0.02) 1.0249 (± 0.02) 
      
Exit dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 0.9597 (± 0.01) 0.9376 (± 0.01) 0.9213 (± 0.01) 0.9430 (± 0.02) 0.8905 (± 0.02) 
10 0.9277  (± 0.01) 0.9537 (± 0.01) 0.9386 (± 0.01) 0.9481 (± 0.02) 0.8882 (± 0.02) 
20 0.9713 (± 0.01) 0.9469 (± 0.01) 0.9412 (± 0.01) 0.9250 (± 0.02) 0.9266 (± 0.02) 
40 0.9626 (± 0.01) 0.9212 (± 0.01) 0.9286 (± 0.01) 0.9093 (± 0.02) 0.9244 (± 0.02) 
      
Lateral dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 0.9794 (± 0.005) 0.9750 (± 0.005) 0.9538 (± 0.005) 0.9869 (± 0.008) 0.9646 (± 0.01) 
10 0.9571 (± 0.005) 0.9661 (± 0.005) 0.9724 (± 0.005) 0.9922 (± 0.008) 0.9900 (± 0.01) 
20 0.9701 (± 0.005) 0.9426 (± 0.005) 0.9589 (± 0 005) 0.9665 (± 0.008) 1.0055 (± 0.01) 
40 0.9583 (± 0.005) 0.9366 (± 0.005) 0.9489 (± 0.005) 0.9347 (± 0.008) 0.9887 (± 0.01) 
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Table 5.11 The dose ratios, R (d, FS, Øt, E), for a 15 MV photon spectrum. The ratios are presented for 
various tumour diameters (Øt), field sizes (FS) and distances from the chest wall to the tumour (d). The 
table is divided into three sections, corresponding to ratios of entrance-to-central dose, exit-to-central 
dose and lateral-to-central dose. The standard deviation, σ, is given in parentheses. 
 
Entrance dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 0.9671 (± 0.01) 0.9654 (± 0.01) 0.9615 (± 0.01) 0.9346 (± 0.01) 0.9656 (± 0.02) 
10 0.9670 (± 0.01) 0.9585 (± 0.01) 0.9391 (± 0.01) 0.9561 (± 0.01) 0.9772 (± 0.02) 
20 0.9450 (± 0.01) 0.9245 (± 0.01) 0.9281 (± 0.01) 0.9267 (± 0.01) 0.9814 (± 0.02) 
40 0.9207 (± 0.01) 0.9053 (± 0.01) 0.9078 (± 0.01) 0.9182 (± 0.01) 0.9750 (± 0.02) 
      
Exit dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 0.9379 (± 0.01) 0.9301 (± 0.01) 0.9219 (± 0.01) 0.9048 (± 0.01) 0.9236 (± 0.02) 
10 0.9546 (± 0.01) 0.9251 (± 0.01) 0.9316 (± 0.01) 0.9331 (± 0.01) 0.9037 (± 0.02) 
20 0.9618 (± 0.01) 0.9254 (± 0.01) 0.9357 (± 0.01) 0.9293 (± 0.01) 0.9014 (± 0.02) 
40 0.9613 (± 0.01) 0.9304 (± 0.01) 0.9499 (± 0.01) 0.9012 (± 0.01) 0.9112 (± 0.02) 
      
Lateral dose 
Øt (mm) / 
FS (mm2) 
    
d (mm) 
10 / 
30 x 30 
16 / 
35 x 35 
20 / 
40 x 40 
30 / 
50 x 50 
50 / 
70 x 70 
5 0.9470 (± 0.003) 0.9260 (± 0.003) 0.9141 (± 0.005) 0.8854  (± 0.005) 0.8914 (± 0.008) 
10 0.9519 (± 0.003) 0.9078 (± 0.003) 0.8979 (± 0.005) 0.8940 (± 0. 005) 0.8998 (± 0.008) 
20 0.9413 (± 0.003) 0.8883 (± 0.005) 0.8898 (± 0.005) 0.8937 (± 0.005) 0.8714 (± 0.008) 
40 0.9206 (± 0.003) 0.8820 (± 0. 005) 0.8971 (± 0.005) 0.8728 (± 0.005) 0.8820 (± 0.008) 
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Table 5.12 The estimated surface dose reduction factor, DRF, for 6 and 15 MV photon spectra. The 
standard deviation, σ, is given in parentheses. The lower uncertainty in the 15 MV case is borne of the 
fact that the uncertainty is a statistical one relating to the fluence. The variance is inversely proportional 
to the square of the number of particles, and since 15 MV photons have higher penetrative ability there 
are a greater number of particles contributing to scored quanta at ‘deeper’ points within the model 
(relative to the 6 MV case), and therefore the statistical uncertainty is lower. 
 
Dose Reduction Factor, DRF 
6 MV Øt (mm)         
d (mm) 10 16 20 30 50 
5 0.98 (± 0.01) 0.98 (± 0.01) 0.96 (± 0.01) 1.00 (± 0.01) 0.97 (± 0.02) 
10 0.96 (± 0.01) 0.98 (± 0.01) 0.98 (± 0.01) 1.00 (± 0.01) 0.99 (± 0.02) 
20 0.97 (± 0.01) 0.95 (± 0.01) 0.97 (± 0.01) 0.98 (± 0.01) 1.00 (± 0.02) 
40 0.96 (± 0.01) 0.94 (± 0.01) 0.95 (± 0.01) 0.94 (± 0.01) 0.98 (± 0.02) 
      
15 MV Øt (mm)         
d (mm) 10 16 20 30 50 
5 0.951 (± 0.001) 0.940 (± 0.001) 0.933 (± 0.001) 0.908 (± 0.002) 0.927 (± 0.002) 
10 0.958 (± 0.001) 0.931 (± 0.001) 0.923 (± 0.001) 0.927 (± 0.002) 0.927 (± 0.002) 
20 0.949 (± 0.001) 0.913 (± 0.001) 0.918 (± 0.001) 0.916 (± 0.002) 0.918 (± 0.002) 
40 0.934 (± 0.001) 0.906 (± 0.001) 0.918 (± 0.001) 0.897 (± 0.002) 0.928 (± 0.002) 
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5.5.3.3 Agreement between the two Monte Carlo transport codes 
The results tabulated in this study correspond to those obtained using EGSnrc. Figure 5.46 
shows the relation between results obtained with EGSnrc and GEANT4. The differences 
between the results from the two codes do not appear to be systematic, and may be attributed 
to the statistical uncertainties (which are larger for GEANT4) and the slightly different 
definition of the simulation geometry, exhibiting no consistent trends as a function of the 
various modelled geometric parameters.  
 
 
5.5.3.4 Comparison with TPS prediction 
For comparison, equivalent calculations of the DRF were undertaken with the pencil beam 
convolution algorithm (PBC). The ratio of the PBC values to those calculated using EGSnrc 
are shown in Figure 5.47 as a function of the distance, d, for the various tumour diameters. 
The treatment planning system generates relatively high DRF values (i.e. close to unity), thus 
underestimating the peripheral under-dosage. For clinics with more advanced TPS dose 
calculation algorithms, similar evaluations of the DRF could be performed locally and 
compared with the Monte Carlo values presented in this work. It is difficult to identify any 
particular trends in the data; the reason for this is that the high degree of competition between 
effects of build-up, build-down, attenuation, varying charged particles ranges and so forth is 
highly complex. 
 
 
 
Figure 5.45 An example of the difference in under-dosage between the two different energy 
modalities, illustrated via the dose reduction factor (DRF) for a distance of 10 mm and various tumour 
diameters. The interesting relatively high value at Ø = 10 mm for the 15 MV beam is a consequence of 
the entirety of the tumour being in a ‘build-up’ region.  
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Figure 5.46 An example of the agreement between EGSnrc and geant4. This figure shows the DRF (see  
main text for definition) for EGSnrc and geant4 data plotted against each other. The data is scattered 
about the line of y = x, the latter corresponding to ideal agreement. There does not appear to be any 
particular bias. The deviation from perfect agreement may be attributed to statistical variance and the 
slightly different definition of the simulation geometry. 
 
 
 
 
Figure 5.47 The ratio of DRF values calculated by the treatment planning system (pencil beam 
convolution, PBC) to those calculated with EGSnrc. This illustrates the limitations of the TPS, which 
inaccurately predicts the DRF – and thus underestimates the peripheral under-dosage – by up to 
approximately 4.5 %. Data is shown for the various tumour sizes as a function of the distance, d. 
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5.5.4 Discussion 
5.5.4.1 Clinical relevance 
Currently, the leading type of cancer mortality is associated with the lung and bronchus. 
Recent data indicates lung cancers also account for approximately 15 % and 14 % of all new 
cancers in men and women respectively, and that 30 % of cancer related deaths in men and 26 
% in women are due to lung cancer (Jemel et al. 2009). In the case of external beam 
radiotherapy of the lung, photon beams first penetrate soft tissue, then lung tissue – which has 
a density about one third that of soft tissue. For tumours within lung tissue (which have 
densities closer to soft tissue), complexities arise relating to the range of secondary electrons, 
which lead to inaccuracies if commercial treatment planning systems are employed to 
determine the dose distributions. This was highlighted recently by Timmerman et al (2009), 
who reported on the Radiation Therapy Oncology Group 0236 Phase II trial, whereby the 
prescribed 20 Gy per fraction dose (totalling 60 Gy) was found to be only 18 Gy per fraction 
(totalling 54 Gy) – an error that arose because of a lack of appropriate tissue heterogeneity. 
Haedinger et al (2005) reported similar discrepancies. 
 
 
5.5.4.2 Influences on dose inhomogeneity 
Describing the effect on the dose to the periphery of the tumour is not straightforward. At the 
proximal region of the tumour, there is electronic disequilibrium borne of the fact that there 
are less forward scattered electrons from the preceding lung tissue, which has a relatively low 
density. At lateral points at the periphery of the tumour, there is a lack of lateral equilibrium 
which results in under-dosage. There is also less forward- and back-scatter which results in 
longitudinal disequilibrium. At the distal region of the tumour, the doses are consistently 
lower than the central doses, resulting from the attenuative effect within the tumour volume 
and loss of backscatter at the exit of the tumour.  
 
Figure 5.44 illustrates the dose differences between the lung tumour model and a 
homogeneous phantom. The inhomogeneity of the dose distribution over the tumour volume 
may be illustrated by the ratio of the peripheral dose to the dose at the centre of the tumour.  
 
We have defined a dose reduction factor (DRF) of the peripheral region. Consideration of this 
reduction due to secondary electron disequilibrium would be particularly important if dose 
were to be prescribed to a covering isodose shell. It is important to recognise that the dose to 
the centre of the tumour may also be affected by the electronic disequilibrium arising from 
the presence of surrounding lung tissue. In the case of small tumours, there is insufficient 
build-up within the tumour to reach equilibrium, reducing the dose there, but this effect is 
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lessened in large tumours or those close to the chest wall within range of forward-scattered 
electrons. Competing with this, the reduced attenuation of the photon beam in the overlying 
lung tissue increases the dose the tumour centre, relative to the homogeneous soft-tissue case. 
Thus, the tumour centre is used as a reference point as a measure for the DRF describing the 
dose deficiency at the tumour periphery. The absolute dose effect at the centre of the tumour 
must be considered separately by comparison, for example, to the doses at similar points in a 
homogeneous soft-tissue medium, as illustrated in Figure 5.44(b). 
 
 
5.5.4.3 Effect on typical treatment 
A typical treatment might involve use of either an arc, or a multi-field arrangement with of 
the order of nine fields (Hiraoka et al. 2007; Timmerman et al. 2007a). In the few cases 
where the front surface dose is higher than the central dose, such as larger tumours close to 
the chest wall treated with a  6 MV beam (see Table 5.10), the effect will be somewhat offset 
by the lower exit region dose when averaged (as intended by the treatment design). In 
general, however, the lower entrance and exit doses to these lung tumours compound, when 
treated from multiple directions, to produce an overall under-dosed peripheral region. From 
observation of Table 5.12, showing the DRF, it is evident that over all arrangements of 
tumour size, Øt, and distance, d, that the dose to peripheral regions of the tumour is, on 
average, about 3 % lower than that to the centre for the 6 MV case and 7 % lower for the 15 
MV case. With a 6 MV beam, the under-dosage increases from about 2 % to 5 % with 
increasing distance, and decreases from 4 % to 2 % with increasing tumour size. For a 15 MV 
beam, the under-dosage increases from about 7 % to 8 % with increasing distance, and 
increases from 5 % to 8 % with increasing tumour size. 
 
 
5.5.4.4 The influence of linac energy 
The range of secondary electrons from the 15 MV beam are more than double that from the 6 
MV beam for the nominal energies, and about a factor of two and one-quarter higher for the 
mean energies, in all the media studied. The ratios, R, are presented for the 15 MV beam in 
Table 5.11. The most pronounced difference with comparison to the 6 MV case is that, for 15 
MV, 1),Ø,,( <EFSdR t  for all arrangements. For the exit regions of the tumour, there is little 
observed difference between the ratios for 15 MV and 6 MV. It is evident that for both the 
entrance and lateral regions of the tumour, the ratios for 15 MV are on average approximately 
7 % lower than those for 6 MV (see Figure 5.45). Relative doses to the entrance point of the 
tumour increase with tumour diameter and decrease with distance from the chest wall. For the 
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exit region, R decreases with tumour size but does not exhibit any significant trend with 
changing chest wall distance. For the lateral regions of the tumour, the dose is consistently 
lower than that at the centre, with R decreasing for increasing tumour size and chest wall 
distance. To illustrate the difference between energy modalities, an example has been 
provided in Figure 5.46, which shows the dose reduction factor as a function of tumour 
diameter for both 6 MV and 15 MV at a distance of 10 mm. 
 
 
5.5.4.5 Application of the DRF 
Most commercial treatment planning systems would not be able to predict the magnitude of 
dose reduction in the periphery of a solid tumour accurately as the calculation grid size is too 
coarse and most algorithms are not designed to calculate dose distributions in the presence of 
inhomogeneities on a millimetre scale. The DRF defined here provides a first estimate of the 
potential under-dose compared to the centre of the lesion, the dose to which is usually better 
estimated by conventional treatment planning. This is of particular relevance when 
prescribing dose to covering isodoses. 
 
 
5.5.5 Conclusions 
The objective of this work was to develop an easy-to-use Dose Reduction Factor for 
clinicians and treatment planners to estimate the degree of under-dosing of lung tumours that 
can occur as a result of electronic disequilibrium due to tissue inhomogeneities but may not 
be evident from clinical treatment planning calculations. Such a factor will be useful for dose 
prescription as well as plan evaluation. Calculations were performed with two Monte Carlo 
radiation transport codes (EGSnrc and GEANT4). Ultimately, doses to peripheral zones of the 
tumour volume may be up to 12 % lower than the dose to the centre of the tumour. The 
disparity is generally more significant if a 15 MV treatment beam is used than for a 6 MV 
treatment beam. 
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5.6 Chapter summary 
This chapter has described the characterisation of stereotactic fields, facilitated by Monte 
Carlo radiation transport calculations. These have been generated for a large number of fields 
shaped with the mini-multileaf collimator. Specifically, this includes the investigation of 
beam characteristics in air, both in and beyond the primary field, including: 
– Photon spectra, 
– Contaminant electron spectra, 
– Spatial variation of mean photon energy, 
– Spatial variation of mean electron energy, and 
– Angular distribution of photons. 
 
Spectral data in water at several depths (5, 10 and 15 cm) has also been calculated, including: 
– Photon energy fluences, 
– Electron energy fluences, and 
– Mean energy distributions. 
 
Further data has been compiled for comparison using ‘backed-up’ field, i.e. jaws set at the 
same field opening as the MMLC. Mean energy, spectral and angular distributions were 
calculated for several representative cases. 
 
Summarised here are the key findings for the in-air study: 
– Out-of-field photon fluence ~1 % of primary beam fluence. 
– Out-of-field electron fluence ~30 % of primary beam fluence. 
– Photon fluence has sharp gradient at field edge. 
– Electron (contaminant) fluence does not have a sharp gradient at field edge. 
– ‘Structure’ evident in fluence profiles just beyond the primary beam (due to interleaf 
leakage through collimator). 
– Mean energy of primary photon field lower than surrounding peripheral regions (due 
to beam hardening by collimators) for small fields; mean energy drops again in far 
out-of-field regions. 
– Photon energy fluence varies with field size, most notably at low energies (below ~1 
MeV). 
– The photon beam is more forward directed for smaller fields, as evidenced by the 
primary field angular photon distributions (in fact, for the 9.8 x 9.8 cm2 field the 
distribution peaks at approx. 3º rather than 0 º). 
– The photons outside the primary field are much less forward-directed. 
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– When fields are backed-up by jaws, the spectral distributions of photons and 
electrons in-field are similar to the non backed-up case. 
– Out-of-field, the mean energies differ significantly between the backed-up and non 
backed-up fields. 
– The angular distribution of photons at the patient plane is significantly different, 
being more forward-directed for small fields but less so for large fields, relative to the 
non backed-up case. 
 
Summarised here are the key findings for the in-water study: 
– Photon spectra harden with depth in water. 
– Electron spectra harden with depth in water. 
– Mean energy of primary photon beam decreases with increasing field size (6 x 6 mm2 
beam is 30 % harder than 98 x 98 mm2 beam). 
– Out-of-field mean photon energies (at 12 cm off-axis distance) decrease with 
increasing field size (6 x 6 mm2 beam is 250 % harder than 98 x 98 mm2 beam). 
– The fraction of total photons in the low energy regime increases with field size (98 x 
98 mm2 beam has ~1000 % more photons with energies < 250 keV than 6 x 6 mm2 
beam). 
– Electron spectrum varies with field size, most notably in the low-energy regime (< 1 
MeV), such that larger fields have a larger fluence of low-energy electrons. 
 
To illustrate the relevance of varying spectra, several illustrative studies were carried out. 
These included: 
– An investigation of the effect of changing secondary electron spectra on the mean 
restricted stopping power ratios relevant to ionisation chamber measurements, 
– The energy dependence of measurements taken using radiographic film, and 
– The energy-dependent effective atomic number of TLD-100 thermoluminescent 
dosimeters. 
 
The effect of the investigation into spectral effects as relevant to ionisation chamber 
measurements showed that the typical assumption of unchanging spectra (field size 
independence) was typically acceptable, with deviation from the reference field case all sub-
percent. The discrepancy worsens with decreasing field size but is nonetheless acceptable. 
However, this only applies to in-field measurements. Out-of-field, spectral variations result in 
discrepancies > 1 %, being worst for larger field sizes. A further consequence of the spatial 
variation of the spectrum is demonstrated in the context of radiographic film dosimetry. A 
Monte Carlo investigation indicates that the film over-responds to the incident stereotactic 
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fields relative to water, but the extent of the over-response varies spatially for the 
aforementioned reason. A third study compares the effective atomic numbers (Zeff, calculated 
using the method described for gel dosimeters in Chapter 3) of TLD-100 and water indicates 
that the greatest discrepancy in Zeff, approximately 80 %, coincides with the peak of the 
photon energy spectrum.  
 
In addition to the Monte Carlo studies of beam characteristics, two ‘case studies’ were 
undertaken – the first a gel dosimetry investigation of stereotactic (intracranial) radiotherapy, 
the second an in silico investigation of lung tumour under-dosage relevant for stereotactic 
body (extracranial) radiotherapy. Measurement of three-dimensional dose distributions in an 
anthropomorphic head phantom using gel dosimetry was shown to be feasible for treatment 
plan verification. Agreement with treatment planning system (pencil beam algorithm) 
calculations was demonstrated for high dose regions (above the 90 % isodose, γ evaluation 
indicated 96 % agreement for criteria of 2%/2mm). The outcome of the lung under-dosage 
study was a ‘look-up’ table for a range of parameters (including beam energy, field size, 
tumour size and distance of tumour from chest wall) that allows clinicians to estimate the 
level of under-dosage not predicted by simplistic treatment planning algorithms. This dataset 
is also useful for the interpretation of clinical trial data (to estimate the true doses actually 
delivered), in which pencil beam convolution algorithms have often been employed. 
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CHAPTER SIX 
 
I should have been a pair of ragged claws 
Scuttling across the floors of silent seas. † 
TS Eliot 
 
 
                                                 
†
 I haven’t, in this instance, contrived any particular reason for the inclusion of this quotation; just a beautiful line 
from Eliot’s The Love Song of J. Alfred Prufock. 
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6.1 Chapter overview 
Thus far, the focus of this thesis has been the in-field characterisation of stereotactic fields, 
which is associated with significant complications as a result of difficult dose measurement 
and calculation. Poor assessment of the characteristics of stereotactic fields can have serious 
detrimental consequences for the patient. Not only does this present a problem to clinicians, 
but radiation delivery to cancer patients for radiotherapy is invariably accompanied by 
unwanted radiation to parts of the patient that are far from the primary field. Traditionally, 
considerable effort has been made to calculate and measure the radiation dose to the target as 
well as to nearby critical structures. Only recently has attention been focused also on the 
relatively low doses that exist far from the primary radiation beams. In several clinical 
scenarios such doses have been associated with cardiac toxicity as well as an increased risk of 
secondary cancer induction. Out of field dose is a result of leakage and scatter and generally 
difficult to predict accurately. 
 
A thorough review indicates that the out of field dose from stereotactic fields in particular has 
received relatively little attention in the published scientific literature. There are three main 
investigations presented in this chapter: 
– A comprehensive review of published literature pertaining to out-of-field doses, 
identifying trends that may be exploited for risk-minimisation. 
– A systematic investigation of out-of-field doses from stereotactic beams, as a function 
of a range of treatment parameters. 
– An investigation of stereotactic radiotherapy of paediatric patients, for whom out of 
field doses are of particular significance in terms of long-term health effects. 
 
While the literature review does not constitute a ‘novel’ scientific study, it is of clinical 
interest; data has been extracted from a large number of studies and presented in a 
comparative manner for a range of treatment parameters, such as treatment type, machine 
type, field size et cetera. The advantage of this comparative investigation is that it facilitates 
exploitation of known low out-of-field dose scenarios such that associated risks (such as 
radiocarcinogenesis) may be minimised. 
 
What is also clear from the review, however, is that out-of-field doses from (particularly 
linac-based) stereotactic fields are less well known. 
 
A novel investigation of out-of-field doses from linac-based stereotactic fields has been 
presented in a systematic fashion. The variation of out-of-dose with field size, source-surface 
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distance, depth in phantom and spatial orientation has been investigated. Higher doses were 
associated with increasing field sizes and shallow phantom depths, whilst variation of source-
surface distance did not exhibit a significant effect. Furthermore, it is demonstrated that if the 
patient lies along the x-plane then out-of-field doses may be reduced by up to an order of 
magnitude compared to the y-plane (where planes are defined by the direction of jaw motion). 
For a stereotactic treatment with dose to the target of the order of tens of Gy, the out-of-field 
doses are of the order of cGy – which is a significant dose in radiation protection terms. An 
example of the clinical consequences is provided for the case of radiation-induced cancer of 
the thyroid following intracranial stereotactic radiotherapy. 
 
A further novel study presented in this chapter investigates the out-of-field doses in the 
context of stereotactic radiotherapy of paediatric patients. As discussed in the following 
sections, children are at particular risk of latent effects following radiation therapy. A number 
of key results are shown that may be exploited to reduce the risk of secondary cancer in 
children. Choice of linac may affect the out-of-field dose by 40 %, appropriate choice of 
collimator rotation can reduce out-of-field dose by 40 %, appropriate choice of treatment 
technique can reduce out-of-field dose by an order of magnitude and simple shielding 
arrangements can reduce the out-of-field dose by 50 %. Interestingly, the out-of-field dose 
resulting from large fields and small stereotactic fields is actually comparable far from the 
primary field. The clinical advantages of electing the appropriate treatment parameters are 
demonstrated via examples of secondary cancer risk reduction calculations under different 
treatment scenarios. 
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6.2 Out-of-field doses far from the targeted volume 
In the case of radiological imaging, the dose delivered to the patient as a consequence of the 
imaging process is entirely detrimental. In the case of radiotherapy, it is the cell-killing 
function of ionising radiation that is the desirable effect for the destruction of a targeted 
tumour. However, as has been discussed, doses to healthy tissues can have a carcinogenic 
effect. This is not only of interest in the immediate regions around the targeted volume, but 
also in critical structures that are quite distant from the primary field, but that nonetheless 
receive a dose from scattered and or leakage radiation.  
 
Numerous studies have been undertaken measuring the out-of-field dose from different 
radiotherapy machines and modalities over the past few decades. About 25 % of 56 
publications reviewed are concerned solely with neutron doses, about 15 % deal with both 
photons and neutrons, and the remaining 60 % or so deal solely with photon doses. 
Intracranial radiotherapy (which constitutes the predominant application of stereotactic 
radiotherapy) typically implements 6 MV beams, and thus out of field photon doses are given 
greater emphasis in the subsequent discussions.  
 
The majority of studies involve measurement of out-of-field doses, but many also make 
calculations of such doses using Monte Carlo radiation transport simulation, analytical 
approaches, or combinations of these, as indicated in Figure 6.1. To help simplify the 
discussion somewhat, a summary of the literature is given heretofore in two sections – the 
first is concerned with what might be called ‘classical’ or ‘conventional’ treatment 
techniques, the second addresses studies that incorporate more recent techniques (namely, 
intensity modulated radiotherapy and stereotactic radiotherapy). 
 
 
 
Figure 6.1 A representation of the percentage of studies (out of 56 selected publications) that have 
undertaken measurement or calculation (analytical or Monte Carlo) of out-of-field dose.  
 
71%
9%
20%
Measurement only
Measurement and analytical calculation
Monte carlo
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In the following sections an overview of studies of out-of-field dose is presented. The 
objective of this is multifold: 
– To highlight the interest and common concerns in out-of-field dose from radiotherapy 
treatments, 
– To note trends and thus identify exploitable means for risk-reduction, and 
– To place the (relatively few) investigations of stereotactic out-of-field dose 
specifically into context.  
 
Much of the work presented in this section has been published by the candidate (Taylor and 
Kron 2011). 
 
 
6.2.1 Conformal radiotherapy and other conventional techniques 
Interest in the out-of-field radiation doses from different machines seems to have started more 
seriously from about the 1970s. The focus of the studies is typically either dose to the 
environment from an occupation radiation safety perspective (particularly in early works), or 
doses to untargeted critical structures in the patient. As mentioned previously, the focus of the 
present study is the dose due to photons, because the peak energy of photons employed is 6 
MeV and the neutron contribution is thus negligible. The concise discussion presented here 
consequently focuses primarily on out-of-field photon doses. 
 
Fraass and Van de Geijn (1983) investigated the peripheral dose for a 60Co beam, as well as 4 
MeV, 6 MeV and 8 MeV photon beams. Doses were reported for water tank measurements 
for multiple field sizes at a range of distances from the field edge. Transmission and in-patient 
scatter were separated, and found to be of similar magnitude. Thermoluminescent dosimetry 
(TLD) was also performed during treatment of patients. Kase et al (1983) similarly studied a 
60Co beam, as well as 4 MeV and 8 MeV photon beams. Kase et al also attempted to 
differentiate head-leakage and scattered radiation, finding that collimator scatter may 
contribute up to about 40 % of the dose outside the treatment field. Francois et al (1988) 
parameterised dose distributions for different beam energies as a function of depth, distance 
from the edge, field size and shape. An algorithm was thus developed to determine the dose to 
organs outside the beam from 10 to 50 cm from the field edge. The measurements were 
undertaken with TLD (calibrated against a Farmer-type ionisation chamber) in an 
anthropomorphic phantom. Measurements were also taken in a large water phantom for the 
various fields. Some limited Monte Carlo calculations were also performed. The American 
Association of Physicists in Medicine (AAPM) report TG-36 (Stovall 1995) studied foetal 
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doses in pregnant women treated with radiotherapy, for a range of delivery conditions. Van 
der Giessen (1996) measured doses in a water phantom for four Cobalt machines and 37 
linear accelerators to investigate variation in peripheral doses amongst machines from seven 
different manufacturers. Variation of leakage radiation dose was found to be small amongst 
the varying designs, however, collimator dose was found to vary up to 50 % depending on the 
collimator / flattening filter design. In his PhD thesis, Van der Giessen (1997a) provides 
results from studies of various machines (with a focus on 60Co), mostly using water phantoms 
to collect data or by evaluation of published data and leakage / collimator scatter data 
provided by other clinics / institutions. Dose was also measured on patients’ perinea using 
TLD. The studies constituting his thesis were published separately as articles mostly in Int. J. 
Radiat. Oncol. Biol. Phys. (Van der Giessen and Hurkmans 1993; Van der Giessen 1994; 
1996; 1997b; Van der Giessen and Bierhuizen 1997).  
 
Broadly, regarding photon doses outside the treatment volume for ‘classical’ methods, one 
may conclude that: the photon dose decreases with decreasing field size and drops 
approximately exponentially away from the field edge. Neutron doses (less relevant here) are 
more dependent on beam energy than distance from the field edge. 
 
 
6.2.2 Intensity modulated radiotherapy 
The advent of intensity modulated radiotherapy (IMRT) has given rise to concerns over the 
fact that the total number of monitor units used is often greater than for treatments for 
equivalent cases using, for instance, three-dimensional (3D) conformal radiotherapy. The 
additional monitor units may result in additional scattered or transmitted dose, and thus 
increase the dose to untargeted critical structures. Contemporary IMRT delivery is typically 
undertaken with multileaf collimators (MLC) or mini-multileaf collimators (MMLC) attached 
as tertiary / quaternary collimators on a linear accelerator. Many of the works discussed here 
involve measurements to investigate the influence of the MLC on out-of-field doses, as well 
as in the specific context of IMRT. Note again that the focus of the discussion remains with 
peripheral photon doses. 
 
Followill et al (1997) undertook a study of doses outside the treatment fields for IMRT with 6 
MeV, 18 MeV and 25 MeV beams, for which the photon whole body equivalent doses per 
cGy were 80 µSv, 6.5 µSv and 10 µSv respectively. The respective neutron doses were 0.0 
µSv, 46 µSv and 76 µSv. Using risk values recommended by the National Council on 
Radiation Protection and Measurements (NCRP) they calculated worst-case scenario risks of 
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cancers to be between 1 % (for the 6 MeV beam) and 24.4 % (for the 25 MeV beam). Stern 
(1999) investigated whether the presence of an MLC would influence the peripheral dose 
when positioned at the field edge defined by the jaws. For 6 MeV and 18 MeV beams at all 
depths and distances studied, configuring the MLC leaves at the field edge yielded a 
reduction in peripheral dose of 6 – 50 % compared to the MLC leaves fully retracted. In the 
latter case, peripheral doses matched those for a linac without an MLC. As mentioned earlier, 
the AAPM report TG-36 can be used to estimate the peripheral dose distributions (Stovall 
1995). Mutic and Klein (1999) undertook a number of measurements with an ionisation 
chamber in a water-equivalent plastic phantom with various MLC leaf settings including full 
retraction. Peripheral dose distributions with the MLC fully retracted and collimator rotated to 
180 degrees were similar to TG-36 data, but lower with MLC field shaping. They also 
showed that rotating the collimator to 90 degrees with full MLC retraction may reduce the 
peripheral dose up to a factor of three (compared to TG-36).  
 
Chibani and Ma (2003) employed MCNPX to study the dose from photon-induced nuclear 
particles (neutrons, protons and alpha particles). Varian beams are found to produce more 
particles than the Siemens, due to higher primary electron energies. Neutrons are found to 
contribute more than 75 % of the total dose equivalent ratio. Chibani and Ma compare the 
model to measurements. The dose equivalent from leakage neutrons (at 50 cm off-axis 
distance) represent 1.1, 1.1 and 2.0 % likelihood of fatal secondary cancer from a 70 Gy 
treatment delivered by the Siemens 18 MV, Varian 15 MV and Varian 18 MV beams 
respectively. Vanhavere et al (2004) performed measurements in air, at different depths in a 
plexi-phantom and using a Rando-Alderson phantom for gammas and neutrons with an 18 
MV linac. Organ equivalent doses and effective doses (estimated by different methods) were 
evaluated for a range of organs. For a prostate cancer IMRT treatment, the effective dose 
(using Rando-Alderson phantom) was found to be about 30 mSv per 2 Gy target dose, 13 % 
of which is attributed to neutrons.  
 
Sharma et al (2006a) noted that dynamic fields (consisting of constant-width strips moved 
from one bank to the other) required between two and fourteen times as many monitor units 
as static fields to achieve the same dose at isocenter, for various arrangements. Peripheral 
doses were between two and fifteen times higher for the dynamic case, depending on field 
size et cetera. They also compared patient specific intensity modulated fields with uniform 
dynamic MLC fields with similar jaw settings, and discovered that the two are sufficiently 
similar to use the dynamic MLC data to predict out-of-field doses for comparable patient-
specific cases (Sharma et al. 2006b). Kry et al (2006) identified that the dose to the patient 
outside the treatment field is important, however determination of such out-of-field doses 
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requires tedious measurement or calculations that exhibit high uncertainty. They used the 
MCNPX Monte Carlo code to model a Varian Clinac 2100 operated at 6 MV, modelling dose 
distributions away from the central axis and measuring dose distributions with an ionisation 
chamber (in a water phantom) and TLD (in an acrylic phantom). In a different publication, 
Kry et al (2007b) describe a similar study for 18 MV photons. In the latter work, discussion 
of neutron dose was also included.  
 
Wiezorek et al (2007) performed point dose measurements at different depths in a solid 
phantom at 29 cm off-axis distance, for a Siemens Oncor Impression linac with energies of 6 
and 15 MeV. Peripheral doses associated with artificial fluence distributions were compared 
with open beam contributions. Measurements were performed with two types of TLD to 
quantify photon and neutron dose separately. Neutrons were only detected for 15 MV. The 
photon contribution to peripheral dose increased (compared to open field) when using 
segmented multi-leaf modulation (sMLM) for IMRT, and even further when using 
compensators. 
 
IMRT treatments sometimes require between 3 and 5 times the number of monitor units to 
deliver (compared to a conventional treatment). Kry et al (2005b) measured the photon and 
neutron out-of-field dose equivalents to various organs from different treatment strategies, 
energies and accelerators. Photon dose decreased exponentially away from primary field; 
neutron dose was found to be independent of the distance from treatment field. Neutrons 
contributed significantly to out-of-field dose for E > 15 MeV. Considering out-of-field doses, 
Kry et al (2005a) found that the maximum risk of fatal secondary malignancy was 1.7 % for 
conventional radiation, 2.1 % for IMRT with 10 MeV x-rays and 5.1 % for IMRT with 15 
MeV x-rays. Kry et al (2007a) also examined the uncertainty in risk estimates relating to out-
of-field doses, with the result that risk estimates for secondary malignancy were subject to 
very large uncertainties. It was shown, however, that it is possible with relatively good 
accuracy to identify preferable modalities based on the ratio of risk estimates. In a recent 
study at the William Buckland Radiotherapy Centre (The Alfred Hospital, Melbourne), 
Ruben et al (2008) compared IMRT with three-dimensional CRT in terms of carcinogenic 
risk. Equivalent plans were constructed for prostate, breast and head-and-neck treatments. 
The risk of radiation induced malignancies in organs outside the target volume was calculated 
using two dose-response models for radiocarcinogenesis. Ultimately, the risks were found to 
be comparable between the two modalities. Depending on the technique and region of 
interest, risks ranged between 1 and 2 % for one risk model, and between 0.5 and 1 % for the 
other model. There is a significant body of literature covering epidemiological studies of 
cancer induction in radiotherapy patients, an overview of which is given in the subsequent 
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section. Reft et al (2006) performed in vivo patient and phantom measurements of the 
secondary out-of-field photon and neutron dose equivalent for 18 MV IMRT treatments. It 
was found that the photon dose drops by a factor of two from 10 cm to 20 cm from the field 
edge while the neutron dose remains the same (within experimental uncertainties). There is an 
indication that 18 MV IMRT results in higher neutron doses (factor of 2 to 3) compared to 
3DCRT. Klein et al (2006) collected peripheral dose data in a phantom at distances ranging 
from 5 to 72 cm away from the field edges of small (2 to 10 cm) IMRT fields. Micro- and 
cylindrical ionisation chambers were arranged in a phantom representing a 3 yr old at 
locations corresponding to the thyroid, breast, ovaries and testes. Distant peripheral dose 
(dominated by head scatter) was higher than predicted. Doses to the testes were three to five 
times higher for IMRT compared to conventional treatment.  
 
 
6.2.3 Stereotactic radiotherapy 
Relevant to the present study is the existence of peripheral doses from intracranial stereotactic 
radiotherapy (SRT). The doses/fraction involved in SRT are generally much higher than those 
in IMRT treatments, and are delivered in relatively few fractions (note that stereotactic 
radiosurgery involves a single fraction only). The out-of-field doses from these high dose 
treatments are thus of significant interest. 
 
Ioffe et al (2002) quantified the dose rate as a function of distance from the isocenter in a 
RANDO phantom for Gamma-Knife treatments. Hasanzadeh et al (2006) constructed an 
anthropomorphic phantom and undertook TLD measurements of dose in untargeted organs 
for Gamma-Knife radiosurgery. Petti et al (2006) developed Cyber-Knife plans for a thorax 
lesion and brain lesion in an anthropomorphic phantom and measured the dose at various 
depths and distances outside the treatment field using TLD. Peripheral doses were found to be 
2 to 5 times higher than a comparable Gamma-Knife treatment and up to 4 times higher than 
an IMRT treatment. The relatively large peripheral dose is attributed to greater leakage of the 
Cyber-Knife unit. Chuang et al (2008) investigated reduction of out-of-field doses from the 
Cyber-Knife system resulting from a shielding upgrade, with the observation that doses were 
generally reduced by 20 to 55 %. 
 
The latter studies mentioned have focused on the Cyber-Knife and Gamma-Knife systems. 
Maarouf et al (2005) examined the radiation exposure of organs at risk and assessed the risk 
of late effects (such as secondary tumours or hereditary disorders) following stereotactic linac 
radiosurgery of intracranial tumours. TLDs were placed superficially on patients’ (N = 21) 
eyelids, thyroid, breast and regions of the ovary / testes. The organ receiving the highest doses 
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was the eye lens (276 ± 200 mGy), then the thyroid (155 ± 83 mGy), breast (47 ± 22 mGy), 
ovary (12 mGy) and lastly the testes (9 ± 3 mGy). The absorbed doses thus ranged between 
0.025 and 0.76 % of the target dose. They recommended the use of conformal beams 
employing micro-multileaf collimators and avoiding beams directed toward the trunk. 
Solberg et al (2001) compared conventional non-coplanar arc, static field conformal and 
dynamic arc field shaping approaches to radiosurgery. In terms of peripheral dose, it was 
found to decrease as additional beams or arc degrees are added with either of the conformal 
approaches. Ultimately, dynamic arc shaping was found to be preferred in efficiency and 
efficacy in delivery of a homogenous dose whilst minimising peripheral dose, for 
radiosurgery applications. 
 
Comparatively, there has been little study of out-of-field doses from stereotactic fields than 
other treatment approaches. 
 
 
6.2.4 Contributions to out-of-field dose 
Out-of-field dose is essentially the combination of leakage from the accelerator head, scatter 
from collimators, from within the patient and from the rest of the treatment room. If, for 
example, a different accelerator, patient orientation or treatment type is considered, it is 
logical that the out-of-field dose will not necessarily be the same as another arrangement. As 
such, it is possible to reduce out-of-field doses (and corresponding risks to the patient) by 
careful choice of treatment arrangement. To help facilitate this, the main influences on out-of-
field dose are discussed here. 
 
 
6.2.4.2 The influence of accelerator type 
Because out of field dose to untargeted regions of a patient is a result of a combination of 
leakage and scatter, it is logical that different linac models will have different shielding 
designs and that the out-of-field doses they generate may then differ. Figure 6.2 illustrates this 
quite clearly for a Siemens Primus, Varian 2100 and Philips SL-C operated at 18 MV (listed 
in order of decreasing out-of-field photon dose).  
 
Figure 6.4 illustrates the differences between Siemens and Varian machines, with the latter 
delivering out-of-field doses only 20-50 % of that delivered by the Siemens Primus (Chibani 
and Ma 2003). Neutron doses are clearly higher with the Varian machine, however (see 
Figure 6.2). The different contributions to out-of-field dose from collimator scatter for a range 
of machines are given in Figure 6.6. Kry et al (2005a) found that intensity modulated 
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radiotherapy (IMRT) in 6 MV mode with Varian and Siemens linacs resulted in risks of fatal 
secondary cancer of 2.9 % and 3.7 % respectively. 
 
 
6.4.2.3 The influence of field size 
Intuitively, one would expect that for larger field sizes more dose would be delivered to out-
of-field regions, as a result of purely geometric reasons and increased patient-scatter. 
Generally this is indeed the case. This is shown in Figure 6.3 (note that Figure 6.3 shows the 
distance from field edge not from isocentre); another interesting note is that the discrepancy 
decreases with distance. The conclusion one may draw from this is that the field size 
dependent influences on out-of-field dose (i.e. collimator and patient scatter) become less 
important at large distances. This means that at large distances head leakage is the dominant 
influence on out-of-field dose. Figure 6.5 also shows the influence of field size on patient 
scatter (Van der Giessen and Hurkmans 1993) and collimator scatter and leakage (Van der 
Giessen 1994). 
 
 
 
Figure 6.2 Data from Reft et al (2006) shows the difference between linac models in terms of out-of-
field dose for 18 MV IMRT of the prostrate. In vivo measurements were undertaken measuring both 
photon (solid) and neutron (cross-hatched) doses; the data shown here corresponds to doses at a 
distance of 20 cm from the field edge. Measurements were performed for the same model accelerator at 
different centres (reflected by the number n). 
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Figure 6.3 (a) An indication of the variation of out-of-field dose from a Siemens Primus as it varies 
with field size (shaped with jaws, full MLC retraction) Close to the primary field the doses from the 
larger fields are greater, but this difference decreases with increasing distance from the field edge. (b) 
An illustration of the difference in out-of-field dose depending on energy mode. The out-of-field doses 
in 6 MV mode are consistently greater than in 18 MV mode. The data shown is adapted from 
Mazonakis and Zacharopolou (2008). 
 
 
 
6.4.2.4 The influence of energy mode 
The energy mode also influences out-of-field dose. One might expect that because higher 
energy photons have higher penetrative ability, and are thus less attenuated by shielding and 
collimator devices, that out-of-field dose at high energies may be greater. However, this is not 
the case, as evidenced by Figure 6.2, Figure 6.3(b) and Figure 6.4.  
 
Lower energy modes tend to result in greater out-of-field photon doses than higher energy 
modes. This is because lower energy photons are less forward scattered than higher energy 
photons (consider the Klein-Nishina (1929) formula). As such, one would expect patient 
scatter in low-energy modes to result in greater out-of-field dose. One would also expect, 
however, that this would be pronounced at intermediate distances but less so at far distances, 
since from the previous section we expect patient scatter to be less influential far out-of-field. 
Indeed, from Figure 6.4 it is clear that the Varian linac in 15 MV and 18 MV mode generate 
comparable out-of-field dose at far off-axis distances. The problem with high energy modes, 
however, is that the photonuclear effect may generate neutrons that contribute to the out-of-
field dose. This is illustrated in Figure 6.2. It has been shown that neutron doses may not 
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significantly increase the risk of radiocarcinogenesis for IMRT with a linac operated in 18 
MV rather than 6 MV mode (Kry et al. 2009). 
 
 
Figure 6.4 An indication of the variation in neutron dose that exists between operating at 15 and 18 
MV modes, and between different linac manufacturers. This data shows MCNPX calculated neutron 
doses along the plane of the couch for a Varian 2160C (15 MV and 18 MV) and Siemens Primus (18 
MV) (Chibani and Ma 2003). Also shown are several measured data points for the Varian 15 MV. The 
sub-plot below the primary figure shows the ratio of these doses to the Siemens 18 MV case.  
 
 
 
6.4.2.5 The influence of leakage, collimator and patient scatter 
The influence of leakage, collimator and patient scatter may be inferred to some extent by the 
influence of field size. A number of authors have made explicit attempts to determine 
separate influences of these. Figure 6.5(a) directly indicates that the (percentage of central 
axis, CAX) dose attributable to patient scatter decreases with increasing distance. Van der 
Giessen (1994) treated the collimator scatter and leakage together, and from Figure 6.5(b) it is 
clear that the different field sizes converge far from the primary beam and the contribution to 
out-of-field dose plateaus.  
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Figure 6.5 (a) The percentage contribution of patient scatter to out-of-field dose for a range of field 
sizes from a 60Co unit (Theratron 780) (Van der Giessen and Hurkmans 1993). (b) The contribution of 
collimator scatter and head leakage (as a percentage) to out-of-field dose for a range of field sizes from 
a 6 MV treatment beam (GE Saturne 41) (Van der Giessen 1994). 
 
 
 
 
Figure 6.6 The contribution of out-of-field dose as a result of collimator scatter varies amongst linac 
designs. This figure shows data adapted from Van der Giessen (1996) indicating this variation. The 
percentage contribution of collimator-scattered dose (at an off-axis distance of 50 cm) relative to the 
dose at the central axis is given for seven different linac types. Measurements were taken at different 
centres with various models; the total number of measurements is given as n in the figure. The doses 
correspond to a standard field size of 10 x 10 cm2. 
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6.4.2.6 The influence of treatment type 
The nature of the treatment affects the out-of-field dose. Intensity modulated radiotherapy 
(IMRT) is of particular interest in this regard (Hall 2006; Ruben et al. 2008), as discussed 
earlier, because it typically involves a greater number of monitor units than other delivery 
methods. Wang and Xu (2008) found that out-of-field doses are indeed significantly higher 
for an IMRT treatment than for conformal radiotherapy (CRT), as shown in Figure 6.7(a). 
Sharma et al (2006a) showed that achieving an equivalent field size with a sliding field rather 
than a static MLC can result in an increase in out-of-field dose of up to an order of 
magnitude; see Figure 6.7(b). Hall and Wu (2003) found that IMRT of prostate cancer rather 
than conventional radiotherapy resulted in double the risk of fatal secondary cancer (3 % Sv-1 
compared to 1.5 % Sv-1). Kry et al (2005a) found that 18 MV IMRT with a Varian unit 
resulted in a risk of fatal secondary cancer of 5.1 % Sv-1, while the risk for 18 MV 
conventional radiotherapy was 1.7 %. 
 
 
 
Figure 6.7 (a) A comparison of IMRT with conformal (CRT) techniques based on data adapted from 
Wang and Xu (2008). Far from the primary field, the IMRT treatment generates more dose than the 
CRT deliveries. The sub-plot beneath the primary figure is a ratio plot of the 6-field CRT and IMRT 
deliveries compared to the 4-field CRT delivery. Note that the number of monitor units employed for 
the 4- and 6- field CRT and IMRT treatments were 1260, 1308 and 2850 respectively. (b) This data, 
adapted from Sharma et al (2006a), shows the difference between achieving a 14 x 14 cm2 field with a 
static MLC or with a  sliding window technique (in this case, a 0.5 cm strip field that moves 
dynamically to achieve a field equivalent to that generated with the static MLC. The sub-plot beneath 
the main figure shows the ratio of the sliding window to static case; achieving an equivalent field with 
the sliding window generates up to an order of magnitude more out-of-field dose. 
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6.2.5 Summary 
There is a large body of literature associated with the measurement of out-of-field doses from 
radiotherapy with a medical linear accelerator. However, this is of little use or interest without 
consideration of the potential consequences for the patient. Untargeted structures in the 
patient, including critical organs, may receive a dose (albeit small) as a result of such 
scattered and leaked radiation. This can lead to radiation-induced cancer growth. This is a 
dynamic and complex area of research. In the following chapter, a summary of the data 
sources for dose response behaviour is given, along with an explanation of approaches for 
risk estimation. 
 
 
 
6.3 Radiocarcinogenesis 
In the previous sections it has been shown that measurements and radiation transport 
simulations indicate doses exist well beyond the treatment field. There is epidemiological 
evidence to suggest these may give rise to secondary cancers, as can doses to healthy tissues 
in the immediate vicinity of the targeted tumour volume. Radiation induced cancer is of 
increasing clinical interest, as reflected by Figure 6.8.  
 
 
 
Figure 6.8 An illustration of the increasing interest in radiocarcinogenesis, as reflected by a PubMed 
search of the terms “radiation induced cancer”, presented over the past six decades. 
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In the first instance it is useful to know such peripheral doses so that treatments may be 
compared and optimal methods identified, but calculation of cancer induction risks associated 
with radiotherapy is the ultimate desired outcome. This typically takes the form of a dose 
response function. There is a linear increase of cancer risk with dose between around 0.1 and 
2.5 Sv, as evidenced from the atomic bomb cohort data (Ron et al. 1994; Thompson et al. 
1994; Preston et al. 2003; Preston et al. 2004; Preston et al. 2007). Beyond 2.5 Sv the 
relationship between dose and risk is less well known. There is evidence to suggest that the 
curve may be somewhat bell-shaped, with an ultimate decrease in cancer induction risk 
because of the relatively high likelihood of cell-killing compared to the induction of 
transformed cells. In the following sections, an introduction to the mechanisms of and 
influences on radiocarcinogenesis is given, since this is typically considered the gravest 
potential consequence of out-of-field dose to untargeted organs. The various dose response 
models will be discussed. 
 
 
 
6.3.1 Mechanisms of radiocarcinogenesis 
It is well accepted that even low doses of ionising radiation may induce cancer (ICRP 2005; 
BEIR 2006). This has been evidenced by documented studies of radiation exposure to 
populations as a result of war, accidents, occupation or from the diagnosis and treatment of 
disease. Cell damage occurs as a result of discrete interactions whereby electrons lose their 
kinetic energy via ionisation events. There is scientific consensus that the cytotoxic effect of 
ionising radiation on cells results from damage to deoxyribonucleic acid (DNA) (Latarjet 
1972; Hutterman et al. 1978; Teebor et al. 1984; Errera 1985; Thacker 1986). Strands of 
DNA can be broken directly or indirectly, via interaction with free radicals. The term ‘direct 
action’ applies to ionisation that occurs within the DNA molecule. The fraction of cell-killing 
resulting from direct action is of the order of 80 % for high linear energy transfer (LET) 
radiation (Roots et al. 1985). Indirect damage to DNA is caused by free radicals that are 
generated from the radiolysis of water – the predominant reaction in living systems for low 
LET radiation. Free radicals are a highly reactive chemical species. Although most free 
radicals formed in these reactions recombine to form oxygen and water in a time scale of ~ 
10-5 seconds, some may interact with other chemical compounds and result in damaging 
biological effects. Of the products of water radiolysis, the hydroxyl (OH*) radical (an 
oxidising species) is the most important radical in terms of damage to DNA (Cadet et al. 
1999).  
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The lesions in DNA that result from ionising radiation include: (i) double or single strand 
breaks of the duplex molecule, (ii) chemical alteration of the bases, (iii) chemical alteration of 
the sugar moieties and (iv) cross linking to DNA related matrix proteins or nucleotides in the 
DNA molecule itself (Ward 1985). Single strand breaks are generated at a rate of about 1000 
per Gy of ionising radiation, whereas double strand breaks occur at a rate of 15 – 60 breaks 
per Gy (Ward 1990). Single strand breaks are typically easily and rapidly repaired, whereas 
double strand breaks are less readily repaired. The latter can eventuate from the simultaneous 
scission of both strands close together, or by the interaction of two adjacent single strand 
breaks. About 25 % of repairs are misrepairs in the case of double strand breaks (Lobrich et 
al. 1995), depending on the mechanism of repair, and can result in mutations that may 
ultimately lead to cell death. In the case of damage not resulting in cell death, the daughter 
cells can carry a radiation-induced mutation. It is generally accepted that unrepaired or 
misrepaired double strand breaks are of principal importance in terms of the induction of 
chromosomal abnormalities and gene mutations (ICRP 2005). Much of the current scientific 
understanding of low dose radiobiological effects that is described in the recent ICRP Report 
103 (2007) is similar to the earlier Report 60 (1991). One important feature of radiation 
damage that has been recognised only more recently is that of damage clusters. The latter may 
incorporate a single strand break or double strand break associated with base damage, as well 
as far more complex associations including multiple densely clustered double strand breaks. 
This concept is illustrated in Figure 6.9. Approximately 30 % of double strand breaks induced 
by low linear energy transfer radiation (such as photons) are complex in nature, involving 
multiple double strand breaks (Nikjoo et al. 1999; Nikjoo et al. 2000; Nikjoo et al. 2001; 
Nikjoo et al. 2002; ICRP 2005). This clustering effect associated with ionising radiation does 
not seem to occur with chemical carcinogens. 
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Figure 6.9 This illustrates the concept of ‘cluster damage’. In this figure, photons (low LET) and an 
example electron path are presented. A cluster of ionisation events (represented by stars) in close 
proximity to a DNA molecule shows the potential for plural damage zones. 
 
 
 
Such mutation resulting from ionising radiation is effectively the first stage of the 
carcinogenic process, known as initiation. The second stage, promotion, involves the 
acquisition of new properties, such as immortalisation, resistance to hypoxia and so on. This 
comes about by the accumulation of a number of faults in the genome. Subclones can arise 
from clones of initiated cells in which mutations have occurred. Amongst subclones there is 
what Tubiana (2009) describes as Darwin-esque competition, which allows the subclones of 
more rapid growth to gain dominance. Ultimately, new subclones emerge with greater 
autonomy, growing more rapidly, until finally a subclone of cells exists which may proliferate 
autonomously. Following this stage is progression, in which the cells proliferate frequently 
despite the absence of stimuli. Cells eventually gain the potential for invasion of peripheral 
tissues or metastasis. 
 
Generally accepted as being of single-cell origin, the development of cancer occurs as a result 
of successive mutations and extensive proliferation. The period of time over which cancer 
develops (i.e. the latency) is in the order of decades for solid tumours, and relies on the 
unregulated proliferation of mutated cells that are not removed over time via apoptosis or 
immune system action. A clinically-diagnosed cancer will be constituted by of the order of 
γ-ray 
γ-ray 
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several billion cancerous cells. The low doses to untargeted healthy organs in the human body 
that occur as a result of scattered and leaked radiation in radiotherapy have the potential to 
induce cancer (and other health complications) as a result of the treatment. This is a typical 
stochastic effect whereby the probability of cancer induction is dependent upon the dose 
whilst the severity is independent. Radiocarcinogenesis is the most serious potential 
consequence of out-of-field doses, thus it is appropriate to discuss the different influences on 
the risk of radiocarcinogenesis so as to better understand the contexts in which out-of-field 
dose reduction may be especially important. 
 
 
 
6.3.2 Dose response models 
Within a population, there is an incidence of cancers that is expected to occur naturally. The 
objective is to determine the potential for an increase in incidence as a result of radiation 
exposure. This is facilitated by use of a dose-response relationship from which one may 
obtain risk coefficients. An additional consideration is the nature of the assumption(s) made 
about the mechanisms of radiocarcinogenesis.  
 
There are multiple dose-response models. Their applicability is mostly dependent upon the 
dose regime of interest. For low doses, the most appropriate model is a linear relationship 
between dose and risk. At higher doses there is evidence for quadratic behaviour. At high 
doses where cell-killing becomes the dominant biological effect, there is evidence that the risk 
of cancer induction decreases with dose. 
 
‘Relative risk’ (RR), defined in Equation 6.8, describes the excess risk of the disease as the 
ratio of the incidence of disease in equivalent exposed (I1) and non-exposed (I0) groups. 
 
0
1
I
I
RR =
 
(6.8) 
 
Also worth mentioning is the ‘excess relative risk’ (ERR). This is equal to the rate of cancer 
incidence (or mortality, etc) in an exposed population, divided by the rate in an unexposed 
population, minus one (i.e., ERR = RR – 1). The Committee on the Biological Effects of 
Ionizing Radiation (BEIR 1990) concluded some time ago that the RR model is the most 
appropriate model for analysis and projection of radiation-induced cancer incidence (1988; 
Shimizu et al. 1990). 
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6.3.3 Sources for radiocarcinogenesis data and associated risk relationships 
Radiation studies using experimental animals have been performed since the 1930s or so, and 
only the key observations will be discussed here. Most early data suggests that the incidence 
rate increases significantly at low dose levels, that the relationship exhibits a complex non-
linear behaviour, and decreasing incidence is often found for doses beyond the maximum. 
Later (more accurate) data indicates that the initial slope at low dose levels is linear.  
 
Key findings of animal studies include (Upton 1986): 
– the fact that neoplasms of almost any type may be induced via irradiation under 
appropriate conditions; 
– incidence rises steeply with dose and is less dependent on dose rates of high linear 
energy transfer (LET) radiations than low LET radiation (such as γ-rays); 
– the effects of radiation on the development of neoplasms can be modified by other 
physical / chemical agents; 
– at high doses the dose-incidence curve appears to ‘bend over’ as a result of 
sterilisation of potentially transformed cells, and 
– the time in which radiation-induced tumours appear depends on a large number of 
variables other than the conditions of radiation exposure, such as tumour type and the 
genetic background of the animal et cetera. 
 
There are a range of in vitro experiments that can be performed that model the cellular 
transformation process. As described above, the transformation of a single cell into one which 
is potentially cancerous is an initial part of a larger process, which is subject to influences 
from other modifying effects in the organism. It should be that noted in vitro investigation of 
the transformation aspect of the process neglects these influences arising from the organism’s 
response. However, cell culture studies have shown interesting results for dose fractionation – 
namely, that the transformation frequency is decreased via dose fractionation.  
 
There is also data available from medically-exposed persons. A brief overview of risk 
estimates based on epidemiological data is given in Table 6.: the risk estimates for subjects 
treated with external-beam radiation sources, for leukaemia, stomach, breast, thyroid and lung 
cancer. 
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Table 6.1 Some risk estimates (ERR per Gy) from selected studies for cancer of the stomach, breast, 
thyroid, lung and leukaemia following exposure to external-beam radiation. The average dose in the 
treatment, as well as the number (N) of cases and in the control population is given (where available).  
 
Study Average 
dose (Gy) 
N (cases) N (control) ERR (Gy-1), 95 % CI 
 
 
 
  
Stomach cancer     
(Boice et al. 1989) 2 348 658 0.54, [0.05, 1.5] 
(Mattsson et al. 1997) 0.66 14 1,216 1.3, [0, 4.4] 
(Weiss et al. 1994) 3.2 127 1,745 -0.004, [-0.05, 0.05] 
(Carr et al. 2002) 8.9 11 1,859 0.20, [0, 0.73] 
     
Breast cancer     
Incidence     
(Boice et al. 1991) 0.79 147 2,573 0.61, [0.3, 1.01] 
(Mattsson et al. 1995) 5.8 47 - 1.63, [0.77, 2.89] 
(Shore et al. 1986) 3.8 51 601 0.40, [0.2, 0.7] 
(Travis 2002) 22 67 122 0.15, [0.04, 7.3] 
Mortality     
(Weiss et al. 1994) 0.59 42 - 3.56, [-0.3, 0.65] 
(Howe and McLaughlin 1996) 2.13 578 - 0.40, [0.13, 0.77] 
(Doody et al. 2000) 0.11 70 4942 2.7, [-0.2, 9.3] 
     
Thyroid cancer     
(Ron et al. 1989) 0.09 98 10,834 30.0, 90 % CI: [0, 0.9] 
(Schneider et al. 1993) 0.6 309 234 3.00, N/A 
(Shore et al. 1993) 1.36 37 2,657 9.00, 90 % CI: [4, 24] 
(Ron et al. 1995) - 700 58,000 7.7, [2.1, 28.7] 
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Table 6.1 cont. Some risk estimates (ERR per Gy) for cancer of the stomach, breast, thyroid, lung and 
leukaemia following exposure to external-beam radiation. The average dose in the treatment, as well as 
the number (N) of cases and in the control population is given. 
 
Study 
Average 
dose 
(Gy) 
N (cases) N (control) ERR (Gy-1) , 95 % CI 
 
 
 
  
Lung cancer     
Incidence     
(Inskip et al. 1994) 4.6 61 120 0.20, [-0.62, 1.03] 
(Mattsson et al. 1997) 0.75 10 1,216 0.38, [0, 0.6] 
(Gilbert et al. 2003) 20 146 271 0.15, [0.06, 0.39] 
Mortality     
(Weiss et al. 1994) 8.88 282 - 0.09, [0.03, 0.15] 
(Howe 1995) 1.02 1,178 25,007 0.00, [-0.06, 0.07] 
(Carr et al. 2002) 1.1 21 - 0.43, [-0.12, 1.35] 
     
Leukaemia     
Incidence     
(Boice 1985) 7 143 745 0.88, (std. error: 0.69) 
(Inskip 1993) 0.59 4 1,407 0.50, [-0.6, 3.3] 
Mortality     
(Weiss et al. 1995) 4.38 35 1,745 12.4, [2.25, 52.1] 
     
 
 
 
In the present work, low out-of-field doses from radiotherapy are of particular interest. For a 
comprehensive overview, the Board on Radiation Effects Research (BEIR) Report VII: 
Health Risks from Exposure to Low Levels of Ionising Radiation provides a detailed review of 
studies of second cancer incidence resulting from radiotherapy (BEIR 2006). In this study, the 
BEIR (2006) risk estimates have been adopted as being the most appropriate for low-dose 
exposures. Much of their work is based on data from the atomic bomb cohort. 
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By far the best data on human exposure comes from the ‘atomic bomb cohort’, – the 
survivors of the nuclear weapon detonations in Nagasaki and Hiroshima, Japan. This study is 
often referred to as the Life Span Study (LSS). This group has been studied in detail for many 
decades. The LSS cohort is composed of a sample of around 195,000 residents of Hiroshima 
and Nagasaki who responded to the atomic bomb survivor census (conducted in 1950) and 
about 32,000 people who were not in the city at the time of the bombing (as identified in a 
further consensus conducted between 1950 and 1953). Some studies of cancer incidence in 
atomic bomb survivors have been published in Radiation Research: including an overview of 
use of the tumour registries for incidence studies (Mabuchi et al. 1994), a study of solid 
tumour incidence (Thompson et al. 1994), a study of leukaemia, lymphoma and multiple 
myeloma (Preston et al. 1994) and a comparison of cancer incidence and mortality (Ron et al. 
1994). Preston et al (2003) have published the thirteenth report on the mortality of atomic 
bomb survivors, including solid cancer and non-cancerous disease mortality, as well as the 
effect of recent changes in atomic bomb survivor dosimetry on mortality risk estimates 
(Preston et al. 2004). 
 
The LSS cohort is a unique data source in that the population is very large and was not 
selected on the basis of disease etc, there has been a long follow-up period, both sexes are 
included as are all ages. This allows investigation of the different factors by comparison of 
risks amongst the various sub-groups. The doses are fairly well known, and the cohort 
incorporates a large group exposed to low-doses, which are of particular relevance in this 
study. The subjects received a whole-body exposure, which facilitates investigation and inter-
comparison of organ-specific cancer risks. 
 
For low dose levels, the best data for radiation-induced cancer risk in humans is the LSS data. 
Some key inferences one may draw from this dataset are that: 
- the risk of radiation-induced cancer increases with post-irradiation time; 
- the risk of radiocarcinogenesis decreases with increasing age at time of exposure; 
- females exhibit a greater risk than males and 
- there is an increased risk of fatal cancer for doses ranging up to 2 Sv that is consistent 
with a linear relationship. 
 
Figure 6.10 shows the solid cancer incidence arranged according to the percentage of the total 
incidence and the excess relative risk.  
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Figure 6.10 Solid cancers for specific cancer site or organ system arranged according to (a) percentage 
of total solid cancer incidence and (b) excess relative risk (per Sv). Data from (Thompson et al. 1994). 
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Shimizu et al investigated cancer mortality amongst atomic bomb survivors. Highlighting the 
dose intervals where a statistically significantly higher cancer mortality is observed, Figure 
6.11 shows the estimated relative risk compared to the control (0 Gy) group, given for dose 
bins less than 2 Gy. 
 
The issue of latency is also worth mentioning. Radiation-induced leukaemia typically 
manifests two or three years after exposure, with peak occurrence within six to eight years, 
after which there is a decrease with time. The latency period for radiation-induced solid 
tumours is typically longer than leukaemia – generally fifteen years or more. It is for this 
reason that paediatric patients are of particular concern in terms of radiation-induced cancer, 
and for this reason later sections of this work deal specifically with doses to paediatric 
patients. 
 
 
 
 
Figure 6.11 The estimated relative risk of mortality for the atomic bomb cohort for doses less than 2 
Gy. This highlights the dose intervals where the observed mortality is statistically higher than the 
control (0 Gy) group. Data from (Shimizu et al. 1993). 
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6.3.4 The nominal risk per Sievert 
Risk models generally allow for the variation in excess risk that occurs with influencing 
factors such as sex, age at exposure and attained age. The nominal risk coefficients presented 
here are derived from averaging sex and exposure-age lifetime risk estimates for combined 
Euro-American and Asian populations (ICRP 2007). The lifetime cancer risks are determined 
from risk estimates for site-specific cancers. Table 6.2 shows the whole-population, sex-
averaged nominal risk of fatal, non-fatal and total tumour incidence. The risks are given for 
the oesophagus, stomach, colon, liver, lung, bladder, breast, ovary, thyroid and bone marrow 
from BEIR VII (2006) data. For gonads (heritable) risks, BEIR data was unavailable and 
ICRP (2007) data was used. Remaining tissues were grouped as ‘other’ solid cancers. 
 
 
Table 6.2 The whole-population, sex-averaged nominal risk (% per Sv) of fatal, non-fatal and total 
cancer incidence according to the BEIR VII report (2006). Note that a dose and dose rate effectiveness 
factor (DDREF) of 1.5 is used by the BEIR committee. 
* Note that BEIR VII did not consider lifetime risk estimates for gonads and so these values are from 
the ICRP (2007). 
 
Cancer site Total Fatal Non-fatal 
 
 
 
 
Oesophagus 0.141 0.131 0.01 
Stomach 0.963 0.798 0.165 
Colon 0.745 0.356 0.389 
Liver 0.4 0.382 0.018 
Lung 1.369 1.218 0.151 
Bladder 0.519 0.15 0.37 
Breast  1.119 0.329 0.789 
Ovary  0.115 0.065 0.05 
Thyroid 0.32 0.021 0.299 
Bone marrow 0.419 0.28 0.139 
Other solid cancers 1.633 0.801 0.832 
Gonads (heritable) * 0.2 0.16 0.04 
Total 7.943 4.691 3.252 
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6.3.5 Risk estimation for non-cancerous diseases based on LSS data 
The Life Span Study data also shows evidence for a link between radiation exposure and non-
cancer disease mortality. This is discussed in detail elsewhere (Shimizu et al. 1999). Preston 
et al (2003) showed that a linear (L) fit for the dose response is a suitable model, with the 
linear-quadratic (LQ) model not fitting significantly better. Table 6.3 shows the cause-
specific excess relative risk per Sv for mortality from non-cancer diseases, based on LSS data. 
 
 
Table 6.3 Excess relative risk (ERR per Sv) of mortality for non-cancer diseases, identified for 
individual causes, shown with the 90 % confidence interval (CI). Based on LSS data (Preston et al. 
2003). 
 
Cause ERR (Sv-1) 90 % CI 
 
  
Heart disease 0.17 0.08, 0.26 
Stroke 0.12 0.02, 0.22 
Respiratory disease 0.18 0.06, 0.32 
Digestive disease 0.15 0.00, 0.32 
Infectious disease -0.02 -0.2, 0.25 
Other (non-blood) diseases 0.08 -0.04, 0.23 
All non-cancer diseases 0.14 0.08, 0.2 
 
  
 
 
 
6.3.6 Summary 
Various data sources for radiocarcinogenesis are available, including experimental animal 
studies, in vitro tissue studies and epidemiological data from human exposures including 
medical, occupational, accidental and atomic bomb exposures. For low doses, a linear dose-
response model is appropriate for solid-tumour induction. Here, the BEIR VII Phase 2 risk 
estimates are chosen to be most appropriate. Much of this data is based on the atomic-bomb 
cohort. There are also risks of noncancerous diseases related to radiation exposure, and these 
have been summarised. 
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6.4 The lack of data for out-of-field doses from stereotactic fields 
In the previous sections, a detailed review has been given of studies investigating out-of-field 
dose and of the risks for detrimental side-effects that may occur far from the primary field, in 
low-dose regions. It is evident from this overview that despite the fervent interest in out-of-
field doses and the potential for radiation-induced carcinogenesis from low doses, there is 
relatively little data pertaining to such doses from small fields, such as those used in 
stereotactic radiotherapy. 
 
Intuitively, one might expect that out-of-field doses from a stereotactic radiotherapy treatment 
may be lower than, for instance, a whole-brain radiotherapy treatment. However, this does not 
necessarily imply that the former may generate out-of-field doses which are entirely without 
an associated increased risk to the patient of detrimental effects, such as radiation-induced 
cancer. In fact, as the novel studies undertaken in this work show, far from the primary field 
the doses are not dependent on field-size (see the following sections), negating such 
dismissive points of view. 
 
As such, it seems prudent that any comprehensive study – such as this one – characterising 
the doses from small fields must also investigate out-of-field doses. The least-studied 
stereotactic out-of-field doses are those delivered using linac-based radiotherapy. In the 
following sections, peripheral doses from mini-multileaf collimator shaped stereotactic fields 
are characterised in a systematic way, as a function of various parameters such as field size, 
depth in phantom, source-surface distance and so on. Additionally, since it is paediatric 
patients whom are at most risk of developing latent radiation-induced cancers, doses to 
critical organs are measured in a paediatric phantom subjected to small-field treatments, and 
corresponding cancer risks are calculated. 
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6.5 Systematic evaluation of the peripheral doses from stereotactic fields 
Despite the highly localised doses that may be delivered via stereotactic radiotherapy, a small 
dose is nonetheless delivered to out-of-field regions, which may cause detriment to the 
patient. In this work, a systematic set of dose measurements have been undertaken up to a 
distance of 45 cm from the isocentre, for stereotactic fields shaped by a BrainLAB mini-
multileaf collimator (MMLC) mounted on a Varian 600C linear accelerator. A range of 
treatment parameters were varied so as to determine the factors of greatest influence and 
establish relationships with dose. The commercial treatment planning software (TPS) 
miscalculates the dose to out-of-field regions. Measured dose decreases consistently out to 45 
cm, whereas the TPS decreases out to 10-15 cm, at which point the predicted dose is constant. 
At 5-10 cm off-axis distance (OAD), measurements indicate doses of about 5-10 % of the 
dose at isocentre, 1 % at 15 cm OAD and 0.1 % at 45 cm OAD. There are several observed 
trends. Greater MMLC field sizes (with static jaw) result in higher out-of-field dose, as do 
shallower depths. The source-to-surface distance does not greatly influence peripheral dose. 
However, the results given in this work do indicate that simple treatment arrangements, such 
as preferable collimator rotation, would in certain cases reduce out-of-field dose by an order 
of magnitude. Peripheral dose raises questions of treatment optimisation, particularly in cases 
where patients have a long life expectancy in which secondary effects may become manifest, 
such as in the treatment of paediatric patients or those with a non-malignant primary. For 
instance, for a 20 Gy hypo-fractionated treatment, dose to out-of-field regions is of the order 
of cGy – a substantial dose in radiation protection terms. 
 
Note that for the sake of scientific integrity, this section of the chapter repeats the associated 
publication verbatim (Taylor et al. 2010c). 
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6.5.1 Introduction 
The function of stereotactic radiotherapy is to deliver highly localised doses to small lesions; 
however, treatment of these conditions nonetheless results in a small amount of dose being 
delivered to untargeted regions. The unfortunate irony of contemporary radiotherapy is that 
its increasing efficacy is successfully lengthening patients’ lifetimes, and thus there is greater 
time in which radiation-induced cancers may become manifest. The potential for 
radiocarcinogenesis due to doses received outside the primary field is of particular importance 
for paediatric patients and those with a non-malignant primary condition, and knowledge of 
such doses may influence the choice of treatment options adopted.  
 
Treatment planning systems (TPS) are normally commissioned using measured data that 
extend only a few centimetres beyond the field edge, with penumbra defined as 80 % to 20 % 
of the maximum dose for the field. Dose extending outside the field is not intended to be used 
for the overall calculation of the dose distribution or contribute to the inverse optimisation 
procedure. Therefore, one would expect the dose distributions predicted by the TPS to be 
inaccurate in regions far from the primary field. 
 
A large body of published literature exists pertaining to the measurement and calculation of 
doses to out-of-field regions for various modes of external beam radiotherapy (Xu et al. 
2008). There is, however, relatively little literature relating to peripheral doses from 
stereotactic radiotherapy. Intensity-modulated radiotherapy typically uses doses of the order 
of a couple of Gy over a large number of fractions so as to achieve a total of 60 – 70 Gy. In 
contrast, stereotactic radiotherapy often employs high doses (10 – 20 Gy per fraction) in a 
hypofractionated regime of few fractions. As such, the out-of-field doses from each high dose 
single fraction is of interest. Ioffe et al (2002) quantified the dose rate as a function of 
distance from the isocenter in a RANDO phantom for Gamma-Knife treatments. Hasanzadeh 
et al (2006) constructed an anthropomorphic phantom and undertook thermoluminescent 
dosimeter (TLD) measurements of dose in untargeted organs for Gamma-Knife radiosurgery. 
Petti et al (2006) developed Cyber-Knife plans for a thorax lesion and brain lesion in an 
anthropomorphic phantom and measured the dose at various depths and distances outside the 
treatment field using TLD. Peripheral doses were found to be 2 to 5 times higher than a 
comparable Gamma-Knife treatment and up to 4 times higher than an IMRT treatment. The 
relatively large peripheral dose is attributed to greater leakage of the Cyber-Knife unit. 
Chuang et al (2008) investigated reduction of out-of-field doses from the Cyber-Knife system 
resulting from a shielding upgrade, with the observation that doses were generally reduced by 
20 to 55 %. The latter studies mentioned have focused on the Cyber-Knife and Gamma-Knife 
systems. Maarouf et al (2005) examined the radiation exposure of organs at risk and assessed 
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the risk of late effects (such as secondary tumours or hereditary disorders) following 
stereotactic linac radiosurgery of intracranial tumours. TLD were placed superficially on 
patients’ eyelids, thyroid, breast and regions of the ovary / testes, with measured doses in the 
order of cGy and mGy. 
 
Ultimately, there have been few studies of out-of-field doses from linac-based stereotactic 
radiotherapy. The present study characterises the peripheral doses from a BrainLAB 
(Feldkirchen) m3 mini-multileaf collimator (MMLC) used for stereotactic radiotherapy. Doses 
were measured at various points in a water phantom up to 45 cm from the central axis. A 
range of field sizes was employed along with variation of other parameters, such as source-
surface distance and depth in water, so as to determine the factors of greatest influence and 
establish relationships with dose. The doses at these positions were also calculated with the 
BrainLAB iPlan treatment planning system.  
 
A set of results have been presented as concisely as possible here, to indicate the general 
behaviour of peripheral doses from stereotactic fields and demonstrate the influence of typical 
treatment parameters. A comparison with the treatment planning software dose calculation 
indicates the limitations thereof, and preferable treatment options are identified to limit 
unnecessary patient dose.   
 
 
6.5.2 Dose measurement and Calculation 
6.5.2.1 Experimental method 
At the William Buckland Radiotherapy Centre (Alfred Hospital, Melbourne), stereotactic 
radiotherapy is performed using a BrainLAB m3™ mini-multleaf collimator mounted on a 
Varian 600C as a tertiary collimation device. The maximum effective field size is 9.8 x 9.8 
cm2 at isocenter, shaped by 26 leaf pairs: 14 of width 3 mm, six of width 4.5 mm and an outer 
set of six with 5.5 mm width. The leaves move orthogonally to the beam axis, and have a 
complex tongue and groove cross-section. This cross section is also shaped to match the beam 
divergence across the field. The leaf edges are not curved, but rather have three angled 
straight edges, the total length of which is 6 cm. The middle section is milled parallel to the 
beam axis to match the (non-) divergence of the beam when centred. The upper section is at 
an angle corresponding to the beam divergence when the leaf is fully extended (5 cm beyond 
the centre), and the angle of the lower section corresponds to full retraction (5 cm back from 
the centre). 
 
  268
The dose was measured with ionisation chambers IC3 and IC13 (Wellhöfer, Schwarzenbruck) 
at 5 cm steps along a line (in both the x- and y-planes) from the isocentre (0 cm) to 45 cm 
away. The smaller IC3 was used in the near out-of-field region to elucidate expected 
structure, while the larger IC13 was used in the far out-of-field region. For consistency the 
same measurement points were used for all field sizes, with 5 cm distance from the central 
axis being the nearest out-of-field distance of interest for the set of field sizes studied. The 
detectors were placed inside a large (50 x 50 x 50 cm3) water-filled tank (Wellhöfer, 
Schwarzenbruck) and their position controlled via the scanning mechanism. This was 
undertaken for various combinations of delivery parameters, as indicated in Table 6.4. 
Measuring in a homogenous water phantom (water-tank) allows for the systematic 
characterisation of peripheral doses. This facilitates isolation of geometrical parameters from 
other compounding effects introduced when measuring in more realistic situations, such as in 
vivo or with anthropomorphic phantoms. These include six field sizes shaped with the MMLC 
(with a static 9.8 x 9.8 cm2 jaw), three source-surface-distances (SSD) and three depths with 
collimator rotations of 0 º and 90º. All measurements were taken with sufficient monitor units 
(hundreds to thousands) to obtain a dose in the order of at least mGy, and were corrected for 
electrometer leakage, temperature, pressure and daily linac output variation; repeated 
measurements indicate variations of ~0.5 %.  
 
Table 6.4 The comprehensive set of measurement parameters varied in this study, including source-
surface distance (SSD), depth in water tank and MMLC field size (with static 9.8 x 9.8 cm2 jaw 
setting). 
 
Direction Cross-plane and in-plane 
SSD (cm) 85, 90 and 100 
Depth (cm) 2, 5, 10 and 20 
Field sizes (mm2) 0 x 0, 24 x 24, 42 x 42, 60 x 60, 80 x 80 and 98 x 98 
 
 
6.5.2.2 iPlan dose calculation 
Treatment plans were generated with iPlan RT Dose version 3.0 (BrianLAB, Feldkirchen) 
dose calculation software, which has been commissioned according to the manufacturer’s 
specifications. Note that this commissioning does not incorporate data more than a few 
centimetres from the field edge. The iPlan pencil beam algorithm uses photon beam data 
calculated by Mohan et al (1985; 1986; 1987). In this method, the incident beams are 
subdivided into small ‘beamlets’. For each beamlet, a radiological path length correction is 
applied to correct for density inhomogeneity. A fast Fourier transform (FFT) is applied for the 
beam kernel convolution with the fluence distribution of the beam. 
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6.5.3 Results and Discussion 
6.5.3.1 Overview of results 
The results presented here have been chosen to best indicate the trends of out-of-field dose 
from stereotactic fields, and to demonstrate the influence of typical treatment parameters, 
such as depth in phantom, field size, SSD and collimator rotation (data was taken along the x- 
and y-planes, as defined by the direction of jaw motion). The dose per monitor unit (MU) is 
given as a function of distance from isocentre for these various parameters, as shown in 
Figure 6.12. In the same fashion, a comparison with treatment planning software predictions 
is given in Figure 6.13, and an indication of the discrepancies between measurement and dose 
calculation is given in Table 6.5. The discussion of results is broken up into sections, each 
discussing the influence of the different delivery parameters. A brief discussion of the 
potential for detrimental radiation-induced effects is also given, facilitated by an example for 
a paediatric patient treated for an arteriovenous malformation. 
 
 
 
Table 6.5 This table summarises the discrepancies between the doses (relative to the dose at isocentre) 
as measured and as calculated with the treatment planning system (TPS) at selected distances from the 
isocentre. The data shown incorporates maximum (max.) and mean doses (with standard deviation, σ) 
over multiple depths along both the x- and y-planes for 98 x 98 mm2 field. The TPS-calculated out-of-
field doses plateau beyond a certain distance (as evidenced in Figure 6.13). In order to generate 
comparable data, a large number of monitor units were employed in the TPS calculation; it should be 
noted that with a lower number of monitor units (such as that for a typical treatment) the TPS assumes 
zero dose far from the primary field. In most contexts, therefore, the TPS significantly underestimates 
peripheral dose. 
 
Distance from isocentre (cm) 5 10 15 45 
Max. measured dose (rel. to isocentre dose) 81 % 4.80 % 1.81 % 0.05 % 
Mean measured dose (rel. to isocentre dose) 35 % 2.19 % 0.85 % 0.03 % 
σ 30 % 1.64 % 0.62 % 0.01 % 
Max. TPS calculated dose (rel. to isocentre dose) 58 % 5.01 % 2.03 % 1.11 % 
Mean TPS calculated dose (rel. to isocentre dose) 38 % 2.27 % 0.89 % 0.59 % 
σ 24 % 1.68 % 0.67 % 0.32 % 
Ratio of max. relative doses (measured / TPS) 1.39 0.96 0.89 0.05 
Ratio of mean relative doses (measured / TPS) 0.94 0.97 0.95 0.05 
  270
 
 
Figure 6.12 Plot of dose per monitor unit (MU) as a function of distance from isocentre, indicating the 
influence of measurement depth on the peripheral dose. Example taken along the y-plane direction for 
a 24 x 24 mm2 field at an SSD of 90 cm. (b) Plot of dose per monitor unit (MU) as a function of 
distance from isocentre, indicating the influence of SSD and measurement plane (x-direction, x, or y-
direction, y) on the peripheral dose. Example taken for a 24 x 24 mm2 field at a depth of 10 cm. (c) 
Shows the off-axis doses from a closed (0 x 0 mm2) field compared to a 24 x 24 mm2 field at a depth of 
10 cm for 90 cm SSD, along both the x- and y-plane directions. (d) Plot of dose per monitor unit (MU) 
as a function of distance from isocentre, indicating the influence of stereotactic field size (in mm2) on 
peripheral dose. Example taken along the x-plane direction at an SSD of 90 cm. 
 
 
 
 
 
(c) (d) 
(a) (b) 
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Figure 6.13 Plot of dose per monitor unit (MU) as a function of distance from isocentre, which 
indicates the poor dose prediction of the treatment planning system for a selection of field sizes at 10 
cm depth and 90 cm SSD. Beyond the field edge the dose calculation either overestimates or 
underestimate the peripheral dose. 
 
 
 
6.5.3.2 Influence of depth 
Figure 6.12(a) indicates the relationship between the peripheral dose and the measurement 
depth (2, 5, 10 and 20 cm). This is shown for a 24 x 24 mm2 field at 90 cm SSD along the y-
plane direction; similar data (not shown) has also been measured for other field sizes 
(including a closed field) and the x-plane direction. Generally, the peripheral dose is higher 
for shallower depths – as shown in Figure 6.12 (a), at a distance of 45 cm from the isocentre, 
the dose per MU is about five times higher at a depth of 2 cm than that at 20 cm. This is not 
unexpected, and may be explained more or less by attenuation. As evidenced by typical depth 
dose curve measurements, the attenuation of the primary beam along the central axis results 
in a dose at 20 cm depth of about 2.6 times less than that at 2 cm depth. For the out-of-field 
regions, such data is relatively less well-known. A dosimetrically matched Monte Carlo 
model of the 600C linac constructed using BEAMnrc (Rogers et al. 1995; Kawrakow and 
Rogers 2006) indicates that the primary beam has a mean energy of around 2 MeV, and far 
from the primary field, the spectral qualities of the beam change quite significantly, having a 
much lower mean energy (of the order of 0.5-0.6 MeV). The detector response is quite flat, 
and would change by only about 1 % – thus not significantly affecting the results. 
Consideration of simple linear attenuation in water (Attix 2004) gives a factor of 2.4 
difference between 2 cm and 20 cm depth for a 2 MeV beam, and a factor of 5.7 for a 500 
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keV beam. The attenuation at an off-axis distance of 45 cm is thus more pronounced, 
providing some explanation for the differences observed in out-of-field dose for the different 
measurement depths as illustrated in Figure 6.12(a). 
 
 
6.5.3.3 Influence of SSD 
Figure 6.12(b) demonstrates the relationship between the peripheral dose and the source-to-
surface distance (SSD). In this case, data is shown along the x-plane and y-plane directions 
for a 24 x 24 mm2 field at a depth of 10 cm. From the data, it is evident that the SSD has a 
negligible influence on the out-of-field dose. The slight differences between curves can also 
be partially attributed to the uncertainty in the measurements taken in these very low fluence 
regions (where doses are fractions of mGy). 
 
 
6.5.3.4 Influence of collimator rotation 
Unlike the SSD, collimator rotation has a significant effect on the peripheral dose, as 
indicated in Figure 6.12(b) and (c). Close to the primary field, as one would expect, doses do 
not vary significantly with collimator rotation. With increasing off-axis distance, however, 
doses along the y-plane are up to an order of magnitude higher than those along the x-plane. 
The jaws are thick and, as a result, one pair is mounted above the other (such that the y-jaws 
sit almost 9 cm vertically above the x-jaws (top-to-top), both being approximately 8 cm 
thick). While this does not appear have an effect on in-field doses (Metcalfe et al. 1993), 
there is clearly a difference for out-of-field doses. The difference in height may have some 
influence, in as far as a particle interacting in the x-jaws and scattering arbitrarily into the 
primary field may be scattered outside of the field if it interacted at an equivalent point in the 
upper jaws and scattered at the same angle. The upper jaws are also exposed to greater 
primary radiation than the lower jaws, which are somewhat shadowed by the former, and thus 
generate more scatter. Because the lower jaws are oriented perpendicularly to the upper jaws, 
this scatter is un-collimated along the y-direction. The MMLC construction has a strong 
influence on the level of disparity between the x and y directions, with differences being more 
pronounced for small field sizes (field size differences are discussed in the following section). 
The leaves move in the x-plane direction, the drive machinery lies beneath the x-jaws and the 
leaf bank is slightly longer in that direction. For larger fields where the relative influence of 
in-phantom scatter from the primary beam is higher, the difference between x and y is less 
pronounced. 
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At about 10 cm off-axis distance, the out-of-field dose from a small field along the y-plane is 
a factor of three higher than that along the x-plane, and at 45 cm off-axis distance it is almost 
an order of magnitude higher. As such, the clinical recommendation is that, where possible, 
for a couch orientation of 0º one should employ a collimator rotation of 0º. For each field, 
the collimator rotation should be preferentially chosen such that the x-plane is aligned 
with the craniocaudal axis of the patient (i.e. parallel to the couch). 
 
 
6.5.3.5 Influence of field size 
Figure 6.12 (c) and (d) show the relationship between the peripheral dose and the size of the 
stereotactic field. The most strikingly different field is of course the closed field (0 x 0 mm2), 
which is compared to the 24 x 24 mm2 field in Figure 6.12 (c) along both the y- and x-plane 
directions. The difference between doses in the x- and y-planes has been discussed in the 
previous section and, as with open fields, the dose with closed leaves is still significantly 
higher along the y-plane than the x-plane. Consider first doses along the x-plane, in which 
direction the MMLC leaves move. At isocentre, the 24 x 24 mm2 field clearly results in a dose 
significantly higher (two orders of magnitude) than the closed field. However, at about 5 cm 
off-axis the dose from the closed field is a factor of about one and a half times higher than the 
small field. The reason for this is that the MMLC leaves close such that the isocentre is best 
shielded, with one bank fully extended and the other bank fully retracted. The slight airgap 
between the two banks of leaves allows some leakage which results in the relatively higher 
dose at about 5 cm from the isocentre. Beyond this point, the dose from the closed field is 
lower than the 24 x 24 mm2 field until about 30 cm off-axis distance, at which point the dose 
again rises above that of the small field. A trigonometric calculation suggests that this 
corresponds to scatter beneath the jaws passing behind the fully-extended leaf bank. Doses 
along the y-plane agree with what one would intuitively expect, i.e. the dose due to the 24 x 
24 mm2 field is higher than the closed field, the difference decreasing with increasing off-axis 
distance.  
 
In Figure 6.12(d), data is shown along the x-plane direction for five different field sizes at a 
depth of 10 cm and an SSD of 90 cm. The general trend is that dose per MU decreases with 
distance in a consistent manner for the various field sizes, with the larger field sizes clearly 
resulting in higher out-of-field dose. While head leakage will be a significant contributor to 
out-of-field dose, this is expected to remain more or less consistent regardless of the field 
size, since the jaws are static. As such, the ‘vertical shift’ of the dose curves for different field 
sizes may be attributed chiefly to the change in primary fluence. The dose at a distant point is 
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related to the energy and fluence of the radiation scattered there (and the mass energy 
absorption coefficient of the medium). Considering the primary beam incident upon the 
phantom, the dominant interaction mode for this energy (Ē ≈ 2 MeV) is inelastic photon 
scattering. The scattered photon fluence at the distant point is related to the primary fluence, 
by a proportionality constant incorporating the Klein-Nishina (1929) cross section for the 
Compton effect, an inverse-square law factor and an attenuation factor. From a practical 
perspective, if one wishes to estimate the increase in out-of-field dose resulting from an 
increased field size in a clinical context, the results show an increase proportionate to the 
increase in side-length of the field. Compare, for instance, the 24 x 24 mm2 field to the 98 x 
98 mm2 field. The 98 mm side length is four times the 24 mm side length, and the peripheral 
dose is four times higher. This approximate trend is also exhibited by other ratios of field 
sizes (within around ten or fifteen percent). 
 
 
6.5.3.6 Limitations of the treatment planning dose calculation software 
Figure 6.13 illustrates the limited capacity of the treatment planning software to calculate out-
of-field doses. This is shown for various field sizes at 90 cm SSD and a depth of 10 cm along 
the x-plane. Beyond the field edge, the dose calculation either overestimates or 
underestimates the peripheral dose. The treatment planning software effectively does not 
calculate dose beyond about 10 cm from the isocentre. Selecting a large number of monitor 
units (MU) and then observing the dose per MU indicates that iPlan simply assumes that the 
dose plateaus beyond a given distance. There is generally under-prediction of the peripheral 
dose close to the primary field, and over-prediction far from the primary field (because of the 
dose plateau). In order to generate comparable data, a large number of monitor units were 
employed in the TPS calculation (up to 103); it should be noted that with a lower number of 
monitor units (such as that for a typical treatment) the TPS assumes zero dose far from the 
primary field. In most contexts, therefore, the TPS significantly underestimates peripheral 
dose.  
 
 
6.5.3.7 Implications and recommendations 
Aside from the normal tissue complications that may arise in the vicinity of the treatment 
zone, low doses to untargeted regions may result in harmful long-term effects, such as 
radiocarcinogenesis. The patients of most concern are those whose lifetimes might otherwise 
be quite long, and hence have a greater time period in which radiation-induced cancers may 
become manifest, such as paediatric patients or those without a primary malignancy. For 
example, consider paediatric patients treated for arteriovenous malformations (AVM); for 
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small AVMs, minimum target doses of 20 to 25 Gy are not unusual (Aoyama et al. 2001; 
Chang and Adler 2001). To illustrate the potential for detriment, in this case consider a dose 
of 18 Gy applied to a 12 year old patient delivered with a 6 cm2 field (see, for instance, the 
study by Maity et al (2004)). Making an estimate from the out-of-field dose data presented in 
this study, the dose to the thyroid (about 12 cm from mid-brain) would be of the order of 70 
mGy. Using the preferred model for risk estimation of thyroid cancer (for low doses) based 
on the study by Ron et al (1995), and recommended by the Committee on the Biological 
Effects of Ionizing Radiation (BEIR 2006), the increased relative risk of thyroid cancer as a 
result of the treatment would be increased by a factor of 1.2 or 1.3 for a male or female 
patient respectively. While few would argue against the notion that the curative effects of 
radiotherapy outweigh the potential negative consequences, the results nonetheless highlight 
the importance of maintaining an awareness of out-of-field doses, and by employing a simple 
treatment arrangement, out-of-field dose to the patient may be minimised.  
 
 
 
6.5.4 Conclusions 
A systematic set of measurements of out-of-field dose have been undertaken for various fields 
of relevance to stereotactic radiotherapy shaped with a BrainLAB m3 MMLC mounted on a 
Varian 600C. The treatment planning software was shown to considerably miscalculate doses 
beyond the primary field. Higher peripheral doses are associated with increasing field sizes 
and shallow phantom depths, while varying the SSD was shown to have a negligible 
influence on out-of-field dose. Furthermore, it is recommended that clinical treatments are 
undertaken in such a fashion that the patient lies along the x-plane direction, where peripheral 
doses to untargeted regions may be up to an order of magnitude lower than along the y-plane 
direction. For a stereotactic treatment with a treatment dose in the tens of Gy, out-of-field 
doses are of the order of cGy, which is a considerable dose in radiation protection terms. 
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6.6 Small-field radiotherapy of paediatric patients: Doses to untargeted 
critical structures and the risk of radiation-induced carcinogenesis 
The objective of this study is to characterise out-of-field doses in paediatric radiotherapy, and 
to identify simple means by which out-of-field dose may be minimised, with a view to 
reducing the risk of secondary cancers. With the aim of characterising peripheral doses under 
different treatment conditions, dose measurements in an anthropomorphic child phantom 
were taken in various organs and critical structures outside the primary field using 
thermoluminescent dosimetry. Doses from Varian 600C and Varian Trilogy linear 
accelerators (linacs), both at 6 MV, were investigated. Larger field sizes are shown to result in 
higher peripheral doses close to the primary beam, with the difference becoming less 
considerable at large distances, indicating that most of out-of-field dose is due to head 
leakage and collimator scatter beyond 40 cm from the primary field. The use of lead shields is 
shown to reduce the absorbed dose resulting from leakage. Aligning the craniocaudal axis of 
the patient with the x-plane of the collimator results in a dose reduction of 40 %, for both 
machines. Out-of-field doses from the Varian Trilogy were shown to be approximately 40 % 
higher than those from the 600C, despite being operated at the same energy. Out-of-field 
doses to paediatric patients may be minimised by employing simple treatment options, such 
as using the single energy mode linac rather than the multi-mode, orienting the couch and 
collimator such that the patient lies along the x-plane, and avoiding fields directed along the 
trunk of the body. 
 
Note that for the sake of scientific integrity, this section of the chapter repeats the associated 
publication verbatim (Taylor et al. 2011c). 
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6.6.1 Introduction 
The most common fatal disease in children is cancer. In fact, after accidents, it is the leading 
cause of death in children between the ages of one and fourteen years (Bleyer 1990; Jemal et 
al. 2009). There are a number of treatment options available, such as surgery, chemotherapy 
or radiation therapy (radiotherapy). However, there are long term negative potential 
consequences from treatment – via any modality – of childhood cancers. Survivors of 
childhood cancer are prone to social difficulties in later life, being more likely to require 
special education services and having a reduced likelihood of undertaking tertiary education, 
marrying as a young adult and finding employment (Pang et al. 2008; Gurney et al. 2009). 
Also concerning is the potential for late health complications, in particular, those that arise as 
a result of the treatment for the primary disease. Such cases are of interest to clinicians 
because they are amenable to risk minimisation by careful choices regarding the nature of the 
treatment. 
 
In Australia, approximately 28 % of children under the age of 15 diagnosed with cancer are 
treated with radiotherapy (Ahern and Berry 2003). In radiotherapy, it is the cell-killing 
function of ionising radiation that is the desirable effect for the destruction of a targeted 
tumour. However, unwanted doses to untargeted healthy tissues can have deleterious 
consequential effects, such as respiratory and cardiac complications or radiocarcinogenesis. 
This is not only of interest in the immediate regions around the targeted volume, but also in 
critical structures that are quite distant from the primary field, which nonetheless receive a 
dose from scattered and leaked radiation. In the case of paediatric patients, the issue of doses 
to untargeted tissues is of particular concern. Normal tissues in children have the capacity not 
only to repair but to grow, and are affected by radiation to a greater extent than adult tissues. 
Furthermore, the long potential lifetimes of paediatric patients means that there is greater time 
in which radiation-induced cancers may become manifest. 
 
Strong interest in out-of-field radiation doses from medical linear accelerators (linacs) seems 
to have started from about the 1970s. The focus of earlier studies is typically from an 
occupational radiation safety perspective. More recently, there has been greater 
acknowledgement and interest in doses to untargeted critical structures in the patient. For a 
review of out-of-field doses from external photon beams, the reader is referred to the recent 
paper by Xu et al (Xu et al. 2008). In the present study, the objective is to identify 
straightforward treatment arrangements that may be readily applied clinically to reduce the 
level of unnecessary dose to untargeted organs in the patient. This has been achieved by 
experimental measurement of out-of-field doses undertaken for a range of treatment 
arrangements using a paediatric phantom. 
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6.6.2 Method 
6.6.2.1 Thermoluminescent dosimetry in paediatric phantom 
Dose measurements were taken in a 5 yr old paediatric phantom (CIRS Incorporated, Virginia 
USA). The phantom is made using tissue-equivalent material with homogeneity of bone and 
lung equivalent materials better than 1 and 3 %, over an energy range of 30 keV to 20 MeV 
(ICRU 1984a). The phantom incorporates a set of 5 mm holes designed for organ dosimetry 
using thermoluminescent detectors (TLD). LiF:Mg,Cu,P TLD-100H chips (Harshaw, Kansas 
USA) were employed, and display less variation in response with photon energy than 
standard TLD-100 LiF:Mg,Ti. This TLD is highly sensitive in the low-dose regime (Duggan 
et al. 2004). Multiple TLDs were placed at each of the following anatomic locations: the right 
and left lenses of the eye, optic nerve, brain, thyroid, lungs, heart, kidneys, abdomen and 
gonads (Table 6.6). Calibration was performed at 6 MV with TLDs at 1.5 cm depth in solid 
water, using a 10 x 10 cm2 field at 100 cm source-surface distance (SSD). For each set of 
measurements, the calibration group had two TLDs that received zero dose, four received 0.1 
Gy and another four received 1 Gy. The reproducibility of TLD measurements was better 
than 2 % (1σ). Using multiple TLDs for calibration yielded an overall uncertainty of 4 % at 
the 95 % confidence level for a given dose reading. Read-out was performed using a Harshaw 
automatic TLD reader. 
 
 
6.6.2.2 Radiation delivery arrangements 
Measurements of out-of-field dose were taken in the paediatric phantom for a range of 
delivery conditions. Multiple measurements were taken for several combinations of treatment 
parameters, over different days. Two static-field deliveries were applied to the phantom with 
a target in the posterolateral region of the brain: one with a posterior and lateral field (1:1 
weighting), the other incorporating a third field along the vertex (2:2:1 weighting). A twin-arc 
treatment was also applied (1:1 weighting). For each case, irradiations were performed with a 
0.5 x 0.5 cm2 field (total of 5 Gy delivered) and a 5 x 5 cm2 field (total of 2.5 Gy delivered), 
chosen for generality and reproducibility. Identical irradiations were performed on both a 
Varian™ Clinac 600C and Trilogy operated at 6 MV. Both upright and supine patient 
positions were investigated, as were collimator rotations of 0º and 90º. The patient positions 
are illustrated in Figure 6.14. A whole-brain radiotherapy (WBRT) field was also applied (20 
x 10 cm2) for comparison, since it is often employed in the treatment of metastases or acute 
lymphocytotic leukaemia. The use of a shielding block placed on the couch next to the 
phantom was studied in terms of the potential for reduction of leakage dose to the torso of the 
patient.  
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Figure 6.14 A schematic indicating the three different phantom orientations employed in this study: (a) 
supine (the typical arrangement), (b) upright and (c) prone. For clarity, not all treatment fields have 
been illustrated. The two-field treatments are indicated in (a) and (b), and the whole-brain radiotherapy 
(WBRT) field is illustrated in (c). Note the presence of the lead (Pb) shielding block in the latter 
arrangement. The uncertainties in each measurement point are better than 4 % at the 95 % confidence 
limit. 
 
 
 
6.6.3 Results  
The results are presented as graphs of dose as a function of distance in the phantom from the 
isocentric plane. Note that at each distance there are multiple data – corresponding to dose 
measurement points in organs in the same plane and hence same distance (see Table 6.6). The 
uncertainty at each point is better than 4 % (95 % confidence interval) and the spread of 
values at a given distance represents the dose to different organs at the same superior-inferior 
distance or different doses at multiple locations within a single organ. 
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Table 6.6 The TLD locations for the small field and whole-brain radiotherapy (WBRT) field 
treatments. 
 
 Small fields  WBRT fields  
Location  
# measurement 
points 
Sup/inf distance 
from field centre 
(cm) 
# measurement 
points 
Sup/inf distance 
from field centre 
(cm) 
     
Right and left 
lenses of the eye 
2 4 2 6 
Optic nerve 1 4 1 6 
Mid-brain 1 4 1 5 
Cord C spine - - 1 10 
Mouth - - 1 10 
Thyroid 2 16.5 2 16.7 
Upper Lung  2 21.5 2 21.5 
Cord T spine - - 1 21.5 
Anterior heart 2 29 2 29 
Lower Lung - - 2 29 
Kidneys 4 36.5 4 36.5 
Abdomen  2 46.5 4 46.5 
Gonads 2 56.5 2 56.5 
End of phantom 
(mid upper 
thigh) 
2 61.5 - - 
     
 
 
 
The peripheral doses from two different linacs were studied – a Varian 600C and a Varian 
Trilogy. The results show that doses from a Trilogy are about 40 % higher than those from the 
600C (at a distance of > 20 cm), and that doses along the x-plane (defined by the direction of 
jaw motion) are 40 % less than doses along the y-plane. This result is consistent with data 
recently reported elsewhere for stereotactic fields (Taylor et al. 2010c). Aligning the 
craniocaudal axis of the patient with the x-plane so as to minimise dose effectively requires 
setting a collimator angle of 90° for a couch rotation of 0°. To illustrate this, Figure 6.15 
shows the dose from these two linacs, with collimator rotations of 0° and 90°.  
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Figure 6.15 The out-of-field dose at various distances for a 5 x 5 cm2 two-field treatment delivered 
with two different linacs. (a) and (b) Dose with collimator rotations of 0° and 90° from the 600C and 
Trilogy respectively. (c) The ratio of the dose with a collimator rotation of 90° to that with 0° for both 
machines (with a couch rotation of 0°), while (d) shows the ratio of dose from the Trilogy to that from 
the 600C for both collimator rotations. The uncertainties in each measurement point are better than 4 % 
at the 95 % confidence limit. 
 
 
 
Two field sizes are compared, as shown in Figure 6.16 – a 5 x 5 cm2 field and a 0.5 x 0.5 cm2 
field. With equivalent deliveries, the large field is shown to result in significantly more 
peripheral dose in closer proximity to the isocentre, however, with increasing distance there is 
less disparity. The reason for this is that, for out-of-field regions which are close to the 
primary field, there is a relatively large amount of patient/collimator scatter from a large field 
compared to a small field. Patient and collimator scatter are field size dependent; the 
convergence of dose due to small and large fields with increasing distances indicates that the 
field size dependent components become less important than leakage. As can be seen in 
Figure 6.16(c), the contribution to out-of-field dose from leakage is higher for the Trilogy. 
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The structure of the treatment head differs between the 600C and the Trilogy, the latter 
having notable differences such as interchangeable electron targets and a flattening filter 
entirely beneath (rather than extending into) the primary collimator. Another significant 
difference is the fact that the 600C has a standing vertical waveguide, whilst the Trilogy 
incorporates a bending magnet to facilitate the longer horizontal waveguide that is necessary 
for higher operating energies. The significantly different structure and in particular the 
different head shielding between the two linacs is the most likely source of the considerable 
disparity in out-of-field dose; the fact that the difference is most pronounced at far distances 
where head leakage is of greater influence than patient scatter supports this hypothesis. 
 
 
 
Figure 6.16 Illustrates the difference in out-of-field dose for a small field (0.5 x 0.5 cm2) irradiation 
compared to a relatively larger field (5 x 5 cm2) irradiation. Data from the Trilogy linac is shown in (a) 
while the 600C doses are plotted in (b). The ratio of the small-field doses to the large-field doses is 
plotted in (c). A further study was carried out to investigate the influence of the patient orientation 
relative to the accelerating structure – and so a comparison of the typical supine orientation of the 
phantom on the couch was made with an upright orientation, shown in (d). The uncertainties in each 
measurement point are better than 4 % at the 95 % confidence limit. 
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An investigation of the distance from the accelerating structure was also investigated by 
orienting the phantom in an upright position in addition to the typical supine arrangement. 
Doses in the supine orientation were about 40 % lower than those with the phantom sitting 
upright, as shown in Figure 6.16 (d). 
 
Three delivery methods were compared – a two-field treatment, a three-field treatment 
involving a vertex field and a twin-arc treatment. Both arcs had an initial angle of 0° (vertex 
field for the phantom placed upright on the couch) and an arc angle of 90°. With couch 
positions of 0° and 90° the resultant stop position was a lateral and posterior field, 
respectively. Figure 6.17 indicates that the doses away from the target due to the three-field 
and arc deliveries are an order of magnitude greater than the two-field treatment that avoids 
the trunk of the body. 
 
 
 
 
 
Figure 6.17 The variation of out-of-field dose with the type of the applied field. The examples shown 
are a comparison of (a) two arcs to two static fields with the Trilogy (measured along y-plane) and (b) 
a three-field treatment (including a low-weighted vertex field) to a two-field treatment on the 600C 
(measured along the x-plane). Note the doses presented are mean doses at each particular plane. The 
uncertainties in each measurement point are better than 4 % at the 95 % confidence limit. 
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Figure 6.18 The out-of-field dose for a whole-brain radiotherapy field (WBRT) of 20 x 10 cm2. In (a), 
this is plotted against a 5 x 5 cm2 field for comparison. Doses measured with a Pb block between the 
patient and linac (at a distance of 45 cm from the isocentre) indicates the potential for shielding. In (b), 
the mean doses at each distance with the shielding block placed between the phantom and linac are 
plotted as a ratio of the WBRT field with no block. This illustrates the shielding possible, with the 
block placed approximately 45 cm from the isocentre. The uncertainties in each measurement point are 
better than 4 % at the 95 % confidence limit. 
 
 
 
As shown in Figure 6.18, an additional investigation of out-of-field doses from WBRT fields 
indicated significantly higher (an order of magnitude) out-of-field dose than the small-field 
treatments. The use of a lead shielding block at 40-45 cm from the isocentre reduced out-of-
field dose by around 50 % for those points covered by the lead, indicating the amount of 
peripheral dose that may be attributed to leakage (rather than patient scatter), and the efficacy 
of simple shielding techniques for far out-of-field anatomy.  
 
 
6.6.4 Discussion 
The key concern with out-of-field doses in general is that epidemiological evidence indicates 
that there is an increased probability of contracting cancer as a result of radiation exposure, 
relative to the normal background rate. The likelihood of radiation-induced cancer is higher 
for children than for patients exposed as adults. The results presented in this study indicate 
that for a given treatment, this risk could be halved just by employing the various simple 
treatment arrangements suggested here. 
 
One such approach would be the preferential use of a vertical straight waveguide linac (such 
as the 600C). The reason for the notable disparity in out-of-field dose between the two linac 
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models has been suggested in the Results section. There are significant differences in the 
construction of a low-energy single-mode linac, such as the 600C, and a high-energy multi-
mode linac operated in low-energy mode, such as the Trilogy. While in-field doses should be 
equivalent (except for small differences in the beam spectra), the difference in head design 
evidently leads to differences in out-of-field dose. In the case of the Trilogy, the electrons are 
accelerated in the first third of the accelerating waveguide, which lies in a plane parallel to the 
patient. A bending magnet directs the beam towards the patient, and contributes additional 
bremsstrahlung radiation. The 600C has a waveguide that is smaller, directed toward the 
isocentre and shielded by the linac head. As an interesting side note, one would expect the 
problem of leakage to be greater (in a relative sense) when operated at 6 MV as opposed to 
the higher energy modes. From purely theoretical considerations, the expected dose due to 
leakage photons relative to that at the isocentre would be higher when operating in low 
energy modes because of the inverse relationship between the energy of the electrons and 
angle of peak radiation intensity. In other words, as the electron energy increases, the 
resulting bremsstrahlung photon distribution becomes more forward-peaked. For instance, the 
angle of deviation from the initial electron trajectory corresponding to the bremsstrahlung 
peak from a 6 MV beam would be about a factor of three greater than the angle for an 18 MV 
beam. Thus, the leakage radiation in 6 MV mode would be generated on a path less tangential 
to the arc of the bending magnet than in the higher energy modes – i.e. more towards the 
patient plane. Ultimately there will also be differences in the structure of the head shielding 
which would likely contribute significantly to the disparity in out-of-field dose between the 
two linacs. 
 
An additional means of risk reduction is alignment of the craniocaudal axis of the patient with 
the x-plane of the collimator. This may be explained in terms of the geometrical arrangement 
of the secondary and tertiary collimators in the linac head. The y-jaws in a Varian linac are 
located above the x-jaws. The upper (y) jaws move in an arc trajectory about a point defined 
by the linac target such that the angle of the face matches the divergence of the photon beam. 
The lower (x) jaws slide in a straight line along a direction perpendicular to the beam axis, 
tilting such that the faces of the jaws match the field divergence. The primary field (defined 
by the opening of the jaws) is quite flat, but a difference is observed in the out-of-field dose. 
The lower jaws are shadowed to a degree by the upper jaws, which would result in less 
transmission in the direction of the lower jaw motion. Furthermore, simple geometrical 
considerations indicate a greater spread of angles of particles borne of interactions in the 
upper jaws are able to scatter into regions outside the primary field, compared to those which 
have interacted in the lower jaws. In addition, beneath the secondary collimators is a mini-
multileaf collimator, the leaf bank of which is slightly longer in the direction of leaf travel. 
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The latter is aligned with the x-axis, thus providing an additional level of 
attenuation/shielding for radiation scattered in the x-plane.  
 
It must be noted that these explanations are only applicable to Varian linear accelerators of 
the type studied. Linear accelerators of other manufactures (or other Varian designs) may 
have different properties which need to be studied. While the aim of the present work is to 
alert to the potential of dose reduction the methods suggested may not be readily applicable to 
other equipment. 
 
Further risk reduction is possible by using beam directions that provide equivalent target 
coverage but avoid the trunk of the patient. This result is no doubt intuitively expected. While 
out-of-field dose due to leakage and collimator scatter would be equivalent under any such 
arrangement (assuming the same beam-on time), the dose due to the primary field and patient 
scatter differ. Calculations (not shown) using a Monte Carlo model of a dosimetrically-
matched Varian 600C linac show that at a depth of 0.3 metres in water, doses due to a 6 MV 
photon field are still > 20 % of the maximum. Furthermore, the mean energy of a 6 MV beam 
is approximately 2.1 MeV, and the dominant interaction process in this energy regime is 
inelastic (Compton) scattering. At such energies the Klein Nishina formula (Klein and 
Nishina 1929) predicts generally forward-directed secondary radiation. These combined 
effects encourage the use of fields that are not directed along the craniocaudal axis of the 
patient. summarises the simple considerations that may be made when treating paediatric 
patients with radiotherapy so as to minimise the dose to untargeted organs. The present data 
was acquired using only equipment of one manufacturer. It will be necessary to study these 
effects. Table 6.7 in each centre using the equipment available for other manufacturers or 
configurations. 
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Table 6.7  Lists the various considerations that may function as simple means to reduce the out-of-field 
dose to patients in paediatric radiotherapy. 
 
Parameter Influence on peripheral dose 
  
Collimator rotation Out-of-field doses along the x-plane (defined by direction of jaw-
motion) are 40 % less than those along the y-plane for both linacs 
studied. 
Treatment technique A three-field treatment involving a vertex field or an arc treatment 
increases the dose beyond the thyroid by an order of magnitude 
compared to a two-field treatment avoiding the trunk of the body. 
Field size The study on field size indicates that beyond 40 cm distance from 
the isocentre, about half of the out-of-field dose is due to leakage 
(i.e. less dependent on field-size). 
Linac Using the Trilogy (bending magnet) linac operated at 6 MV results 
in doses higher 40 % higher than the (straight waveguide) 600C for 
both collimator rotations. 
Shielding The use of a shielding block on the couch between the patient and 
linac may halve the out-of-field dose.  
  
 
 
 
As mentioned, associated with these out-of-field doses is the grave potential clinical 
consequence of radiation-induced carcinogenesis. Children are at particular risk because of 
their long potential lifetimes, in which latent secondary cancers have greater time to become 
manifest, and because there is evidence of increased radiosensitivity in children. In fact, 
though the data is sparse, it is thought that the greatest risk of cancer induction in children 
may be as a result of radiotherapy (BEIR 2006). For a five year old patient, which the 
anthropomorphic phantom employed in this study is intended to represent, the lifetime 
probability of death attributable to low radiation doses (such as peripheral doses from a 
radiotherapy treatment) is about 16 % Gy-1 for females and 13 %  Gy-1 for males. This risk is 
approximately a factor of five greater than that for an adult of age 50 years (ICRP 1991). The 
risk that a child may contract a second cancer as a result of radiotherapy may be as high as 12 
% in 25 years (Tucker et al. 1991) and up to 51 % in 50 years (Wong et al. 1997) after the 
initial cancer. Also reported, based on a cohort presenting with malignant tumours within 2 
years of diagnosis of the first tumour, was an increased risk of bone cancer, demonstrating a 
relative risk of 2.7 at the 95 % confidence interval (CI)(Tucker et al. 1987). Soft tissue 
sarcoma has been reported with an odds ratio of 19 at 95 % CI (Menu-Branthomme et al. 
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2004). Melanoma (Guerin et al. 2003) and thyroid cancer (De Vathaire et al. 1999) have been 
reported with odds ratios of 1.4 to 13 at 95 % CI and relative risks between 4 and 26 at 90 % 
CI (depending on dose) respectively. 
 
To illustrate the differing risks of radiocarcinogenesis for various techniques, an example is 
given (based on the results presented in this work) for dose to the thyroid from the 5 x 5 cm2 
fields delivering 3 Gy to isocentre in different arrangements. For a 5 year old patient aligned 
with the x-plane and exposed to a 2 field treatment with the Trilogy, the lifetime attributable 
risk of cancer incidence (per 100,000 people) is approximately 4.3 for males and 23.5 for 
females. When aligned with the y-plane, the lifetime attributable risk of cancer incidence (per 
100,000 people) is reduced to approximately 2.5 for males and 13.8 for females. For a patient 
treated using 2 fields on the 600C, the lifetime attributable risk of cancer incidence (per 
100,000 people) is approximately 4 and for males and 22 for females. When a 3 field 
treatment is used, these risks increase to approximately 8.5 and for males and 47 for females. 
These estimates are combined estimates based on relative and absolute risk transport, adjusted 
by a DDREF of 1.5 (BEIR 2006). These examples indicate the potential for detriment arising 
from out-of-field doses and the reduction in risk that is achievable by implementation of some 
of the simple recommendations suggested in this paper. 
 
 
6.6.5 Conclusion 
This work has characterised out-of-field doses in paediatric radiotherapy of brain lesions 
under various treatment conditions, and has identified several straightforward means of 
reducing dose to untargeted organs. For typical treatment fields used in paediatric 
radiotherapy, the disparity in out-of-field dose between small fields and large fields decreases 
with increasing distance from the primary field. This could be attributed to the fact that, at 
larger distances, the dominance of leakage and collimator scatter increases relative to patient 
scatter. Simple methods such as choice of linac, collimator angle and external shielding can 
help to reduce these out-of-field doses, and therefore reduce the associated risks of radiation-
induced health complications (including radiocarcinogenesis), which are known to be of 
particular importance in the context of paediatric radiotherapy. These methods are also of 
great utility in the context of adult radiotherapy – especially for treatments for non-malignant 
disease which typically have long survival times and hence radiation protection must be taken 
very seriously. 
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6.7 Summary and clinical recommendations 
There is a demonstrated interest in out-of-field doses from radiotherapy procedures. However, 
thus far the consideration of out-of-field dose from (in particular, linac-based) stereotactic 
radiotherapy has been limited, perhaps because of the assumption that such doses will be 
significantly lower than other techniques. While it is certain that at near- and mid-field 
distances this may indeed be the case, it has been demonstrated that doses far from the 
primary field are comparable because of a reduced field size dependence. In this chapter, the 
current literature pertaining to out-of-field doses from radiotherapy and theory of 
radiocarcinogenesis has been reviewed. Out-of-field doses have been characterised in a 
systematic fashion for linac-based stereotactic radiotherapy. These results show: 
– The systematic variation of out-of-field dose with field size, source-surface distance, 
depth in phantom and collimator orientation. 
– Higher doses are associated with increasing field sizes and shallow phantom depths. 
– Variation with source-surface distance is not significant. 
– If the patient lies along the x-plane then out-of-field doses may be reduced by up to 
an order of magnitude. 
– For a stereotactic treatment of tens of Gy, the out-of-field dose is of the order of cGy 
(a significant dose in radiation protection terms). 
 
In addition to this, out-of-field doses in the context of small-field radiotherapy of paediatric 
patients has also been investigated, since children are more susceptible to and have greater 
lifetimes in which radiation-induced cancer may become manifest. Key clinical 
recommendations that may be made based on the results presented here include: 
– Out-of-field dose reduction of approximately 40 % may be achieved by using a 
single-mode (vertical waveguide) linac as opposed to a multi-mode. 
– Appropriate choice of collimator rotation can reduce out-of-field dose by 40 %. 
– Appropriate choice of treatment technique can reduce out-of-field dose by an order of 
magnitude (step-and-shoot, without field along craniocaudal axis, results in less out-
of-field dose than arc delivery). 
– Simple shielding can reduce out-of-field dose by 50 %. 
– Field size has a reduced influence far from the primary field (i.e. out-of-field doses 
from stereotactic fields deliver similar doses to larger-field treatments at large 
distances from isocentre). 
– Examples have been given illustrating that implementing these approaches can reduce 
relative risks of cancer induction by over 50 %. 
– The Paediatric Unit of Peter MacCallum Cancer Centre (Aust.) is planning changes to 
treatment protocols based on these results. 
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CHAPTER SEVEN 
 
Let us not conjecture at random about the most important things. † 
 Ήράκλειτος ό Έφέσιος 
 
 
                                                 
†
 Pragmatic advice from Heraclitus of Ephesus, if indeed we can trust the account of Heraclitus’ 
thoughts provided by Diogenes Laërtius. 
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7.1 Stereotactic radiotherapy 
The objective of this thesis has been to characterise the small radiation fields employed in 
stereotactic radiotherapy. Specifically, this refers to spectral, fluence and dosimetric 
properties in the primary beam and its immediate periphery (in-field) as well as far from the 
primary field (out-of-field).  
 
Stereotactic radiotherapy (SRT) is an increasingly popular treatment modality for tumours 
both intracranial and, more recently, of extracranial anatomic locations. Stereotactic 
radiotherapy procedures are also often used for benign intracranial lesions. In this thesis and 
an associated review paper submitted to Acta Oncologica, the following definition of 
stereotactic radiotherapy has been proposed: 
 
Stereotactic radiotherapy may be defined as the use of beams of ionising radiation from 
multiple directions intersecting at a target (usually intracranial), spatially defined using 
a three-dimensional coordinate system. 
 
Comparing, for instance, to an alternative advanced mode of radiotherapy such as intensity 
modulated radiotherapy (IMRT), stereotactic radiotherapy has several notable differences. 
The doses delivered per fraction in SRT (and stereotactic body radiotherapy, SBRT) are 
typically much higher, ranging from approximately 5 – 25 Gy, compared to 1.8 – 3 Gy for 
IMRT. The number of fractions is fewer, typically 1 – 5 fractions as opposed to 10 – 30. 
Furthermore, the margins in conventional radiotherapy may be of the order of centimetres, 
whilst in SRT the margins are of the order of millimetres.  
 
The point of mentioning this is to emphasise that we are concerned with large doses which 
must necessarily be delivered with high spatial accuracy. As such, the issues of dosimetry 
(whether pertaining to measurement or calculation) are of critical importance for efficacious 
treatments, and thus improved patient outcomes. 
 
There are a number of complexities associated with dosimetry for the small fields employed 
in stereotactic radiotherapy. Considering first conventional dose calculation with a treatment 
planning system (TPS), the accuracy of dose distributions calculated for stereotactic fields 
may be questionable because of issues of charged particle equilibrium in particular (especially 
where the field size employed approaches the range of secondary electrons). Furthermore, 
calculations performed by the TPS are ‘informed’ by linac-specific parameters that have been 
experimentally measured under broad-beam reference conditions. The extrapolation to small-
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fields may not always be accurate/appropriate. Additionally, the direct measurement of 
dosimetric characteristics of small fields is often difficult, and a common clinical approach 
might be to undertake multiple measurements of the same arrangement with different detector 
types and average the results. A further issue is that the treatment planning system is not 
designed to accurately determine dose to the patient far from the primary field, and such out-
of-field doses are not incorporated into routine treatment optimisation. Associated with these 
doses is an increased risk of health complications, including radiocarcinogenesis.  
 
Thus it is evident that to facilitate the thorough characterisation of stereotactic fields both in-
field and out-of-field, which is the ultimate aim of the present work, it is necessary to adopt 
more specialised methodologies for measurement and calculation, which may be less 
common clinically. 
 
 
 
7.2 The measurement and calculation of dose and other quantities 
The objective of this thesis is to characterise stereotactic radiotherapy fields and has focused 
on two approaches in particular: 
– Three-dimensional gel dosimetry for measurement, and 
– Monte Carlo radiation transport methods for calculations. 
 
Gel dosimetry is a promising dosimeter for small-field dosimetry as relevant to the 
characterisation of stereotactic radiotherapy fields. Ideally, gel dosimeters yield three-
dimensional dose information, are not subject to issues of detector volume averaging, and 
function as both the phantom and dosimeter material and thus do not perturb the radiation 
field. However, there are a number of complexities associated with gel dosimetry that 
currently limit routine clinical implementation. In this thesis, two key issues were identified: 
(i) The extent to which the radiological properties of gels matched water or soft tissue (i.e. 
water equivalence), and (ii) The absence of a standard for gel dosimeter calibration in the 
published literature. 
 
With respect to the former, the effective atomic number (Zeff) was investigated in its oft-
employed capacity as an indicator of the radiological properties of gel dosimeters. Inspection 
of the literature indicated inconsistent and dubious methods for the calculation of Zeff. A novel 
methodology for calculating the Zeff of gel dosimeters was described in this thesis, and 
energy-dependent values were determined for total and partial photon and electron 
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interactions in a range of biological media, water and fourteen Fricke and polymer gel 
dosimeter types. The key findings were: 
– The typical power-law method by which one generates a single-valued Zeff is of 
limited usefulness for the broad spectrum of energies involved in radiotherapy. 
– Conclusions drawn by comparison of Zeff values in this way are of questionable 
validity, even in the intended regime (low-energy) of applicability. 
– The smooth correlation between interaction cross section and atomic number may be 
exploited to yield an effective atomic number for a given composite medium. 
– When required, a single-valued Zeff may be obtained by weighting against the 
radiation spectrum of interest. 
– Broadly, gel dosimeters may be considered to be water-equivalent over a broad 
energy range, for both photon and electron interaction processes. 
– The BANG-1 gel is found to be most water-equivalent. 
 
Having thus established gel dosimeters as being appropriate from a radiological perspective, 
the next key issue requiring resolution prior to implementation was that of gel calibration. 
Inspection of the literature revealed a number of published techniques, none of which were 
considered a ‘standard’. Furthermore, there was little justification for the common assumption 
that the gel composition and containment vessel would not result in deviations from water 
equivalence. High resolution Monte Carlo radiation transport methods were employed to 
investigate the influence of containers and different gel compositions on the level of water 
equivalence. This yielded several key findings: 
– Under strict conditions specified in this thesis, the majority of published methods 
may be employed to calibrate gels with a tolerance of [-1%, 1%] at the 95 % 
confidence interval. 
– The most appropriate method is that of a ‘large tub’ of gel, with dose read out at Dmax 
(though away from Dmax the error increases significantly). 
– The least suitable method is the approach employing a long test tube in water to yield 
a depth-dose curve within the gel (exhibiting errors > 2 %). 
– The most appropriate gel formulations are BANG-1 and Fricke. 
 
Resolution of these two issues (described in Chapter 3), radiological properties and 
calibration, provided the confidence to employ gel dosimetry for stereotactic field 
measurements, as described later. 
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The limited accuracy of treatment planning systems for the calculation of small-field doses, 
doses in the vicinity of interfaces, and the infeasibility of calculating or measuring spectral 
qualities, prompted the development of a Monte Carlo model (described in Chapter 4). A 
model of a Varian 600C linear accelerator with mounted BrainLAB m3 mini-multileaf 
collimator was constructed using EGSnrc. This was commissioned using experimental data 
measured at the Alfred Hospital (Melbourne, Australia). The advantage of the Monte Carlo 
model is that it facilitates: 
– Confident calculation of dose distributions for small fields as relevant to stereotactic 
radiotherapy. 
– More accurate determination of doses at interfaces of heterogeneous media. 
– Determination of photon spectra, mean energy and angular distributions. 
– Determination of contaminant and secondary electron spectra, mean energy and 
angular distributions. 
 
The Monte Carlo model is thus critical for the thorough characterisation of stereotactic fields. 
In short, it facilitates: (i) Accurate determination of dose distributions resulting from 
stereotactic fields (where the treatment planning system may be of limited accuracy), and (ii) 
Determination of beam spectra both in air and in water (which is not measurable due to high 
beam fluxes). 
 
 
 
7.3 Characterisation: In-field 
Characterisation of stereotactic radiation fields is the primary objective of this thesis. The 
difficulties of measuring spectral characteristics in megavoltage photon beams are 
circumvented with use of a dosimetrically-matched Monte Carlo model. Highly systematic 
characterisation (described in Chapter 5) has been undertaken.  
Data have been generated for a large number of fields shaped with the mini-multileaf 
collimator.  
Beam characteristics in air, both in and beyond the primary field were investigated, including: 
– Photon spectra, 
– Contaminant electron spectra, 
– Spatial variation of mean photon energy, 
– Spatial variation of mean electron energy, and 
– Angular distribution of photons. 
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Spectral data in water at several depths (5, 10 and 15 cm) has also been calculated, including: 
– Photon energy fluences, 
– Electron energy fluences, and 
– Mean energy distributions. 
 
Further data has been compiled for comparison using ‘backed-up’ field, i.e. jaws set at the 
same field opening as the MMLC. Mean energy, spectral and angular distributions were 
calculated for several representative cases. 
 
Summarised here are the key findings for the in-air study: 
– Out-of-field photon fluence ~1 % of primary beam fluence. 
– Out-of-field electron fluence ~30 % of primary beam fluence. 
– Photon fluence has sharp gradient at field edge. 
– Electron (contaminant) fluence does not have a sharp gradient at field edge. 
– ‘Structure’ evident in fluence profiles just beyond the primary beam (due to interleaf 
leakage through collimator). 
– Mean energy of primary photon field lower than surrounding peripheral regions (due 
to beam hardening by collimators) for small fields; mean energy drops again in far 
out-of-field regions. 
– Photon energy fluence varies with field size, most notably at low energies (below ~1 
MeV). 
– The photon beam is more forward directed for smaller fields, as evidenced by the 
primary field angular photon distributions (in fact, for the 9.8 x 9.8 cm2 field the 
distribution peaks at approx. 3º rather than 0 º). 
– The photons outside the primary field are much less forward-directed. 
 
With regards to backed-up fields: 
– Spectral distributions of photons and electrons for backed-up field show strong 
similarity in-field. 
– For smaller fields, the mean energy distributions beyond the primary field differ 
noticeably. 
– Mean energies typically increase closer to the field edge than the non backed-up case. 
– For the backed-up case, mean energies are low in the shadow of the MMLC then 
remain higher far from the primary field. 
– Notable difference in angular distributions of photons at the patient plane, being more 
forward-directed for smaller fields but less so for larger fields, relative to the non 
backed-up case. 
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A number of observations were made regarding the spectra in water: 
– Photon spectra harden with depth in water. 
– Electron spectra soften with depth in water. 
– Mean energy of primary photon beam decreases with increasing field size (6 x 6 mm2 
beam is 30 % harder than 98 x 98 mm2 beam). 
– Out-of-field mean photon energies (at 12 cm off-axis distance) decrease with 
increasing field size (6 x 6 mm2 beam is 250 % harder than 98 x 98 mm2 beam). 
– The fraction of total photons in the low energy regime increases with field size (98 x 
98 mm2 beam has ~1000 % more photons with energies < 250 keV than 6 x 6 mm2 
beam). 
– Electron spectrum varies with field size, most notably in the low-energy regime (< 1 
MeV), such that larger fields have a larger fluence of low-energy electrons. 
 
To illustrate the relevance of varying spectra, several illustrative studies were carried out. 
These included: 
– An investigation of the effect of changing secondary electron spectra on the mean 
restricted stopping power ratios relevant to ionisation chamber measurements, 
– The energy dependence of measurements taken using radiographic film, and 
– The energy-dependent effective atomic numbers of TLD-100 thermoluminescent 
dosimeters. 
 
The effect of the investigation into spectral effects as relevant to ionisation chamber 
measurements showed that the typical assumption of unchanging spectra (field size 
independence) was typically acceptable, with deviation from the reference field case all sub-
percent. The discrepancy worsens with decreasing field size but is nonetheless acceptable. 
However, this only applies to in-field measurements. Out-of-field, spectral variations result in 
discrepancies > 1 %, being worst for larger field sizes. In the case of the response of 
radiographic film, the degree of over-response of film (relative to water) is of the order of ~1 
%. The difference between the radiological properties of TLD-100 and water are highlighted 
using the energy-dependent effective atomic number (Zeff, see Chapter 3). Of particular note is 
the fact that the peak photon fluence coincides with the maximum discrepancy in Zeff. 
 
As described in the previous section, gel dosimeters were hypothesised as being suited to the 
measurement of small-field dose distributions. This was demonstrated in a study (described in 
Chapter 5), investigating stereotactic radiotherapy for treatment of small, intracranial lesions. 
The potential for stereotactic treatment validation using normoxic polymer gel dosimetry 
(with optical-CT readout) in an anthropomorphic head phantom was assessed. A 12-field 
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stereotactic treatment plan for meningioma was recalculated onto a computed tomography 
scan of the head phantom with gel insert and was delivered using a Varian 2100 linear 
accelerator with mounted BrainLAB m3 mini-multileaf collimator: 
– Using quantitative comparison using indices such as percentage pixel agreement and 
gamma analysis, it is demonstrated that 3D gel dosimetry may be readily employed 
for assessment of PTV coverage. 
– Agreement with treatment planning system (pencil beam algorithm) calculations was 
demonstrated for high dose regions (above the 90 % isodose, γ evaluation indicated 
96 % agreement for criteria of 2%/2mm). 
– Gamma analysis showed that above the 80 % isodose line, 94 % of the gamma values 
were less than unity (for criteria of 5%/5mm). 
– Poorer agreement was observed at low isodoses, most likely because in these regions: 
(i) the gel is receives only low doses and may exhibit nonlinearity, (ii) the effects of 
slight misregistration of the plan and gel dose distributions may be more pronounced, 
(iii) optical scatter and (iv) the treatment planning system may not accurately 
calculate dose adjacent to the container 
 
An additional study was undertaken in the context of stereotactic body radiotherapy. Lung 
tumours present challenges in terms of treatment planning dose calculations, because of the 
juxtaposition of high and low density media. This may affect the minimum dose received by 
lesions and is particularly important when prescribing dose to covering isodoses. This work 
(see Chapter 5) quantified under-dosage in key regions around a hypothetical target using 
Monte Carlo dose calculation methods, and developed a factor for clinical estimation of such 
under-dosage. A systematic set of calculations were undertaken using two Monte Carlo 
radiation transport codes (EGSnrc and GEANT4): 
– Discrepancies in dose were determined for a number of parameters, including beam 
energy, tumour size, field size and distance from chest wall. 
– Calculations were performed for 1 mm3 regions at proximal, distal and lateral aspects 
of a spherical tumour, determined for a 6 MV and a 15 MV photon beam. 
– The simulations indicate regions of tumour under-dose at the tumour-lung interface.  
– Comparison with TPS data (pencil beam convolution) indicates such under-dosage 
would not have been predicted accurately in the clinic. 
– A Dose Reduction Factor (DRF) as the average of the dose in the periphery in the six 
cardinal directions divided by the central dose in the target, the mean of which is 0.97 
and 0.95 for a 6 MV and 15 MV beam respectively. 
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– The DRF can assist clinicians in the estimation of the magnitude of potential 
discrepancies between prescribed and delivered dose distributions as a function of 
tumour size and location. 
– Calculation for a systematic set of ‘generic’ tumours allows application to many 
classes of patient case, and is particularly useful for interpreting clinical trial data. 
 
 
 
7.4 Characterisation: Out-of-field 
As shown by the detailed literature review provided in Chapter 6, there is an increasing 
interest in out-of-field doses from radiotherapy procedures. This is because the higher cure 
rates, longer patient survival and better follow-up raise the awareness of associated latent 
risks such as cardiac or respiratory complications, or radiation-induced cancer. 
 
However, thus far the consideration of out-of-field dose from (in particular, linac-based) 
stereotactic radiotherapy has been limited. In this thesis, the current literature pertaining to 
out-of-field doses from radiotherapy and theory of radiocarcinogenesis has been reviewed. 
Out-of-field doses have been characterised in a highly systematic fashion for linac-based 
stereotactic radiotherapy. These results show: 
– The systematic variation of out-of-field dose with field size, source-surface distance, 
depth in phantom and collimator orientation. 
– Higher doses are associated with increasing field sizes and shallow phantom depths. 
– Variation with source-surface distance is not considerable. 
– If the patient lies along the x-plane then out-of-field doses may be reduced by up to 
an order of magnitude. 
– For a stereotactic treatment of tens of Gy, the out-of-field dose is of the order of cGy. 
 
In addition to this, out-of-field doses in the context of small-field radiotherapy of paediatric 
patients has also been investigated, since children are more susceptible to and have greater 
lifetimes in which radiation-induced cancer may become manifest. Key clinical 
recommendations that may be made based on the results presented here include: 
– Out-of-field dose reduction of approximately 40 % may be achieved by using a 
single-mode (vertical waveguide) linac as opposed to a multi-mode. 
– Appropriate choice of collimator rotation can reduce out-of-field dose by 40 %. 
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– Appropriate choice of treatment technique can reduce out-of-field dose by an order of 
magnitude (step-and-shoot, without field along craniocaudal axis, results in less out-
of-field dose than arc delivery). 
– Simple shielding can reduce out-of-field dose by 50 %. 
– Field size has a reduced influence far from the primary field (i.e. out-of-field doses 
from stereotactic fields deliver similar doses to larger-field treatments at large 
distances from isocentre). 
 
The results provided in this thesis show uncomplicated means of reducing out-of-field doses 
and corresponding risks to both adult and, or particular importance, paediatric patients. This 
outcome is one of the results with direct clinical utility, as described in the following section 
on Impact. 
 
 
 
7.5 Clinical significance 
There are a number of results presented in this thesis that extend beyond issues of purely 
academic interest, and have direct clinical impact. 
 
These are summarised here: 
(i) Effective atomic number of gels. Although it was initially not anticipated to be a 
groundbreaking study, the investigation of the effective atomic number of gel 
dosimeters has stirred significant interest in the scientific community. This is 
evidenced not solely by citations, but by the large number of personal 
communications from researchers internationally inquiring about the work. 
(ii) Calibration of gel dosimeters. Until this publication, there has been no strong 
justification for one calibration method over another beyond issues of convenience. 
This thesis describes the most appropriate and accurate means of calibration, 
facilitating improved absolute dosimetry. 
(iii) Spectral qualities of stereotactic fields and clinical consequences. Until now, there 
has been no systematic investigation of stereotactic field spectra from the BrainLAB 
mini-multileaf collimator. Such spectral information has clinical consequences, most 
notably in the use of dosimeters which exhibit energy dependence. In particular, the 
investigation of systematic errors in ionisation chamber calibration resulting from 
the assumption of unchanging secondary electron spectra described in this thesis has 
– to the best of the author’s knowledge – not been published elsewhere. 
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(iv) Lung tumour under-dosage lookup table. Clinicians have already shown interest in 
obtaining the tabulated estimates of lung tumour under-dosage presented in this 
thesis, to inform judgements regarding prescribed doses and retrospective analysis. 
(v) Methodologies for reducing the risk of radiation-induced cancer. The 
straightforward approaches detailed in this thesis allow significant reduction of out-
of-field doses and corresponding risks of radiocarcinogenesis (and other 
complications). Based on the results in this thesis, the Paediatric Unit of the Peter 
MacCallum Cancer Centre (Melbourne, Australia) is planning changes to treatment 
protocols. The impact of this study is also reflected by recent media interest. 
 
 
 
7.6 Outlook 
This thesis has been successful in characterising the radiation fields used in stereotactic 
radiotherapy, both in- and out-of-field. Spectral characteristics for small fields may be used to 
inform interpretation of measured data, the potential of radiosensitive gels for stereotactic 
dosimetry of small and complex dose distributions has been demonstrated, and clinical 
recommendations have been made to exploit the spatial anisotropy of out-of-field doses and 
minimise risks of cancer induction.  
 
In this thesis, the focus has related to spectral and dosimetric characterisation. However, 
stereotactic radiotherapy is a field that has grown dramatically over the last couple of years 
and many different radiation tools are available. In such a multifaceted field, there are many 
challenges that may be addressed in order to generate an improved treatment and the present 
thesis must therefore have limitations that should be noted. 
 
For instance, there remain a number of challenges associated with gel dosimetry that restrict 
routine clinical implementation. This includes the requirement for a chemical handling and 
gel preparation laboratory, equipped with acid safe, chemical disposal facilities, fume 
cupboard, and so on. It may be difficult for some centres to maintain such a facility. Other 
issues include the fact that each batch requires individual calibration, the dosimeters are 
single-use and MRI readout may not always be readily available, necessitating optical readout 
(which for polymer gels may be nontrivial depending on the scanner and scatter corrections 
employed). The recommended method for dose calculation is Monte Carlo radiation 
transport. The only real limitation is that the computationally-demanding nature of the Monte 
Carlo approach requires supercomputer access for efficient calculations. Although, as has 
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been reviewed in this thesis, there are several commercially available treatment planning 
system implementations of Monte Carlo codes – these are yet to undergo rigorous comparison 
with full Monte Carlo codes. As a further note, anecdotal evidence from using, for example, 
the iPlan Monte Carlo algorithm on a standard desktop computer (as used in the clinic) 
suggests that to achieve the recommended accuracy of 1 %, a given patient plan requires days 
to finish computation. 
 
More than this, there are various difficulties associated with stereotactic radiotherapy that are 
beyond the scope of this thesis; in particular, the handling of tumour motion. All tumours 
move to some extent, but tumours in the thoracic cavity, for instance, may undergo significant 
intrafraction motion. If not accounted for, this would have serious consequences for tumour 
coverage and normal tissue complications. A cursory inspection of recent issues of medical 
physics journals indicates that this is a dominant challenge facing physicists and clinicians in 
contemporary stereotactic body radiotherapy. There are a number of studies investigating the 
efficacy of real-time image guidance, respiratory gating and so on, being undertaken both 
internationally and locally at RMIT University by the Medical Physics Research Group. 
 
However, it is hoped that the work presented in this thesis and the associated publications will 
contribute to more accurate dosimetry in small radiation fields. While primarily concerned 
with stereotactic radiotherapy fields, the findings of this thesis are also applicable to other 
areas in radiotherapy where small fields and field segments are used. Intensity modulated 
radiotherapy is such an example. Most importantly, however, it is hoped that the outcomes of 
this thesis will help to make the treatment of patients more accurate and reproducible. By 
considering both theory and measurement, it is also hoped that building blocks for future 
work that further enhances treatment approaches have been created. 
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